<SEC-DOCUMENT>0001193125-22-150129.txt : 20220513
<SEC-HEADER>0001193125-22-150129.hdr.sgml : 20220513
<ACCEPTANCE-DATETIME>20220513162025
ACCESSION NUMBER:		0001193125-22-150129
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20220511
FILED AS OF DATE:		20220513
DATE AS OF CHANGE:		20220513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONIM TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001178697
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		IRS NUMBER:				943336783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38907
		FILM NUMBER:		22923033

	BUSINESS ADDRESS:	
		STREET 1:		6500 RIVER PLACE BLVD.
		STREET 2:		BUILDING 7, SUITE 250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78730
		BUSINESS PHONE:		650-378-8100

	MAIL ADDRESS:	
		STREET 1:		6500 RIVER PLACE BLVD.
		STREET 2:		BUILDING 7, SUITE 250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78730
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d259893dpre14a.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Preliminary Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Filed by the
Registrant&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Soliciting Material Under <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Sonim Technologies, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s)
Filing Proxy Statement, if other than the Registrant) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payment of Filing Fee (Check all boxes that apply): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Fee paid previously with preliminary materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <FONT
STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6500 River Place Blvd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Building 7, Suite 250 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Austin, TX 78730 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE
OF A SPECIAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Stockholder, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You are
cordially invited to attend a special meeting of stockholders of Sonim Technologies, Inc., a Delaware corporation (the &#147;Company&#148;). The meeting will be held on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at 9:00 a.m. local time at 1875 South Grant Street, Suite 770, San Mateo, California 94402, and any adjournments of the special meeting (which we
refer to as the &#147;special meeting&#148;). This proxy statement and the enclosed proxy card are furnished in connection with the solicitation of proxies by the Board of Directors (which we refer to as the &#147;board of directors&#148; or
&#147;board&#148;) of the Company for use at the special meeting of the Company&#146;s stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the special meeting, you will be
asked to consider and vote upon the following proposals: (i)&nbsp;to approve the transactions contemplated by the Subscription Agreement, dated April&nbsp;13, 2022 (which we refer to as the &#147;Subscription Agreement&#148;) by and between the
Company and AJP Holding Company, LLC, a Delaware limited liability company (the &#147;Purchaser&#148; or &#147;AJP Holding&#148;), pursuant to which Purchaser has agreed to purchase from the Company an aggregate of 20,833,333 shares of the
Company&#146;s common stock (which we refer to as the &#147;Purchased Shares&#148;) for an purchase price of $17,500,000 (which we refer to as the &#147;Aggregate Consideration&#148;) in two (2)&nbsp;tranches: (a) 14,880,952 shares of the
Company&#146;s common stock (which we refer to as the &#147;initial shares&#148;) will be issued in consideration for a purchase price of $12,500,000 (which we refer to as the &#147;first purchase price&#148;) (which we refer to as the &#147;first
closing&#148;) and (b)&nbsp;subject to the occurrence of the first closing, on August&nbsp;1, 2022 (except that if the first closing has not occurred by August&nbsp;1, 2022, the second closing will take place no later than the fifth business day
following the date of the first closing) or such other date as agreed by the Company and the Purchaser, 5,952,381 shares of the Company&#146;s common stock (which we refer to as the &#147;remaining shares&#148;) will be issued in consideration for a
purchase price of $5,000,000 (which we refer to as the &#147;second purchase price) (which we refer to as the &#147;second closing&#148;) (collectively, which we refer to as the &#147;Transaction Proposal&#148;) and such transactions requires
stockholder approval under Nasdaq Listing Rule 5635(b), (ii) to approve an amendment to the Company&#146;s Certificate of Incorporation, as amended, to effect a reverse stock split of the Company&#146;s common stock pursuant to which any whole
number of outstanding shares between and including two (2)&nbsp;and fifteen (15)&nbsp;shares would be combined, converted and changed into one (1)&nbsp;share of common stock, with the final exchange ratio to be determined by our board of directors
in its discretion (the &#147;Reverse Stock Split Proposal&#148;), (iii)&nbsp;to approve an amendment to the Company&#146;s Certificate of Incorporation, as amended, to include a restriction on certain transactions with the Purchaser or its
affiliates (the &#147;Charter Restriction Proposal&#148;) and (iv)&nbsp;a proposal to adjourn the special meeting to a later date or time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the special
meeting to approve the Transaction Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>After careful consideration, our board of directors has unanimously determined that the
Subscription Agreement and the transactions contemplated thereby are fair to and in the best interests of the Company&#146;s stockholders and adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby.
Accordingly, the board of directors of the Company unanimously recommends that our stockholders vote &#147;FOR&#148; the approval of the Transaction Proposal; &#147;FOR&#148; the Reverse Stock Split Proposal; &#147;FOR&#148; the Charter Restriction
Proposal; and &#147;FOR&#148; the adjournment of the special meeting to a later date or time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the special meeting to approve the Transaction Proposal.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The accompanying proxy statement provides detailed information about the special meeting, the Subscription Agreement, the Reverse
Stock Split Proposal and the Charter Restriction Proposal. A copy of the Subscription Agreement is attached as <B>Annex A</B> to the proxy statement. A copy of the proposed amendments to the Company&#146;s Certificate of Incorporation are attached
hereto as <B>Annex C</B> to the proxy statement. The proxy statement also describes the actions and determinations of the board of directors in connection with its evaluation of the Subscription Agreement and the transactions contemplated thereby.
We encourage you to read the proxy </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
statement and its annexes, including the Subscription Agreement, carefully and in their entirety. The accompanying proxy statement is dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, and is first being mailed to stockholders on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Whether or not you plan to attend
the special meeting in person, please complete, sign, date and return, as promptly as possible, the enclosed proxy card in the accompanying prepaid envelope or grant your proxy electronically over the Internet or by telephone. If you hold your
shares in street name, you should instruct your broker, bank or other nominee how to vote in accordance with the voting instruction form you will receive from your broker, bank or other nominee. Your broker, bank or other nominee cannot vote on
certain of the proposals at the special meeting, including the Transaction Proposal, without your instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Your vote is very
important. The transactions contemplated by the Subscription Agreement cannot be completed unless the Transaction Proposal is approved by the affirmative vote of the holders of a majority of the votes cast by the stockholders present in person or by
proxy at the special meeting and entitled to vote thereon, provided a quorum is present. Therefore, please submit your proxy or voting instruction form as soon as possible to ensure your shares are represented and voted at the special meeting. The
Reverse Stock Split Proposal is not contingent upon the approval of the Transaction Proposal and the reverse stock split thereunder may be effected in the event the Transaction Proposal is not approved. The Charter Restriction Proposal is not
contingent upon the approval of the Transaction Proposal and the charter amendment thereunder may be effected in the event the Transaction Proposal is not approved. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These items of business are more fully described in the Proxy Statement accompanying this Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The record date for the special meeting is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2022. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#146; Meeting to Be Held on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at 9:00 a.m. at 1875 South Grant Street, Suite 770, San Mateo, California 94402. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Proxy Statement and annual report to stockholders are available at www.sonimtech.com under Investor Relations.
</P></div> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you have any questions or need assistance voting your shares, please contact our proxy solicitor: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kingsdale Advisors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">745 Fifth
Avenue, 5<SUP STYLE="font-size:85%; vertical-align:top">th Floor </SUP></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10151 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">North American Toll Free Phone:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-518-6812</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Call
Collect Outside North America: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-867-2272</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email:
contactus@kingsdaleadvisors.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">By Order of the Board of Directors </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g259893g20s20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Robert Tirva </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Austin, Texas </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>You are cordially invited to attend the meeting in person. Whether or not you expect to
attend the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the Internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. A return
envelope (which is postage prepaid if mailed in the United States) has been provided for your convenience. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of
record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </B></P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6500 River Place Blvd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Building 7, Suite 250 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Austin, TX 78730 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE SPECIAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETING AGENDA </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Proposals</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Voting Standard</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Board<BR>Recommendation</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Approve the Subscription Agreement and the transactions contemplated thereby</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affirmative vote of the holders of a majority of the votes cast by the stockholders present in
person or by proxy at the special meeting and entitled to vote thereon, provided a quorum is present</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">For</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adopt the Amendment to the Company&#146;s Certificate of Incorporation, as amended, to effect a
reverse stock split of the Company&#146;s common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Majority of outstanding shares entitled to vote on the matter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">For</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adopt the Amendment to the Company&#146;s Certificate of Incorporation, as amended, to include a
restriction on certain transactions with the Purchaser or its affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Majority of outstanding shares entitled to vote on the matter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">For</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vote on Adjournment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Majority of shares present in person or represented by proxy and entitled to vote on the matter,
irrespective of whether the quorum is present</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">For</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_1">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_2">Parties to the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_3">The Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_4">The Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_5">Financing of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_6">Interests of Certain Persons in the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_7">Material U.S. Federal Income Tax Consequences of the
Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_8">Regulatory Approvals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_9">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE
TRANSACTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_10">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_11">PARTIES TO THE TRANSACTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_12">THE SPECIAL MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_13">Date, Time and Place of the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_14">Purpose of the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_15">Deadline for Voting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_16">Revocation of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_17">Voting by the Company&#146;s Directors and Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_18">Solicitation of Proxies; Payment of Solicitation Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_19">Householding</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_20">Adjournments and Postponements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_21">Anticipated Date of Completion of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_22">Questions and Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_23">PROPOSAL 1: APPROVAL OF THE ISSUANCE OF COMMON STOCK CONTEMPLATED BY THE SUBSCRIPTION
 AGREEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_24">THE TRANSACTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_25">Transaction Consideration</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_26">Description of the Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_27">Background of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_28">Reasons for the Transaction; Recommendation of the Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_29">Certain Company Forecasts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_30">Opinion of B. Riley Securities, Inc.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_31">Financing of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_32">Closing of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_33">Interests of Certain Persons in the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_34">Indemnification and Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_35">THE SUBSCRIPTION AGREEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_36">Explanatory Note Regarding the Subscription Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_37">Directors and Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_38">Closing of the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_39">Representations and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_40">Conduct of Our Business Pending the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_41">No Solicitation of Acquisition Proposals; Board Recommendation
Changes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_42">Stockholders Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_43">Filings; Other Actions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_44">Employment and Severance Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_45">Golden Parachute Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_46">Other Covenants and Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_47">Conditions to the Transaction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_48">Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_49">Termination Fee&nbsp;&amp; Reimbursement Obligation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_50">Directors&#146; and Officers&#146; Indemnification and
Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_51">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_52">Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_53">Specific Performance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_54">Amendments</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_55">Governing Law</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_56">No Appraisal Rights </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_57">Required Vote </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_59">PROPOSAL 2: AMENDMENT TO THE COMPANY&#146;S CERTIFICATE OF INCORPORATION, AS AMENDED
 TO EFFECT A REVERSE STOCK SPLIT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_60">Background</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_61">Reasons for the Reverse Stock Split</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_62">Board Discretion to Implement the Reverse Stock Split</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_63">Discretionary Authority of the Board to Abandon Reverse Stock
Split</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_64">Criteria to be Used for Decision to Effect a Reverse Stock
Split</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_65">Effects of the Reverse Stock Split</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_66">Certain Risks and Potential Disadvantages Associated with the Reverse Stock Split
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_67">Effective Time</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_68">Cash Payment In Lieu of Fractional Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_69">Exchange of Stock Certificates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_70">No Appraisal Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_71">Certain Material Federal Income Tax Consequences of the Reverse Stock Split to
U.S. Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_72">Required Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_74">PROPOSAL 3: AMENDMENT TO THE COMPANY&#146;S CERTIFICATE OF INCORPORATION, AS AMENDED
 TO INCLUDE A MAJORITY OF THE MINORITY VOTE FOR TAKE PRIVATE TRANSACTIONS BY AJP HOLDING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_75">Background</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_76">Purpose and Effect of Amendment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_77">Required Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_79">PROPOSAL 4: VOTE ON ADJOURNMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_80">Required Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_82">MARKET PRICE OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_83">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_84">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_85">OTHER INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_87">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_88">Subscription Agreement, dated April&nbsp;
13, 2022, by and among Sonim Technologies, Inc. and AJP Holding Company, LLC</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_89">Opinion of B. Riley Securities, Inc., dated as of April&nbsp;13,
2022</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx259893_90">Certificates of Amendment to Certificate of Incorporation of the
Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1&nbsp;&amp;&nbsp;C-3</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_1"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>This summary, together with the following section entitled &#147;Questions and Answers About The Special
Meeting and The Transaction,&#148; highlights selected information in this proxy statement and does not contain all of the information that may be important to you. Accordingly, we encourage you to read carefully this entire proxy statement, its
annexes, and the documents referred to or incorporated by reference in this proxy statement for a more complete understanding of the matters being considered at the special meeting. Each item in this summary includes a page reference directing you
to a more complete description of that topic. This proxy statement is dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, and is first being mailed to our stockholders of record on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>In this proxy statement, the terms &#147;Sonim,&#148; the &#147;Company,&#148; &#147;we,&#148;
&#147;us&#148; and &#147;our&#148; refer to Sonim Technologies, Inc. and, where appropriate, its subsidiaries. We refer to AJP Holding Company, LLC as &#147;Purchaser&#148; or &#147;AJP Holding.&#148; All references to the &#147;transaction&#148;
refer to the investment by AJP Holding in the Company in exchange for shares of common stock of the Company and all references to the &#147;Subscription Agreement&#148; refer to the Subscription Agreement, dated April&nbsp;13, 2022, as it may be
amended from time to time, by and between the Company and AJP Holding, a copy of which is included as </I><B><I>Annex A</I></B><I> to this proxy statement. &#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx259893_2"></A>Parties to the Transaction (Page 18) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Sonim Technologies, Inc.</B>, a Delaware corporation, is a leading U.S. provider of ultra-rugged mobile
phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Company currently sells its ruggedized mobile phones and accessories to three of the four largest
wireless carriers in the United States&#151;AT&amp;T, Sprint and Verizon&#151;as well as the three largest wireless carriers in Canada&#151;Bell, Rogers and Telus Mobility. The Company&#146;s phones and accessories connect workers with voice, data
and workflow applications in two end markets: industrial enterprise and public sector. The Company&#146;s principal executive offices are located at 6500 River Place Boulevard, Bldg. 7, Suite 250, Austin, TX, 78730. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s common stock (which we refer to as our &#147;common stock&#148;) is listed on the Nasdaq
Stock Market LLC (which we refer to as &#147;Nasdaq&#148;), under the symbol &#147;SONM.&#148; Additional information about the Company can be found at <I>www.sonimtech.com</I>. The information provided on or accessible through the Company&#146;s
website is not a part of or incorporated by reference in this proxy statement or any other report or document we file with or furnish to the Securities and Exchange Commission (which we refer to as the &#147;SEC&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>AJP Holding Company, LLC</B>, a Delaware limited liability company, is a newly-created holding company
formed specifically for the contemplated transaction solely for the purpose of ownership of the shares of common stock of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx259893_3"></A>The Special Meeting (Page 19) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>Date, Time and Place of the Special Meeting (Page 19) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This proxy statement is being furnished to our stockholders of record as part of the solicitation of proxies
by the Board for use at the special meeting to be held on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at 9:00 am, local time, at 1875 South Grant Street, Suite 770, San Mateo, California 94402, or at any adjournment or postponement thereof. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>The Purpose of the Special Meeting (Page 19) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the special meeting, holders of our common stock will be asked to vote on the (i)&nbsp;proposal to approve
the Subscription Agreement and issue the shares to the Purchaser, which will result in the Purchaser owning approximately 52% of the Company (which we refer to as the &#147;Transaction Proposal&#148;) and thus the transaction is subject to
stockholder approval pursuant to Nasdaq Listing Rule 5635(b), (ii) the proposal to approve an amendment to the Company&#146;s Certificate of Incorporation, as amended, to effect a reverse stock split of the Company&#146;s common stock (which we
refer to as the &#147;Reverse Stock Split Proposal&#148;), (iii) the proposal to approve an amendment to the Company&#146;s Certificate of Incorporation, as amended, to include a restriction on certain transactions with the Purchaser or its
affiliates (which we refer to as the &#147;Charter Restriction Proposal&#148;) and (iv)&nbsp;the proposal to approve a proposal to adjourn the special meeting to a later date or time, if necessary, to solicit additional proxies if there are not
sufficient votes at the time of the special meeting to approve the Transaction Proposal (which we refer to as the &#147;Adjournment Proposal&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has unanimously determined that the Subscription Agreement and the transactions contemplated
thereby are fair to and in the best interests of the Company&#146;s stockholders, adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby and recommends that our stockholders vote <B>&#147;FOR&#148; the
approval of the Transaction Proposal; &#147;FOR&#148; the Reverse Stock Split Proposal; &#147;FOR&#148; the Charter Restriction Proposal; and &#147;FOR&#148; the adjournment of the special meeting to a later date or time, if necessary, to solicit
additional proxies if there are not sufficient votes at the time of the special meeting to approve the Transaction Proposal.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>Record Date, Notice and Quorum </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You are entitled to receive notice of, and to vote at, the special meeting if you held shares of our common
stock at the close of business on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, which the Board has set as the record date for the special meeting. As of the close of business on the record
date, there were &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock outstanding. The presence at the special meeting, in person or represented by proxy, of the holders of <FONT
STYLE="white-space:nowrap">one-third</FONT> of our common stock issued and outstanding and entitled to vote at the special meeting constitutes a quorum for the transaction of business at the special meeting. If a quorum is not present at the special
meeting, we expect that the special meeting will be adjourned to solicit additional proxies as permitted by our Amended and Restated Bylaws (which we refer to as our &#147;bylaws&#148;). Abstentions will count as present and entitled to vote for
purposes of determining the existence of a quorum. If you hold your shares of common stock in street name and fail to instruct your broker, bank or other nominee how to vote your shares at the special meeting, your shares will be counted for
purposes of determining the existence of a quorum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>Vote Required </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each holder of our common stock is entitled to one vote for each share of our common stock
held on the record date. </P></div> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of the Transaction Proposal requires the affirmative vote of the holders of a majority of the
votes cast by the stockholders present in person or represented by proxy at the special meeting and entitled to vote thereon. If you do not provide voting instructions with respect to your shares of common stock, your shares will not be voted on any
<FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposals. This vote is called a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> The Transaction Proposal is a
<FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposal. Abstentions or a broker non-vote will have no impact on the outcome of the vote on the Transaction Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of the Reverse Stock Split Proposal requires the affirmative vote of the holders of a majority of the outstanding shares of our
common stock entitled to vote thereon. Abstentions will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Reverse Stock Split Proposal. If you hold your shares in &#147;street name&#148; (that is, your shares are held in an account at
and registered in the name of a brokerage firm, bank, broker-dealer or similar organization), your broker or other organization may vote your shares under limited circumstances if you do not provide voting instructions before the special meeting.
These circumstances include voting your shares on <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;routine matters.&#148; The Reverse Stock Split Proposal is a &#147;routine&#148; matter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of the Charter Restriction Proposal requires the affirmative vote of the holders of
a majority of the outstanding shares of our common stock entitled to vote thereon. If you do not provide voting instructions with respect to your shares of common stock, your shares will not be voted on any
<FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposals. This vote is called a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> The Transaction Proposal is a
<FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposal. Abstentions and broker non-votes will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Charter Restriction Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of the Adjournment Proposal requires the affirmative vote of the holders of a majority of the shares of our common stock present in
person or represented by proxy and entitled to vote on the matter, irrespective of whether a quorum is present. Abstentions will have no impact on the outcome of the vote on the Adjournment Proposal. If you hold your shares in &#147;street
name&#148; (that is, your shares are held in an account at and registered in the name of a brokerage firm, bank, broker-dealer or similar organization), your broker or other organization may vote your shares under limited circumstances if you do not
provide voting instructions before the special meeting. These circumstances include voting your shares on <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;routine matters.&#148; The Adjournment Proposal is a &#147;routine&#148; matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of the record date, the directors and executive officers of the Company beneficially owned and were entitled to vote, in the aggregate,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%) shares of our common stock (not including any shares
of our common stock deliverable upon exercise or conversion of or underlying any options or the Company restricted stock unit awards). The directors have informed the Company that they currently intend to vote all such shares of our common stock
<B>&#147;FOR&#148; the approval of the Transaction Proposal; &#147;FOR&#148; the Reverse Stock Split Proposal; &#147;FOR&#148; the Charter Restriction Proposal; and &#147;FOR&#148; the adjournment of the special meeting to a later date or time, if
necessary, to solicit additional proxies if there are not sufficient votes at the time of the special meeting to approve the Transaction Proposal.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>How to Vote Your Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a stockholder of record, you may cause your shares to be voted by using one of the following methods: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in person at the special meeting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">via the Internet, at the Internet address provided on the proxy card; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by telephone, by using the toll-free number listed on the proxy card; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by mail, by completing, signing and dating the enclosed proxy card and returning it in the accompanying
prepaid envelope. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you hold your shares in street name, you will receive instructions from the broker, bank or other
nominee that holds your shares as to how to vote your shares at the special meeting. If you hold your shares in street name, you may not vote your shares in person at the special meeting unless you obtain a &#147;legal proxy&#148; from the broker,
bank or other nominee that holds your shares, giving you the right to vote the shares at the special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a stockholder of
record, you may change or revoke a previously submitted proxy at any time before it is exercised by one of the following methods: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering a later dated proxy card or by submitting another proxy by telephone or the Internet (your latest
telephone or Internet voting instructions will be followed); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the Secretary of the Company a written notice of revocation prior to the voting of the proxy at
the special meeting; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by voting in person at the special meeting. Attendance at the special meeting will not, by itself, revoke your
proxy. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_4"></A>The Transaction (Page 22) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement provides that, subject to the satisfaction or waiver of the conditions set forth therein, AJP Holding will acquire
the Purchased Shares. Holders of common stock of the Company will not receive any proceeds in the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed
on Nasdaq, and, as such, we are subject to the Nasdaq Listing Rules, including Nasdaq Listing Rule 5635. In order to comply with the Nasdaq Listing Rules and to satisfy conditions under the Subscription Agreement, we are seeking stockholder approval
of this Proposal No.&nbsp;1. Nasdaq Listing Rule 5635(b) requires stockholder approval for issuance of securities that will result in a &#147;change of control&#148; of the issuer. Nasdaq may deem a change of control to occur when, as a result of an
issuance, an investor or a group would own, or have the right to acquire, 20% or more of the outstanding shares of common stock or voting power and such ownership or voting power of an issuer would be the largest ownership position of the issuer.
The Board is not seeking the approval of our stockholders to authorize our entry into the Subscription Agreement. The Subscription Agreement has already been executed and delivered. We seek your approval of this proposal in order to satisfy the
requirements of Nasdaq Listing Rule 5635 with respect to the issuance of the common stock to the Purchaser in a &#147;change of control&#148; transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Transaction Consideration (Page 22) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the transaction, AJP Holding will acquire each share of our common stock for $0.84 for an aggregate purchase price of $17,500,000 (which we
refer to as the &#147;Aggregate Consideration&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Reasons for the Transaction; Recommendation of the Board (Page 38)
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After careful consideration of various factors as described in the section entitled &#147;The Transaction&#151;Reasons for the
Transaction; Recommendation of the Board&#148; beginning on page 38, the Board unanimously determined that the Subscription Agreement and the transactions contemplated thereby are fair to and in the best interests of the Company&#146;s stockholders,
and adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby. The Board unanimously resolved, subject to certain provisions of the Subscription Agreement, to recommend that the Company&#146;s stockholders
adopt the Subscription Agreement (which we refer to as the &#147;Board recommendation&#148;), all upon the terms and subject to the conditions set forth therein. The Board consulted with the Company&#146;s outside financial and legal advisors and
senior management and considered a number of factors that the Board believes support its decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In considering the recommendation of
the Board with respect to the Transaction Proposal, you should be aware that our directors and executive officers may have interests in the transaction that may be different from, or in addition to, yours. The Board was aware of and considered these
interests, among other matters, in evaluating and negotiating the transaction agreement, and in recommending that the transaction agreement be adopted by the stockholders of the Company. See &#147;The Transaction&#151;Interests of Certain Persons in
the Transaction&#148; beginning on page&nbsp;51. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board has unanimously determined that the Subscription Agreement and the
transactions contemplated thereby are fair to and in the best interests of the Company&#146;s stockholders, adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby and recommends that you vote
&#147;FOR&#148; approval of the Transaction Proposal. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Opinion of B. Riley Securities, Inc. (Page 45) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company engaged B. Riley Securities, Inc. (which we refer to as &#147;B. Riley&#148;) to provide financial advice in connection with the
proposed transaction based on B. Riley&#146;s qualifications, expertise, reputation and knowledge of the Company&#146;s business and the industry in which the Company operates. At the meeting of the Board on
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
April&nbsp;13, 2022, B. Riley delivered to the Board its oral opinion, subsequently confirmed in writing, to the effect that, as of April&nbsp;13, 2022 and based upon and subject to the various
assumptions, qualifications, limitations and other matters set forth therein, the transaction consideration to be received by the holders of shares of common stock pursuant to, and in accordance with, the terms of the Subscription Agreement was
fair, from a financial point of view, to such holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The full text of the opinion of B. Riley, dated as of April&nbsp;13, 2022, is
attached to this proxy statement as Annex B and is incorporated into this proxy statement by reference. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and limitations and qualifications of
the review undertaken by B. Riley in rendering its opinion. You should read the opinion carefully in its entirety. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley&#146;s
opinion was provided to the Board and addressed only, as of the date of the opinion, the fairness, from a financial point of view, of the transaction consideration to be received by the holders of shares of common stock pursuant to, and in
accordance with, the terms of the Subscription Agreement to such holders. It does not address any other aspect of the transaction. It does not constitute a recommendation to any Company stockholder as to how to vote with respect to the transaction
or any other matter and does not in any manner address the prices at which the shares of common stock will trade at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_5">
</A>Financing of the Transaction (Page 50) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">AJP Holding expects to fund amounts needed to acquire the Company under the Subscription
Agreement through cash on hand at the closings. The Company and AJP Holding&#146;s obligations under the Subscription Agreement are not subject to, or conditioned on, the receipt or availability of any funds or financing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_6"></A>Interests of Certain Persons in the Transaction (Page 51) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In considering the recommendation of the Board that you vote to approve the Transaction Proposal, you should be aware that the Company&#146;s
directors and executive officers may have interests in the transaction that may be different from, in conflict with or in addition to, those of the Company stockholders generally. Members of the Board were aware of and considered these interests, at
the time, among other matters, in evaluating and negotiating the Subscription Agreement and the transaction, approving the Subscription Agreement and in recommending to the Company stockholders that the Subscription Agreement be adopted. For more
information, see the section entitled &#147;The Transaction&#151;Interests of Certain Persons in the Transaction&#148; beginning on page&nbsp;51. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.00pt;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For more information, see the sections entitled &#147;The Transaction&#151;Background of the
Transaction&#148; beginning on page&nbsp;22 and &#147;The Transaction&#151;Reasons for the Transaction; Recommendation of the Board&#148; beginning on page 38. </P></div>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_7"></A>Material U.S. Federal Income Tax Consequences of the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following discussion is a summary of U.S. federal income tax considerations relating to the issuance of Company common stock pursuant to
the transaction. This summary is based on the U.S. Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), Treasury Regulations promulgated thereunder, administrative pronouncements and judicial decisions, all in effect as of the date of
this Proxy Statement and all subject to change, possibly with retroactive effect. This summary does not address consequences of the transaction under state, local and foreign tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For U.S. federal income tax purposes, the issuance of Company common stock will not result in taxable income or gain for the Company, for its
subsidiaries or for stockholders that own common stock of the Company prior to the transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result of the issuance of Company common stock, the Company and its U.S. subsidiaries
(collectively, the &#147;U.S. Subsidiaries&#148;) will undergo an &#147;ownership change&#148; within the meaning of Sections 382 and 383 of the Code. In general terms, an &#147;ownership change&#148; with respect to a corporation occurs if the
stock ownership in the corporation of one or more five-percent or greater shareholders increases by more than fifty (50)&nbsp;percentage points over a period of three (3)&nbsp;years or less. Sections 382 and 383 of the Code impose limitations on a
corporation&#146;s ability to utilize its net operating loss carryforwards (&#147;U.S. NOLs&#148;), capital loss carryovers and tax credits if the corporation (a &#147;Loss Corporation&#148;) experiences an &#147;ownership change.&#148; Generally
the amount of otherwise available <FONT STYLE="white-space:nowrap">pre-ownership-change</FONT> NOLs and other affected tax attributes of a Loss Corporation that can be used by the Loss Corporation in any single post-ownership-change tax year is
limited to the fair market value of the Loss Corporation at the time of the ownership change, multiplied by the applicable long-term <FONT STYLE="white-space:nowrap">tax-exempt</FONT> bond rate (which is 2.01% for ownership changes in May 2022). As
of December&nbsp;31, 2021, the Company and its U.S. Subsidiaries had approximately $89,245,000 of U.S. NOLs, $0 U.S. capital loss carryovers and $132,000 of U.S. federal tax credit carryovers. For U.S. tax years ending after the issuance of Company
common stock pursuant to the transaction, the annual use of those favorable <FONT STYLE="white-space:nowrap">pre-ownership-change</FONT> tax attributes will be limited as described above and may result in a portion of the U.S. NOLs and other tax
attributes expiring unutilized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_8"></A>Regulatory Approvals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and AJP Holding have agreed to cooperate and coordinate with each other and, subject to the terms and conditions of the
Subscription Agreement, use their respective reasonable best efforts to, among other matters, obtain and maintain all approvals, consents, registrations, permits, authorizations, licenses, waivers and other confirmations required to be obtained from
any governmental entity or applicable law that are necessary to consummate the transactions contemplated by the Subscription Agreement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>No Solicitation of Acquisition Proposals; Board Recommendation Changes (Page 58) </I></B></P></div>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the terms of the Subscription Agreement, subject to certain exceptions, the Company has agreed not to, directly or indirectly
(i)&nbsp;solicit, initiate or knowingly facilitate or encourage the submission of any inquiry, proposal or offer that constitutes, or would reasonably be expected to result in, an acquisition proposal (as defined in the section entitled &#147;The
Subscription Agreement&#151;No Solicitation of Acquisition Proposals; Board Recommendation Changes&#148; beginning on page&nbsp;58), (ii) enter into, continue or participate in any discussions or negotiations with, or furnish any <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its subsidiaries to, any third party in connection with an acquisition proposal, (iii)&nbsp;approve, recommend, publicly declare advisable or enter into any
agreement in principle, letter of intent, subscription agreement, acquisition agreement, joint venture agreement or other similar agreement relating to an acquisition proposal (other than a confidentiality agreement entered into in accordance with
the provisions of the Subscription Agreement (we refer to such a confidentiality agreement as an &#147;acceptable confidentiality agreement&#148;)), or (iv)&nbsp;agree to or propose publicly to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding these restrictions, at any time prior to the time the Subscription Agreement is adopted by our stockholders, subject to the
terms and conditions described in the Subscription Agreement, the Company may engage in negotiations or discussions with a third party and its representatives and actual or potential sources of financing and furnish to such persons <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its subsidiaries pursuant to an acceptable confidentiality agreement so long as such actions are in response to a written acquisition proposal from any third
party that did not result from a breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations of the Company contained in the Subscription Agreement and that the Board determines in good faith: (i)&nbsp;to be bona fide,
(ii)&nbsp;after consultation with its financial advisor and outside legal counsel, constitutes, or would reasonably be expected to result in, a superior proposal (as defined in the section entitled &#147;The Subscription Agreement&#151;No
Solicitation of Acquisition Proposals; Board Recommendation Changes&#148; beginning on page&nbsp;58) or (iii)&nbsp;after consultation with its outside legal counsel, that the failure to take such action would reasonably be expected to result in a
breach of the fiduciary duties of the Company&#146;s directors under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company must notify Purchaser both orally and in writing promptly (but in no event later
than twenty-four (24)&nbsp;hours) after receipt of any acquisition proposal, any proposals or inquiries that would reasonably be expected to lead to an acquisition proposal, or any inquiry or request for nonpublic information relating to the Company
or its subsidiaries by any person who had made or has expressly indicated that it is contemplating making any acquisition proposal. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement provides that (subject to certain exceptions described below) the
Board will not (i)&nbsp;fail to make, withdraw or modify in a manner adverse to Purchaser (or publicly propose to withdraw, modify or qualify in any manner adverse to Purchaser) the Board recommendation, (ii)&nbsp;adopt, approve or publicly
recommend, endorse or otherwise declare advisable the adoption of an acquisition proposal or (iii)&nbsp;fail to include in this proxy statement the Board recommendation (any of the foregoing, we refer to as an &#147;adverse recommendation
change&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, the Board may make an adverse recommendation change (or
terminate the Subscription Agreement as described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; starting on page&nbsp;65) in response to an acquisition proposal only so long as (i)&nbsp;such acquisition proposal was
not the result of a breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations of the Company set forth in the Subscription Agreement and such acquisition proposal is not withdrawn, and (ii)&nbsp;the Board determines in good
faith, after consultation with its financial advisor and outside legal counsel and after taking into account any revisions to the terms of the Subscription Agreement that may be offered in writing by Purchaser in accordance with the Subscription
Agreement (including following the provision of the negotiation period set forth in the Subscription Agreement), (A) that such acquisition proposal constitutes a superior proposal, and (B)&nbsp;that the failure to make an adverse recommendation
change would reasonably be expected to result in a breach of its fiduciary duties under applicable law. Further, the Board may make an adverse recommendation change in response to a material fact, event, circumstance, development or change (other
than in connection with any acquisition proposal) that occurs, arises or comes to the attention of the Board after the date of the Subscription Agreement that affects the business, assets or operations of the Company and its subsidiaries, that was
not known by, or if known, the effect of which was not reasonably foreseeable by, the Board on the date of the Subscription Agreement and the Board determines in good faith, after taking into account any revisions to the terms of the Subscription
Agreement that may be offered in writing by Purchaser in accordance with the Subscription Agreement (including following the provision of the negotiation period set forth in the Subscription Agreement) and after consultation with its outside legal
counsel and its financial advisors, that the failure to effect an adverse recommendation change would reasonably be expected to result in a breach of its fiduciary duties under applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>Conditions to the Transaction (Page 64) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The respective obligations of the Company and AJP Holding to consummate the transaction are subject to the
satisfaction or waiver of certain customary conditions, including the adoption of the Subscription Agreement by our stockholders, the absence of any legal prohibitions to the consummation of the transaction, the accuracy of the representations and
warranties of the parties and compliance in all material respects by the parties with their respective obligations under the Subscription Agreement. See &#147;The Subscription Agreement&#151;Conditions to the Transaction&#148; beginning on
page&nbsp;64. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><I>Termination (Page 65) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and Purchaser may, by mutual written agreement, terminate the Subscription
Agreement and abandon the transaction at any time prior to the closing of the transaction. </P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement may also be terminated and the transaction abandoned at any time
prior to the closing of the transaction, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either the Company or Purchaser, if: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the first closing has not been consummated on or before the date that is six (6)&nbsp;months after the date of
the Subscription Agreement (which we refer to as the &#147;end date&#148;), as described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; beginning on page&nbsp;65; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any order permanently restraining, enjoining or otherwise prohibiting consummation of the transaction has
become final and <FONT STYLE="white-space:nowrap">non-appealable,</FONT> so long as the breach of the terminating party in any material respect is not the primary cause of such governmental restraint; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">stockholder approval of the Transaction Proposal is not obtained at the special meeting (after giving effect
to any adjournment or postponement of the special meeting), as described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; beginning on page&nbsp;65; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Purchaser (with certain limitations as set forth in the Subscription Agreement), if: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to obtaining stockholder approval of the Transaction Proposal, (i)&nbsp;the Board makes an adverse
recommendation change, or (ii)&nbsp;the Company or its representatives willfully and materially violate Section&nbsp;4.1(a) of the Subscription Agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is any inaccuracy of any representation or warranty made by the Company in the Subscription Agreement or
any breach, violation or failure to perform any covenant or agreement on the part of the Company set forth in the Subscription Agreement and such inaccuracy, breach, violation or failure, if continuing at the first closing, would cause the Company
to fail to satisfy the applicable condition to closing of the first closing related to performance of covenants and agreements or accuracy of representations and warranties and that inaccuracy or breach is incapable of being cured by the end date as
described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; beginning on page&nbsp;65; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the Company (with certain limitations as set forth in the Subscription Agreement), if:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is any inaccuracy of any representation or warranty made by Purchaser in the Subscription Agreement or
any breach, violation or failure to perform any covenant or agreement on the part of the Purchaser set forth in the Subscription Agreement and such inaccuracy or breach would cause Purchaser to fail to satisfy the applicable condition to closing of
the transaction related to performance of covenants and agreements or accuracy of representations and warranties and that inaccuracy or breach is incapable of being cured by the end date (collectively, we refer to such termination trigger a
&#147;the Company terminating breach&#148;), as described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; beginning on page&nbsp;65; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Board authorizes the Company, pursuant to, and in compliance with the applicable terms of the
Subscription Agreement, to enter into a definitive agreement concerning a superior proposal; so long as the Company pays a termination fee of $750,000 to the Purchaser and reimburses the Purchaser for up to $350,000 in reasonable, documented and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the Purchaser in connection with the Subscription Agreement, including but not limited to, reasonable, documented and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal and advisory fees paid in connection therewith, substantially concurrently with (and as a condition to) such termination (which we refer to as the
&#147;superior proposal termination event&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Termination Fee&nbsp;&amp; Reimbursement Obligation (Page 66)
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In certain circumstances, the Company may be required to pay AJP Holding a termination fee of $750,000 (which we refer to as the
&#147;termination fee&#148;) if the Subscription Agreement is terminated, as well as reimburse AJP Holding for certain reasonable, documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses up
to $350,000 (which we refer to as the &#147;reimbursement obligation&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The termination fee and reimbursement obligation would be payable in the following
circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Purchaser terminates the Subscription Agreement pursuant to an adverse recommendation change termination
event, in which case the Company must pay Purchaser the termination fee and the reimbursement obligation within two (2)&nbsp;business days after such termination; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company terminates the Subscription Agreement pursuant to a superior proposal termination event, in which
case the Company must pay Purchaser the termination fee substantially concurrently with (and as a condition to) such termination. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The reimbursement obligation would be payable in the following circumstances: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Either party terminates the Subscription Agreement due to failure to obtain stockholder approval of the
Transaction Proposal, in which case the Company must pay the reimbursement obligations to the Purchaser within two (2)&nbsp;business days after such termination </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Specific Performance (Page 68) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and AJP Holding have agreed that irreparable damage for which monetary damages, even if available, would not be an adequate remedy
that would occur in the event that the parties do not perform their obligations under the Subscription Agreement in accordance with its specified terms or otherwise breach such provisions. The Company and AJP Holding have further agreed that each
party is entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of the Subscription Agreement and to enforce specifically the terms and provisions of the Subscription Agreement without proof of
damages. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Market Price of Common Stock (Page 80) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s common stock is listed on Nasdaq under the symbol &#147;SONM.&#148; The closing price of our common stock on Nasdaq on
April&nbsp;12, 2022, the last trading day prior to the public announcement of the execution of the Subscription Agreement, was $0.66 per share. On &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2022, the most recent practicable date before this proxy statement was mailed to our stockholders, the closing price for our common stock on Nasdaq was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share. You are encouraged to obtain current market quotations for our common stock in connection with voting your shares of common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_9"></A>QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE
TRANSACTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following questions and answers are intended to briefly address some commonly asked questions regarding the
transaction, the Subscription Agreement and the special meeting. These questions and answers may not address all of the questions that may be important to you as a stockholder of the Company. Please refer to the &#147;Summary&#148; beginning on page
1 and the more detailed information contained elsewhere in this proxy statement, the annexes to this proxy statement and the documents referred to or incorporated by reference in this proxy statement, which you should read carefully and in their
entirety. You may obtain the information incorporated by reference in this proxy statement without charge by following the instructions under &#147;Where You Can Find More Information&#148; beginning on page 83 or &#147;Incorporation of Certain
Information By Reference&#148; beginning on page&nbsp;83. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. Why am I receiving this proxy statement? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">On April&nbsp;13, 2022, the Company entered into the Subscription Agreement providing for the transaction
with AJP Holding, whereby AJP Holding would purchase 20,833,333 shares of the Company&#146;s common stock for $17,500,000. This proxy statement and the enclosed proxy card are furnished in connection with the solicitation of proxies by the Board of
the Company for use at the special meeting of the Company&#146;s stockholders to be held on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at 9:00 am, local time, at the offices of the Company,
located at 1875 South Grant Street, Suite 770, San Mateo, California 94402, and at any adjournments of the special meeting. You are receiving this proxy statement in connection with the solicitation of proxies in favor of the Transaction Proposal
and to approve the other proposals to be voted on at the special meeting, including at any adjournments or postponements of the special meeting and because you have been identified as a stockholder of the Company as of the close of business on the
record date. You are invited to attend the special meeting to vote on the proposals described in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. See below under &#147;How do I vote?&#148;
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. What is the proposed transaction and what effects will it have on the Company? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The proposed transaction is the acquisition of 20,833,333 shares of the Company&#146;s common stock by AJP
Holding. If the Transaction Proposal is approved by our stockholders and the other closing conditions under the Subscription Agreement have been satisfied or waived, AJP Holding would become a majority owner of the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. When and where is the special meeting? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The special meeting of stockholders of the Company will be held on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at 9:00 am, local time, at the offices of the Company, located at 1875 South Grant Street, Suite 770, San Mateo, California 94402.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. What am I being asked to vote on at the special meeting? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">At the special meeting, holders of our common stock will be asked to consider and vote on the following four
proposals: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Transaction Proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Reverse Stock Split Proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Charter Restriction Proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Adjournment Proposal. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. How does the Board recommend that I vote? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board recommends that you vote your shares of our common stock: <B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>&#147;FOR&#148; the approval of the Transaction Proposal;</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>&#147;FOR&#148; the approval of the Reverse Stock Split Proposal;</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>&#147;FOR&#148; the approval of the Charter Restriction Proposal; and</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>&#147;FOR&#148; the approval of the Adjournment Proposal.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For a discussion of the factors that the Board considered in determining to approve the execution and delivery of the
Subscription Agreement by the Company and to recommend the approval of the transactions contemplated by the Subscription Agreement, please see the section entitled &#147;The Transaction&#151;Reasons for the Transaction; Recommendation of the
Board.&#148; In considering the recommendation of the Board that you vote to approve the Subscription Agreement, you should be aware that the Company&#146;s directors and executive officers may have interests in the transaction that may be different
from, or in addition to, those of the Company stockholders generally. For a discussion of these interests, please see the section entitled &#147;The Transaction&#151;Interests of Certain Persons in the Transaction.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. Who is entitled to vote at the special meeting? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">All holders of shares of the Company common stock as of the close of business on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the record date, are entitled to vote at the special meeting. Each holder of our common stock is entitled to one vote for each share of our
common stock held on the record date. As of the close of business on the record date, there were &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock outstanding.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. What is the difference between holding shares as a stockholder of record and in street name as a beneficial
owner? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Our stockholders may hold their shares of our common stock through a broker, bank or other nominee (that is,
in &#147;street name&#148;) rather than directly in their own name. Summarized below are some of the differences between shares held of record and those owned beneficially in street name. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stockholder of Record</I>. If your shares are registered directly in your name with the Company&#146;s
transfer agent, American Stock Transfer&nbsp;&amp; Trust Company, LLC, you are considered, with respect to those shares, the stockholder of record and this proxy statement was sent directly to you by the Company. As the stockholder of record, you
have the right to vote your shares in person at the special meeting or to grant your proxy directly to certain officers of the Company to vote your shares at the special meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Beneficial Owner</I>. If your shares are held through a broker, bank or other nominee, you are considered
the beneficial owner of shares held in street name, and this proxy statement was forwarded to you by your broker, bank or other nominee. As the beneficial owner, you have the right to direct your broker, bank or other nominee how to vote your shares
on your behalf at the special meeting, or you may contact your broker, bank or other nominee to obtain a &#147;legal proxy&#148; giving you the right to vote in person at the special meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. What must I do if I want to attend the special meeting in person? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">All holders of shares of the Company common stock as of the close of business on the record date, including
stockholders of record and stockholders who hold our common stock through a broker, bank or other nominee, are invited to attend the special meeting. Proof of ownership of the Company common stock (such as a brokerage statement or the appearance of
such stockholder&#146;s name on the Company&#146;s stockholder list as of the record date), along with valid photo identification (such as a driver&#146;s license or passport), must be presented to be admitted to the special meeting. Please note
that if you hold your shares in street name, you may not vote your shares in person at the special meeting unless you obtain a &#147;legal proxy&#148; from the broker, bank or other nominee that holds your shares, giving you the right to vote your
shares at the special meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. How do I vote? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Voting in Person at the Special Meeting</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All holders of shares of the Company&#146;s common stock as of the close of business on the record date, including stockholders
of record and stockholders who hold shares of our common stock in street name, may attend the special meeting and vote their shares in person. Please note that if you hold your shares in street name, you may not vote your shares in person at the
special meeting unless you obtain a &#147;legal proxy&#148; from the broker, bank or other nominee that holds your shares, giving you the right to vote the shares at the special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Voting by Proxy </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Submitting a Proxy for Shares Registered Directly in the Name of the Stockholder</I></B>. If you hold
your shares of common stock as a record holder, you may cause your shares to be voted by completing, signing, dating and returning the enclosed proxy card in the accompanying prepaid envelope. You may also submit a proxy over the Internet or by
telephone by following the instructions on the enclosed proxy card. If you submit a proxy by Internet or telephone, you do not need to return a written proxy card by mail. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Submitting Voting Instructions for Shares Registered in Street Name</I></B>. If you hold your shares of
common stock in street name, you will receive instructions from your broker, bank or other nominee on how to vote your shares. Your broker, bank or other nominee will allow you to deliver your voting instructions over the Internet and may also
permit you to provide your voting instructions by telephone. In addition, you may submit your voting instructions by completing, signing and dating the voting instruction form that was included with this proxy statement and returning it in the
accompanying prepaid envelope. If you provide voting instructions by Internet or telephone, you do not need to return a written voting instruction form by mail. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Q. What is the deadline for voting? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If you are a stockholder of record, your proxy must be received by telephone or Internet by 11:59 p.m.,
Pacific Time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the day before the special meeting, in order for your shares to be voted at the special meeting. If you are a stockholder of
record and you cause your shares to be voted by completing, signing, dating and returning the enclosed proxy card, your proxy card must be received before the special meeting for your shares to be voted at the special meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you hold your shares in street name, please comply with the deadlines for voting provided by the broker, bank or other
nominee that holds your shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>How can I change or revoke my vote? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If you are a stockholder of record, you may change or revoke a previously submitted proxy at any time before
it is exercised by one of the following methods: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering a later dated proxy card or by submitting another proxy by telephone or the Internet (your latest
telephone or Internet voting instructions will be followed); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the Secretary of the Company a written notice of revocation prior to the voting of the proxy at
the special meeting; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by voting in person at the special meeting. Attendance at the special meeting will not, by itself, revoke your
proxy. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Written notices of revocation should be addressed to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6500 River Place Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Building
7, Suite 250 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Austin, TX 78746 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Robert Tirva, Secretary </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any change to your proxy that is provided by telephone or the Internet must be submitted by 11:59 p.m., Pacific Time, on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the day before the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If your shares are held in &#147;street name,&#148; you must contact your broker, bank or other nominee to find out how to
change or revoke your voting instructions. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What happens if I do not give specific voting instructions? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If you are a stockholder of record and you properly submit a signed proxy card or submit your proxy by
telephone or the Internet but do not specify how you want to vote your shares on a particular proposal, then the named proxy holders will vote your shares in accordance with the recommendations of the Board on all matters presented in this proxy
statement. See above under &#147;How does the Board recommend that I vote?&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with
applicable stock exchange rules, if you hold your shares through a brokerage account and you fail to provide voting instructions to your broker, your broker may generally vote your uninstructed shares of common stock in its discretion on routine
matters at a stockholder meeting. However, a broker cannot vote shares of common stock held in street name on <FONT STYLE="white-space:nowrap">non-routine</FONT> matters unless the broker receives voting instructions from the stockholder. Generally,
if a broker exercises this discretion on routine matters at a stockholder meeting, a stockholder&#146;s shares will be voted on the routine matter in the manner directed by the broker but will constitute a &#147;broker
<FONT STYLE="white-space:nowrap">non-vote&#148;</FONT> on all of the <FONT STYLE="white-space:nowrap">non-routine</FONT> matters to be presented at the stockholder meeting. The Transaction Proposal and the Charter Restriction Proposal are <FONT
STYLE="white-space:nowrap">non-routine</FONT> matters. Accordingly, if you hold your shares in street name through a brokerage account, your broker will not be able to exercise its discretion to vote uninstructed shares on those proposals presented
at the special meeting. The Reverse Stock Split Proposal and the Adjournment Proposal are routine matters. Accordingly, if you hold your shares in street name through a brokerage account, your broker will be able to exercise its discretion to vote
uninstructed shares on those proposals presented at the special meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What will happen if I abstain from voting or fail to vote on the proposals or fail to instruct my broker,
bank or other nominee how to vote on the proposals? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For the Transaction Proposal, you may vote <B>&#147;FOR,&#148; &#147;AGAINST&#148;</B> or
<B>&#147;ABSTAIN.&#148;</B> Abstentions or a broker non-vote will have no impact on the outcome of the vote on the Transaction Proposal. In addition, if you do not submit a valid proxy or attend the special meeting to vote your shares of common
stock in person or if you hold your shares of common stock in street name and fail to instruct your broker, bank or other nominee how to vote your shares on the Transaction Proposal, it will have no effect on the outcome of the Transaction Proposal.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the Reverse Stock Split Proposal, you may vote <B>&#147;FOR,&#148; &#147;AGAINST,&#148;</B> or
<B>&#147;ABSTAIN.&#148;</B> Abstentions will have the same effect as a vote <B>&#147;AGAINST&#148;</B> the Reverse Stock Split Proposal. In addition, if you do not submit a valid proxy or attend the special meeting to vote your shares of common
stock in person or if you hold your shares of common stock in street name and fail to instruct your broker, bank or other nominee how to vote your shares on the Reverse Stock Split Proposal, your broker will be able to exercise its discretion to
vote uninstructed shares on the Reverse Stock Split Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the Charter Restriction Proposal, you may vote
<B>&#147;FOR,&#148; &#147;AGAINST,&#148;</B> or <B>&#147;ABSTAIN.&#148;</B> Abstentions will have the same effect as a vote <B>&#147;AGAINST&#148;</B> the Charter Restriction Proposal. In addition, if you do not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
submit a valid proxy or attend the special meeting to vote your shares of common stock in person or if you hold your shares of common stock in street name and fail to instruct your broker, bank
or other nominee how to vote your shares on the Charter Restriction Proposal, it will have the same effect as a vote <B>&#147;AGAINST&#148;</B> the Charter Restriction Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the Adjournment Proposal, you may vote <B>&#147;FOR,&#148; &#147;AGAINST,&#148;</B> or <B>&#147;ABSTAIN.&#148;</B>
Abstentions will have no impact on the outcome of the vote on the Adjournment Proposal. In addition, if you do not submit a valid proxy or attend the special meeting to vote your shares of common stock in person or if you hold your shares of common
stock in street name and fail to instruct your broker, bank or other nominee how to vote your shares on the Adjournment Proposal, your broker will be able to exercise its discretion to vote uninstructed shares on the Adjournment Proposal. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Who will count the votes? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The votes will be counted by the inspector of elections appointed for the special meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What do I do if I receive more than one proxy or set of voting instructions? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If you received more than one proxy card or voting instruction form, your shares are likely registered in
different names or with different addresses or are in more than one account. You must separately vote the shares shown on each proxy card or voting instruction form that you received in order for all of your shares to be voted at the special
meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What vote is required for the Company&#146;s stockholders to approve the Transaction Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Approval of the Transaction Proposal requires the affirmative vote of the holders of a majority of the votes
cast by the stockholders present in person or represented by proxy at the special meeting and entitled to vote thereon. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What vote of our stockholders is required to approve the proposal to approve the Reverse Stock Split
Proposal? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Approval of the Reverse Stock Split Proposal requires the affirmative vote of the holders of a majority of
the shares of our common stock entitled to vote thereon. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What vote of our stockholders is required to approve the Charter Restriction Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Approval of the proposal to approve the Charter Restriction Proposal requires the affirmative vote of the
holders of a majority of the shares of our common stock entitled to vote thereon. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What vote of our stockholders is required to approve the Adjournment Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Approval of the Adjournment Proposal requires the affirmative vote of the holders of a majority of the
outstanding shares of our common stock present in person or represented by proxy at the special meeting and entitled to vote thereon, irrespective of whether the quorum is present. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>How does the transaction consideration compare to the market price of our common stock?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The consideration for the shares sold to AJP Holding of $0.84 per share represents a premium of
approximately 27% to $0.66 per share, the closing price of our common stock on Nasdaq on April&nbsp;12, 2022, the last trading day prior to the public announcement of the execution of the Subscription Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>When do you expect the transaction to be completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">We are working towards completing the transaction as soon as possible. Assuming timely receipt of required
regulatory approvals and satisfaction of other closing conditions, including approval by our stockholders of the Transaction Proposal, we anticipate that the transaction will be completed in the second half of calendar year 2022.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What happens if the transaction is not completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If the Transaction Proposal is not approved by the stockholders of the Company or if the transaction is not
completed for any other reason, AJP Holding will not acquire the 20,833,333 shares of common stock of the Company and the Company will not receive the $17,500,000 in consideration for such shares. Under specified circumstances, the Company may be
required to pay to AJP Holding a $750,000 termination fee with respect to the termination of the Subscription Agreement, as described under &#147;The Subscription Agreement&#151;Termination Fee&nbsp;&amp; Reimbursement Obligation&#148; beginning on
page 66 and/or reimburse AJP Holding for certain reasonable, documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses of up to $350,000. The Reverse Stock Split Proposal is not contingent upon
the approval of the Transaction Proposal and the reverse stock split thereunder may be effected in the event that the Transaction Proposal is not approved. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What conditions must be satisfied to complete the transaction? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Company and AJP Holding are not required to complete the transaction unless a number of conditions are
satisfied or waived. These conditions include, among others: (i)&nbsp;the approval of the Transaction Proposal by our stockholders at the special meeting; (ii)&nbsp;no temporary restraining order, decree, ruling, injunction or judgment, preliminary
or permanent injunction or other judgment issued by any governmental authority of competent jurisdiction being in effect enjoining, restraining or otherwise prohibiting the consummation of the transaction and no governmental authority of competent
jurisdiction having enacted, issued, promulgated, enforced or declared applicable to the transaction any applicable law that is in effect, which has the effect of enjoining, restraining or otherwise prohibiting the consummation of the transaction,
and (iii)&nbsp;customary conditions in favor of each of the parties regarding the accuracy of the other party&#146;s representations and warranties (subject to customary materiality qualifiers) and the other party&#146;s compliance with its
covenants and agreements contained in the Subscription Agreement (subject to customary materiality qualifiers). For a more complete summary of the conditions that must be satisfied or waived prior to the completion of the transaction, see &#147;The
Subscription Agreement&#151;Conditions to the Transaction&#148; beginning on page 64. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Is the transaction expected to be taxable to me? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No. For U.S. federal income tax purposes, the issuance of Company common stock will not result in taxable
income or gain for the Company, for its subsidiaries or for stockholders that own stock of the Company prior to the transaction. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Do any of the Company&#146;s directors or officers have interests in the transaction that may differ from
or be in addition to my interests as a stockholder? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">In considering the recommendation of the Board with respect to the Transaction Proposal, you should be aware
that our directors and executive officers may have interests in the transaction that may be different from, in conflict with or in addition to the interests of our stockholders generally. The Board was aware of and considered these interests, at the
time, among other matters, in evaluating and negotiating the Subscription Agreement, approving the Subscription Agreement and the transaction and in recommending that the Subscription Agreement be adopted by the stockholders of the Company. See
&#147;The Transaction&#151;Interests of Certain Persons in the Transaction&#148; beginning on page 51. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>What happens if I sell my shares of our common stock before the special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The record date for stockholders entitled to vote at the special meeting is earlier than both the date of
the special meeting and the consummation of the transaction. If you transfer your shares of our common stock after the record date but before the special meeting, you will retain your right to vote such shares at the special meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Who will solicit and pay the cost of soliciting proxies? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Company has engaged Kingsdale Advisors (which we refer to as the &#147;proxy solicitor&#148;) to assist
in the solicitation of proxies for the special meeting. The Company estimates that it will pay the proxy solicitor a fee of approximately $11,000, plus reimbursement of related expenses. The Company has also agreed to reimburse the proxy solicitor
for certain reasonable and documented fees and expenses and will indemnify the proxy solicitor and all of its directors, officers, employees and agents against certain claims, expenses, losses, damages and/or liabilities. The Company may also
reimburse banks, brokers or their agents for their expenses in forwarding proxy materials to beneficial owners of our common stock. Our directors, officers and employees may also solicit proxies by telephone, by facsimile, by mail, on the Internet
or in person. They will not be paid any additional amounts for soliciting proxies. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Who can help answer any other questions I might have? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If you have additional questions about the transaction, need assistance in submitting your proxy or voting
your shares of our common stock or need additional copies of the proxy statement or the enclosed proxy card, please contact Kingsdale Advisors, our proxy solicitor using the contact information below: </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kingsdale Advisors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">745 Fifth
Avenue, 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10151 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">North American Toll Free Phone:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-518-6812</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Call
Collect Outside North America: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-867-2272</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email:
contactus@kingsdaleadvisors.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_10"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This proxy statement contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as
amended (which we refer to as the &#147;Securities Act&#148;), and Section&nbsp;21E of the Exchange Act, which statements involve substantial risks and uncertainties. All statements, other than statements of historical or current facts included in
this proxy statement, are forward-looking statements. These statements are often identified by the words &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;project,&#148;
&#147;plan,&#148; &#147;assume,&#148; &#147;seek to&#148; or other similar expressions, whether in the negative or the affirmative, that are not statements of historical fact. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are
difficult to predict and many of which we have no control over. You should not place undue reliance on our forward-looking statements. These factors, risks and uncertainties include, but are not limited to, the following: (i)&nbsp;the possibility
that the Company may be unable to obtain the required stockholder approval or that other conditions to closing the transaction may not be satisfied, such that the transaction will not close or that the closing may be delayed; (ii)&nbsp;the reaction
of customers to the transaction; (iii)&nbsp;general economic conditions; (iv)&nbsp;the amount of the costs, fees, expenses and charges related to the transaction; (v)&nbsp;the outcome of any legal proceedings related to the transaction, if any;
(vi)&nbsp;the occurrence of any event, change or other circumstances that could give rise to the termination of the Subscription Agreement; and (vii)&nbsp;other factors discussed from time to time in our reports filed with the SEC, including the
factors discussed in Item 1A, &#147;<I>Risk Factors</I>&#148; of the Company&#146;s 2021 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the SEC on March&nbsp;21, 2022 and subsequent filings the Company makes with the
SEC, which are available at <I>www.sec.gov</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should not rely upon forward-looking statements as predictions of future events. New
risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this proxy statement. We cannot assure you that the
results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The forward-looking statements made in this proxy statement relate only to events as of the date on which the statements are made. We
undertake no obligation to update any forward-looking statements made in this proxy statement to reflect events or circumstances after the date of this proxy statement or to reflect new information or the occurrence of unanticipated events, except
as required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_11"></A>PARTIES TO THE TRANSACTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Sonim Technologies, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sonim Technologies, Inc., a Delaware corporation, is a leading U.S. provider of ultra-rugged mobile phones and accessories designed
specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Company currently sells its ruggedized mobile phones and accessories to three of the four largest wireless carriers in the United
States&#151;AT&amp;T, Sprint and Verizon&#151;as well as the three largest wireless carriers in Canada&#151;Bell, Rogers and Telus Mobility. The Company&#146;s phones and accessories connect workers with voice, data and workflow applications in two
end markets: industrial enterprise and public sector. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s common stock is listed on Nasdaq under the symbol
&#147;SONM.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>AJP Holding Company, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">AJP Holding Company, LLC, a Delaware limited liability company, was formed specifically for the contemplated Transaction solely for the purpose
of ownership of the shares of common stock of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_12"></A>THE SPECIAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>We are furnishing this proxy statement to the Company stockholders as part of the solicitation of proxies by the Board for use at the
special meeting or any adjournment or postponement thereof. This proxy statement provides the Company stockholders with the information they need to know to be able to vote at the special meeting or any adjournment or postponement thereof. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_13"></A>Date, Time and Place of the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The special meeting will be held on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022 at
9:00 am, local time, at the offices of the Company, located at 1875 South Grant Street, Suite 770, San Mateo, California 94402, or at any adjournment or postponement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_14"></A>Purpose of the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the special meeting, holders of our common stock will be asked to consider and vote on the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Transaction Proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Reverse Stock Split Proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Charter Restriction Proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board has unanimously determined that the Subscription Agreement and the transactions contemplated thereby are fair to and in the best
interests of the Company&#146;s stockholders, adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby and recommends that our stockholders vote &#147;FOR&#148; the approval of the Transaction Proposal;
&#147;FOR&#148; the Reverse Stock Split Proposal; &#147;FOR&#148; the Charter Restriction Proposal; and &#147;FOR&#148; the adjournment of the special meeting to a later date or time, if necessary, to solicit additional proxies if there are not
sufficient votes at the time of the special meeting to approve the Transaction Proposal. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If our stockholders fail to approve the
Transaction Proposal, the transaction will not occur. A copy of the Subscription Agreement is attached as<B> Annex A</B> to this proxy statement, and the material provisions of the Subscription Agreement are summarized in the section of this proxy
statement entitled &#147;The Subscription Agreement&#148; beginning on page 52 of this proxy statement. The Reverse Stock Split Proposal is not contingent upon the approval of the Transaction Proposal and the reverse stock split thereunder may be
effected in the event the Transaction Proposal is not approved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_15"></A>Deadline for Voting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a stockholder of record, your proxy must be received by telephone or Internet by 11:59 p.m., Pacific Time, on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the day before the special meeting, in order for your shares to be voted at the special meeting. If you are a stockholder of record and you
choose to cause your shares to be voted by completing, signing, dating and returning the enclosed proxy card, your proxy card must be received before the special meeting for your shares to be voted at the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you hold your shares in street name, please comply with the deadlines for voting provided by the broker, bank or other nominee that holds
your shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_16"></A>Revocation of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering a later dated proxy card or by submitting another proxy by telephone or the Internet (your latest
telephone or Internet voting instructions will be followed); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the Secretary of the Company a written notice of revocation prior to the voting of the proxy at
the special meeting; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by voting in person at the special meeting. Attendance at the special meeting will not, by itself, revoke your
proxy. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your most current proxy card or telephone or internet proxy is the one that will be counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any change to your proxy that is provided by telephone or the Internet must be submitted by 11:59 p.m., Pacific Time, on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the day before the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If your shares are held in &#147;street name,&#148; you must contact your broker, bank or other nominee to find out how to change or revoke
your voting instructions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_17"></A>Voting by the Company&#146;s Directors and Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of the record date, the directors and executive officers of the Company beneficially owned and were entitled to vote, in the aggregate,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ( &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%) shares of our common stock (not including any
shares of our common stock deliverable upon exercise or conversion of or underlying any options or the Company restricted stock unit awards). The directors have informed the Company that they currently intend to vote all such shares of our common
stock &#147;<B>FOR</B>&#148; approval of the Transaction Proposal, &#147;<B>FOR</B>&#148; approval of the Reverse Stock Split Proposal; &#147;<B>FOR</B>&#148; the Charter Restriction Proposal; and &#147;<B>FOR</B>&#148; the Adjournment Proposal.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_18"></A>Solicitation of Proxies; Payment of Solicitation Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company has engaged Kingsdale Advisors to assist in the solicitation of proxies for the special meeting. The Company estimates that it will
pay the proxy solicitor a fee of approximately $11,000, plus reimbursement of related expenses. The Company has also agreed to reimburse the proxy solicitor for certain reasonable and documented fees and expenses and will indemnify the proxy
solicitor and all of its directors, officers, employees and agents against certain claims, expenses, losses, damages and/or liabilities. The Company may also reimburse banks and brokers or their agents for their expenses in forwarding proxy
materials to beneficial owners of our common stock. The Company&#146;s directors, officers and employees may also solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts for
soliciting proxies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_19"></A>Householding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for special meeting
materials with respect to two (2)&nbsp;or more stockholders sharing the same address by delivering a single set of special meeting materials addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148;
potentially means extra convenience for stockholders and cost savings for companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This year, a number of brokers with account holders
who are Sonim stockholders will be &#147;householding&#148; the Company&#146;s proxy materials. A single set of special meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received
from the affected stockholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke
your consent. If, at any time, you no longer wish to participate in &#147;householding&#148; and would prefer to receive a separate set of special meeting materials, please notify your broker or Sonim. Direct your written request to Sonim
Technologies, Inc., Attention: Robert Tirva, 6500 River Place Blvd., Building 7, Suite 250, Austin, TX 78730 or contact Robert Tirva, CFO at (650) 703&#150;4002. Stockholders who currently receive multiple copies of the special meeting materials at
their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_20"></A>Adjournments and Postponements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although it is not currently expected, the special meeting may be adjourned or postponed. If there is no quorum, the holders of a majority of
shares present at the meeting in person or represented by proxy may adjourn the meeting to another date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_21"></A>Anticipated Date of Completion of the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are working towards completing the transaction as soon as possible. Assuming satisfaction of the closing conditions, including the approval
by our stockholders of the Transaction Proposal, we anticipate that the transaction will be completed in the second half of calendar year 2022. If our stockholders vote to approve the Transaction Proposal, the transaction will close as promptly as
practicable following the satisfaction or waiver of the remaining conditions to the transaction, subject to the terms of the Subscription Agreement. See &#147;The Subscription Agreement&#151;Closing of the Transaction&#148; beginning on page 52.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_22"></A>Questions and Additional Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you have questions about the transaction, need assistance in submitting your proxy or voting your shares of our common stock or need
additional copies of the proxy statement or the enclosed proxy card, please contact the proxy solicitor using the contact information below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kingsdale Advisors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">745 Fifth
Avenue, 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10151 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">North American Toll Free Phone:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-518-6812</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Call
Collect Outside North America: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-867-2272</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email:
contactus@kingsdaleadvisors.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_23"></A>PROPOSAL 1: APPROVAL OF THE ISSUANCE OF COMMON STOCK
CONTEMPLATED </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BY THE SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_24"></A>THE TRANSACTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This discussion of the transaction is qualified in its entirety by reference to the Subscription Agreement, which is attached to this proxy
statement as<B> Annex A</B>. You should read the entire Subscription Agreement carefully and in its entirety, as it is the legal document that governs the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement provides that, subject to the satisfaction or waiver of the conditions set forth in the Subscription Agreement, AJP
Holding will acquire the Purchased Shares for the Aggregate Consideration. As a result of the transaction, AJP Holding will own approximately 52% of the Company. Holders of common stock of the Company will not receive any consideration from the
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed on Nasdaq, and, as such, we are subject to the Nasdaq Listing Rules, including Nasdaq Listing
Rule 5635. In order to comply with the Nasdaq Listing Rules and to satisfy conditions under the Subscription Agreement, we are seeking stockholder approval of this Proposal No.&nbsp;1. NASDAQ Listing Rule 5635(b) requires stockholder approval for
issuance of securities that will result in a &#147;change of control&#148; of the issuer. Nasdaq may deem a change of control to occur when, as a result of an issuance, an investor or a group would own, or have the right to acquire, 20% or more of
the outstanding shares of common stock or voting power and such ownership or voting power of an issuer would be the largest ownership position of the issuer. The Board is not seeking the approval of our stockholders to authorize our entry into the
Subscription Agreement. The Subscription Agreement has already been executed and delivered. We seek your approval of this proposal in order to satisfy the requirements of Nasdaq Listing Rule 5635 with respect to the issuance of the common stock to
the Purchaser in a &#147;change of control&#148; transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_25"></A>Transaction Consideration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the transaction, each share of common stock is being sold for $0.84. Holders of common stock of the Company will not receive any
consideration from the transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_26"></A>Description of the Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The shares of our common stock to be issued to Purchaser, if any, will be unregistered and the same class of common stock that we have listed
on Nasdaq under the trading symbol &#147;SONM.&#148; Holders of our common stock have no preemptive rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_27"></A>Background of the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On a regular basis, the Board, together with Sonim&#146;s management team, which we refer to as &#147;management&#148;, has reviewed and
assessed Sonim&#146;s performance, future growth prospects, net losses (including, as a result thereof, substantial doubt about Sonim&#146;s ability to continue as a going concern during 2022), business strategies, opportunities and competitive
position and challenges as part of its evaluation of Sonim&#146;s prospects and strategies for enhancing stockholder value. As part of that review process, including as a result of Sonim&#146;s current financial position and substantial doubt about
Sonim&#146;s ability to continue as a going concern during 2022), the Board and management have regularly reviewed and considered Sonim&#146;s strategic direction and business objectives, including strategic opportunities that might be available to
Sonim, such as possible acquisitions, investments, divestitures and business combination transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The transaction and the terms of
the Subscription Agreement are the result of arm&#146;s length negotiations conducted between representatives of Purchaser, Sonim and their respective advisors. The following is a summary of the principal events, meetings, negotiations and actions
among the parties leading to the execution and public announcement of the merger agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Commencing 2021 through the execution of the Subscription Agreement, Sonim has sought to
engage in a potential strategic transaction or other sale transaction with a counterparty, including engaging a financial advisor to assist Sonim and the Board with such process, which we refer to herein as the &#147;Prior Financial Advisor.&#148;
During the course of this process, Sonim and its advisors contacted at least 45 potential transaction partners. Certain of these potential transaction parties executed a confidentiality agreement with Sonim, participated in management meetings with
Sonim management, and were provided electronic data room access. All of the confidentiality agreements or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements entered into by Sonim in this process either contained a standstill provision
that automatically terminated upon Sonim&#146;s entry into the Subscription Agreement or did not contain a standstill provision. Prior to the engagement of B. Riley as Sonim&#146;s financial advisor, Sonim received
<FONT STYLE="white-space:nowrap">non-binding</FONT> indications of interest and letters of intent from potential strategic partners (including from Party A and from Party C (each as defined below), several of which were sent by Party C to Sonim
during this period), and the Board held multiple special meetings to discuss and consider the terms of such <FONT STYLE="white-space:nowrap">non-binding</FONT> indications of interest and letters of intent. The Board, together with Prior Financial
Advisor, B. Riley and Sonim&#146;s representatives, engaged in discussions and negotiations with such potential strategic partners, none of which resulted in an executed definitive agreement for a strategic transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Inclusive of the contacts listed in the paragraph above, following the engagement of B. Riley, B. Riley, on behalf of Sonim, and Sonim
contacted 17 potential transaction partners, of which 16 were potential strategic transaction partners and 1 was a potential financial transaction partner, 11 executed a confidentiality agreement with Sonim, 8 participated in management meetings
with Sonim management, and 6 were provided electronic data room access. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;1, 2021, the Board held a special meeting. Also
present were members of management and representatives of O&#146;Melveny. Management provided the Board with a financial update, which included Sonim&#146;s then current cash position of approximately $12&nbsp;million and that management expected
Sonim&#146;s cash position to decrease to under $5&nbsp;million by the end of the second quarter, 2021. Management stated that it recommended that Sonim pursue an equity raise transaction to bring in additional cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;12, 2021, the Board held a special meeting. Also present were members of management, a representative of O&#146;Melveny,
representatives of the Prior Financial Advisor (for a portion of the meeting) and a representative of B. Riley (for a portion of the meeting). The Board discussed, together with representatives of the Prior Financial Advisor, potential financing
alternative transactions, including an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> Issuance program, which we refer to herein as an &#147;ATM&#148;, a public offering and a private placement
transaction. The representatives of the Prior Financial Advisor then left the meeting and a representative of B. Riley joined the meeting. The representative of B. Riley discussed B. Riley&#146;s ATM program, including the set up process and
potential benefits of an ATM program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;18, 2021, the Board held a special meeting. Also present were members of management,
a representative of O&#146;Melveny and a representative of the Prior Financial Advisor (for a portion of the meeting). The Board discussed, together with a representative of the Prior Financial Advisor, potential strategic opportunities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;28, 2021, Sonim received a deficiency letter from the Listing Qualifications Department of Nasdaq notifying Sonim that, for the
last 30 consecutive business days, the bid price for Sonim&#146;s common stock had closed below $1.00 per share, which is the minimum closing price required to maintain continued listing on Nasdaq under Nasdaq list rules. In accordance with Nasdaq
listing rules, the Company had 180 calendar days to regain compliance with such requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On May&nbsp;2, 2021, the Board held a
special meeting. Also present were members of management and representatives of O&#146;Melveny. The Board discussed the formation of an advisory committee of the Board to explore potential strategic transactions, including (among other things)
capital raising activities. Following such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
discussion, the Board approved the formation of the Strategic Alternatives and Operating Committee, which we refer to herein as the &#147;Strategic Committee&#148;, to generally assist the Board
in the negotiation, consideration, review and evaluation of a potential acquisition of Sonim and other strategic alternative transactions involving Sonim, including capital raising activities and certain operating matters. Ms.&nbsp;Sue Swenson and
Messrs. Mike Mulica and Ken Naumann, each being members of the Board, were appointed members of the Strategic Committee. Following such meeting, management and certain members of the Board interviewed B. Riley and the Prior Financial Advisor to
potentially engage one as Sonim&#146;s financial advisor in connection with its current review and consideration of potential strategic transactions. After such interviews the members of the Board (with Mr.&nbsp;Kenny Young, a then current member of
the Board recusing himself as he is the Chief Executive Officer of B. Riley) stated their approval of the engagement of B. Riley to serve as Sonim&#146;s financial advisor in connection with its review and consideration of potential strategic
transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following the formation of the Strategic Committee, the members of the Strategic Committee, from time to time, had
discussions, which at times included management and representatives of B. Riley, regarding potential strategic transactions, capital financing transactions and matters relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On May&nbsp;10, 2021, Sonim entered into an engagement letter with B. Riley. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on May&nbsp;10, 2021, Sonim terminated its engagement with the Prior Financial Advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On May&nbsp;23, 2021, the Board held a special meeting. Also present were members of management and a representative of O&#146;Melveny. The
Board discussed the ATM program, including the status of the documentation for such transaction and the steps involved for launching the ATM program. Following such discussion, the Board approved, with Messrs. Alan Howe and Young, both members of
the Board, abstaining, the ATM program with B. Riley and authorized the Strategic Committee to (i)&nbsp;from time to time in its discretion select additional investment banks to serve as sales agents and approve any sales agreements with such
additional sales agents, (ii)&nbsp;negotiate the terms and provisions to be contained in, and to authorize the execution delivery and performance of, the sales agreement, (iii)&nbsp;approve and authorize certain Sonim officers to take all actions
that the Strategic Committee determines to be necessary or advisable to effect the sale of shares of common stock of Sonim pursuant to the ATM program, and (iv)&nbsp;determine from time to time the number and/or minimum price or specified dollar
value of shares of common stock of Sonim to be issued and sold by Sonim, not to exceed a specified amount, through the sales agents pursuant to the sales agreement. Thereafter, Sonim, together with its advisors, commenced work on preparing for an
ATM program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On May&nbsp;26, 2021, representatives of B. Riley contacted representatives of a potential strategic partner, which we refer
to herein as &#147;Party A&#148;, regarding a potential strategic transaction with Sonim, including the letters of intent delivered by Party A to representatives of Sonim prior to such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;1, 2021, representatives of a potential strategic partner, a private company which we refer to herein as &#147;Party B&#148;,
contacted representatives of B. Riley, on behalf of Sonim to discuss a potential strategic transaction between Party B and Sonim. The representatives of Party B that contacted representatives of B. Riley was another advising team of B. Riley, which
we refer to herein as the &#147;Party B Advisors.&#148; Representatives of B. Riley informed management and members of the Strategic Committee of the outreach from the Party B Advisors and the affiliation with the Party B Advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;5, 2021, the Board held a special meeting. Also present was a member of management, a representative of O&#146;Melveny and a
representative of B. Riley. B. Riley provided the Board with an overview of potential strategic transactions, including a potential strategic transaction with Party B, and the Board discussed and asked questions of B. Riley. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;6, 2021, members of the Strategic Committee discussed with the chief executive officer and chief financial officer of Party B a
potential strategic transaction between Party B and Sonim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On or around June&nbsp;8, 2021, Sonim and Party B entered into a confidentiality agreement,
which agreement included a customary standstill provision that would automatically terminate upon Sonim&#146;s entry into the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On or around June&nbsp;9, 2021, the Strategic Committee had discussions regarding the need to move forward with pursuing potential strategic
transactions, in particular given the complexity and timing uncertainty associated with an ATM program. The Strategic Committee then expressed their support in commencing a more formal process to evaluate and consideration potential strategic
transactions, including that B. Riley should reach out to potential strategic partners regarding such a transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;11,
2021, representatives of B. Riley contacted representatives of a potential strategic partner, which we refer to herein as &#147;Party C&#148;, regarding a potential strategic transaction with Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on June&nbsp;11, 2021, members of the Strategic Committee and representatives of B. Riley discussed with representatives of Party B the
cash position of Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;13, 2021, the Board held a special meeting. Also present were members of management. The Board
discussed Sonim&#146;s liquidity position and following such discussion, the Board directed management to pursue fundraising opportunities and review and conserve a minimum cash balance that would be required for an orderly bankruptcy filing if the
Company&#146;s fundraising efforts were not successful. The Board then discussed potential strategic alternative transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
June&nbsp;15, 2021, Sonim and Party A entered into a confidentiality and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, which did not contain a standstill provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on June&nbsp;15, 2021, management and representatives of Party B held a meeting during which management presented on Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;16, 2021, the Board held a special meeting. Also present were members of management, a representative of O&#146;Melveny and a
representative of B. Riley (for a portion of the meeting). The representative of B. Riley provided an update on potential strategic transactions. The representative of B. Riley then left the meeting. The Board continued the discussion regarding the
status of its review of potential strategic transactions. The Board then discussed that B. Riley had requested that Sonim execute a consent and waiver. The Board discussed that in February 2021, B. Riley acquired National Securities Corporation,
which we refer to herein as &#147;NSC&#148;, and that NSC then represented a potential strategic partner of Sonim, which we refer to herein as &#147;Party D&#148;, in connection with a potential strategic transaction with Sonim. The Board discussed
such relationship and the consent and waiver that B. Riley had requested that Sonim sign, which would provide that Sonim is waiving any conflict of interest as a result of the affiliation between B. Riley and NSC. The Board also discussed that B.
Riley had provided in the consent and waiver that appropriate safeguards would be implemented among the B. Riley team representing Sonim and the NSC team representing Party D. Following such discussion, the Board (with Messrs. Howe and Young recused
and Mr.&nbsp;Mulica not in attendance) determined that it was advisable and in the best interests of Sonim and its stockholders to continue to use B. Riley as its financial advisor notwithstanding B. Riley&#146;s affiliation with NSC. The Board
(with Messrs. Howe and Young recused and Mr.&nbsp;Mulica not in attendance) authorized and approved the execution and delivery of such consent and waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on June&nbsp;16, 2021, representatives of Party A delivered to representatives of B. Riley, on behalf of Sonim, a <FONT
STYLE="white-space:nowrap">non-binding</FONT> a letter of intent, which we refer to herein as the &#147;Party A Offer&#148;, which provided that (among other things)&nbsp;(a) Party A, a then privately held company, would combine with Sonim pursuant
to which the Sonim stockholders would own following such transaction 16.67% of the outstanding shares of Sonim calculated on a fully diluted basis using the treasury method for outstanding options and warrants (implying an equity value to Sonim of
$20&nbsp;million and an equity value to Party A of $100 million), (b) the current business of Sonim would be separated into a wholly owned subsidiary of Sonim and management would continue to operate such business
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with a view toward selling or disposing of the business, (c)&nbsp;each stockholder of Sonim immediately prior to the closing of such transaction would be entitled to a contingent value right
entitling the holder thereof to 90% of the consideration from the sale of the legacy Sonim business, less the costs, fees, penalties, damages and expenses associated with the resolution of the SEC investigation disclosed in Sonim&#146;s public
filings, which we refer to as the &#147;SEC Matter&#148; or the then ongoing stockholder derivative action disclosed in Sonim&#146;s public filings, which we refer to as the &#147;Stockholder Matter&#148;, in each case to the extent not covered by
insurance, and (d)&nbsp;that the composition of the Board following the closing of such transaction would be seven members, one of which is designated by Sonim and the remaining six are designated by Party A. The letter of intent also included a 60
day exclusivity period and a termination fee equal to $375,000 if Sonim received a superior unsolicited offer from a third party and Sonim terminated the letter of intent with Party A to pursue an unsolicited superior offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on June&nbsp;16, 2021, representatives of Party B informed representatives of B. Riley that Party B was in the process of preparing a
letter of intent with respect to a potential strategic transaction between Party B and Sonim and anticipated being able to provide such letter of intent in the coming days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;19, 2021, representatives of Party B delivered to representatives of B. Riley, on behalf of Sonim, a <FONT
STYLE="white-space:nowrap">non-binding</FONT> letter of intent, which provided that Sonim and Party B would combine such that Party B would become a wholly owned subsidiary of Sonim. The consideration in the transaction would be the issuance of
shares of common stock of Sonim to the Party B stockholders such that, immediately following such transaction, on a fully diluted basis, the <FONT STYLE="white-space:nowrap">pre-transaction</FONT> stockholders of Sonim would own 10% of Sonim and the
stockholders of Party B would own 85% of Sonim (with the remaining 5% being made up of equity incentive awards). The <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent also provided that a transaction between Sonim and Party B
would be conditioned on (among other things)&nbsp;(i) Sonim must have at least $5&nbsp;million of unrestricted cash at closing, net of liabilities and any amount paid with respect to the SEC Matter, (ii)&nbsp;the SEC Matter must have been or is
agreed to be settled or terminated on terms reasonably acceptable to Party B, (iii)&nbsp;the Sonim stockholders approving the transaction and (iv)&nbsp;Party B stockholders receiving freely tradable shares of Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;21, 2021, management and representatives of Party A held a meeting during which management presented on Sonim and representatives
of Party A presented on Party A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;22, 2021, representatives of B. Riley discussed with representatives of Party A the
management presentation from June&nbsp;21, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Between June&nbsp;22, 2021 and June&nbsp;29, 2021, the Board held multiple special
meetings, which were also attended by management, representatives of O&#146;Melveny and representatives of B. Riley. During these meetings, the Board discussed, together with representatives of B. Riley, the current status of discussions regarding
potential strategic transactions. The Board also reviewed, discussed and approved the carveout projections prepared by management, which were made available to the Board. In addition, the Board, together with management, also discussed potential
opportunities for raising capital, including discussing the potential benefits of having a larger the authorized limited of the ATM program than initially authorized. The Board discussed increasing the aggregate limit of Sonim&#146;s ATM program
from $5&nbsp;million to $10&nbsp;million. Following multiple meetings discussing whether to continue to pursue a potential strategic transaction or to engage in a capital raising transaction, including that a potential strategic transaction would
take longer to complete than it would to commence the ATM program and Sonim&#146;s need for additional cash, the Board determined against pursuing a potential strategic transaction at that time and to instead move forward with a capital raising
transaction and approved certain resolutions relating thereto, which provided for increasing the authorized limit of the ATM program to $10&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On or around June&nbsp;25, 2021, representatives of a potential financial investor, which we refer to herein as &#147;Party E&#148;, delivered
to representatives of B. Riley, on behalf of Sonim, a <FONT STYLE="white-space:nowrap">non-binding</FONT> term sheet providing for a registered direct offering of $5&nbsp;million. The term sheet provided that the purchase price in such offering
would be at a 20% discount to Sonim&#146;s trading price the day prior to announcement of such transaction and that Party E </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
would receive warrants. The term sheet was delivered by Party E in connection with, and dependent upon, a potential transaction between Sonim and Party A. Thereafter, representatives of Sonim and
representatives of Party E negotiated the terms of such term sheet, but ultimately did not agree upon terms and the term sheet was never executed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;29, 2021, representatives of Sonim and B. Riley delivered notices to the potential strategic partners considering a potential
strategic transaction with Sonim at this time, including Party A, Party B, Party C, Party D and Party E, that Sonim had determined not to pursue a potential strategic transaction at that time and was terminating such discussions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;30, 2021, Sonim entered into a sales agreement with B. Riley and another sales agent, EF Hutton, to sell shares of common stock
of Sonim pursuant to the ATM program up to an aggregate offering price of $10&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On July&nbsp;8, 2021, representatives of
Party A delivered to representatives of B. Riley, on behalf of Sonim, an unsolicited revised <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent, which was substantially similar to the
<FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent delivered on June&nbsp;16, 2021, but (among other things) provided that the contingent value right percentage range was from 90% to 100% of the proceeds received from selling the
legacy Sonim business (depending on how long it takes to sell such legacy Sonim business), subject to the same offsets as in the prior letter of intent and that the Sonim stockholders would own 16.67% of the outstanding shares of Sonim calculated on
a fully diluted basis using the treasury method for outstanding options and warrants (implying an equity value to Sonim of $20&nbsp;million and an equity value to Party A of $100 million). Because Sonim was engaging in the ATM program, Sonim did not
engage with Party A at this time regarding such <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Between
July&nbsp;9, 2021 and July&nbsp;26, 2021, the Board held multiple special meetings, which were also attended by management, representatives of O&#146;Melveny and representatives of B. Riley. The Board discussed, among other matters relating to
potential strategic transactions, the <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent received from Party A on July&nbsp;8, 2021 and discussed recent capital raising efforts, including through the ATM program. The Board also
discussed Sonim&#146;s current liquidity position. With the continuing capital raising process of Sonim through the ATM program, neither Sonim nor its Representatives responded to Party A&#146;s <FONT STYLE="white-space:nowrap">non-binding</FONT>
letter of intent sent on July&nbsp;8, 2021 at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On July&nbsp;16, 2021, Mr.&nbsp;Naumann resigned as a member of the Board.
Mr.&nbsp;Naumann&#146;s resignation was not due to a disagreement with Sonim on any matter relating to Sonim&#146;s operations, policies or practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On July&nbsp;21, 2021, representatives of Party A delivered to representatives of B. Riley, on behalf of Sonim, an updated unsolicited <FONT
STYLE="white-space:nowrap">non-binding</FONT> letter of intent, which was substantially similar to the letter of intent delivered on July&nbsp;8, 2021, but (among other things) provided that the contingent value right percentage range was from 87.5%
to 97.5% of the proceeds received from selling the Sonim business, subject to the same offsets as in the prior letter of intent and that the Sonim stockholders would own 14.17% of the outstanding shares of Sonim calculated on a fully diluted basis
using the treasury method for outstanding options and warrants (implying an equity value to Sonim of $17&nbsp;million and an equity value to Party A of $103 million). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On July&nbsp;26, 2021, representatives of Sonim and B. Riley had a discussion with representatives of Party A regarding the <FONT
STYLE="white-space:nowrap">non-binding</FONT> letter of intent sent by Party A to representatives of B. Riley, on behalf of Sonim, on July&nbsp;21, 2022, including informing representatives of Party A that because of the current status of
Sonim&#146;s ATM program Sonim was not going to further engage with Party A on a potential strategic transaction at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
August&nbsp;5, 2021, representatives of B. Riley discussed with representatives of Party C that the prior <FONT STYLE="white-space:nowrap">non-binding</FONT> indications of interests and <FONT STYLE="white-space:nowrap">non-binding</FONT> letters of
intent received by representatives of Sonim from representatives of Party C between October 2020 and February 2021. Representatives of B. Riley also stated that if Sonim and Party C pursue a potential transaction, even with the then current ATM
program of Sonim, Sonim may require a loan from Party C through the closing of a potential strategic transaction between such companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Representees of B. Riley then informed representatives of Party C that because of the current status of Sonim&#146;s ATM program, Sonim was not going to further engage with Party C on a potential
strategic transaction at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On September&nbsp;1, 2021, representatives of Party C delivered to representatives of B. Riley, on
behalf of Sonim, a <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest pursuant to which Party C expressed its desire to acquire certain assets of Sonim, including accounts receivable and finished gods inventory. The
indication of interest indicated that the value of such assets was approximately $14.4&nbsp;million, but did not include a specific offer price for such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On September&nbsp;15, 2021, in order to regain compliance with the Nasdaq listing rules, Sonim effected a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-for-10</FONT></FONT> reverse stock split of its issued and outstanding shares of common stock on that date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On September&nbsp;6, 2021, the Board held a special meeting. Also present were members of management and representatives of B. Riley (for a
portion of the meeting). Representatives of B. Riley provided the Board with an overview of potential strategic transactions, including the offer received from Party C on September&nbsp;1, 2021. Following such discussion, the Board determined that,
based on the terms of the offer from Party C, including that the offer was to purchase balance sheet assets, the offer from Party C received on September&nbsp;1, 2021 was not in the best interests of the Company&#146;s stockholders and that Sonim
would decline the offer from Party C. Representatives of B. Riley left the meeting and the Board then continued discussing potential strategic transactions and potential capital raising transactions. Thereafter, representatives of B. Riley informed
Party C of the Board&#146;s determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On September&nbsp;17, 2021, the Board held a special meeting. Also present were members of
management. The Board, together with management, discussed the current status of discussions regarding potential strategic transactions. In addition, the Board, together with management, also discussed potential strategic opportunities for raising
capital. The Board discussed that it had previously authorized an ATM program for an aggregate amount of $10&nbsp;million and discussed increasing such authorized limited to approximately $41.6&nbsp;million. Following discussion whether to continue
to pursue a potential strategic alternative transaction or to engage in a capital raising transaction and taking into consideration (among other things) the cash needs of Sonim and that any potential strategic transaction would take more time to
complete and require capital to complete, the Board determined not to pursue a potential strategic transaction at this time and instead to move forward with a capital raising transaction and approved increasing the authorized limit of the ATM
program to approximately $41.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On September&nbsp;23, 2021, Sonim entered into a sales agreement with B. Riley to sell
shares of common stock of Sonim pursuant to the ATM program up to an aggregate offering price of approximately $41.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
September&nbsp;27, 2021, Sonim opened its ATM program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On October&nbsp;15, 2021, Sonim halted its ATM program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October 2021, Dr. Charles Wang and other members of the Wang family, including those who subsequently arranged the formation of the
Purchaser and became its sole equityholders, informally approached Mr.&nbsp;Peter Liu, then the Executive Vice President for Global Operations and Engineering of Sonim, and inquired about the possibilities of investing in or purchasing Sonim. Mr.
Liu subsequently discussed the same with Mr.&nbsp;Tirva. Thereafter, Mr.&nbsp;Liu introduced Mr. Tirva to the Wang family. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
November&nbsp;1, 2021, Sonim and an entity associated with Purchaser entered into a <FONT STYLE="white-space:nowrap">One-Way</FONT> <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement,
which<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>did not include a standstill provision. Thereafter, representatives of Sonim had periodic discussions with representatives of Purchaser regarding a potential strategic transaction between
Sonim and Purchaser, but such discussions ceased prior to November&nbsp;15, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On November&nbsp;15, 2021, Sonim opened its ATM program for the sale of additional shares of
common stock of Sonim and halted such program on November&nbsp;16, 2021 as a result of Sonim&#146;s stock price being below the minimum stock price established by the Board in the ATM program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;3, 2021, the Board held a special meeting. Also present were members of management and a representative of O&#146;Melveny.
The Board discussed the current status of the ATM program and approved adjusting the ATM floor price to an amount below $1.00 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;6, 2021, representatives of Purchaser delivered to Sonim, an unsolicited <FONT STYLE="white-space:nowrap">non-binding</FONT>
letter of intent, which we refer to herein as the &#147;Initial Purchaser Offer&#148;, which provided (among other things): (a) for the investment of $15&nbsp;million in Sonim for at least 51% ownership at an above market price, with the transaction
closing in two tranches whereby at the first closing the Purchaser would invest $5&nbsp;million and at the second closes the Purchaser would invest $10&nbsp;million (which would be 6 months after the first closing, (b)&nbsp;as a condition to the
first closing, Mr.&nbsp;Liu, be appointed the chief executive officer of Sonim (c)&nbsp;all transaction expenses of Purchaser are paid from proceeds from the transaction and (d)&nbsp;that Purchaser would be entitled to indemnification. Sonim did not
discuss with Purchaser this <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on December&nbsp;6,
2021, Sonim reopened its ATM program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;4, 2021, Sonim halted its ATM program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;5, 2022, at the request of certain members of the Board, representatives of B. Riley contacted representatives of a potential
strategic partner, which we refer to herein as &#147;Party F&#148;, regarding a potential strategic transaction with Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Later on
January&nbsp;5, 2022, Sonim and Party F entered into a Mutual Confidentiality Agreement, which agreement included a customary standstill provision that would automatically terminate upon Sonim&#146;s entry into the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on January&nbsp;5, 2022, management and representatives of Party F held a meeting during which management presented on Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;7, 2022, the Board held a special meeting. Also present were members of management and a representative of O&#146;Melveny. The
Board discussed, together with management, the financial position of Sonim as well as a presentation prepared by management regarding the same, including that Sonim&#146;s then current cash position was approximately $10&nbsp;million, but that
management believed that Sonim&#146;s cash position would trend downward toward approximately $2&nbsp;million in the second quarter of 2022 without any additional cash from the ATM program. The Board then discussed that (i)&nbsp;Sonim had sufficient
cash to continue operations at its current spending rates until the end of June 2022, but did not expect to have sufficient cash to launch its new products in the fourth quarter of 2022, (ii) that the ATM program had been generally successful in
raising capital to continue operations, but that with the end of 2021, Sonim would not continue the ATM program until the 2021 audit was completed and publicly disclosed and (iii)&nbsp;that this period provided an opportunity for Board to consider
potential strategic transactions. The Board then discussed the Initial Purchaser Offer and the potential for Sonim to pursue a potential strategic transaction. Following such discussion, the Board determined that it was advisable and in the best
interests of the Company and its stockholders to evaluate and consider potential strategic transactions and, in light of the pending 2021 audit as well as the desire to pursue a potential strategic transaction, to halt the ATM program at this time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;10, 2022, representatives of B. Riley, management and certain members of the Board (which included Ms.&nbsp;Swenson and
Messrs. Mulica and John Kneuer, a member of the Board) had an informal discussion regarding pursuing a potential strategic transaction. Representatives of B. Riley reviewed materials regarding potential strategic partners. Following such discussion,
such Board members expressed their support for B. Riley to reach out to potential strategic partners regarding a potential strategic transaction with Sonim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;10, 2022, representatives of B. Riley first connected with representatives
of Purchaser regarding a potential strategic transaction with Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;18, 2022, representatives of B. Riley, management
and certain members of the Board (which included Ms.&nbsp;Swenson and Messrs. Mulica and Kneuer) had an informal discussion regarding the current status a potential strategic transaction its discussions with potential strategic partners. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;20, 2022, representatives of B. Riley had an introductory discussion with representatives of Purchaser, including that
Purchaser was in the process of engaging a financial advisor and legal counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on January&nbsp;20, 2022, management and
representatives of Purchaser held a meeting during which management presented on Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;24, 2022, representatives of
Party C delivered to representatives of B. Riley, on behalf of Sonim, a <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest substantially similar to the <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of
interest delivered on September&nbsp;1, 2022, except that this updated indication of interest provided that the value of the assets to be acquired was approximately $8.69&nbsp;million, but again did not include a specific offer price for such
assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;26, 2022, representatives of Purchaser introduced representatives of B. Riley to Purchaser&#146;s financial
advisor and legal counsel. Representatives of B. Riley and representatives of Purchaser discussed the terms of the Initial Purchaser Offer, including the amount of cash to be invested and the valuation of Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;27, 2022, Sonim granted access to an electronic data room to Purchaser and its advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On January&nbsp;31, 2022, Party A resubmitted its <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent for a potential
strategic transaction with Sonim to representatives of B. Riley, on behalf of Sonim, and included a presentation regarding an overview of Party A and a recent acquisition by Party A, which was made available to the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;3, 2022, the Board held a special meeting. Also present were members of management and a representative of O&#146;Melveny.
The Board discussed that B. Riley had been engaged by Party F for a financing matter unrelated to a potential strategic transaction between Sonim and Party F. The Board discussed whether to engage a different financial advisor in light of the
relationship between B. Riley and Party F. The Board decided not to make a decision regarding whether to engage a new financial advisor at this time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on February&nbsp;3, 2022, Mr.&nbsp;Young resigned as a member of the Board. Mr.&nbsp;Young&#146;s resignation was not due to a
disagreement with Sonim on any matter relating to Sonim&#146;s operations, policies or practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;9, 2022,
representatives of Purchaser redelivered to representatives of B. Riley, on behalf of Sonim, the Initial Purchaser Offer together with a presentation providing information regarding Purchaser&#146;s business plans with respect to Sonim following the
closing of the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on February&nbsp;9, 2022, the Board held a special meeting. Also present were members of management and
a representative of O&#146;Melveny. The Board again discussed the relationship between B. Riley and Party F and determined that, because the relationship with Party F was unrelated to a potential strategic transaction with Sonim, that B. Riley had
not received any fees from Party F and that B. Riley was not actively advising Party F (notwithstanding that a formal engagement was in effect), the Board determined that it was advisable and in the best interests of the Company and its stockholders
to continue to retain B. Riley as its financial advisor during this process. The Board then discussed the Initial Purchaser Offer and decided to not make any decisions at this point regarding the Initial Purchaser Offer and to discuss further at the
next special meeting of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;11, 2022, management and representatives of Party A held a meeting during which
management provided representatives of Party A with additional information on Sonim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on February&nbsp;11, 2022, representatives of Party F delivered to representatives of
B. Riley, on behalf of Sonim, a <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent providing for the acquisition of certain assets of Sonim for $10&nbsp;million, payable in cash. The
<FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent stated that Party F may request that certain key employees of Sonim agree to remain with the business following the closing of a transaction and that certain key members of
Sonim&#146;s management team will have the opportunity to assume expanded leadership roles after the transaction. No specific employees were identified in the letter of intent. Party F also requested 30 days of exclusivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;15, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and
representatives of B. Riley. At the request of the Board, representatives of B. Riley reviewed a summary of the offers received from Purchaser, Party C and Party F to date. The Board did not discuss the offers from Party A at this time as any
potential strategic transaction with Party A was dependent on first completing a sale of substantially all of Sonim&#146;s assets. The Board discussed that the offer from Party F was $10&nbsp;million for certain assets of Sonim, but that Sonim would
retain the public company shell should it desire to pursue a potential &#147;reverse merger&#148; transaction with Party A or another counterparty. The Board discussed that the value of such a potential public company shell could be approximately
$20&nbsp;million and that with that assumption, the offer from Party F could result in an implied valuation of Sonim of approximately $39&nbsp;million (taking into account assets that would be retained by Sonim, including (among others) cash and
accounts receivable, and taking into account liabilities that would remain with Sonim following such transaction). The Board discussed that while pursuing a potential strategic transaction with Party F could result in an implied valuation of Sonim
equal to approximately $39&nbsp;million, such value was dependent not just on consummating a transaction with Party F, but also effecting a &#147;reverse merger&#148; thereafter with Party A or another counterparty and that there is meaningful deal
risk in completing that transaction. The Board then discussed the Initial Purchaser Offer, together with the presentation provided by Purchaser on February&nbsp;9, 2022. The Board noted that the presentation included projections of Sonim taking into
account the investment by Purchaser, prepared by Purchaser, and the Board expressly stated that the Board would not rely on such projections and instructed B. Riley likewise not to rely on such projections. The Board discussed that the implied
valuation of Sonim based on the Initial Purchaser Offer was between $27.1&nbsp;million to $39.3&nbsp;million (with such range due to Sonim&#146;s future cash flows discounted at a range of different discount rates). The Board then discussed that the
implied valuation of Sonim based on Party C&#146;s offer delivered on January&nbsp;24, 2022 was approximately $32.2&nbsp;million. Following such discussion, the Board instructed representatives of B. Riley to communicate to Party C and Party F,
separately, that each should provide their best and final offers. The Board also stated that B. Riley should continue to work with Party A on negotiating a potential &#147;reverse merger&#148; transaction and that the signing of any such transaction
with Party A should be subject to resolution of the SEC Matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;16, 2022, representatives of B. Riley stated separately
to representatives of Party C and Party F that Party C and Party F, respectively, should deliver a best and final offer with respect to a potential strategic transaction with Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on February&nbsp;16, 2022, Sonim received a deficiency letter from the Listing Qualifications Department of Nasdaq notifying Sonim that,
for the last 30 consecutive business days, the bid price for Sonim&#146;s common stock had closed below $1.00 per share, which is the minimum closing price required to maintain continued listing on Nasdaq under Nasdaq list rules. In accordance with
Nasdaq listing rules, the Company had 180 calendar days to regain compliance with such requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;22, 2022, the Board
held a special meeting. Also present was a member of management, a representative of O&#146;Melveny and representatives of B. Riley. The Board discussed a potential strategic transaction with Purchaser, including whether any potential regulatory
filings beyond the filings with the SEC would be required in connection with the potential investment transaction. Following such discussion, the Board instructed the representative of O&#146;Melveny to discuss with representatives of Venable
whether the potential investment transaction would be subject to any regulatory approvals or clearances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;23, 2022, representatives of O&#146;Melveny and representatives of Venable
discussed whether potential regulatory approvals or clearances would be required in connection with the potential investment transaction between Sonim and Purchaser, beyond filings with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on February&nbsp;23, 2022, management and representatives of Party C held a meeting during which management presented on Sonim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;24, 2022, representatives of B. Riley discussed with representatives of Purchaser the terms of the offer provided by
Purchaser on February&nbsp;9, 2022 and potential revisions to such offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;25, 2022, management and representatives of
Party C held a meeting during which management provided representatives of Party C with additional information on Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on
February&nbsp;25, 2022, the Board held a special meeting. Also present was a member of management, a representative of O&#146;Melveny and representatives of B. Riley. At the request of the Board, the representative of O&#146;Melveny reported to the
Board on the discussions with Venable regarding whether any regulatory approvals are required in connection with the potential transaction and stated that, based on the statements made by Venable on such call, it was not expected that any regulatory
approvals or clearances would be required in connection with the potential transaction, other than filings with the SEC. The Board then discussed the structure of a potential transaction with Purchaser, including the requirement for Sonim
stockholder approval. The Board also discussed the terms of the <FONT STYLE="white-space:nowrap">non-binding</FONT> offer received from Purchaser on February&nbsp;9, 2022, including the size of the investment, the percentage ownership of the
Purchaser based on the size of such investment, the desire to have certain members of the Board continue as members of the Board following the closing of such potential investment transaction until the resolution of the SEC Matter given the
historical knowledge of the current members of the Board regarding the SEC Matter, that Purchaser would pay for its own expenses out of investment transaction proceeds and Purchaser&#146;s request for indemnification. Following such discussion, the
Board instructed that the <FONT STYLE="white-space:nowrap">non-binding</FONT> offer from the Purchaser be revised to provide (a)&nbsp;that the investment amount be $17.5&nbsp;million for the purchase of 48% ownership of Sonim, which will close in
one tranche, (b)&nbsp;that the per share purchase price be $0.98 per share, (c)&nbsp;that certain current directors of Sonim would continue on the Board following the closing until resolution of the SEC Matter, (d)&nbsp;that Purchaser will pay its
own expenses, which cannot be paid out of the investment transaction proceeds and (e)&nbsp;that the right of Purchaser to indemnification be removed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;26, 2022, the Board held a special meeting. Also present was a member of management, a representative of O&#146;Melveny and
representatives of B. Riley. At the request of the Board, representatives of B. Riley provided an update regarding the status of discussions with Party C and Party F. Representatives of B. Riley reported to the Board that Party C had not submitted
any additional indication of interest or letter of intent since the <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest provided on January&nbsp;24, 2022 and that representatives of B. Riley had instructed Party C to formulate
a valuation and deal structure for a potential strategic transaction with Sonim, but that, to date, Party C had not done so. Representatives of B. Riley then discussed the <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent
delivered by Party F on February&nbsp;11, 2022 to acquire certain assets of Sonim and that since delivery of such letter on February&nbsp;11, 2022, Party F had verbally increased its offer price for such assets from $10&nbsp;million to
$11.25&nbsp;million. Representatives of B. Riley reported that Party F had stated that it would not increase its offer price beyond $11.25&nbsp;million for such assets of Sonim. Representatives of B. Riley then discussed that a call was scheduled
with representatives of Party F for March&nbsp;1, 2022 regarding the potential transaction structure. The Board then discussed that if Sonim were to pursue a potential strategic transaction with Party F, following the closing thereof, it may seek a
potential &#147;reverse merger&#148; transaction whereby, as a public shell company with no further operations, a private company, such as Party A, could merge with and into Sonim (or a wholly owned subsidiary thereof) such that the merging private
company would then become a public company. Representatives of B. Riley and of O&#146;Melveny then reviewed for the Board the revised Initial Purchaser Offer, which was made available to the Board prior to the meeting. The Board then discussed the
terms of such revised Initial Purchaser Offer. The Board also discussed that, to date, Purchaser had not requested exclusivity. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Board then discussed that Purchaser had been in contact with Mr.&nbsp;Liu and that it was Purchaser&#146;s intention that Mr.&nbsp;Liu become the Chief Executive Officer of Sonim. The Board
discussed that, as of such time, to its knowledge and based on inquires made of representatives of Purchaser, Mr.&nbsp;Liu was not currently expected to be an equityholder in Purchaser. Following such discussion, the Board instructed representatives
of B. Riley to (a)&nbsp;send the revised offer to Purchaser and (b)&nbsp;to continue discussions with Party C and Party F regarding a potential strategic transaction, including encouraging Party C to provide a valuation and deal structure for a
potential strategic transaction with Sonim and to hold the conference call with representatives of Party F on March&nbsp;1, 2022. The Board stated that if Purchaser requested exclusivity, it would evaluate such request at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Later on February&nbsp;26, 2022, representatives of B. Riley, on behalf of Sonim, delivered to representatives of Purchaser a revised draft of
the Initial Purchaser Offer, which we refer to herein as the &#147;Revised Offer&#148;, whereby Sonim revised the draft to provide: (a)&nbsp;that the investment amount is $17.5&nbsp;million for the purchase of 48% ownership of Sonim, which will
close in one tranche, (b)&nbsp;that the per share purchase price be $0.98 per share, (c)&nbsp;that certain current directors of Sonim would continue as members of the Board following the closing until resolution of the SEC Matter, (d)&nbsp;that
Purchaser will pay its own expenses, which cannot be paid out of the investment transaction proceeds and (e)&nbsp;that the right of Purchaser to indemnification is removed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;28, 2022, representatives of Purchaser delivered to representatives of B. Riley, on behalf of Sonim, a response to the
Revised Offer, which we refer to herein as &#147;Purchaser&#146;s Response&#148;, whereby it was communicated that (a)&nbsp;Purchaser accepted the increased investment amount of $17.5&nbsp;million, but stated that it required that such investment
result in Purchaser owning 52% of the outstanding capital stock of Sonim, which results in an effective price per share of approximately $0.84, (b) Purchaser desired that the transaction be closed in two tranches, the first being for
$12.5&nbsp;million and the second occurring in the third calendar quarter of 2022 for $5&nbsp;million, (c)&nbsp;Purchaser reserves on points relating to the SEC Matter and indemnification rights and (d)&nbsp;Purchaser desired that Sonim start to
implement its business plan as early as possible and that Sonim would be cooperative and supportive of such strategy, including appointing Mr.&nbsp;Liu as the Chief Executive Officer of Sonim concurrent with signing the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;1, 2022, representatives of B. Riley and O&#146;Melveny discussed with representatives of Party F potential transaction
structures and certain other potential deal terms relating to a potential strategic transaction between Sonim and Party F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Later on
March&nbsp;1, 2022, the Board held a special meeting. Also present was a member of management, a representative of O&#146;Melveny and representatives of B. Riley. At the request of the Board, representatives of B. Riley reviewed the status of the
potential strategic transactions with Party C, Party F and Purchaser. Representatives of B. Riley reported to the Board that Party C had not yet formed a conclusion regarding an updated proposal for a potential strategic transaction with Sonim.
Representatives of B. Riley and of O&#146;Melveny then discussed the conference call they had earlier in the day with representatives of Party F, including discussion topics relating to the structure of a transaction with Party F, the assets that
would be acquired, the liabilities that would be assumed (if any) and whether Party F would be entitled to indemnification. Representatives of B. Riley informed the Board that Party F had reiterated its request for 30 days of exclusivity.
Representatives of B. Riley then summarized for the Board the Purchaser&#146;s Response. The Board discussed that Purchaser had communicated the desire to start to implement Purchaser&#146;s business plan as early as possible and that Purchaser did
not want to wait until May 2022 or later to start implementing its business plan for Sonim. The Board then discussed the request to appoint Mr.&nbsp;Liu as Chief Executive Officer concurrent with the signing of the Subscription Agreement. The Board
then asked representatives of B. Riley whether Purchaser had requested exclusivity and B. Riley responded that Purchaser had not made a request to date for exclusivity. The Board then further discussed the Purchaser&#146;s Response, including (among
other things) that (i)&nbsp;Purchaser had previously provided to the Board a presentation providing information regarding Purchaser&#146;s business plans for the <FONT STYLE="white-space:nowrap">go-forward</FONT> company, (ii)&nbsp;that the
potential transaction with Purchaser allowed Sonim&#146;s current stockholders to continue to hold an equity interest in Sonim and may realize any potential increase in value of Sonim should Purchaser achieve some or all of its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
business plan for Sonim, (iii)&nbsp;the implied value of Sonim of approximately $33.7&nbsp;million in the potential transaction with Purchaser, (iv)&nbsp;that Party C had not moved with as much
speed as Purchaser and had not provided a final letter of intent setting forth valuation and structure for a transaction and (v)&nbsp;that the transaction with Party F involved unique complexity and uncertainty than the transaction with Purchaser as
the transaction with Party F required a sale of assets (including likely third party consents to consummate the transaction) and following such sale, the Board would look to sell the Sonim &#147;shell&#148; company in a reverse merger. Following
such discussion, the Board instructed representatives of B. Riley to inform representatives of Purchaser that the Board would continue to pursue a potential strategic transaction with Purchaser pursuant to the terms outlined in the Revised Offer, as
modified by Purchaser&#146;s Response, subject to further discussion regarding the implementation of Purchaser&#146;s business plan and appointing Mr.&nbsp;Liu Chief Executive Officer of Sonim prior to the first closing. Representatives of B. Riley
then left the meeting and the Board discussed the desire to have B. Riley deliver a fairness opinion in connection with the contemplated transaction with Purchaser. The Board stated that it was desirable and in the best interests of Sonim and its
stockholders for the Board to obtain a fairness opinion from B. Riley in connection with the contemplated transaction with Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
March&nbsp;3, 2022, Sonim granted access to an electronic data room to Party C, but prior to such time, representatives of B. Riley and management were delivering to Party C diligence information and materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on March&nbsp;3, 2022, representatives of Venable, on behalf of Purchaser, requested that Sonim grant Purchaser exclusivity through
March&nbsp;31, 2022 and delivered a draft exclusivity agreement. Thereafter, representatives of B. Riley alerted the Board to the request for exclusivity from representatives of Venable, on behalf of Purchaser. The members of the Board expressed
that they were willing to agree to exclusivity, but wanted the exclusivity period to expire on March&nbsp;15, 2022. Representatives of O&#146;Melveny then revised the draft exclusivity agreement to, among other changes, reflect the expiration of the
exclusivity period as March&nbsp;15, 2022 and delivered the revised exclusivity agreement to representatives of Venable. Representatives of Venable never responded to the revised draft of the exclusivity agreement and prior to the execution of the
Subscription Agreement, Sonim never entered into exclusivity with Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;4, 2022, representatives of O&#146;Melveny
discussed with representatives of Venable the SEC Matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on March&nbsp;4, 2022, representatives of Party C delivered to
representatives of B. Riley, on behalf of Sonim, an updated <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest, which provided (among other things) that Party C was seeking to acquire selected accounts receivable and selected
inventory (including finished goods inventory and PCBA (printed circuit board assembly) inventory, subject to further diligence), which it stated had a value of approximately $14.395&nbsp;million. The indication of interest again did not include a
specific offer price. The <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest also provided that all current carrier and key OEM and supplier contracts under which Sonim operates would be included as part of the asset
transfer. In addition, Party C stated in the <FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest that Party C would be interested in retaining select employees and that any costs associated with the termination of the
employment of any employees would be the responsibility of Sonim. No specific persons were identified as employees that Party C was potentially interested in retaining. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On or around March&nbsp;4, 2022, representatives of B. Riley discussed with representatives of Party C the
<FONT STYLE="white-space:nowrap">non-binding</FONT> indication of interest sent by Party C on that day, including that Party C needed to improve its offer and that it would be helpful if Party C could conduct further due diligence regarding the
current financial position of Sonim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;7, 2022, representatives of O&#146;Melveny delivered the initial draft of the
Subscription Agreement to representatives of Venable, which included, among other things (a)&nbsp;a provision providing that at least two current directors of the Board (or one current Director and Mr.&nbsp;Tirva) would continue to serve on the
Board and would constitute the sole members of a select matters committee of the Board, which would have sole and exclusive authority to address, negotiate and resolve the SEC Matter, <FONT STYLE="white-space:nowrap">(b)&nbsp;non-solicitation</FONT>
and deal protection provisions and related termination rights and fees, including that the Sonim termination fee would equal $300,000 payable if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Subscription Agreement is terminated due to an adverse recommendation change or the acceptance of a superior proposal, (c)&nbsp;the right of Sonim to seek to amend its certificate of
incorporation to provide that following the closing of the transaction, any transaction whereby Purchaser or an affiliate of Purchaser seeks to take Sonim private, a majority of the unaffiliated stockholders of Sonim would be required to approve,
(d)&nbsp;that Mr.&nbsp;Liu would be appointed Chief Executive Officer of Sonim concurrent with the first closing and (e)&nbsp;that the representations and warranties of Sonim in the Subscription Agreement do not survive the closing of the
transaction and thus there is no indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;8, 2022, the Board held a special meeting. Also present was a member of
management, representatives of O&#146;Melveny and representatives of B. Riley. At the request of the Board, representatives of B. Riley provided the Board with an update that Party C was continuing to do work on a valuation and transaction structure
and that there were no new developments with Party F since the Board determined not enter into an exclusivity agreement with Party F. Representatives of O&#146;Melveny reported to the Board that the initial draft of the Subscription Agreement was
delivered to representatives of B. Riley on March&nbsp;7, 2022. Representatives of O&#146;Melveny reviewed with the Board certain of the material terms in the initial draft of the Subscription Agreement. Representatives of O&#146;Melveny also noted
for the Board that it had not received a response from representatives of Venable to the revised exclusivity agreement. Management discussed with the Board that Party C had requested a diligence conference call with Mr.&nbsp;Liu. The Board
determined that it was acceptable to have Mr.&nbsp;Liu attend such due diligence call with representatives of Party C, but that representatives of B. Riley should also attend such call. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;11, 2022, Mr.&nbsp;Liu and representatives of Party C held a meeting during which management provided representatives of Party C
with additional information on Sonim. Representatives of B. Riley as well as another member of management attended the call. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On
March&nbsp;15, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and representatives of B. Riley. The Board discussed the qualitative aspects of Purchaser&#146;s business plan for
Sonim and the fact that the value of Sonim may increase based on Purchaser achieving some or all of its business plan. The Board then discussed potential transaction costs, including advisor expenses and the cost of a director and officer tail
insurance policy. The Board discussed that, to date, Purchaser had not requested information regarding the potential cost of a director and officer tail insurance policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Later on March&nbsp;15, 2022, representatives of Party C delivered to representatives of B. Riley, on behalf of Sonim, a <FONT
STYLE="white-space:nowrap">non-binding</FONT> letter of intent, which provided (among other things) that Party C would acquire certain assets for a purchase price of $10&nbsp;million, subject to adjustments as provided in any definitive agreement.
The <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent provided that Party C would not acquire any liabilities from Sonim and that Party C would acquire, among other assets identified in due diligence, Sonim&#146;s key customer and
supplier contracts. The <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent included a request for 45 days of exclusivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;19, 2022, representatives of Venable delivered to representatives of O&#146;Melveny, on behalf of Sonim, a list of certain
issues in the initial draft of the Subscription Agreement, including (among others)&nbsp;(a) that Mr.&nbsp;Liu should be appointed Chief Executive Officer of Sonim concurrent with the signing of the Subscription Agreement and that Sonim will make
its best efforts to implement Purchaser&#146;s business plan, subject to the Board&#146;s fiduciary duties, (b)&nbsp;that Sonim would owe Purchaser a fee of $500,000 if Sonim&#146;s stockholders do not approve the transaction or would owe Purchaser
a fee of $1,500,000 if the Subscription Agreement is terminated as a result of an adverse recommendation change, due to Sonim&#146;s acceptance of a superior proposal or as a result of a breach of the
<FONT STYLE="white-space:nowrap">no-solicitation</FONT> provision, (c)&nbsp;that Purchaser be entitled to receive additional shares of common stock of Sonim in the amount of any fines or expenses incurred by Sonim in connection with the SEC Matter,
which we refer to herein as the &#147;SEC Matter <FONT STYLE="white-space:nowrap">True-Up&#148;,</FONT> (d) that the Subscription Agreement include indemnification and (e)&nbsp;Sonim, as a condition to closing the transaction, must be in compliance
with Nasdaq continuous listing rules, which may include effecting a reverse stock split. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;22, 2022, representatives of Venable and representatives of O&#146;Melveny
discussed the issues list delivered by representatives of Venable to representatives of O&#146;Melveny on March&nbsp;19, 2022, including Sonim&#146;s positions (a)&nbsp;that Mr.&nbsp;Liu be appointed as Chief Executive Officer of Sonim concurrent
with the first closing, (b)&nbsp;that Sonim would anticipate cooperating with Purchaser with respect to the implementation of its business plan prior to the first closing, but would not be required contractually to agree to implement the plan,
(c)&nbsp;proposing an expense reimbursement provision payable by Sonim to Purchaser if the Sonim stockholders do not approve the transaction with such obligation capped at $250,000, (d) proposing a $500,000 termination fee in the event of a
termination of the Subscription Agreement for an adverse recommendation change, the acceptance of a superior proposal or a material and willful breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions in the Subscription
Agreement, (e)&nbsp;that Sonim would accept the SEC Matter <FONT STYLE="white-space:nowrap">True-Up,</FONT> (f)&nbsp;that indemnification by Sonim in favor of Purchaser was not acceptable and (g)&nbsp;that Sonim would accept including a reverse
stock split proposal in its proxy statement for the special meeting of stockholders to approve the deal, but that approval of such proposal by the Sonim stockholders would not be a condition to closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Later on March&nbsp;22, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and
representatives of B. Riley. At the request of the Board, representatives of O&#146;Melveny summarized its discussion with representatives of Venable regarding the issues list to the Subscription Agreement, including that such issues were not
resolved on the call and that representatives of Venable would get back to representatives of O&#146;Melveny regarding the issues list. Representatives of O&#146;Melveny then discussed with the Board its fiduciary duties in connection with the
contemplated transaction with Purchaser, including as it relates to any implementation of Purchaser&#146;s business plan. The Board then discussed that it had reviewed Purchaser&#146;s business plan, but that it would be beneficial to schedule a
diligence conference call with representatives of Purchaser and Mr.&nbsp;Liu to discuss the business plan to better assess such plan. Following such discussion, the Board instructed representatives of B. Riley to organize such diligence conference
call. The Board also discussed the <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent received from Party C on March&nbsp;15, 2022 and determined not to further proceed with Party C regarding a potential strategic transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;24, 2022, representatives of Venable delivered to representatives of O&#146;Melveny, on behalf of Sonim, an updated issues list
in which Purchaser conveyed that (a)&nbsp;Mr.&nbsp;Liu must be appointed Chief Executive Officer of Sonim concurrent with signing the Subscription Agreement and that such position of Purchaser was a &#147;deal braker&#148;, (b) Sonim commence
implementing Purchaser&#146;s business plan concurrent with signing of the Subscription Agreement and that such position of Purchaser was a &#147;deal braker&#148;, (c) Purchaser generally accepted Sonim&#146;s positions on expense reimbursement and
the termination fee, but proposed an expense reimbursement cap of $350,000 and a termination fee of $750,000, (d) accepted that Sonim would not indemnify Purchaser and (e)&nbsp;accepted that approval of the reverse stock split would not be a
condition to closing, but required as a condition to closing that Sonim be in compliance with Nasdaq continuous listing rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Between
March&nbsp;24, 2022 and April&nbsp;4, 2022, representatives of Venable and representatives of O&#146;Melveny, on behalf of Sonim, corresponded regarding the open points in the issues list, including that Sonim would agree to appoint Mr.&nbsp;Liu as
Chief Executive Officer of Sonim concurrent with the signing of the Subscription Agreement, that Sonim would agree to implement Purchaser&#146;s business plan prior to the first closing, subject to compliance with applicable laws and the
Board&#146;s fiduciary duties and regarding Purchaser&#146;s request to condition the transaction on Sonim&#146;s compliance with Nasdaq continuous listing rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;25, 2022, management and the Board, on the one hand, and representatives of Purchaser, on the other hand, held a meeting during
which Purchaser provided management and the Board information regarding Purchaser&#146;s business plan for Sonim following the closing of the transaction, including (i)&nbsp;the creation of a new product roadmap encompassing mobile carrier expansion
proposals and pricing; (ii)&nbsp;entry into the <FONT STYLE="white-space:nowrap">semi-rug</FONT> market; (iii)&nbsp;addressing the market need of <FONT STYLE="white-space:nowrap">5G-capable</FONT> devices; (iv)&nbsp;development of a
performance-based KPI and incentives for employees and contractors with a focus on result-oriented growth of Sonim; (v)&nbsp;evaluation of the need for introduction of new key positions and roles in the marketing division; (vi)&nbsp;review and
revision of the sales commission plan in order to optimize the volume growth incentive; and (vii)&nbsp;shift the focus of sales on mobile carriers as opposed to other distribution channels. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Also on March&nbsp;25, 2022, management delivered to B. Riley the management projections for
B. Riley&#146;s use with respect to its fairness analysis. The management projections were derived from the carveout projections reviewed by the Board in June 2021, with management updating the management projections to reflect a <FONT
STYLE="white-space:nowrap">non-carve</FONT> out strategic transaction in which Sonim continues to incur customary overhead expenses of a publicly listed company, which resulted in an add back of such expenses, and with management updating the
management projections to reflect results of operations since the preparation of the carveout projections and refining the management projections to reflect the best currently available estimates and judgments of Sonim&#146;s management at such
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;27, 2022, the Board held a special meeting. Also present was a member of management, representatives of
O&#146;Melveny and representatives of B. Riley. Representatives of O&#146;Melveny discussed the current state of the open points in the issues list. The Board then discussed the cost of a director and officer tail insurance policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;29, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and
representatives of B. Riley. Representatives of O&#146;Melveny discussed the current state of the open points in the issues list, including relating to the Nasdaq continuous listing rules compliance condition. Representatives of B. Riley discussed
that it had received evidence that Purchaser has proof of funds to pay the purchase price in the first closing and that B. Riley was working on gathering the proof of funds for Purchaser to pay the purchase price in the second closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;4, 2022, representatives of Venable delivered to representatives of O&#146;Melveny, on behalf of Sonim, a revised draft of the
Subscription Agreement, which, among other things, reflected the terms agreed upon by the parties during the negotiation of the issues list. With respect to the Nasdaq compliance issue, the revised Subscription Agreement provided that as a condition
to closing, Sonim must either clear be in compliance with Nasdaq continuous listing rules or obtain an additional 180 day extension from Nasdaq in order to comply with any Nasdaq deficiency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;5, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and
representatives of B. Riley. Representatives of O&#146;Melveny discussed the revised draft of the Subscription Agreement received from representatives of Venable on April&nbsp;4, 2022, including the open point regarding the Nasdaq compliance
condition. The Board discussed scheduling a conference call with representatives of Purchaser to discuss the implications of such a condition, including on the potential timing of the first closing if such condition remains in the Subscription
Agreement and the impact of a delayed closing on the cash position of Sonim. Following such discussion, the Board instructed representatives of O&#146;Melveny to schedule such a conference call with representatives of Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;6, 2022, representatives of Purchaser, Sonim, B. Riley, Venable and O&#146;Melveny discussed, among other points, the Nasdaq
compliance condition. Following such discussion, representatives of Purchaser conveyed that Purchaser would agree to remove such condition from the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;7, 2022, the Board held a special meeting. Also present was a member of management, representatives of O&#146;Melveny and
representatives of B. Riley. Representatives of O&#146;Melveny reported on the conference call had with representatives of Purchaser on April&nbsp;7, 2022 regarding the Nasdaq compliance condition, including that Purchaser had agreed to remove the
Nasdaq compliance condition. The Board discussed Purchaser&#146;s business plan and the requirement in the Subscription Agreement that the Company in good faith commence the enhancement and optimization of the Company&#146;s business pursuant to the
strategy developed by Mr.&nbsp;Liu, which is Purchaser&#146;s business plan. The Board discussed that such obligation is conditioned on the Board&#146;s continuing determination that pursuing that strategy is not contrary to the Board&#146;s
fiduciary duties. The Board then discussed the obligations of the Company to certain members of management with respect to severance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Between April&nbsp;7, 2022 and April&nbsp;13, 2022, representatives of O&#146;Melveny, on behalf of Sonim, and representatives of Venable, on
behalf of Purchaser, exchanged drafts of the Subscription Agreement. Also, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
during such period, representatives of Sonim and representatives of Purchaser discussed final deal points, including costs associated with the contemplated potential strategic transaction between
Sonim and Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;12, 2022, the Board held a special meeting. Also present was a member of management, representatives
of O&#146;Melveny and representatives of B. Riley. The Board discussed the cost of a potential director and officer tail insurance policy and the severance obligations of Sonim. The Board stated that it was supportive of pursuing a director and
officer tail insurance policy with a premium not to exceed approximately $1&nbsp;million. The Board also discussed the severance rights of Mr.&nbsp;Tirva in his current employment agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;13, 2022, the Board held a special meeting to consider the terms of the final proposed strategic alternative transaction with
Purchaser, including the terms of the Subscription Agreement. Also present were representatives of O&#146;Melveny and representatives of B. Riley. Representatives of B. Riley highlighted for the Board the above-described process that had been
conducted by the Board, management and representatives of B. Riley. The Board reviewed the management projections included in the materials provided by B. Riley and did not provide any comments or revisions to such management projections. The Board
also discussed the current financial position of Sonim. The Board discussed that at its current spending rate, Sonim would not have sufficient cash to continue its operations starting in June 2022. Representatives of B. Riley then presented to the
Board their financial analyses of the proposed $17.5&nbsp;million investment in Sonim by Purchaser pursuant to the Subscription Agreement. At the request of the Board, a representative of B. Riley then delivered its oral opinion, which was
subsequently confirmed in writing, to the effect that, based on and subject to the assumptions in the written opinion letter, B. Riley was of the opinion that, as of April&nbsp;13, 2022, the aggregate consideration of $17.5&nbsp;million to be
received by the Company for the shares of common stock of Sonim to be issued pursuant to the Subscription Agreement to Purchaser is fair to the Company from a financial point of view. The full text of the written opinion of B. Riley, dated
April&nbsp;13, 2022, which sets forth, among other matters, the assumptions made, procedures followed, matters considered and limitations and qualifications of the review undertaken by B. Riley in rendering their opinion, is attached as <B>Annex
B</B> to this proxy statement. See also &#147;The Transaction&#151;Opinion of B. Riley Securities, Inc.&#148;. Representatives of O&#146;Melveny reviewed for the Board its fiduciary duties under Delaware law. Representatives of O&#146;Melveny also
informed the Board that it had provided Purchaser&#146;s proof of funds to complete the first closing and the second closing, and further discussion among the Board ensued. Representatives of O&#146;Melveny then reviewed with the Board the proposed
investment by Purchaser in Sonim and the final material terms of the Subscription Agreement, including that it is expected that Mr.&nbsp;Liu would invest approximately $800,000 of the $17.5&nbsp;million, but would not be an equityholder of
Purchaser. After discussion among the directors, the Board unanimously (i)&nbsp;determined that the Subscription Agreement and the transactions contemplated thereby are fair to and in the best interests of Sonim&#146;s stockholders,
(ii)&nbsp;adopted and declared advisable the Subscription Agreement and the transactions contemplated thereby and (iii)&nbsp;resolved, subject to Section&nbsp;4.1 of the Subscription Agreement, to recommend adoption of the Subscription Agreement by
the stockholders of Sonim. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_28"></A>Reasons for the Transaction; Recommendation of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board recommends that you vote &#147;FOR&#148; the Transaction Proposal. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board held numerous meetings at which the business strategies, opportunities and challenges of the Company were evaluated and potential
strategic alternatives were considered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At a meeting held on April&nbsp;13, 2022, after careful consideration, the Board unanimously
(i)&nbsp;determined that the Subscription Agreement and the transactions contemplated thereby are fair to and in the best interests of the Company&#146;s stockholders, (ii)&nbsp;adopted and declared advisable the Subscription Agreement and the
transactions contemplated thereby and (iii)&nbsp;resolved, subject to certain provisions of the Subscription Agreement, to recommend that the Company&#146;s stockholders adopt the Subscription Agreement, all upon the terms and subject to the
conditions set forth therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In evaluating and reaching its decision, the Board consulted with senior management and the
representatives of O&#146;Melveny&nbsp;&amp; Myers LLP and B. Riley at various times and considered a number of factors, including the following material factors (not in any relative order of importance) that the Board believes support its decision
to approve the transaction and adopt the Subscription Agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">historical information regarding (i)&nbsp;the Company&#146;s business, financial performance and results of
operations, (ii)&nbsp;market prices, volatility and trading activity with respect to the Company Stock and (iii)&nbsp;market prices with respect to other industry participants and general market indices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current information regarding (i)&nbsp;the Company&#146;s business, prospects, financial condition,
operations, technology, products, services, management, competitive position and strategic business goals and objectives, (ii)&nbsp;general economic, industry and financial market conditions and (iii)&nbsp;opportunities and competitive factors
within the Company&#146;s industry; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the current cash position of the Company, including that the Board anticipates that the Company will run out
of cash in June 2022 based on current spending rates and the potential of liquidation, dissolution and/or bankruptcy proceedings if the Company does not affect the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the qualitative proposed business and integration plan provided by the Purchaser to the Board with respect to
the Purchaser&#146;s plans for business of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Mr.&nbsp;Peter Liu, the Company&#146;s current Executive VP for Global Operations and
Engineering, is required to be appointed as the Chief Executive Officer of the Company as of the date of the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Company will continue to exist as a public company and the Company&#146;s stockholders will
continue to own shares of capital stock of the Company and will not forego any future increase in the value of the Company as a public company that might result from the possible growth of the Company, including in connection with the
Purchaser&#146;s business plan (together with the possibility of near- and long-term fluctuations in the value of the common stock); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that through Purchaser&#146;s relationships, the Company expects to have access to <FONT
STYLE="white-space:nowrap">low-cost</FONT> product-development and manufacturing relationships that the Company would not otherwise have access to without the contemplated transaction, which the Board believes is critical to the future profitability
of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dilutive impact of the transaction to the Company&#146;s stockholders and that following the second
closing, the Purchaser will own more than 50% of the outstanding capital stock of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following the second closing, the Company will be majority owned by the Purchaser and the Purchaser will have
the right, as the stockholder of the Company, to appoint the members of the Board (subject to the rights of the Continuing Directors (Messrs. Mike Mulica and Alan Howe, who we refer to as the &#147;continuing directors&#148;)) and, except as
required by applicable law and as contemplated by the Charter Restriction Proposal, the Company&#146;s current stockholders will have no express minority stockholder rights or protections; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that (i)&nbsp;the Company and the Purchaser may not achieve the business plan presented by the
Purchaser to the Board and (ii)&nbsp;that the Purchaser and the Company have no binding legal obligation to pursue the Purchaser&#146;s proposed business plan of the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s stockholders will not receive any consideration in the transaction and that the purchase
price will be paid to the Company, which the Board understands will be used to support future operations of the Company, but there is no legally binding obligation for such funds to be used for such purpose; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price per share of common stock to be paid by the Purchaser to the Company in the transaction equals
$0.84, which represents a premium of approximately 27% to the stock price at the close of the market on April&nbsp;12, 2022, which was $0.66; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prospects and likelihood of realizing superior benefits if the Company does not consummate the
transaction, risks associated with not consummating the transaction and possible alternative business strategies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consideration of other potential strategic alternative transactions offered to the Company, including
sales by the Company of certain of its assets to a third party and the amount of consideration proposed to be paid therein, and the fact that such other potential strategic alternative transactions did not afford the Company&#146;s existing
stockholders an opportunity to continue to participate in any potential future growth and value increase of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential for other third parties to enter into strategic relationships with or to seek to acquire the
Company, including a review of management&#146;s dealings with other potential strategic partners or acquirers of the Company in the past and the assessment of the likelihood that a third party would offer a strategic alternative transaction more
beneficial to the Company and its stockholders of the Company than the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that if the Company does not accept the Purchaser&#146;s offer now (as provided for in the
Subscription Agreement), it may not have another opportunity to do so or a comparable opportunity that is as beneficial to the Company&#146;s stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Subscription Agreement does not contain a floor or a ceiling for the value of the shares to
be purchased and that the value of the shares to be issued in the transaction could rise or fall based on the value of the common stock prior to the first closing, in the case of the initial shares, and prior to the second closing, in the case of
the remaining shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) the belief of the Board that continuing with the strategic alternative review process was unlikely to
result in a transaction that is more beneficial to the Company&#146;s stockholders than offered by the Purchaser in the transaction and (ii)&nbsp;the fact that the Company would be permitted, under circumstances described in the Subscription
Agreement, to terminate the Subscription Agreement in order to enter into an agreement with respect to a superior proposal after giving the Purchaser the opportunity to match the superior proposal and upon payment of a termination fee equal to
$750,000, or 4.3% of the purchase price and reimbursement of up to $350,000 of reasonable, documented and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the Purchaser in connection
with the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that if the Company&#146;s stockholders do not approve the transaction and the Subscription Agreement
is terminated as a result thereof, the Purchaser will be entitled to the reimbursement obligation from the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, under the terms of the Subscription Agreement, the Purchaser has agreed to use its reasonable
best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable law to consummate the transaction as promptly as practicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the belief of the Board that the transaction has a reasonable likelihood of closing without potential issues
from any governmental authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) the financial analyses reviewed by B. Riley with the Board and (ii)&nbsp;the opinion of B. Riley rendered
to the Board to the effect that, as of the date hereof, and based upon and subject to the assumptions, qualifications, limitations and other matters considered in connection with the preparation of such opinion, the consideration to be received by
the Company in the transaction is fair, from a financial point of view, to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible negative effect of the transaction and public announcement of the transaction on the
Company&#146;s financial performance, operating results and stock price and the Company&#146;s relationships with customers, suppliers, other business partners, management and employees; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Subscription Agreement (i)&nbsp;precludes the Company from actively soliciting competing
acquisition proposals and (ii)&nbsp;obligates the Company (or its successor) to pay the Purchaser the termination fee and reimbursement obligations under specified circumstances, which could discourage the making of a competing acquisition proposal
or adversely impact the price offered in such a proposal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Subscription Agreement imposes restrictions on the conduct of the Company&#146;s business in
the <FONT STYLE="white-space:nowrap">pre-closing</FONT> period, which may adversely affect the Company&#146;s business in the event the transaction is not completed (including by delaying or preventing the Company from pursuing business
opportunities that may arise or precluding actions that would be advisable if the Company were to not consummate the transaction); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Subscription Agreement provisions referenced in the immediately above bullet may
significantly restrict the operation of the Company&#146;s business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commencing with the execution of the Subscription Agreement, the Company is required to, subject to compliance
with applicable laws and the Board&#146;s fiduciary duties, in good faith commence the enhancement and optimization of the Company&#146;s business pursuant to the strategy developed by Mr.&nbsp;Liu, which has previously been reviewed by the Board,
which may adversely affect the Company&#146;s business in the event the transaction is not completed (including by delaying or preventing the Company from pursuing business opportunities that may arise or by the Company having incurred costs and
expense, and become subject to obligations, in connection with implementing such business plan); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Purchaser has represented to the Company that the Purchaser (i)&nbsp;has as of the date of
the Subscription Agreement, and will have as of the first closing, sufficient immediately available funds to pay the first purchase price pursuant and (ii)&nbsp;has as of the date of the Subscription Agreement, and will have as of the second
closing, sufficient immediately available funds to pay the second purchase price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that no external or third party financing is required by the Purchaser to consummate the transaction;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks involved with the transaction and the likelihood that the Company and Purchaser will be able to
complete the transaction, the possibility that the transaction might not be consummated and the Company&#146;s prospects going forward without the investment by the Purchaser; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the substantial transaction expenses to be incurred in connection with the transaction and the negative impact
of such expenses on the Company&#146;s cash reserves and operating results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all known interests of directors and executive officers of the Company in the transaction that may be
different from, or in addition to, their interests as stockholders of the Company or the interests of the Company&#146;s other stockholders generally; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">two (2)&nbsp;current members of the Board, the Continuing Directors, will remain on the Board following the
first closing until the Director End Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Purchaser will enter into a voting agreement to vote in favor of the appointment, election and reelection
of the Continuing Directors in accordance with the terms of the voting agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each member of the Board and Mr.&nbsp;Bob Tirva will enter into an insider voting agreement whereby, subject
to the terms and provisions thereof, each such person will agree to vote in favor of the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other than the Continuing Directors, the current members of the Board will resign effective upon the first
closing and the Purchaser will have the right to appoint members to the Board proportionate to the interest in the capital stock of the Company that the Purchaser owns following the first closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the various constituencies of the Company, as and to the extent the Board is permitted to consider such
constituencies; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all other factors the Board deems relevant. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_29"></A>Certain Company Forecasts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sonim does not, as a matter of course, make public disclosure of detailed forecasts or projections of its expected financial performance for
extended periods due to, among other things, the uncertainty, unpredictability and subjectivity of the underlying assumptions and estimates. However, in connection with Sonim&#146;s evaluation of potential strategic transactions involving Sonim,
Sonim management prepared certain projections and estimates of future financial and operating performance with respect to Sonim&#146;s fiscal year 2022, 2023 and 2024 (which we refer to herein as the &#147;management projections&#148;). Sonim made
available the management projections to the Board and B. Riley. In addition, management prepared certain projections and estimates of future financial and operating performance with respect to Sonim&#146;s fiscal year 2022, 2023 and 2024 as if the
Sonim business had been sold in a <FONT STYLE="white-space:nowrap">&#147;carve-out&#148;</FONT> transaction whereby such business would no longer be subject to customary overhead costs and expenses of a public company, which we refer to herein as
the &#147;carveout projections&#148;. The management projections were derived from the carveout projections, with management updating the management projections to reflect a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">non-carve-out</FONT></FONT> strategic transaction in which Sonim continues to incur customary overhead expenses of a publicly listed company, which resulted in an add back of such
expenses, and with management updating the management projections to reflect results of operations since the preparation of the carveout projections and refining the management projections to reflect the best currently available estimates and
judgments of Sonim&#146;s management at such time. The management projections were not shared with AJP Holdings or any other potential strategic partner, but the carveout projections were shared with AJP Holdings and certain other potential
strategic partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A summary of the management projections is being included in this proxy statement because they were made available to
the Board and B. Riley and a summary of the carveout projections is being included in this proxy statement because they were made available to AJP Holdings and other potential strategic partners. This information is not intended to influence your
decision whether to vote for or against the transaction proposal. The inclusion of this information should not be regarded as an indication that the Board, its advisors or any other person considered, or now considers, the management projections or
the carveout projections to be material or to be a reliable prediction of actual future results, and neither management projections nor the carveout projections should be relied upon as such. The management projections and the carveout projections
are subjective in many respects. There can be no assurance that the management projections or the carveout projections will be realized or that actual results will not be significantly higher or lower than reflected in the management projections or
the carveout projections. The management projections and the carveout projections cover multiple years and such information by its nature becomes subject to greater uncertainty with each successive year. As a result, the inclusion of the management
projections and the carve out projections in this proxy statement should not be relied on as necessarily predictive of actual future events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The management projections were prepared on a stand-alone basis and do not take into account any of the transactions contemplated by the
subscription agreement, including the acquisition of common stock and associated expenses, or Sonim&#146;s compliance with its covenants under the subscription agreement. The management projections assume sufficient liquidity to continue to operate
through the planning period, which would require Sonim to raise additional capital. For these reasons and for the reasons described above, actual results likely will differ, and may differ materially, from those contained in the management
projections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The carveout projections were prepared on a stand-alone basis, but do assume that the Sonim business is sold to a strategic
partner whereby customary overhead costs of a public company would no longer be applicable. For these reasons and for the reasons described above, actual results likely will differ, and may differ materially, from those contained in the carveout
projections. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The management projections were prepared by, and are the responsibility of, Sonim&#146;s
management for internal use and use by B. Riley. The carveout projections were prepared by, and are the responsibility of, Sonim&#146;s management, but such projections were not relied upon by the Sonim Board or B. Riley and were provided to AJP
Holdings and certain other potential strategic partners. The management projections were (i)&nbsp;used by B. Riley in its financial analyses undertaken in connection with rendering its opinion to the Board, (ii)&nbsp;not prepared for purposes of
public disclosure and (iii)&nbsp;not prepared on a basis designed to comply with published guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial data, published
guidelines of the SEC (including those regarding forward-looking statements and the use of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures) or GAAP. Moss Adams LLP, Sonim&#146;s independent registered public accounting firm, has not
audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the management projections or the carveout projections contained in this proxy statement and, accordingly, Moss Adams LLP does not express an opinion or any
other form of assurance with respect thereto. Further, the management projections and the carveout projections include <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures. <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> financial
measures are not prepared in accordance with GAAP and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although the management projections and carveout projections presented below are presented with numerical specificity, they are estimates of
future performance and not historical facts. The management projections and the carveout projections were based on numerous variables and assumptions that were deemed to be reasonable as of the respective dates when such projections were finalized.
Realization of such assumptions is inherently uncertain and may be beyond the control of Sonim. Important factors that may affect actual results and cause the management projections or the carveout projections not to be achieved include, but are not
limited to, risks and uncertainties relating to Sonim&#146;s business (including, without limitation, risks relating to competition; customer risks; scale; market and product diversification; breadth of solution offerings; technology risks;
innovation demands of customers; organic growth opportunities; inorganic opportunities; and industry consolidation and other factors described or referenced under &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on
page 17. In the view of Sonim&#146;s management, the management projections had been reasonably prepared on a basis reflecting the best currently available estimates and judgments of Sonim&#146;s management of the future financial performance of
Sonim and other matters covered thereby. In the view of Sonim&#146;s management, the carveout projections had been reasonably prepared on a basis reflecting the best currently available estimates and judgments of Sonim&#146;s management of the
future financial performance of Sonim and other matters covered thereby, taking into account that the Sonim business was sold in a <FONT STYLE="white-space:nowrap">carve-out</FONT> transaction and was no longer subject to customary overhead costs of
a public company. In addition, the assumptions underlying the management projections and the carveout projections are subject to change and have not been revised since their preparation to reflect any changes in Sonim&#146;s business, industry
performance, the legal or regulatory environment, general business or economic conditions, or any other transaction or event that has occurred or that may occur and that was not anticipated as the management projections and the carveout projections
were prepared. Neither Sonim nor AJP Holding undertakes any obligation, except as required by law, to update or otherwise revise the management projections or the carveout projections to reflect circumstances existing since their preparation or to
reflect the occurrence of unanticipated events, even in the event that any or all of the underlying assumptions are shown to be in error or to not be appropriate, or to reflect changes in Sonim&#146;s business, industry performance, the legal or
regulatory environment, or general business or economic conditions. There can be no assurance that the management projections or the carveout projections will be realized or that Sonim&#146;s future financial results will not materially vary from
the management projections or the carveout projections. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Management Projections </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of the management projections prepared by Sonim&#146;s management and provided to the Board and B. Riley. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B></B><I>($ in millions, except percentages)</I><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ending December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 61.9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;93.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;111.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>% Growth</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>13.4</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>50.7</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>19.5</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(14.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6.6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>% Margin</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>(23.0</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%)&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>2.6</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>5.9</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Depreciation&nbsp;&amp; Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBIT<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(14.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6.6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>% Margin</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>(23.0</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%)&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>2.6</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>5.9</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Taxes <SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NOPAT<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(14.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Plus: Depreciation&nbsp;&amp; Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Working Capital Cash Adjustments
<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: &#916; in Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Capital Expenditures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered Free Cash Flow<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>($</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;19.6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>($</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;3.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 2.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;Adjusted EBITDA&#148; is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure and is
calculated as earnings before interest, taxes, depreciation and amortization. No further adjustments were made to such calculation. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;Adjusted EBIT&#148; is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure calculated
by starting with Adjusted EBITDA and subtracting depreciation and amortization, of which there were none. No further adjustments were made to such calculation. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Taxes includes net operating losses limited to 80% of taxable income under the Tax Cuts and Jobs Act.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;NOPAT&#148; is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure calculated by
starting with Adjusted EBIT and deducting taxes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Working capital cash adjustments include accrued expense cash outflows for: XP5 and XP3 <FONT
STYLE="white-space:nowrap">non-recurring</FONT> engineering, minimum order obligations, accrued vacation payout and severance payments. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;Unlevered Free Cash Flow&#148; is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure
calculated by starting with NOPAT and adding back depreciation and amortization, adjusting for working capital cash adjustments and changes in net working capital (which, in this case, were deductions) and deducting for capital expenditures.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Carveout Projections </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of the carveout projections prepared by Sonim&#146;s management and provided to the Board and B. Riley, each of
which did not rely on such projections in connection with its consideration of the subscription agreement and the transactions contemplated thereby, and was provided to AJP Holdings and certain other potential strategic partners. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B></B><I>($ in millions, except percentages)</I><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ending December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;63.6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;88.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;108.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Costs of Sales</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 43.5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 58.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 72.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Gross Margin</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 20.1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 30.1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 35.6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>% Gross Margin</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>32.0</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>34</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;</I></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><I>33</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: R&amp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Third Party Engineer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 10.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 5.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 2.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B></B><I>($ in millions, except percentages)</I><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ending December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less Sales and Marketing<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 7.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 7.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 7.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: G&amp;A<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 0.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 18.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 13.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 10.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating Profit (Loss)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 1.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 16.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 25.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Sales and marketing expense was assumed to be $7.2&nbsp;million per year. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">G&amp;A expense was assumed to be approximately $100,000 per year. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;Operating Profit (Loss)&#148; is calculated by starting with Gross Margin and subtracting Total
Operating Expenses. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_30"></A>Opinion of B. Riley Securities, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;13, 2022, B. Riley rendered to the Board its oral opinion (which was subsequently confirmed in writing by
delivery of B. Riley&#146;s written opinion dated April&nbsp;13, 2022), to the effect that, as of April&nbsp;13, 2022, and based upon and subject to the qualifications, limitations, assumptions and other matters considered by B. Riley in connection
with the preparation of the opinion, the Aggregate Consideration to be received by the Company in exchange for the Purchased Shares in the transaction pursuant to the Subscription Agreement was fair from a financial point of view to the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>B. Riley&#146;s opinion was directed to the Board (in its capacity as such) and only addressed the fairness, from a
financial point of view, to the Company of the Aggregate Consideration to be received by the Company in exchange for the Purchased Shares in the transaction pursuant to the Subscription Agreement and did not address any other aspect or implication
of the transaction, the Subscription Agreement or any other agreement or understanding entered into in connection with the transaction or otherwise. The summary of B. Riley&#146;s opinion in this proxy statement is qualified in its entirety by
reference to the full text of its written opinion, which is included as Annex&nbsp;B to this proxy statement and sets forth the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters
considered by B. Riley in preparing its opinion. However, neither B. Riley&#146;s written opinion nor the summary of its opinion and the related analyses set forth in this proxy statement is intended to be, and they do not constitute, a
recommendation to the Board, the Company, any security holder of the Company or any other person as to how to act or vote on any matter relating to the transaction or otherwise. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of B. Riley&#146;s opinion, the Company advised B. Riley and directed B. Riley to assume (i)&nbsp;the
Company&#146;s consolidated financial statements as of and for the year ended December&nbsp;31, 2021, were prepared on the assumption that the Company would continue as a going concern, (ii)&nbsp;the Company was experiencing significant liquidity
issues, (iii)&nbsp;the Company had not obtained, and did not expect to obtain, alternative financing on terms more favorable to the Company from a financial point of view, and (iv)&nbsp;in the absence of the transaction, or alternative financing for
which the Company had not arranged and did not believe it could arrange to obtain on terms more favorable to the Company at the time, the Company&#146;s ability to function as a going-concern would likely be severely impaired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In arriving at its opinion, B. Riley, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed the financial terms of a draft, dated April&nbsp;13, 2022, of the Subscription Agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain publicly available business and financial information related to the Company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain other information relating to the Company concerning its business, financial condition and
operations made available to B. Riley by the Company, including (a)&nbsp;forecasts with respect to the future financial performance of the Company prepared by the management of the </P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Company relating to the Company in the absence of the transaction (the &#147;Status Quo Projections&#148;) and (b)&nbsp;solely for informational purposes, forecasts with respect to the future
financial performance of the Company prepared by the management of the Purchaser relating to the Company giving effect to the transaction and the business strategy contemplated thereby (the &#147;Financing Plan Projections&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Held discussions with members of senior management of the Company and the Purchaser concerning the transaction
and the business, financial condition, and strategic objectives of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain publicly available financial data, stock market performance data and trading multiples of
companies which B. Riley deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed the publicly available financial terms of certain business combinations that B. Riley deemed
relevant; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performed such other financial studies, analyses and investigations, and considered such other matters, as B.
Riley deemed necessary or appropriate for purposes of rendering its opinion. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In preparing its opinion,
at the Company&#146;s direction, B. Riley relied, without assuming responsibility or liability for independent verification, upon the accuracy and completeness of all financial and other information available from public sources and all other
information provided to B. Riley or otherwise discussed with or reviewed by B. Riley. Company management advised B. Riley and, at the Company&#146;s direction, B. Riley assumed that the Status Quo Projections were reasonably prepared in good faith
and represented Company management&#146;s best currently available estimates and judgments with respect to the future financial performance of the Company in the absence of the transaction. In addition, at the Company&#146;s direction, B. Riley
assumed that the Financing Plan Projections were reasonably prepared in good faith and represented Purchaser management&#146;s best currently available estimates and judgments with respect to the future financial performance of the Company giving
effect to the transaction and the business strategy contemplated thereby. B. Riley assumed no responsibility for and expressed no view or opinion as to the Status Quo Projections, the Financing Plan Projections or the respective assumptions on which
they were based. At the Company&#146;s direction, B. Riley used and relied upon the Status Quo Projections for purposes of its analyses and opinion and assumed that the Status Quo Projections provided a reasonable basis upon which to evaluate the
Company and the proposed transaction. B. Riley also assumed that there had been no changes in the assets, financial condition, results of operations, business or prospects of the Company since the respective dates of the last financial statements
and other information, financial or otherwise, made available to B. Riley that would be material to its analyses or opinion, and that there was no information or any facts or developments that would make any of the information reviewed by B. Riley
inaccurate, incomplete or misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley was not asked to, and did not, undertake an independent verification of
any information provided to or reviewed by it, nor was B. Riley furnished with any such verification, and B. Riley did not assume any responsibility or liability for the accuracy or completeness such information. B. Riley did not make an independent
evaluation or appraisal of the assets or the liabilities (contingent or otherwise) of the Company, nor did B. Riley evaluate the solvency of the Company under any state or federal laws. B. Riley did not undertake any independent analysis of any
pending or threatened litigation, possible unasserted claims or other contingent liabilities to which the Company was a party or may have been subject, including, without limitation, the ongoing investigation of the Company by the SEC, and B.
Riley&#146;s opinion made no assumption concerning, and therefore did not consider, the possible assertion of claims, outcomes or damages arising out of any such matters, including, without limitation, the additional shares of common stock that may
become issuable to Purchaser in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley also assumed, with the Company&#146;s consent, that
(i)&nbsp;in the course of obtaining any regulatory or third party consents or approvals in connection with the transaction, no delay, limitation, restriction or condition would be imposed that would have an adverse effect on the Company or the
contemplated benefits of the transaction, (ii)&nbsp;the representations and warranties made by the parties in the Subscription Agreement were accurate and complete in all respects; (iii)&nbsp;each party to the Subscription Agreement would perform
all of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
covenants and obligations thereunder; and (iv)&nbsp;the transaction would be consummated in accordance with the terms of the Subscription Agreement, without waiver, modification or amendment of
any term, condition or provision thereof. B. Riley also assumed that the Subscription Agreement, when executed by the parties thereto, would conform to the draft reviewed by B. Riley in all respects material to its analyses and opinion. B. Riley is
not a legal, tax or regulatory advisor and relied upon, without independent verification, the assessments of the Company and its legal, tax and regulatory advisors with respect to such matters. Without limitation to the foregoing, with the
Company&#146;s consent, B. Riley did not evaluate the impact, if any, of the transaction on the Company&#146;s ability to utilize its net operating loss carryforwards to reduce future tax liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley&#146;s opinion was limited to the fairness, from a financial point of view, to the Company of the Aggregate
Consideration to be received by the Company for the Purchased Shares in the transaction pursuant to the Subscription Agreement, and B. Riley expressed no view or opinion as to the fairness of the transaction to the holders of any class of
securities, creditors or other constituencies of the Company. B. Riley&#146;s opinion did not address any other aspect or implication of the transaction, the Subscription Agreement, or any other agreement or understanding entered into in connection
with the transaction or otherwise. B. Riley also expressed no view or opinion as to the fairness of the amount or nature of the compensation to any of the Company&#146;s officers, directors or employees, or any class of such persons, relative to the
Aggregate Consideration or otherwise. B. Riley expressed no view or opinion as to the prices or range of prices at which Company common stock may trade at any time. Furthermore, B. Riley did not express any opinion as to the impact of the
transaction on the solvency or viability of the Company or the Purchaser, or the ability of the Company or the Purchaser to pay its obligations when they become due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley&#146;s opinion was necessarily based upon economic, market, monetary, regulatory and other conditions as they existed
and could be evaluated, and the information made available to B. Riley, as of the date of its opinion. Although subsequent developments may affect its opinion, B. Riley does not have any obligation to update, revise or reaffirm its opinion. As the
Company was aware, the credit, financial and stock markets were experiencing significant volatility, and B. Riley expressed no view or opinion as to any potential effects of such volatility on the Company or the proposed transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley&#146;s opinion was for the information of the Board (in its capacity as such) in connection with its consideration of
the proposed transaction. B. Riley&#146;s opinion does not constitute a recommendation to the Board, the Company, any security holder of the Company or any other person as to how to act or vote on any matter relating to the transaction or otherwise
including, without limitation, whether or not to participate in any offering of securities by the Company. B. Riley&#146;s opinion did not address the relative merits of the transaction as compared to alternative transactions or strategies that
might have been available to the Company or any other party to the transaction, nor did it address the underlying business decision of the Board, the Company or any other party to effect the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In preparing its opinion to the Board, B. Riley performed a variety of analyses, including those described below. The summary
of B. Riley&#146;s analyses is not a complete description of the analyses underlying B. Riley&#146;s opinion. The preparation of such an opinion is a complex process involving various quantitative and qualitative judgments and determinations with
respect to the financial, comparative and other analytical methods employed and the adaptation and application of these methods to the unique facts and circumstances presented. As a consequence, neither B. Riley&#146;s opinion nor its underlying
analyses is readily susceptible to summary description. B. Riley arrived at its opinion based on the results of all analyses undertaken by it and assessed as a whole and did not draw, in isolation, conclusions from or with regard to any individual
analysis, methodology or factor. While the results of each analysis were taken into account in reaching B. Riley&#146;s overall conclusion with respect to fairness, B. Riley did not make separate or quantifiable judgments regarding individual
analyses. Accordingly, B. Riley believes that its analyses and the following summary must be considered as a whole and that selecting portions of its analyses, methodologies and factors, without considering all analyses, methodologies and factors,
could create a misleading or incomplete view of the processes underlying B. Riley&#146;s analyses and opinion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In performing its analyses, B. Riley considered general business, economic,
industry and market conditions, financial and otherwise, and other matters as they existed on, and could be evaluated as of, the date of its opinion. No company, transaction or business used in B. Riley&#146;s analyses for comparative purposes is
identical to the Company or the proposed transaction and an evaluation of the results of those analyses is not entirely mathematical. The estimates contained in the Status Quo Projections and the implied value reference ranges indicated by B.
Riley&#146;s analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than those suggested by the analyses. In addition, any analyses relating to the value
of assets, businesses or securities do not purport to be appraisals or to reflect the prices at which businesses or securities actually may be sold, which may depend on a variety of factors, many of which are beyond the control of the Company. Much
of the information used in, and accordingly the results of, B. Riley&#146;s analyses are inherently subject to substantial uncertainty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley&#146;s opinion was only one of many factors considered by the Board in evaluating the proposed transaction. Neither
B. Riley&#146;s opinion nor its analyses were determinative of the Aggregate Consideration or of the views of the Board or management with respect to the transaction or the Aggregate Consideration. The type and amount of Aggregate Consideration
payable in the transaction were determined through negotiation between the Company and Purchaser, and the decision to enter into the Subscription Agreement was solely that of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Material Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of the material financial analyses performed by B. Riley in connection with the preparation of its
opinion and reviewed with the Board on April&nbsp;13, 2022. The order of the analyses does not represent relative importance or weight given to those analyses by B. Riley. The analyses summarized below include information presented in tabular
format. The tables alone do not constitute a complete description of the analyses. Considering the data in the tables below without considering the full narrative description of the analyses, as well as the methodologies underlying, and the
assumptions, qualifications and limitations affecting, each analysis could create a misleading or incomplete view of B. Riley&#146;s analyses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of its analyses, B. Riley reviewed a number of financial metrics, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value &#151;&nbsp;generally, the value as of a specified date of the relevant company&#146;s
outstanding equity securities plus the amount of debt outstanding, preferred stock and <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests, and less the amount of cash and cash equivalents </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">EBITDA &#151;&nbsp;generally, the amount of the relevant company&#146;s earnings before interest, taxes,
depreciation and amortization for a specified time period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adjusted EBITDA &#151;&nbsp;generally, the amount of the relevant company&#146;s earnings before interest,
taxes, depreciation and amortization and adjustments for <FONT STYLE="white-space:nowrap">non-recurring</FONT> items for a specified time period. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the context indicates otherwise, enterprise values and equity values used in the selected companies analysis described
below were calculated using the closing price of the Company&#146;s common stock and the common stock of the selected companies listed below as of April&nbsp;13, 2022, and transaction values for the selected transactions analysis described below
were calculated on an enterprise value basis based on the value of the equity consideration in the announced transaction and other publicly available information at the time of the announcement. The estimates of the future financial performance of
the Company relied upon for the financial analyses described below were based on the Status Quo Projections. The estimates of the future financial performance of the selected companies listed below were based on publicly available research analyst
estimates for those companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Selected Companies Analysis</I></B>. B. Riley reviewed certain financial data for
selected companies with publicly traded equity securities that B. Riley deemed relevant. The financial data reviewed included enterprise value as a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
multiple of revenue for the year ending December&nbsp;31, 2021, or &#147;2021 Revenue,&#148; and enterprise value as a multiple of estimated revenue for the year ending December&nbsp;31, 2022, or
&#147;2022E Revenue.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The selected companies and corresponding multiples were: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Enterprise&nbsp;Value&nbsp;/<br>2021 Revenue</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Enterprise&nbsp;Value&nbsp;/<BR>2022E Revenue</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Xiaomi Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kyocera Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lenovo Group Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BK Technologies Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Socket Mobile, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Siyata Mobile Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonim Technologies, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;NA&#148; refers to not available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Taking into account the results of the selected companies analysis, B. Riley applied selected multiple ranges of 0.2x to 1.3x
to the Company&#146;s 2021 revenue and 0.1x to 1.3x to the Company&#146;s estimated 2022E revenue. The selected companies analysis indicated implied aggregate equity value reference ranges for the Purchased Shares of $10.0&nbsp;million to
$41.1&nbsp;million, based on 2021 revenue, and $7.5&nbsp;million to $46.0&nbsp;million, based on estimated 2022E revenue, in each case as compared to the Aggregate Consideration of $17.5&nbsp;million in the transaction pursuant to the Subscription
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Selected Transactions Analysis</I></B>. B. Riley reviewed certain financial terms of certain
transactions involving target companies that B. Riley deemed relevant. The financial data reviewed included enterprise value as a multiple of revenue for the last twelve months available prior to the date of announcement, or &#147;LTM Revenue.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The selected transactions and corresponding multiples were: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Date&nbsp;Announced</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Target</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Acquiror</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Enterprise<BR>Value/<BR>LTM<BR>Revenue</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7/22/2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BK Technologies Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metrolina Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0.9x</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">8/14/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Xplore Technologies Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zebra Technologies Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.0x</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">5/30/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WinMate Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Onyx Healthcare&nbsp;Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.5x</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1/10/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Point Mobile Co., Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consortium of Investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0.9x</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Taking into account the results of the selected transactions analysis, B. Riley applied a
selected multiple range of 0.9x to 1.5x to the Company&#146;s revenue for the last twelve months. The selected transactions analysis indicated an implied aggregate equity value reference range for the Purchased Shares of $29.7&nbsp;million to
$46.7&nbsp;million, as compared to the Aggregate Consideration of $17.5&nbsp;million in the transaction pursuant to the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Discounted Cash Flow Analysis</I></B>. B. Riley performed a discounted cash flow analysis of the Company based on the
Status Quo Projections provided by the Company management. B. Riley applied ranges of terminal value multiples of 0.2x to 1.0x to the Company&#146;s estimated 2024E revenue and 6.0x to 10.0x to the Company&#146;s estimated 2024E adjusted EBITDA and,
in each case, discount rates ranging from 30.0% to 40.0%. The discounted cash flow analysis indicated implied aggregate equity value reference ranges for the Purchased Shares of $0.6&nbsp;million to $22.1&nbsp;million, based on multiples of
estimated 2024E revenue, and $3.8&nbsp;million to $11.3&nbsp;million, based on multiples of estimated 2024E adjusted EBITDA, in each case as compared to the Aggregate Consideration of $17.5&nbsp;million in the transaction pursuant to the
Subscription Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Additional Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Illustrative Discount Paid Analysis</I></B>. B. Riley performed a discount paid analysis of the Purchased Shares using
the stock price discounts/premiums paid in 134 PIPE transactions involving U.S. public company issuers over the last seven years prior to April&nbsp;13, 2022, including 115 <FONT STYLE="white-space:nowrap">small-cap</FONT> transactions involving
public companies with market caps of less than $500&nbsp;million. B. Riley calculated the median discounts paid for the purchased shares relative to the issuer company&#146;s <FONT STYLE="white-space:nowrap">single-day</FONT> closing share price for
the date one day prior to the announcement of the transaction. The median discount was (8.2%) for all transactions and (7.4%) for the small cap company transactions, in each case as compared to a premium of 20.0%, based on the price per share in the
transaction of $0.84 and the Company&#146;s closing price of $0.70 on April&nbsp;13, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Taking into account the
results of the illustrative discount paid analysis, B. Riley applied the median discounts indicated for all transactions and the small cap company transactions to the Company&#146;s closing trading price of $0.70 on April&nbsp;13, 2022. The discount
paid analysis indicated illustrative aggregate equity reference values for the Purchased Shares of $13.4&nbsp;million, based on the median discount for all transactions, and $13.5&nbsp;million, based on the median discount for the small cap company
transactions, in each case as compared to the Aggregate Consideration of $17.5&nbsp;million in the transaction pursuant to the Subscription Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Other Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley acted as financial advisor to the Board in connection with the transaction and will receive a fee of $1,225,000 for
such services, all of which is payable upon the consummation of the transaction. B. Riley also became entitled to a fee of $250,000 upon rendering its opinion, which is not contingent upon the conclusion set forth in its opinion or the successful
completion of the transaction. In addition, the Company has agreed to indemnify B. Riley and certain related parties for certain liabilities arising out of or related to its engagement and to reimburse B. Riley for certain expenses incurred in
connection with its engagement. The Board engaged B. Riley based on B. Riley&#146;s knowledge of the Company and its industry, as well as its extensive experience working with the Company and its management. B. Riley is regularly engaged to render
financial opinions in connection with transactions, acquisitions, divestitures, leveraged buyouts, and for other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley is a full-service securities firm engaged in securities trading and brokerage activities as well as providing
investment banking and other financial services. In the ordinary course of business, B. Riley and its affiliates may acquire, hold or sell, for its and its affiliates&#146; own accounts and the accounts of customers, equity, debt and other
securities and financial instruments (including bank loans and other obligations) of the Company, the Purchaser and their respective affiliates. During the last two years B. Riley held significant positions in equity and debt securities of the
Company until August 2021, and a senior executive of its affiliates B. Riley Financial and B. Riley Principal Investments served as a member of the Board until February 2022. In addition, B. Riley and its affiliates have in the past provided, and
are currently providing, investment banking and other financial services to the Company and certain of its affiliates, for which B. Riley and its affiliates have received, or would expect to receive, compensation, including, during the past two
years having acted as the Company&#146;s sales agent in connection with its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> offering&#148; programs for which B. Riley received aggregate
compensation of approximately $1,000,000. B. Riley and its affiliates may in the future provide investment banking and other financial services to the Company, the Purchaser and their respective affiliates, for which B. Riley and its affiliates
would expect to receive compensation. B. Riley has adopted policies and procedures designed to preserve the independence of its research and credit analysts whose views may differ from those of the members of the team of investment banking
professionals advising the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_31"></A>Financing of the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">AJP Holding will be using cash on hand to purchase the common stock of the Company in the transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_32"></A>Closing of the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Assuming timely satisfaction of the closing conditions, including the approval by our stockholders of the Transaction Proposal, we currently expect the closing
of the transaction to occur in the second half of calendar year 2022. See the section entitled &#147;The Subscription Agreement&#151;Closing of the Transaction&#148; beginning on page 52. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_33"></A>Interests of Certain Persons in the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In considering the recommendation of the Board that you vote to approve the issuance contemplated by the subscription agreement, you should be
aware that aside from their interests as Company stockholders, the Company&#146;s directors and executive officers may have interests in the transaction that may be different from, in conflict with or in addition to those of the Company stockholders
generally. Members of the Board were aware of and considered these interests, among other matters, in evaluating and negotiating the Subscription Agreement and the transaction and in recommending to the Company stockholders that the Subscription
Agreement be adopted. For more information, see the sections entitled &#147;The Transaction&#151;Background of the Transaction&#148; beginning on page 22 and &#147;The Transaction&#151;Reasons for the Transaction; Recommendation of the Board&#148;
beginning on page 38. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interests of the Company&#146;s directors and executive officers include, but are not limited to, the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effective as of the first closing, all of the directors (other than Messrs. Howe and Mulica) are to resign
from the Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursuant to the Company&#146;s compensation policy for members of the Board who are not employed by the
Company or any of its subsidiaries <FONT STYLE="white-space:nowrap">(&#147;non-employee</FONT> directors&#148;), awards of restricted stock units (&#147;RSUs&#148;) granted by the Company to <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors that are outstanding immediately prior to the second closing will become fully vested upon the second closing. Assuming the second closing occurred on May&nbsp;6, 2022, the total number of outstanding RSUs held by the <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors that would have accelerated upon the second closing would be 204,197. These accelerated RSUs would have an aggregate value of $144,980 (based on a value for the Company&#146;s common stock of
$0.71 per share, which was the average closing market price of the stock over the first five business days after the first public announcement of the transaction on April&nbsp;14, 2022). The <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors are not receiving any other compensation in connection with the Subscription Agreement or, in the case of directors other than Messrs. Howe and Mulica, the termination of their service on the Board at the first closing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Peter Liu, the former Executive VP for Global Operations and Engineering was appointed the
Company&#146;s Chief Executive Officer of the Company, effective concurrently with the execution of the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Robert Tirva&#146;s employment with the Company will terminate on, and subject to, the first closing
and upon such termination, Mr.&nbsp;Tirva will be entitled to receive the following severance benefits: cash severance of $1,000,000 (payable in installments over 20 months), accelerated vesting of his then-outstanding and unvested equity-based
awards granted by the Company, and, subject to his providing consulting services to the Company for three months after his termination date, reimbursement for his COBRA health insurance premiums for up to 18 months following his termination; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s directors and officers will be entitled to certain ongoing indemnification and advancement
rights as well as coverage under directors&#146; and officers&#146; liability policies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_34"></A>Indemnification and Insurance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the terms of the Subscription Agreement, the Company&#146;s directors and officers will be entitled to certain ongoing
indemnification and advancement rights as well as coverage under directors&#146; and officers&#146; liability insurance policies. See the section entitled &#147;The Subscription Agreement&#151;Directors&#146; and Officers&#146; Indemnification and
Insurance&#148; beginning on page 67 for a description of such ongoing indemnification, advancement and coverage obligations of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_35"></A>THE SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This section describes the material terms of the Subscription Agreement. The description of the Subscription Agreement in this section and
elsewhere in this proxy statement is qualified in its entirety by reference to the complete text of the Subscription Agreement, a copy of which is attached as<B> Annex A</B> and is incorporated by reference into this proxy statement. This summary
does not purport to be complete and may not contain all of the information about the Subscription Agreement that is important to you. We encourage you to read the Subscription Agreement carefully and in its entirety<I>.</I> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_36"></A>Explanatory Note Regarding the Subscription Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement, a copy of which is attached as<B> Annex A</B>, and this summary of its terms are included in this proxy statement
to provide you with information regarding its terms. Factual disclosures about the Company contained in this proxy statement or in the Company&#146;s public reports filed with the SEC may supplement, update or modify the factual disclosures about
the Company contained in the Subscription Agreement. The representations, warranties and covenants made in the Subscription Agreement by the Company and the Purchaser were made solely to the parties to, and solely for the purposes of, the
Subscription Agreement and as of specific dates and were qualified and subject to important limitations agreed to by the Company and the Purchaser in connection with negotiating the terms of the Subscription Agreement. The Company&#146;s
stockholders and other investors are not third-party beneficiaries under the Subscription Agreement. In particular, in your review of the representations and warranties contained in the Subscription Agreement and described in this summary, it is
important to bear in mind that the representations and warranties were negotiated for the principal purposes of establishing the circumstances in which a party to the Subscription Agreement may have the right not to consummate the transaction if the
representations and warranties of the other party prove to be untrue due to a change in circumstance or otherwise, and allocating risk between the parties to the Subscription Agreement, rather than establishing matters as facts. The representations
and warranties may also be subject to a contractual standard of materiality different from those generally applicable to stockholders and reports and documents filed with the SEC and, in some cases, were qualified by matters set forth on the
disclosure letter delivered to Purchaser in connection with the Subscription Agreement (which we refer to as the &#147;disclosure letter&#148;), which disclosures are not reflected in the Subscription Agreement. Moreover, information concerning the
subject matter of the representations and warranties may have changed since the date of the Subscription Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_37">
</A>Directors and Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrent with the first closing, all of the current directors of the Company (other than Messrs. Howe and
Mulica (whom we refer to as the &#147;Continuing Directors&#148;)) will resign and the Purchaser shall be entitled to designate such number of directors on the Board as will give the Purchaser, subject to compliance with applicable laws,
representation on the Board equal to that number of directors, rounded down to the next whole number, that is the product of (i)&nbsp;the total number of directors on the Board (after giving effect to the directors elected pursuant to this sentence,
and after giving effect to any resignations from the Board prior to or concurrent with the first closing) multiplied by (ii)&nbsp;the percentage that (A)&nbsp;such number of initial shares bears to (B)&nbsp;the total number of shares of common stock
outstanding as of the first closing (after giving effect to the issuance of the initial shares). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_38"></A>Closing of
the Transaction </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement provides that the closing of the transaction will take place in two (2)&nbsp;tranches
(which we refer to as the &#147;first closing&#148; and &#147;second closing,&#148; respectively). The first closing will take place as soon as possible, but in any event no later than the second business day following the date on which the last of
the conditions to the first closing (described in the section entitled &#147;The Subscription Agreement&#151;Conditions to the Transaction&#148; beginning on page 64) has been satisfied or waived (other than those conditions that by their nature are
to be satisfied at the first closing, but subject to the satisfaction or waiver of those conditions on the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
first closing date), or such other time and date as may be mutually agreed in writing by the Company and Purchaser. The second closing is to occur on August&nbsp;1, 2022, or such other time and
place as the Continuing Directors and the Purchaser may agree in writing; provided, that if the first closing shall not have occurred by August&nbsp;1, 2022, the second closing shall take place no later than the fifth business day following the date
of the first closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Assuming timely satisfaction or waiver of the closing conditions, including the approval by our stockholders of the
Transaction Proposal, we currently expect the closing of the transaction to occur in the second half of calendar year 2022. However, the parties cannot predict the exact timing of completion of the transaction or whether the transaction will be
completed at an earlier or later time, as agreed by the parties, or at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_39"></A>Representations and Warranties
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Representations and Warranties of the Company </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We made customary representations and warranties in the Subscription Agreement that are subject, in many cases, to exceptions and
qualifications contained in the Subscription Agreement, in the disclosure letter or in certain reports filed with the SEC. These representations and warranties relate to, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our and our subsidiaries&#146; due organization, existence, good standing and authority to carry on our and
their businesses as currently conducted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our corporate power and authority related to the Subscription Agreement, including as it relates to our entry
into and performance of our obligations contemplated by the Subscription Agreement; the required vote of our stockholders to adopt the Subscription Agreement and to consummate the transactions contemplated thereby; and our Board&#146;s
recommendation that the Subscription Agreement and the transactions contemplated thereby are advisable and in the best interests of the Company&#146;s stockholders and recommendation to adopt the Subscription Agreement by the stockholders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required actions by or in respect of, and filings with, governmental authorities in connection with the
transaction and the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our capitalization and the absence of any voting agreements by us (except with respect to the voting agreement
entered into with respect to this transaction) with respect to our securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our subsidiaries&#146; capitalization; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the offer and sale of the purchased shares pursuant to the Subscription Agreement will be exempt from
registration requirements under the Securities Act of 1933, as amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our SEC filings since January&nbsp;1, 2019, the absence of material misstatements or omissions in such filings
and documents and compliance of such filings with legal requirements; any material or unresolved written comments from the SEC; compliance with Sarbanes-Oxley Act; and disclosure controls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial statements and compliance with GAAP; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of certain legal proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our and our subsidiaries&#146; compliance with applicable laws and the absence of written notices from
governmental authorities alleging any such violations, and the absence of any orders from governmental authorities, including all permits and licenses required to conduct our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain tax matters relating to the Company and its subsidiaries, including the filing of all tax returns
required to be filed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain ERISA matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain environmental matters relating to the Company and its subsidiaries; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain matters relating to registration rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain matters relating to the Investment Company Act of 1940, as amended; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance by us with the listing and corporate governance requirements of Nasdaq; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any undisclosed broker&#146;s or finder&#146;s fees except for those owed to B. Riley;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the compliance of the Company, since January&nbsp;1, 2022, and its subsidiaries with the provisions of the
U.S. Foreign Corrupt Practices Act of 1977, as amended, and other applicable anti-corruption and anti-bribery laws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the compliance of the Company with applicable trade laws, and applicable export laws and certain economic
sanction regimes for the past five (5)&nbsp;years; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain matters with respect to affiliate transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maintenance of sufficient and customary insurance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain matters with respect to the intellectual property of the Company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain matters with respect to customers of the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The representations and warranties in the Subscription Agreement of the Company will not survive the consummation of the transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Material Adverse Effect </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Many of our representations and warranties are qualified by, among other things, exceptions relating to the absence of a &#147;material adverse
effect&#148;, which means a material adverse effect upon the financial condition, assets, liabilities or results of operations of the Company and its subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>, that any such effect resulting or
arising from or relating to any of the following matters shall not be considered when determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any change, development, occurrence or event affecting the industry in which the Company and its subsidiaries
operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any conditions affecting the United States general economy or the general economy in any geographic area in
which the Company or its subsidiaries operate or developments or changes therein or the financial and securities markets and credit markets in the United States or elsewhere in the world; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">political conditions, including the continuation, occurrence, escalation, outbreak or worsening of any
hostilities, war, political action, acts of terrorism, sabotage or military conflicts, whether or not pursuant to the declaration of an emergency or war; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any conditions resulting from the existence, occurrence or continuation of any force majeure events, including
any earthquakes, floods, hurricanes, tropical storms, fires or other natural or manmade disasters, any epidemic, pandemic (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or other similar outbreak (including any <FONT
STYLE="white-space:nowrap">non-human</FONT> epidemic, pandemic or other similar outbreak) or any other national, international or regional calamity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in any law, rule, regulation or GAAP; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any action taken or omitted to be taken by or at the written request or with the written consent of the
Purchaser; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any announcement of the Subscription Agreement or the contemplated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market price or trading volume of common stock or any other equity, equity-related or debt
securities of the Company or its affiliates (it being understood that the underlying circumstances, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
events or reasons giving rise to any such change can be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any failure to meet any internal or public projections, forecasts, estimates or guidance for any period (it
being understood that the underlying circumstances, events or reasons giving rise to any such failure can be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur); or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any effect arising out of or resulting from any claims or proceedings made by any of the Company&#146;s
stockholders arising out of or related to the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>provided</U>, that any of the matters
described in the first three matters listed above, will be taken into account for purposes of determining whether or not a Material Adverse Effect has occurred to the extent that such matter disproportionately and adversely affects the Company and
its subsidiaries, taken as a whole, as compared with other companies operating in the industry in which the Company and its subsidiaries operate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Representations and Warranties of Purchaser </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement also contains customary representations and warranties made by Purchaser that are subject, in some cases, to
specified exceptions and qualifications contained in the Subscription Agreement. The representations and warranties of Purchaser relate to, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">its due organization, existence, good standing and authority to carry on its business as presently conducted;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">its corporate power and authority related to the Subscription Agreement, including its power to enter into the
Subscription Agreement, perform their obligations under, and consummate the transactions contemplated by the Subscription Agreement and the enforceability of the Subscription Agreement against it; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required actions by or in respect of, and filings with, governmental authorities in connection with the
subscription agreements and transactions contemplated thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability of funds as of the date of the Subscription Agreement to pay the first purchase price at the
first closing and that the Purchaser will have as of the second closing sufficient immediately available funds to pay the second purchase price at the second closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain representations with respect to the Purchaser&#146;s status as an &#147;accredited investor&#148; as
that term is defined in Rule 501(a) of Regulation D promulgated under the Securities Act and the private placement of the purchased shares; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">its lack of prior ownership of the Company common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any undisclosed broker&#146;s or finder&#146;s fees </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain ERISA matters; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">its status as a wholly-owned and controlled entity of U.S. citizens and that it is not a &#147;foreign
person,&#148; &#147;foreign national,&#148; &#147;foreign government&#148; or &#147;foreign entity.&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
representations and warranties in the Subscription Agreement of the Company will not survive the consummation of the transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_40">
</A>Conduct of Our Business Pending the Transaction </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Subscription Agreement, between the date of the Subscription Agreement
and the earlier of the first closing or the termination of the Subscription Agreement in accordance with its terms, except as required by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
applicable law or governmental authority or with the prior written consent of the Purchaser, the Company shall and shall cause each of its subsidiaries to conduct its business in the ordinary
course consistent with past practice and use its commercially reasonable efforts to (i)&nbsp;preserve intact its present business organization, (ii)&nbsp;keep available the services of its present directors, officers and any employee of the Company
or any of its subsidiaries whose annual base compensation is $200,000 or more (which we refer to as a &#147;key employee&#148;) and (iii)&nbsp;preserve its relationships with its material customers, lenders, suppliers and others having material
business relationships with it. Additionally, except as expressly permitted or required by the Subscription Agreement, as required by applicable law or with the prior written consent of the Purchaser, between the date of the Subscription Agreement
and the earlier of the second closing or the termination of the Subscription Agreement in accordance with its terms, as applicable, the Company shall not nor shall it permit any of its subsidiaries to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) amend the certificate of incorporation or bylaws of the Company or (ii)&nbsp;amend, other than immaterial
changes in respect of wholly-owned subsidiaries, the comparable organizational documents of any subsidiary of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) split, combine or reclassify any shares of its capital stock, (ii)&nbsp;authorize, declare, set aside or
pay any dividends on, or make any other distributions (whether in cash, stock, property or otherwise) in respect of, or enter into any agreement with respect to the voting of, any capital stock of the Company or any of its subsidiaries, other than
dividends and distributions by a direct or indirect wholly-owned subsidiary of the Company to its parent or (iii)&nbsp;redeem, repurchase or otherwise acquire or offer to redeem, repurchase or otherwise acquire any securities of the Company or any
securities of any subsidiary of the Company, other than (A)&nbsp;the acquisition or withholding by the Company of shares of common stock in connection with the surrender of shares of common stock by holders of Company stock options in order to pay
the exercise price thereof, (B)&nbsp;the acquisition or withholding of shares of common stock to satisfy tax obligations with respect to awards granted pursuant to the stock plans, (C)&nbsp;the acquisition by the Company of any restricted shares in
connection with the forfeiture of such awards and (D)&nbsp;as required by any stock plan as in effect on the date of the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) issue, deliver, sell, grant, pledge, transfer, subject to any Lien or otherwise encumber or dispose of,
any securities of the Company or any securities of any subsidiary of the Company, other than the issuance of (A)&nbsp;any shares of common stock upon the exercise of Company stock options or any options or purchase rights under the Company&#146;s
2019 ESPP (as defined herein) or settlement of Company RSUs, in each case, that are outstanding on the date of the Subscription Agreement and in each case in accordance with their terms on the date of the Subscription Agreement, (B)&nbsp;awards of
Company RSUs to consultants under the stock plans and awards of Company RSUs under the stock plans to any newly hired or promoted employees or to employees for retention purposes, in each case, in the ordinary course of business consistent with past
practice or (C)&nbsp;any securities of any subsidiary of the Company to the Company or any other wholly-owned subsidiary of the Company; or (ii)&nbsp;amend any term of any securities of the Company or any securities of any subsidiary of the Company
; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial liquidation,
dissolution, restructuring, recapitalization or other reorganization, each with respect to the Company or any of its subsidiaries (other than the dissolution of any inactive subsidiary of the Company and reorganizations solely among subsidiaries of
the Company) or consummate any of the foregoing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire (by merger, consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any
equity interest or securities in, or any material amount of other assets, properties, interests or businesses of, any person, or enter into any new line of business that is material to the Company and its subsidiaries, taken as a whole;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell, lease, exclusively license, exchange, swap, abandon, allow to lapse or cancel any intellectual property
owned by the Company (other than the natural expiration thereof or, with respect to allowing intellectual property owned by the Company to become abandoned, lapsed or cancelled, in connection with the Company&#146;s exercise of its reasonable
business judgment); or sell, lease, exchange, swap or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
otherwise transfer or dispose of any of the Company&#146;s or its subsidiaries&#146; material assets, securities, properties, interests or businesses, other than (i)&nbsp;pursuant to existing
Contract in effect prior to the date of the Subscription Agreement, or (ii)&nbsp;sales of Company products and services, inventory or used equipment in the ordinary course of business consistent with past practice; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) repurchase, prepay, redeem, defease, assume, endorse, guarantee, incur or otherwise become liable for or
modify the terms of any indebtedness for borrowed money or sell or issue any debt securities or other rights to acquire any debt securities (directly, contingently or otherwise), or (ii)&nbsp;make any loans, advances or capital contributions to, or
investments in, any other person (other than to the Company or any of its wholly-owned subsidiaries in the ordinary course of business and advances of expenses to employees in the ordinary course of business); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as required by the terms of any employee benefit plan of the Company as in effect on the date of the
Subscription Agreement: (i)&nbsp;grant any severance, retention or termination pay to, or enter into or amend any employment, severance, retention, termination, change in control or severance agreement with, any current or former key employee,
(ii)&nbsp;hire any new employee who would constitute a key employee, other than in the ordinary course of business consistent with past practice in order to replace a key employee whose employment terminates (so long as the applicable replacement
key employee receives compensation and benefit terms that are no more favorable to the new key employee than compensation and benefits held by the key employee that is being replaced), (iii) grant to any current or former director or key employee of
the Company or any of its subsidiaries any material increase in compensation, target bonus or benefits, in addition to those pursuant to arrangements in effect on the date hereof, other than in the ordinary course of business, (iv)&nbsp;establish,
adopt, enter into or materially amend or modify any employee benefit plan of the Company (other than entering into offer letters that contemplate &#147;at will&#148; employment that is terminable without payment or notice or, where required by
applicable law, employment agreements consistent with the Company&#146;s practices in the applicable jurisdiction, or cash bonus or cash incentive plans for performance periods not exceeding one (1)&nbsp;year in the ordinary course of business
consistent with past practice to replace such plans covering performance periods that end prior to the second closing), (v) take any action to accelerate any payment or benefit, or the funding of any payment or benefit, payable or to become payable
to any of its directors employees or other service providers, other than in the ordinary course of business consistent with past practice, (vi)&nbsp;establish, enter into, adopt or amend any works council, collective bargaining or similar
labor-related agreement, except as required by applicable law, (vii)&nbsp;announce, implement or effect any material reduction in labor force, <FONT STYLE="white-space:nowrap">lay-off,</FONT> early retirement program or other effort concerning
termination of employment of employees of the Company or any of its subsidiaries (other than routine employee terminations in the ordinary course of business) or (viii)&nbsp;terminate any key employee other than for cause; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change in any financial accounting principles, methods or practices (including any tax accounting
policies or procedures) or any of its methods of reporting income, deductions or other material items for financial or tax accounting purposes, in each case except for any such change required by GAAP or applicable law, including Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Securities Exchange Act of 1934, as amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make, change or revoke any material tax election (other than in the ordinary course of business consistent
with past practice), change any annual tax accounting period, adopt or change any method of material tax accounting, amend, refile or otherwise revise any previously filed tax returns, enter into any closing agreement, settle or compromise any tax
claim or assessment, consent to any extension or waiver of the statutory period of limitations applicable to any claim or assessment in respect of taxes, enter into any tax indemnity or similar agreements or arrangements (other than customary
commercial agreements not primarily related to taxes), undertake any restructuring or engage in any transaction that may transfer the ownership of any intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discharge, pay, settle or offer or propose to settle, (i)&nbsp;any litigation, investigation, arbitration,
proceeding or other claim involving or against the Company or any of its subsidiaries, (ii)&nbsp;any </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
shareholder litigation or dispute against the Company or any of its officers or directors, or (iii)&nbsp;any litigation, arbitration, proceeding or dispute that relates to the contemplated
transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into, as a tenant or subtenant, any lease of real property, under which the rent to be charged exceeds
two hundred fifty thousand ($250,000) for any twelve (12)-month period, other than ordinary course of business extensions and renewals of leases existing as of the date hereof with a term of no more than one (1)&nbsp;calendar year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except in the ordinary course of business consistent with past practice and except as provided in an annual
operating plan as approved by the Board, make any new capital expenditure or expenditures, or commit to do so; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terminate, cancel, amend or modify any insurance coverage policy maintained by the Company or any of its
subsidiaries that is not concurrently replaced by a comparable amount of insurance coverage, other than renewals in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except in the ordinary course of business consistent with past practice, (i)&nbsp;enter into any contract that
would, if entered into prior to the date hereof, be a material contract that was required to be filed or furnished by the Company as exhibits to the SEC documents to which the Company is a party or the property or assets of the Company is subject
(which we refer to as &#147;material contracts&#148;) (ii) materially modify, materially amend or terminate any material contract or (iii)&nbsp;waive, release, terminate, amend, renew or assign any material rights or claims of the Company or any of
its subsidiaries under any material contract; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into or adopt any &#147;poison pill&#148; or similar stockholder rights plan that would prevent or
preclude the contemplated transactions; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">agree, authorize or commit to do any of the foregoing </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_41"></A>No Solicitation of Acquisition Proposals; Board Recommendation Changes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>No Solicitation or Negotiation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as permitted by the terms of the Subscription Agreement described below, from and after the date of the Subscription Agreement until the
earlier of the first closing or the termination of the Subscription Agreement in accordance with its terms, the Company has agreed that neither the Company nor any of its subsidiaries will, nor will the Company or any of its subsidiaries authorize
or knowingly permit any of the directors of the Company, the officers or employees of the Company, or any investment bankers, attorneys, accountants or other advisors or other representatives retained by the Company or its subsidiaries
(collectively, we refer to such persons as &#147;the Company representatives&#148;) to, directly or indirectly: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solicit, initiate or knowingly facilitate or encourage the submission of any inquiry, proposal or offer that
constitutes, or would reasonably be expected to result in, an acquisition proposal (as defined below); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into, continue or participate in any discussions or negotiations with, or furnish any <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its subsidiaries to, any third party in connection with an acquisition proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve, recommend, publicly declare advisable or enter into any agreement in principle, letter of intent,
merger agreement, acquisition agreement, joint venture agreement or other similar agreement relating to an acquisition proposal (other than an acceptable confidentiality agreement); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">agree to or propose publicly to do any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement defines the term &#147;acquisition proposal&#148; to mean, other than the transactions contemplated by the
Subscription Agreement, any written or oral offer, or proposal of any third party or &#147;group&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(as such term is defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) relating to a transaction or series of related transactions involving:
(i)&nbsp;any acquisition or purchase (including through any lease, exchange, exclusive license, transfer or disposition, in each case, other than in the ordinary course of business), direct or indirect, of assets equal to 20% or more of the
consolidated assets or businesses of the Company and its subsidiaries, taken as a whole, or to which 20% or more of the consolidated revenues or earnings of the Company and its subsidiaries, taken as a whole, are attributable, or 20% or more of any
class of equity or voting securities of the Company, (ii)&nbsp;any tender offer or exchange offer that, if consummated, would result in such third party or group beneficially owning 20% or more of any class of equity or voting securities of the
Company or (iii)&nbsp;a merger, consolidation, business combination, sale of all or substantially all of the assets, liquidation, dissolution or other similar extraordinary transaction (A)&nbsp;involving the Company or any of its subsidiaries whose
assets, individually or in the aggregate, constitute 20% or more of the consolidated assets of the Company or to which 20% or more of the consolidated revenues or earnings of the Company and its subsidiaries, taken as a whole, are attributable or
(B)&nbsp;pursuant to which the stockholders of the Company immediately prior to the consummation of such transaction would, as a result of such transaction, hold less than 80% of the equity interests in the surviving entity of such transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>No Solicitation Exceptions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, any time after the date of the Subscription Agreement and prior to the Company stockholders&#146; adoption of
the Subscription Agreement, the Company, directly or indirectly through the Company representatives, may (i)&nbsp;engage in negotiations or discussions with a third party and its representatives and actual or potential sources of financing
(including making any counterproposal) and (ii)&nbsp;furnish to such persons <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its subsidiaries pursuant to an acceptable confidentiality agreement, but
only in the event all of the following occur: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company, any subsidiary of the Company or a Company representatives receives a written acquisition
proposal from such third party that did not result from a breach of the Company&#146;s <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations and that the Board determines in good faith: (i)&nbsp;to be bona fide, (ii)&nbsp;after
consultation with its financial advisor and outside legal counsel, constitutes, or would reasonably be expected to result in, a superior proposal, or (iii)&nbsp;after consultation with its outside legal counsel, that the failure to take such action
would reasonably be expected to result in a breach of the fiduciary duties of the Company&#146;s directors under applicable law; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to or substantially concurrently with the time any <FONT STYLE="white-space:nowrap">non-public</FONT>
information relating to the Company is made available to such third party, the Company makes available to Purchaser any such information that is made available to the third party that was not previously made available to Purchaser.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement defines the term &#147;superior proposal&#148; to mean a bona fide, written acquisition
proposal (with all percentages included in the definition of &#147;acquisition proposal&#148; changed to 50%) made after the date of the Subscription Agreement that the Board determines in good faith, after consultation with its financial advisor
and outside legal counsel, and taking into account all relevant terms and conditions of such acquisition proposal (including any termination or <FONT STYLE="white-space:nowrap">break-up</FONT> fees and conditions to consummation), the person making
such acquisition proposal, the likelihood and timing of consummation of such acquisition proposal and all financial, legal, regulatory and other aspects of such acquisition proposal, is more favorable to the Company&#146;s stockholders from a
financial point of view than the transactions contemplated by the Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company agrees to promptly (but in no event
later than twenty-four (24)&nbsp;hours) notify Purchaser orally and in writing of its receipt of any acquisition proposal, any proposals or inquiries that would reasonably be expected to lead to an acquisition proposal or any inquiry or request for
nonpublic information relating to the Company or any of its subsidiaries by any person who has made, or has expressly indicated that such person is contemplating making, any acquisition proposal. The notice provided to Purchaser must identify the
third party making, and the material terms and conditions of (or the nature of), any such acquisition proposal, inquiry or request and must include a copy of any written acquisition proposal (or summary of the terms of any oral acquisition proposal)
and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
a copy of all written materials provided by such Person with respect to such acquisition proposal. Further, the Company has agreed to keep Purchaser reasonably informed promptly (but in no event
later than twenty-four (24)&nbsp;hours) after any material changes in status or material terms of any acquisition proposal and shall provide to Parent promptly (but in no event later than twenty-four (24)&nbsp;hours) after receipt thereof of copies
of proposed transaction agreements or proposal letters sent or provided to the Company or any of its subsidiaries that describe any material terms or conditions of any acquisition proposal. The Company has also agreed to keep Purchaser reasonably
informed as to the nature of any information requested of the Company with respect thereto. Upon the request of Purchaser, the Company must apprise Purchaser of the status of any such acquisition proposal, inquiry or request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an acquisition proposal is publicly announced (other than by Purchaser, its subsidiaries or any of their respective affiliates or
representatives), the Company has agreed to publicly reaffirm the Board recommendation within ten (10)&nbsp;business days after receipt of a written request by Purchaser to provide such reaffirmation, unless an adverse recommendation change (as
defined below) is permitted under the terms of the Subscription Agreement, except that the Company is not obligated to publicly reaffirm such recommendation on more than one occasion with respect to each such publicly announced acquisition proposal
by any third party or on more than one occasion with respect to each publicly announced material modification thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Adverse
Recommendation Change </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement provides that (subject to certain exceptions described below) the Board will not
(i)&nbsp;fail to make, withdraw or modify in a manner adverse to Purchaser (or publicly propose to withdraw, modify or qualify in any manner adverse to Purchaser) the Board recommendation, (ii)&nbsp;adopt, approve or publicly recommend, endorse or
otherwise declare advisable the adoption of, an acquisition proposal or (iii)&nbsp;fail to include in this proxy statement the Board recommendation (any of the foregoing, we refer to as an &#147;adverse recommendation change&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Adverse Recommendation Change Exceptions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, the Board, at any time before the Company stockholders adopt the Subscription Agreement, may make an adverse
recommendation change (or terminate the Subscription Agreement as described in the section entitled &#147;The Subscription Agreement&#151;Termination&#148; starting on page 65) in response to an acquisition proposal, only so long as (i)&nbsp;such
acquisition proposal was not the result of a breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations of the Company described above and such acquisition proposal is not withdrawn, and (ii)&nbsp;the Board determines in good
faith, after consultation with its financial advisor and outside legal counsel and after taking into account any revisions to the terms of the Subscription Agreement that may be offered in writing by Purchaser in accordance with the Subscription
Agreement, (A)&nbsp;that such acquisition proposal constitutes a superior proposal, and (B)&nbsp;that the failure to make an adverse recommendation change would reasonably be expected to result in a breach of its fiduciary duties under applicable
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the Board may not effect an adverse recommendation change (or terminate the Subscription Agreement as described in the
section entitled &#147;The Subscription Agreement&#151;Termination&#148; starting on page&nbsp;65) unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company notifies Purchaser in writing (which we refer to as a &#147;change notice&#148;) at least three
(3)&nbsp;business days (which we refer to as the &#147;negotiation period&#148;) before the making of any adverse recommendation change or the Board&#146;s determination that such acquisition proposal constitutes a superior proposal and of its
intention to make an adverse recommendation change, with the most current version of all proposed agreements under which such superior proposal is proposed to be consummated and all other material terms and conditions in respect of such acquisition
proposal and the identity of the third party making such superior proposal attached to the change notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">during the negotiation period, the Company was available to negotiate in good faith with Purchaser (if
requested by Purchaser) any proposal by Purchaser to amend the terms and conditions of the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Subscription Agreement such that the acquisition proposal would no longer constitute a superior proposal (provided that the Company delivered a new change notice and entered into a new two
(2)&nbsp;business day negotiation period for any amendment, supplement or modification to any acquisition proposal); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the end of the negotiation period (and any subsequent negotiation periods with respect to an amended,
supplemented or modified acquisition proposal), the Board, after considering in good faith any revisions to the terms of the Subscription Agreement offered in writing by Purchaser pursuant to the Subscription Agreement, determined in good faith,
after consultation with its financial advisor and outside legal counsel, that such acquisition proposal remained a superior proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, the Board may make an adverse recommendation change if (i)&nbsp;an intervening event (as defined below) has occurred, (ii)&nbsp;the
Board determines in good faith and after taking into account any revisions to the terms of the Subscription Agreement that may be offered in writing by Purchaser in accordance with the Subscription Agreement, after consultation with outside legal
counsel and its financial advisors, that the failure to make an adverse recommendation change would reasonably be expected to result in a breach of its fiduciary duties under applicable law and (iii)&nbsp;prior to making the adverse recommendation
change, the Company (A)&nbsp;provided Purchaser at least two (2)&nbsp;business days&#146; prior written notice that it intends to take such action and specifying in reasonable detail the facts underlying the decision by the Board to take such action
(provided that the Company delivered a new notice and entered into a new two (2)&nbsp;business day period for any material change in the facts or circumstances relating to an intervening event) and (B)&nbsp;during such period, if requested by
Purchaser, engaged in good faith negotiations with Purchaser to amend the Subscription Agreement in such a manner that obviates the need for such adverse recommendation change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement defines &#147;intervening event&#148; to mean a material fact, event, circumstance, development or change that
occurs, arises or comes to the attention of the Board after the date of the Subscription Agreement that (w)&nbsp;affects the business, assets or operations of Company and its subsidiaries, (x)&nbsp;was not known by, or if known, the effect of which
was not reasonably foreseeable by, the Board (assuming consultations with appropriate officers and representatives of the Company) on the date of the Subscription Agreement, (y)&nbsp;becomes known to the Board prior to receipt of the company
stockholder approval and (z)&nbsp;did not result from or arise out of the announcement or pendency of, or any actions required to be taken (or refrained from taken) pursuant to the Subscription Agreement; provided, however, that in no event shall
any of the following, alone or in combination, constitute an intervening event: (1)&nbsp;the receipt, existence of or terms of an acquisition proposal, (2)&nbsp;changes in the trading price or trading volume of the Company common stock, in and of
itself (it being understood that the facts or occurrences giving rise or contributing to such changes may be taken into account the extent otherwise permitted by the definition of &#147;intervening event&#148;); or (3)&nbsp;meeting or exceeding any
published analyst estimates or expectations of the Company&#146;s revenue, earnings or other financial performance or results of operations for any period, in and of itself, or exceeding the Company&#146;s internal or external budgets, plans or
forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or contributing to the Company meeting or exceeding such estimates,
projections, budgets, plans or forecasts may be taken into account to the extent otherwise permitted by the definition of &#147;intervening event&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_42"></A>Stockholders Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company has agreed to cause the special meeting to be duly called and held as soon as reasonably practicable following clearance of this
proxy statement by the SEC for the purpose of voting on the Transaction Proposal by the Company&#146;s stockholders. The Company&#146;s Board has agreed to, subject to the provisions of the Subscription Agreement discussed above under &#147;The
Subscription Agreement&#151;No Solicitation of Acquisition Proposals; Board Recommendation Changes&#148; beginning on page 58), recommend that the Company stockholders adopt the Subscription Agreement, to use its reasonable best efforts to obtain
stockholder approval of the Transaction Proposal and to otherwise comply with all legal requirements applicable to the special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_43"></A>Filings; Other Actions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and Purchaser have agreed to cooperate with each other and use their reasonable best efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary, proper or advisable under applicable law to consummate the transactions contemplated by the Subscription Agreement as promptly as practicable, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing and filing as promptly as practicable after the date of the Subscription Agreement with any
governmental authority all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, financial statements, records, applications and other documents, in each case, to the extent
applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and maintaining all approvals, consents, registrations, permits, authorizations, licenses, waivers
and other confirmations required to be obtained from any governmental authority that are necessary to consummate the transactions contemplated by the Subscription Agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">executing and delivering any additional instruments necessary to consummate the transactions contemplated by
the Subscription Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_44"></A>Employment and Severance Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the Company&#146;s entry into the Subscription Agreement, the Board appointed Peter Liu, who had been serving as the
Company&#146;s Executive VP for Global Operations, as Chief Executive Officer of the Company. However, if the Subscription Agreement is terminated prior to the first closing, Mr.&nbsp;Liu&#146;s title will change back to Executive VP for Global
Operations. Mr.&nbsp;Liu did not receive any additional compensation as a result of his appointment as Chief Executive Officer or the transactions contemplated by the Subscription Agreement. Mr.&nbsp;Liu and the Company have entered into an offer
letter, dated July&nbsp;31, 2013 and as amended on February&nbsp;1, 2016, that provides Mr.&nbsp;Liu with an initial annual base salary of $253,000. His current annual base salary is $265,650. Mr.&nbsp;Liu is also eligible for an annual bonus, with
his current target bonus opportunity being 50% of his base salary. Mr.&nbsp;Liu is also eligible to participate in the employee benefit plans generally available to the Company&#146;s employees. The offer letter also provides that if
Mr.&nbsp;Liu&#146;s employment with the Company is terminated by the Company without cause or by Mr.&nbsp;Liu for good reason, in any such case prior to a change in control or more than thirteen (13)&nbsp;months after a change in control, or due to
Mr.&nbsp;Liu&#146;s death or permanent disability, Mr.&nbsp;Liu will receive six (6)&nbsp;months of continued base salary. If Mr.&nbsp;Liu&#146;s employment with the Company is terminated by the Company without cause, or if he terminates his
employment with the Company for good reason, in either case at any time within thirteen (13)&nbsp;months after a change in control, Mr.&nbsp;Liu will receive six (6)&nbsp;months of continued base salary and accelerated vesting of any
then-outstanding options or stock awards granted by the Company to him that would have vested had Mr.&nbsp;Liu remained employed for two (2)&nbsp;years following the date of such termination. The severance benefits described above would, if
triggered, be conditioned on Mr.&nbsp;Liu providing the Company with a release of claims in a form acceptable to the Company. For these purposes, &#147;cause,&#148; &#147;good reason&#148; and &#147;change in control&#148; are defined in the offer
letter. Mr.&nbsp;Liu&#146;s offer letter was amended on April&nbsp;13, 2022 solely to provide for his appointment as Chief Executive Officer and to confirm that he would not be entitled to resign for &#147;good reason&#148; under his offer letter if
the Subscription Agreement terminated and his appointment as Chief Executive Officer were rescinded as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April&nbsp;13,
2022, the Compensation Committee of the Board approved a letter agreement with Robert Tirva, the Company&#146;s President, Chief Financial Officer and Chief Operating Officer (the &#147;Tirva Letter Agreement&#148;). The agreement provides that
Mr.&nbsp;Tirva&#146;s employment with the Company will terminate on, and subject to, the first closing and that upon such termination, Mr.&nbsp;Tirva would be entitled to receive the following severance benefits: cash severance of $1,000,000
(payable in installments over twenty (20)&nbsp;months), accelerated vesting of his then-outstanding and unvested equity-based awards granted by the Company and, subject to his providing consulting services to the Company for three (3)&nbsp;months
after his termination date, reimbursement for his COBRA health insurance premiums for up to eighteen (18)&nbsp;months following his termination. Mr.&nbsp;Tirva&#146;s right </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to receive these benefits is conditioned on his providing the Company with a release of claims in a form acceptable to the Company and continued compliance with his obligations under his
proprietary information agreement with the Company (including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">the&nbsp;non-competition&nbsp;and&nbsp;non-solicitation&nbsp;provisions</FONT></FONT> thereof). If the first closing
occurs, the severance benefits provided in the Tirva Letter Agreement will supersede the severance benefits provided in Mr.&nbsp;Tirva&#146;s existing employment agreement with the Company. If the first closing does not occur, the Tirva Letter
Agreement will terminate, and the severance provisions in Mr.&nbsp;Tirva&#146;s employment agreement will apply in accordance with their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_45"></A>Golden Parachute Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the estimated amounts of &#147;golden parachute&#148; compensation (for purposes of Item 402(t) of Regulation <FONT
STYLE="white-space:nowrap">S-K)</FONT> that each of our named executive officers could receive in connection with the transactions contemplated by the Subscription Agreement. The named executive officers are not entitled to receive any other
payments or benefits solely as a result of such transactions or any other transaction that constitutes a change in control of the Company. The amounts in the table assume, where applicable, that the named executive officer&#146;s employment is
terminated in circumstances that would trigger the right to receive severance benefits under the agreements described above (a &#147;qualifying termination&#148;), and that such a qualifying termination of the executive&#146;s employment occurred on
May&nbsp;6, 2022. The actual amounts that would be paid upon a named executive officer&#146;s termination of employment can be determined only at the time of such executive&#146;s separation from the Company. As a result, the actual amounts received
by a named executive officer may differ in material respects from the amounts set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Severance</B><br><B>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity</B><br><B>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Perquisites/<BR>Benefits</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tax<BR>Reimbursement</B><br><B>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Tirva</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,096,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President, Chief Financial Officer and Chief Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas W. Wilkinson<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Former Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported in this column represents the potential cash severance payments that would be made to
Mr.&nbsp;Tirva assuming a qualifying termination of his employment upon the first closing as provided in the Tirva Letter Agreement, such amount to be paid in 20 monthly installments following his termination. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported in this column reflects the value of Mr.&nbsp;Tirva&#146;s equity awards granted by the
Company that were outstanding as of May&nbsp;6, 2022 and that would vest assuming a qualifying termination of his employment upon the first closing as provided in the Tirva Letter Agreement. These amounts were calculated based on the number of
shares subject to the portion of the award that would accelerate and a value for the Company&#146;s common stock of $0.71 per share, which was the average closing market price of the stock over the first five business days following the first public
announcement of the transaction on April&nbsp;14, 2022 (and, in the case of options and similar awards, less the exercise price for the shares subject to the accelerated portion of the option). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported in this column represents the estimated cost to provide the health and welfare benefits
described above (including reimbursement of COBRA premiums for the applicable period) to Mr.&nbsp;Tirva assuming a qualifying termination of his employment upon the first closing and his provision of consulting services for three months after his
termination, each as provided in the Tirva Letter Agreement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">None of the named executive officers is entitled to a
<FONT STYLE="white-space:nowrap">&#147;gross-up&#148;</FONT> payment for any excise taxes that may be due by reason of Sections 280G and 4999 of the U.S. Internal Revenue Code. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Wilkinson resigned as the Company&#146;s Chief Executive Officer on May&nbsp;31, 2021.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_46"></A>Other Covenants and Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement contains certain other covenants and agreements, including covenants relating to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to the Company, access to certain information during the period prior to the first closing, and
reasonable access during normal business hours to employees, offices, properties, books and records, including arranging meetings and facilitating access for Purchaser and its representatives with customers and suppliers of the company and its
subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each party&#146;s agreement to use commercially reasonable efforts not to take or omit to take any action that
impedes, interferes with, hinders or delays in any material respect, or would reasonably be expected to prevent or materially impede, interfere with, hinder or delay in any material respect, the consummation of the transaction contemplated by the
Subscription Agreement on a timely basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cooperation between the Company and Purchaser in the preparation of this proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cooperation between the Company and Purchaser in connection with press releases and other public announcements
with respect to the transactions contemplated by the Subscription Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">notification by each party in response to certain events, including, among others, (i)&nbsp;any notice or
other communication from any person alleging that the consent of such person is required in connection with the transactions contemplated by the Subscription Agreement; (ii)&nbsp;any notice or other communication from any governmental authority in
connection with the transactions contemplated by the Subscription Agreement; (iii)&nbsp;any actions, suits, claims, investigations or proceedings commenced or, to their knowledge, threatened against the Company or any of its subsidiaries or
Purchaser or any of its subsidiaries, as the case may be, that relate to the consummation of the transactions contemplated by the Subscription Agreement; and (iv)&nbsp;any representation or warranty made in the Subscription Agreement becoming untrue
or inaccurate and such inaccuracy would cause the applicable party to fail to satisfy any condition to closing of the transaction related to performance of covenants and agreements or accuracy of representations and warranties;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to the Company and Purchaser entering into a registration rights agreement at or prior to the
first closing; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to the obligation of the Company to issue additional shares of Company common stock to Purchaser
for certain reasonable and documented out of pocket expenses relating to the current investigation of the Company by the SEC that cannot be recovered under the Company&#146;s insurance policy. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_47"></A>Conditions to the Transaction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The respective obligations of the Company and the Purchaser to consummate the transaction are subject to the satisfaction at or prior to the
first closing of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the affirmative vote in favor of the Transaction Proposal by the holders of a majority of the votes cast by
the stockholders present in person or by proxy at the special meeting and entitled to vote thereon, provided a quorum is present; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no temporary restraining order, decree, ruling, injunction or judgment, preliminary or permanent injunction or
other judgment issued by any governmental authority of competent jurisdiction will be in effect enjoining, restraining or otherwise prohibiting the consummation of the transaction, and no governmental authority of competent jurisdiction will have
enacted, issued, promulgated, enforced or declared applicable to the transaction any applicable law that is in effect, which has the effect of enjoining, restraining or otherwise prohibiting the consummation of the transaction.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The obligations of Purchaser to consummate the transaction are subject to the satisfaction
at or prior to the first closing of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company must have performed or complied with, in all material respects, all of its obligations under the
Subscription Agreement required to be performed by it at or prior to the first closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of the Company regarding organization and power of the Company,
authorization to enter into the transaction and use of a broker must be true in all material respects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of the Company regarding its capitalization must be true and correct in all
but de minimis respects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s other representations and warranties set forth in the Subscription Agreement must be true
and correct, except as would not have, individually or in the aggregate, a Material Adverse Effect on the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company shall have performed or complied with, in all material respects, all covenants and agreements
required to be performed by it at or prior to the first closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company shall have obtained the resignation of all of its current directors (other than the continuing
directors); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Robert Tirva and each director of the Company shall have executed and delivered to the Company a
voting agreement and voted his/her shares for each of the proposals on this proxy statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s
obligation to consummate the transaction is subject to the satisfaction at or prior to the first closing of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Purchaser must have performed, in all material respects, all of its obligations under the Subscription
Agreement required to be performed by it at or prior to the first closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of the Purchaser regarding organization and power of the Company,
authorization to enter into the transaction and sufficiency of funds to complete the transaction must be true in all material respects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of the Purchaser regarding its foreign control status must be true and
correct in all but de minimis respects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Purchaser&#146;s other representations and warranties set forth in the Subscription Agreement must be true
and correct, except as would not have, individually or in the aggregate, a Material Adverse Effect on the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Purchaser shall have paid, or cause to be paid, the first purchase price for the initial shares in full at
the first closing; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Purchaser shall have executed and delivered to the Company a voting agreement and such voting agreement
shall be in full force and effect. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_48"></A>Termination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and Purchaser may, by mutual written agreement, terminate the Subscription Agreement and abandon the transactions contemplated
thereby at any time prior to the first closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement may also be terminated and the transactions contemplated
thereby abandoned at any time prior to the first closing, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either the Company or Purchaser if: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the first closing has not been consummated on or before the date that is six (6)&nbsp;months after the date of
the Subscription Agreement (which we refer to as the &#147;end date&#148;); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any order permanently restraining, enjoining or otherwise prohibiting consummation of the transaction has
become final and <FONT STYLE="white-space:nowrap">non-appealable,</FONT> so long as the breach of the terminating party in any material respect is not the primary cause of such governmental restraint; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">stockholder approval of the Transaction Proposal is not obtained at the special meeting (after giving effect
to any adjournment or postponement of the special meeting); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Purchaser (with certain limitations as set forth in the Subscription Agreement), if: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to obtaining stockholder approval of the Transaction Proposal, (i)&nbsp;the Board makes an adverse
recommendation change, or (ii)&nbsp;the Company or its representatives willfully and materially violate section 4.1(a) of the Subscription Agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is any inaccuracy of any representation or warranty made by the Company in the Subscription Agreement or
any breach, violation or failure to perform any covenant or agreement on the part of the Company set forth in the Subscription Agreement and such inaccuracy, breach, violation or failure, if continuing at the first closing, would cause the Company
to fail to satisfy the applicable condition to closing of the first closing related to performance of covenants and agreements or accuracy of representations and warranties and that inaccuracy or breach is incapable of being cured by the end date;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the Company (with certain limitations as set forth in the Subscription Agreement), if:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is any inaccuracy of any representation or warranty made by Purchaser in the Subscription Agreement or
any breach, violation or failure to perform any covenant or agreement on the part of the Purchaser set forth in the Subscription Agreement and such inaccuracy or breach would cause Purchaser to fail to satisfy the applicable condition to closing of
the transaction related to performance of covenants and agreements or accuracy of representations and warranties and that inaccuracy or breach is incapable of being cured by the end date (collectively, we refer to such termination trigger as a
&#147;the Company terminating breach&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Board authorizes the Company, pursuant to, and in compliance with the applicable terms of the
Subscription Agreement, to enter into a definitive agreement concerning a superior proposal; so long as the Company pays a termination fee of $750,000 to Purchaser and reimburses Purchaser for up to $350,000 in reasonable, documented and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the Purchaser in connection with the Subscription Agreement, including but not limited to reasonable, documented and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal and advisory fees paid in connection therewith, substantially concurrently with (and as a condition to) such termination (which we refer to as the
&#147;superior proposal termination event&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_49"></A>Termination Fee&nbsp;&amp; Reimbursement
Obligation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In certain circumstances, the Company may be required to pay AJP Holding a termination fee of $750,000 (which we refer to
as the &#147;termination fee&#148;) if the Subscription Agreement is terminated, as well as reimburse AJP Holding for certain reasonable, documented, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses up to $350,000 (which we refer to as the &#147;reimbursement obligation&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The termination fee and reimbursement obligation
would be payable in the following circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Purchaser terminates the Subscription Agreement pursuant to an adverse recommendation change termination event
or the Company or its representatives willfully and materially violate the <FONT STYLE="white-space:nowrap">non-solicit</FONT> obligations of the Company , in which case the Company must pay Purchaser the termination fee and the reimbursement
obligation within two (2)&nbsp;business days after such termination; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company terminates the Subscription Agreement pursuant to a superior proposal termination event, in which
case the Company must pay Purchaser the termination fee substantially concurrently with (and as a condition to) such termination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The reimbursement obligation would be payable in the following
circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Either party terminates the Subscription Agreement due to failure to obtain stockholder approval of the
Transaction Proposal, in which case the Company must pay the reimbursement obligations to the Purchaser within two (2)&nbsp;business days after such termination. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_50"></A>Directors&#146; and Officers&#146; Indemnification and Insurance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The obligations of the Company and its subsidiaries under their respective organizational documents and all agreements in respect of all rights
to indemnification, exculpation of liability and advancement of expenses, in effect as of the date of the Subscription Agreement between the Company or any of its subsidiaries and any of their respective present or former directors, officers,
employees or agents (which we refer to as the &#147;indemnified persons&#148;) shall survive the transactions contemplated by the Subscription Agreement and may not be amended, repealed or otherwise modified in any manner that would adversely affect
any right thereunder of any indemnified person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For six (6)&nbsp;years after the first closing, Company and each of its subsidiaries
shall, and the Purchaser shall, if applicable, vote its shares of common stock to cause the Company and each of its Subsidiaries to cause the organizational documents of the Company and its subsidiaries to contain provisions no less favorable with
respect to elimination of liability of directors, indemnification of officers, directors and employees and advancement of expenses than are presently set forth in the organizational documents of the Company and its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, for six (6)&nbsp;years after the first closing, the Company shall, and the Purchaser shall, if applicable, vote its shares of
common stock to cause the Company to indemnify and hold harmless all indemnified persons to the fullest extent permitted by the DGCL in the event of any threatened or actual claim, suit, action, proceeding or investigation, whether civil, criminal
or administrative, based in whole or in part on, or arising in whole or in part out of, or pertaining to (i)&nbsp;the fact that such indemnified person is or was a director, officer, employee or agent of the Company, its subsidiaries or any of their
respective predecessors prior to the first closing or (ii)&nbsp;the Subscription Agreement or any of the transactions contemplated thereby, against any losses, claims, damages, liabilities, costs, expenses (including reasonable attorneys&#146; fees
and expenses) in advance of the final disposition of any claim, suit, proceeding or investigation to the fullest extent permitted by applicable law. The Company shall not settle or consent to the entry of a judgment in any threatened or actual claim
for which indemnification could be sought by an indemnified person under the Subscription Agreement, unless such settlement or consent includes an unconditional release of such indemnified person from all liability arising out of such claim or such
indemnified person otherwise consents in writing to such settlement or consent. The Company will cooperate with an indemnified person in the defense of any matter for which such indemnified person could seek indemnification under the Subscription
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to the first closing, the Company shall obtain and fully pay the premium for the
<FONT STYLE="white-space:nowrap">non-cancellable</FONT> extension of the directors&#146; and officers&#146; liability coverage of the Company&#146;s existing directors&#146; and officers&#146; insurance policies and the Company&#146;s existing
fiduciary liability insurance policies (collectively, we refer to such insurance as the &#147;D&amp;O insurance&#148;), in each case for a claims reporting or discovery period of at least six (6)&nbsp;years from and after the first closing with
respect to any claim related to any period of time at or prior to the first closing from an insurance carrier with the same or better credit rating as the Company&#146;s current insurance carrier with respect to D&amp;O insurance with terms,
conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company&#146;s existing policies; provided that in no event will the Company be obligated to pay annual premiums for insurance in excess
of $1,100,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indemnified persons have the right to enforce the provisions of the Subscription Agreement relating to their
indemnification. Such provisions may not be terminated, amended or otherwise modified in such a manner as to adversely affect any indemnified person without the prior written consent of such person. In addition, the Company shall pay all reasonable
expenses, including reasonable attorneys&#146; fees, that may be incurred by any indemnified person in enforcing the indemnity and other obligations provided in the Subscription Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the Company (i)&nbsp;consolidates with or merges into any other person and is not the
continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers all or substantially all of its properties and assets to any person, then proper provision must be made so that such continuing or surviving
corporation or entity or transferee of such assets, as the case may be, assumes the obligations set forth above relating to the indemnified person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_51"></A>Use of Proceeds </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company shall use the net proceeds from the transaction for working capital, capital expenditure and other general corporate purposes,
including but not limited to, the implementation of the plans to enhance and optimize the Company&#146;s business pursuant to the strategy developed by Mr.&nbsp;Liu as the Chief Executive Officer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_52"></A>Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise provided in the Subscription Agreement, all costs and expenses incurred in connection with the Subscription Agreement will
be paid by the party incurring such cost or expense. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_53"></A>Specific Performance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and Purchaser have agreed that irreparable damage for which monetary damages, even if available, would not be an adequate remedy
would occur in the event that the parties do not perform their obligations under the Subscription Agreement in accordance with its specified terms or otherwise breach such provisions. The Company and Purchaser have further agreed each party is
entitled to an injunction or injunctions, specific performance or any other equitable relief to prevent breaches of the Subscription Agreement and to enforce specifically the terms and provisions of the Subscription Agreement without proof of
damages. If, prior to the end date, any party brings any suit, action or proceeding to prevent breaches of the Subscription Agreement and to enforce specifically the terms and provisions thereof, the end date shall automatically be extended by
(A)&nbsp;the amount of time during which such suit, action or proceeding is pending, plus twenty (20)&nbsp;business days or (B)&nbsp;such other time period established by the court presiding over such suit, action or proceeding, as the case may be.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_54"></A>Amendments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement may be amended, modified or waived by a writing signed by both parties. However, from and after the first closing,
the approval of the continuing directors shall be required for the Company to (i)&nbsp;amend, modify or terminate the Subscription Agreement, (ii)&nbsp;exercise or waive any right of the Company under the Subscription Agreement or (iii)&nbsp;extend
the time for performance of any obligation of the Purchaser under the Subscription Agreement. The Subscription Agreement may not be modified or amended from and after the second closing and the Company cannot waive any provision in the Subscription
Agreement from and after the second closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_55"></A>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the
conflicts of law rules of such state. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_56"></A>No Appraisal Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the DGCL, our stockholders do not have a right to dissent and are not entitled to appraisal rights with respect to this proposal and we
will not independently provide our stockholders with any such rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_57"></A>Required Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The affirmative vote of the holders of a majority of the votes cast by the stockholders present in person or by proxy at the special meeting
and entitled to vote thereon will be required to approve the Transaction Proposal. A copy of the Subscription Agreement is attached hereto as <B>Annex A</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_58"></A>A VOTE IN FAVOR OF PROPOSAL 1. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_59"></A>PROPOSAL 2: AMENDMENT TO THE COMPANY&#146;S CERTIFICATE OF
INCORPORATION, AS AMENDED TO EFFECT A REVERSE STOCK SPLIT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_60"></A>Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has approved a proposed amendment to the Company&#146;s amended and restated certificate of incorporation, as amended (the
&#147;Certificate of Incorporation&#148;) that would effect a reverse stock split whereby a number of outstanding shares of our common stock between and including two (2)&nbsp;and fifteen (15), such number consisting only of whole shares, will be
combined into one share of our common stock, or the Reverse Stock Split. The amendment corresponding to this proposal is attached hereto as <B>Annex C</B>. This Proposal No.&nbsp;2. is not contingent on the outcome of Proposal No.&nbsp;1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the proposed amendment, any whole number of outstanding shares between and including two (2)&nbsp;and fifteen (15)&nbsp;shares would be
combined, converted and changed into one share of common stock. The Board believes that stockholder approval of the range of potential exchange ratios (rather than a single exchange ratio) provides the Board with the flexibility to achieve the
desired results of the Reverse Stock Split and, therefore, is in the best interests of the Company and its stockholders. If the stockholders approve this proposal, the Board would effect the Reverse Stock Split only upon the Board&#146;s
determination that such Reverse Stock Split would be in the best interests of the Company and its stockholders at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
effectiveness of this amendment or the abandonment of this amendment will be determined by the Board in its discretion. To effect the Reverse Stock Split, the Board would set the timing for such a split and select the specific ratio from the range
of ratios described in this Proposal 2. No further action on the part of stockholders will be required to either implement or abandon the Reverse Stock Split. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has recommended that this proposed amendment be presented to the Company&#146;s stockholders for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon receiving stockholder approval of the proposed amendment, the Board will have the sole discretion to elect pursuant to
Section&nbsp;242(c) of the Delaware General Corporation Law (the &#147;DGCL&#148;) as it determines to be in the best interests of the Company and its stockholders, whether to effect a Reverse Stock Split and, if so, the number of shares of our
common stock between and including two (2)&nbsp;and fifteen (15)&nbsp;that will be combined into one share of our common stock, at any time before the first anniversary of the special meeting. If the proposal is approved by stockholders, and the
Board determines to implement a Reverse Stock Split, we would communicate to the public the specific ratio the Board selects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the
Board determines to effect a Reverse Stock Split by filing the amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware, the Certificate of Incorporation would be amended accordingly. The text of the form of
amendment to the Certificate of Incorporation, which would be filed with the Secretary of State of the State of Delaware to effect the Reverse Stock Split reflected therein, is set forth in <B>Annex C</B> to this Proxy Statement. However, such text
is subject to amendment to include such changes as may be required by the office of the Secretary of State of the State of Delaware or as the Board deems necessary and advisable to effect one of the Reverse Stock Split, if any. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except for adjustments that may result from the treatment of fractional shares as described below, each stockholder will hold the same
percentage of outstanding common stock immediately following the Reverse Stock Split as such stockholder held immediately prior to such Reverse Stock Split. The par value of the common stock would remain unchanged at $0.0001 per share. The amendment
would not change the number of authorized shares of common stock. Accordingly, the Reverse Stock Split selected, if any, will have the effect of creating additional unreserved shares of our authorized common stock. These additional shares may be
used by us for various purposes in the future without further stockholder approval, including, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">raising capital to fund our development of our next generation of products or otherwise;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing strategic relationships with other companies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing equity incentives to our employees, officers or directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanding our business through the acquisition of other businesses or products. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should keep in mind that the implementation of a Reverse Stock Split does not have an effect on the actual or intrinsic value of the
Company&#146;s business or your proportional ownership in the Company. You should also consider that in many cases, the market price of a company&#146;s shares declines after events similar to the Reverse Stock Split. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_61"></A>Reasons for the Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed on the Nasdaq Capital Market (which we refer to as &#147;Nasdaq&#148;) under the symbol &#147;SONM.&#148; Nasdaq has
several continued listing criteria that companies must satisfy in order to remain listed on the exchange. One criteria for continued listing is that we maintain a closing bid price that is greater than or equal to $1.00 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We announced on February&nbsp;18, 2022 that we had received a letter dated February&nbsp;16, 2022 from the Listing Qualifications Department
of the Nasdaq Stock Market (the &#147;Staff&#148;) notifying the Company that, for thirty (30)&nbsp;consecutive business days, the bid price for the Company&#146;s common stock had closed below $1.00 per share, which is the minimum closing price
required to maintain continued listing on The Nasdaq Stock Market pursuant to the Nasdaq Listing Rules, or the &#147;Minimum Bid Requirement&#148;. In accordance with the Nasdaq Listing Rules, the Company has one hundred and eighty
(180)&nbsp;calendar days to regain compliance with the Minimum Bid Requirement. To regain compliance with the Minimum Bid Requirement, the closing bid price of the Company&#146;s common stock must be at least $1.00 per share for a minimum of ten
(10)&nbsp;consecutive business days during this one hundred and eighty <FONT STYLE="white-space:nowrap">(180)-day</FONT> compliance period, which expires on August&nbsp;15, 2022, unless the Staff exercises its discretion to extend this period
pursuant to the Nasdaq Listing Rules. If we do not regain compliance with the Minimum Bid Requirement by August&nbsp;15, 2022 but meet the continued listing requirement for market value of publicly held shares and all other initial listing standards
for the Nasdaq Capital Market, with the exception of the Minimum Bid Requirement, and provide written notice of our intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary, we may be
granted an additional one hundred and eighty (180)&nbsp;calendar day compliance period. If we fail to regain compliance during the grace period, our common stock could be subject to delisting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board believes that the continued listing of our common stock on Nasdaq is in the best interests of our stockholders. If our common stock
was delisted from Nasdaq, trading, if any, in our securities may then continue to be conducted in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the OTC bulletin board, OTC Markets or
in the &#147;pink sheets.&#148; In this case, we could face significant material adverse consequences, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of our securities may require compliance with the individual securities laws or &#147;blue
sky&#148; laws of several states, which may be time consuming and costly; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limited availability of market quotations for our securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the determination that our common stock is a &#147;penny stock,&#148; which would require brokers trading in
our common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">more limited amount of news and analyst coverage for us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased ability to issue additional securities or obtain additional financing in the future; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased ability of our security holders to sell their securities in certain states. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The purpose of the Reverse Stock Split is to increase the market price of our common stock. The Board intends to implement a Reverse Stock
Split with a specific conversion ratio only if it believes that a decrease in the number of shares outstanding is likely to improve the trading price for our common stock and improve the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
likelihood that we will be allowed to maintain our listing on Nasdaq. If the trading price of our common stock increases without implementing one of the Reverse Stock Split exchange ratios, the
Board may exercise its discretion not to implement any of the Reverse Stock Split exchange ratios. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, the Board also believes that
the increased market price of our common stock expected as a result of implementing a Reverse Stock Split will improve the marketability and liquidity of our common stock and will encourage interest and trading in our common stock. Because of the
trading volatility often associated with <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks, many brokerage houses and institutional investors have internal policies and practices that either prohibit them from investing in <FONT
STYLE="white-space:nowrap">low-priced</FONT> stocks or tend to discourage individual brokers from recommending <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks to their customers. Some of these policies and practices may function to make
the processing of trades in <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks economically unattractive to brokers. Additionally, because brokers&#146; commissions on <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks generally
represent a higher percentage of the stock price than commissions on higher-priced stocks, the current average price per share of our common stock can result in individual stockholders paying transaction costs representing a higher percentage of
their total share value than would be the case if the share price were substantially higher. It should be noted that the liquidity of our common stock may be harmed by the proposed Reverse Stock Split given the reduced number of shares that would be
outstanding after the Reverse Stock Split. The Board is hopeful, however, that the anticipated higher market price will reduce, to some extent, the negative effects on the liquidity and marketability of the common stock inherent in some of the
policies and practices of institutional investors and brokerage houses described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board does not intend for this transaction to
be the first step in a series of plans or proposals of a &#147;going private&#148; transaction within the meaning of Rule <FONT STYLE="white-space:nowrap">13e-3</FONT> of the Securities Exchange Act of 1934, as amended (the &#147;Exchange
Act&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_62"></A>Board Discretion to Implement the Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the Reverse Stock Split is approved by the Company&#146;s stockholders at the special meeting, the actual Reverse Stock Split will be
effected, if at all, only upon a subsequent determination by the Board that a Reverse Stock Split (with a reverse split ratio determined by the Board as described above) is in the best interests of the Company and its stockholders at the time. Such
determination will be based upon many factors, including existing and expected marketability and liquidity of the common stock, prevailing market conditions and the likely effect on the market price of the common stock. Notwithstanding approval of
the Reverse Stock Split by the stockholders, the Board may, in its sole discretion, abandon the proposed amendment and determine prior to the effectiveness of any filing with the Delaware Secretary of State not to effect the Reverse Stock Split
prior to the one (1)-year anniversary of the special meeting, as permitted under Section&nbsp;242(c) of the DGCL. If the Board fails to implement the Reverse Stock Split prior to the one (1)-year anniversary of the special meeting, stockholder
approval would again be required prior to implementing any Reverse Stock Split. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_63"></A>Discretionary Authority of
the Board to Abandon Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board reserves the right to abandon the Reverse Stock Split without further action by our
stockholders at any time before the effectiveness of the certificate of amendment, even if the Reverse Stock Split has been authorized by our stockholders. By voting in favor of the Reverse Stock Split, you are expressly authorizing our Board to
determine not to proceed with, and abandon, the Reverse Stock Split if it should so decide. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_64"></A>Criteria to be
Used for Decision to Effect a Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the stockholders approve the Reverse Stock Split, the Board will be authorized to
proceed with any of the alternative Reverse Stock Split exchange ratios that it selects in its sole discretion. In determining whether to proceed with one of the Reverse Stock Split exchange ratios, the Board expects to consider a number of factors,
including market conditions, existing and expected trading prices of our common stock, the Nasdaq listing requirements, our additional funding requirements and the amount of our authorized but unissued common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_65"></A>Effects of the Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After the Effective Time (as defined below) of the Reverse Stock Split, each stockholder will own a reduced number of shares of common stock.
This would affect all of the Company&#146;s stockholders uniformly and would not affect any stockholder&#146;s percentage ownership in the Company, except to the extent that the Reverse Stock Split results in a stockholder owning a fractional share
as described below. The number of stockholders of record would not be affected by the Reverse Stock Split, except to the extent that any stockholder holds only a fractional share interest and receives cash for such interest after the Reverse Stock
Split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Proportionate voting rights and other rights of the holders of common stock would not be affected by the Reverse Stock Split
(other than as a result of the payment of cash in lieu of fractional shares as described below). For example, a holder of 2% of the voting power of the outstanding shares of common stock immediately prior to the Reverse Stock Split would continue to
hold 2% of the voting power of the outstanding shares of common stock after the Reverse Stock Split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Reverse Stock Split would reduce
the number of shares of common stock available for issuance under our 2019 Equity Incentive Plan, or the &#147;2019 Plan&#148; and our 2019 Employee Stock Purchase Plan, or the &#147;2019 ESPP&#148;, in proportion to the reverse split ratio of the
Reverse Stock Split. As of March&nbsp;31, 2022, the number of shares of common stock authorized for issuance but unissued under the 2019 Plan is 1,086,701, and the number of shares of common stock authorized for issuance but unissued under the 2019
ESPP is 58,337. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of March&nbsp;31, 2021, the Company has outstanding stock options to purchase approximately 92,643 shares of common
stock, 323,949 shares of common stock subject to outstanding restricted stock units and warrants to purchase 2 shares of common stock, all of which were granted under the 2019 Plan and various other prior plans and
<FONT STYLE="white-space:nowrap">non-plan</FONT> agreements. Under the terms of each of the various plans and agreements governing the Company&#146;s outstanding options, warrants and preferred stock, the Reverse Stock Split will effect a reduction
in the number of shares of the Company&#146;s common stock issuable upon the exercise of such options, warrants and preferred stock conversion, in proportion to the reverse split ratio of the Reverse Stock Split. The Reverse Stock Split will effect
a proportionate increase in the exercise prices of the Company&#146;s outstanding stock options and warrants. In connection with the Reverse Stock Split, the number of shares of the Company&#146;s common stock issuable upon the exercise of
outstanding options and warrants or conversion of outstanding preferred stock will be rounded down to the nearest whole share, and no cash payment will be made in respect of such rounding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Similarly, under the terms of the 2019 Plan and the agreements governing the Company&#146;s outstanding restricted stock units, the Reverse
Stock Split will effect a reduction in the number of shares of the Company&#146;s common stock issuable upon the vesting of such restricted stock units in proportion to the reverse split ratio of the Reverse Stock Split. In connection with the
Reverse Stock Split, the number of shares of the Company&#146;s common stock issuable upon the vesting of outstanding restricted stock units will be rounded down to the nearest whole share, and no cash payment will be made in respect of such
rounding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table contains approximate information relating to the common stock under three specific ratios within the range,
based on share information as of March&nbsp;31, 2022: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common&nbsp;Stock<BR>Before Reverse<BR>Stock Split</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Number of Shares of Common<BR>Stock After the Reverse Stock Split</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2:1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>6:1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>15:1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding <SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,269,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,634,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,211,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,284,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reserved for future issuance pursuant to 2019 Plan and 2019 ESPP <SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,145,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">572,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reserved for future issuance pursuant to outstanding options, RSUs, and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">416,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208,297</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The shares presented do not reflect the additional 20,833,333 shares that would be issued and outstanding
upon approval of Proposal 1. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The shares presented are an estimate as we do not know the number of fractional shares that will be required
to be paid out in cash following the Reverse Stock Split. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Share reserve for 2019 Plan does not include additional shares that would be available for future issuance.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No fractional shares of common stock will be issued in connection with any of the proposed Reverse Stock Split exchange
ratios. Holders of a common stock who would otherwise receive a fractional share of common stock pursuant to the Reverse Stock Split will receive cash in lieu of the fractional share as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The common stock is currently registered under Section&nbsp;12(b) of the Exchange Act, and the Company is subject to the periodic reporting
and other requirements of the Exchange Act. The Reverse Stock Split would not affect the registration of the common stock under the Exchange Act. After the Reverse Stock Split, provided that the Company continues to meet the minimum bid price and
other listing requirements, the common stock would continue to be reported on the Nasdaq Capital Market under the symbol &#147;SONM&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_66"></A>Certain Risks and Potential Disadvantages Associated with the Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the Reverse Stock Split is implemented, some stockholders may consequently own less than one hundred (100)&nbsp;shares of common stock. A
purchase or sale of less than one hundred (100)&nbsp;shares (an &#147;odd lot&#148; transaction) may result in incrementally higher trading costs through certain brokers, particularly &#147;full service&#148; brokers. Therefore, those stockholders
who own less than one hundred (100)&nbsp;shares following the Reverse Stock Split may be required to pay modestly higher transaction costs should they then determine to sell their shares in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The effect of the Reverse Stock Split upon the market prices for the common stock cannot be accurately predicted, and the history of similar
stock split combinations for companies in like circumstances is varied. In particular, there is no assurance that the price per share of the common stock after the Reverse Stock Split will be two (2)&nbsp;to fifteen (15)&nbsp;times, as applicable,
the price per share of the common stock immediately prior to the Reverse Stock Split. Furthermore, there can be no assurance that the market price of the common stock immediately after the proposed Reverse Stock Split will be maintained for any
period of time. Even if an increased share price can be maintained, the Reverse Stock Split may not achieve the other desired results which have been outlined above. Moreover, because some investors may view a Reverse Stock Split negatively, there
can be no assurance that approval of the Reverse Stock Split will not adversely impact the market price of the common stock or, alternatively, that the market price following the Reverse Stock Split will either exceed or remain in excess of the
current market price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, although we believe the Reverse Stock Split may enhance the desirability of our common stock to
certain potential investors, we cannot assure you that, if implemented, our common stock will be more attractive to institutional and other long-term investors or that the liquidity of our common stock will increase since there would be a reduced
number of shares outstanding after the Reverse Stock Split. The increase in the number of shares of authorized but unissued and unreserved common stock may have an anti-takeover effect by permitting the issuance of shares to purchasers who might
oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of the Certificate of Incorporation or the Bylaws of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The increased number of available authorized but unissued shares as a result of the Reverse Stock Split would give the Company&#146;s
management more flexibility to resist or impede a third-party takeover bid that provides an above-market premium that is favored by a majority of the independent stockholders. Any such anti-takeover effect of the Reverse Stock Split would be in
addition to existing anti-takeover provisions of the Certificate of Incorporation and Bylaws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_67"></A>Effective Time </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the proposed Reverse Stock Split is approved at the special meeting and the Board elects to proceed with one of the Reverse Stock Split in
one of the approved ratios, the Reverse Stock Split would become effective as of the filing (which we refer to as the &#147;Effective Time&#148;) of the applicable Certificate of Amendment to the Certificate of Incorporation with the office of the
Secretary of State of the State of Delaware. Except as explained below with respect to fractional shares, at the Effective Time, all shares of common stock issued and outstanding immediately prior thereto will be, automatically and without any
action on the part of the stockholders, combined and converted into new shares of common stock in accordance with the Reverse Stock Split ratio determined by the Board among the choices set forth in this Proposal 2. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_68"></A>Cash Payment In Lieu of Fractional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No fractional shares of common stock will be issued as a result of the Reverse Stock Split. Instead, in lieu of any fractional shares to which
a holder of common stock would otherwise be entitled as a result of the Reverse Stock Split, the Company shall pay cash equal to such fraction multiplied by the average closing sale price of shares of common stock for the ten (10)&nbsp;trading days
immediately prior to the Effective Time (calculated on a post- reverse split basis) or, if no such sale takes place on such days, the average of the closing bid and asked prices for such days, as officially reported on the Nasdaq. Upon stockholder
approval of this proposal, if the Board elects to implement the Reverse Stock Split at a reverse split ratio ranging between and including 2:1 to 15:1, stockholders owning less than two (2)&nbsp;to fifteen (15)&nbsp;shares, as applicable, of common
stock prior to the Reverse Stock Split would be eliminated. However, even if the Board selects the maximum Reverse Stock Split ratio of 15:1, the Company does not expect that cashing out fractional stockholders would substantially reduce the number
of stockholders of record. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_69"></A>Exchange of Stock Certificates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As soon as practicable after the effective date of the Reverse Stock Split, stockholders will be notified that the Reverse Stock Split has been
effected. American Stock Transfer&nbsp;&amp; Trust Company, our transfer agent, will act as exchange agent for purposes of implementing the exchange of stock certificates. Holders of <FONT STYLE="white-space:nowrap">pre-split</FONT> shares will be
asked to surrender to the exchange agent certificates representing <FONT STYLE="white-space:nowrap">pre-split</FONT> shares in exchange for certificates representing post-split shares in accordance with the procedures to be set forth in a letter of
transmittal that will be delivered to our stockholders. No new certificates will be issued to a stockholder until the stockholder has surrendered to the exchange agent his, her or its outstanding certificate(s) together with the properly completed
and executed letter of transmittal. STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATES AND SHOULD NOT SUBMIT THEIR STOCK CERTIFICATES UNTIL THEY RECEIVE A TRANSMITTAL FORM FROM OUR EXCHANGE AGENT. STOCKHOLDERS ARE ENCOURAGED TO PROMPTLY
SURRENDER CERTIFICATES TO THE EXCHANGE AGENT FOLLOWING RECEIPT OF TRANSMITTAL FORMS IN ORDER TO AVOID HAVING SHARES POSSIBLY BECOMING SUBJECT TO ESCHEAT LAWS. Stockholders whose shares are held in book-entry form or by their stockbroker do not need
to submit old share certificates for exchange. These stockholders&#146; book-entry records or brokerage accounts will automatically reflect the new quantity of shares based on the selected Reverse Stock Split ratio. As soon as practicable after the
Effective Time, our transfer agent will send to such stockholders or their brokers a transmittal letter along with a statement of ownership indicating the number of post-Reverse Stock Split shares of common stock held. As of the Effective Time, each
certificate or other share ownership record representing <FONT STYLE="white-space:nowrap">pre-split</FONT> shares will be deemed for all corporate purposes to evidence ownership of post-split shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_70"></A>No Appraisal Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the DGCL, our stockholders do not have a right to dissent and are not entitled to appraisal rights with respect to the proposed amendment
to our Certificate of Incorporation to effect the Reverse Stock Split, and we will not independently provide our stockholders with any such rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_71"></A>Certain Material Federal Income Tax Consequences of the Reverse
Stock Split to U.S. Holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of certain material federal income tax considerations of the proposed Reverse
Stock Split to certain U.S. Holders (as defined below) of our common stock but does not purport to be a complete analysis of all potential tax effects. This summary is based on provisions of the Internal Revenue Code of 1986, as amended (the
&#147;Code&#148;), Treasury Regulations thereunder and administrative rulings, court decisions and other legal authorities related thereto, each as in effect as of the date of this proposal and all of which are subject to change or differing
interpretations. Any such change or differing interpretation, which may or may not be retroactive, could alter the tax consequences to the stockholders described herein. This discussion is included for general informational purposes only and does
not purport to consider all aspects of U.S. federal income taxation that might be relevant to a U.S. Holder. It addresses only stockholders who hold the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares and post-Reverse Stock
Split shares as capital assets. It does not purport to be complete and does not address stockholders subject to special rules, such as financial institutions, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, insurance companies,
dealers in securities, mutual funds, real estate investment trusts, regulated investment companies, stockholders who hold their <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares through individual retirement or other <FONT
STYLE="white-space:nowrap">tax-deferred</FONT> accounts, stockholders who are not U.S. Holders (as defined below), stockholders who have a functional currency other than the U.S. dollar, partnerships or other entities classified as partnerships or
disregarded entities for U.S. federal income tax purposes (or persons holding <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares through such entities), stockholders who hold the
<FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares as part of a straddle, hedge or conversion transaction, stockholders who hold the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares as qualified small
business stock within the meaning of Section&nbsp;1202 of the Code or Section&nbsp;1244 stock for purposes of Section&nbsp;1244 of the Code, stockholders who acquired their stock in a transaction subject to the gain rollover provisions of
Section&nbsp;1045 of the Code, stockholders who are subject to the alternative minimum tax or Medicare contribution tax provisions of the Code or stockholders who acquired their <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares
pursuant to the exercise of employee stock options or otherwise as compensation. In addition, this summary does not address any tax consequences other than certain U.S. federal income tax consequences of the Reverse Stock Split, including the tax
consequences of the Reverse Stock Split under state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws, or under estate, gift, excise or other <FONT STYLE="white-space:nowrap">non-income</FONT> tax laws, the tax consequences of
transactions effectuated prior or subsequent to, or concurrently with, the Reverse Stock Split (whether or not any such transactions are consummated in connection with the Reverse Stock Split) including, without limitation, the tax consequences to
holders of options, warrants or similar rights to acquire our common stock. Furthermore, we have not obtained a ruling from the Internal Revenue Service or an opinion of legal or tax counsel with respect to the consequences of the Reverse Stock
Split. There can be no assurance that the IRS will not take a position contrary to these statements or that a contrary position taken by the IRS would not be sustained by a court. Each stockholder is advised to consult his, her or its tax advisor as
to the federal income tax consequences of the Reverse Stock Split in such stockholder&#146;s situation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of this discussion,
a &#147;U.S. Holder&#148; means a beneficial owner of shares of our common stock that is any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States or someone treated as a U.S. citizen or
resident for U.S. federal income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or
organized in or under the laws of the United States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if (i)&nbsp;a U.S. court can exercise primary supervision over the trust&#146;s administration and one
or more &#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code) are authorized or have the authority to control all substantial decisions of the trust or (ii)&nbsp;it has a valid election in effect under
applicable U.S. Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Reverse Stock Split is intended to be treated as a &#147;recapitalization&#148; for U.S.
federal income tax purposes, and the remainder of this discussion assumes the Reverse Stock Split so qualifies. The federal income tax consequences of the Reverse Stock Split will vary depending on whether a stockholder receives solely a reduced
number of shares in the Reverse Stock Split or receives cash for fractional shares. A stockholder who solely receives a reduced number of shares generally will not recognize gain or loss in the Reverse Stock Split. A stockholder who receives cash
for fractional shares generally should recognize gain (but not loss) equal to the difference between the portion of the tax basis of the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares allocated to the fractional share
interest and the cash received for such fractional shares. Such gain will be a capital gain and will be short-term if the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares were held for one (1)&nbsp;year or less and long-term if
held more than one (1)&nbsp;year at the time of the Reverse Stock Split. Long-term capital gains of <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders are generally subject to preferential tax rates. The aggregate tax basis of the
post-Reverse Stock Split shares received will be equal to the aggregate tax basis of the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares exchanged therefor (excluding any portion of the holder&#146;s basis allocated to
fractional shares), and the holding period of the post-Reverse Stock Split shares received will include the holding period of the <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Stock Split shares exchanged. U.S. Holders should consult their tax
advisors as to application of the foregoing rules where shares of common stock were acquired at different times or at different prices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No gain or loss will be recognized by the Company as a result of the Reverse Stock Split. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>STOCKHOLDERS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR
SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXING JURISDICTION OR UNDER ANY
APPLICABLE INCOME TAX TREATY. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_72"></A>Required Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The affirmative vote of the holders of a majority of the shares of the common stock outstanding will be required to approve the Reverse Stock
Split Proposal and the corresponding amendment to the Certificate of Incorporation to effect the Reverse Stock Split. A copy of the proposed amendment to the Certificate of Incorporation is attached hereto as <B>Annex C</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_73"></A>THE BOARD OF DIRECTORS RECOMMENDS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A VOTE IN FAVOR OF PROPOSAL 2. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_74"></A>PROPOSAL 3: AMENDMENT TO THE COMPANY&#146;S CERTIFICATE OF
INCORPORATION, AS AMENDED TO INCLUDE A MAJORITY OF THE MINORITY VOTE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR TAKE PRIVATE TRANSACTIONS BY AJP HOLDING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_75"></A>Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has approved a proposed amendment to the Company&#146;s amended and restated certificate of incorporation, as amended (the
&#147;Certificate of Incorporation&#148;). Such amendment would include a provision requiring that any transaction entered into with AJP Holding or an affiliate of AJP Holding that would result in the common stock of the Company no longer being
listed on a nationally recognized securities exchange shall require the approval by a majority of the holders of common stock of the Company that are unaffiliated with AJP Holding prior to the closing of such transaction. The amendment corresponding
to this proposal is attached hereto as <B>Annex C</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has recommended that this proposed amendment be presented to the
Company&#146;s stockholders for approval. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_76"></A>Purpose and Effect of Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The principal purpose and effect of the Charter Restriction Proposal is to provide protection to the minority shareholders of the Company if
the Transaction Proposal is approved. If the Transaction Proposal is approved, AJP Holding will own a majority of the Company, approximately 52%. By including the proposed provision as described above in the Company&#146;s charter, it would provide
the minority investors with a vote on any transaction with AJP that would result in the Company no longer being listed on a nationally recognized securities exchange and likely all minority holders of the Company being bought out. If the Charter
Restriction Proposal is not approved then AJP Holding could approve such a transaction by the fact that it owns the majority of the common stock outstanding of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_77"></A>Required Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The affirmative vote of the holders of a majority of the shares of the common stock outstanding will be required to approve the Charter
Restriction Proposal and the corresponding amendment to the Certificate of Incorporation.<B> </B>A copy of the proposed amendment to the Certificate of Incorporation is attached hereto as <B>Annex C</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_78"></A>THE BOARD OF DIRECTORS RECOMMENDS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A VOTE IN FAVOR OF PROPOSAL 3. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_79"></A>PROPOSAL 4: VOTE ON ADJOURNMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If at the special meeting there are not sufficient votes to approve the Transaction Proposal and adopt the Subscription Agreement, we intend
to move to vote on this Adjournment Proposal. We do not intend to move to a vote on this Adjournment Proposal if the Transaction Proposal is approved by the requisite number of shares of the Company common stock at the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this Adjournment Proposal, the Company&#146;s stockholders are being asked to approve a proposal that will give the Board authority to
adjourn the special meeting to a later date or time, if necessary, to solicit additional proxies in favor of the Transaction Proposal if there are insufficient votes at the time of the special meeting to approve the Transaction Proposal. If the
stockholders approve this Adjournment Proposal, we could adjourn the special meeting and any adjourned session of the special meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from stockholders
that have previously voted. Among other things, approval of this Adjournment Proposal could mean that, even if we had received proxies representing a sufficient number of votes against the Transaction Proposal to defeat that proposal, we could
adjourn the special meeting without a vote on the Transaction Proposal and seek to convince the holders of those shares to change their votes to votes in favor of the Transaction Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_80"></A>Required Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the proposal
at the special meeting, irrespective of whether the quorum is present, will be required to adjourn the special meeting to solicit additional proxies in favor of the Transaction Proposal, if necessary or appropriate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_81"></A>A VOTE IN FAVOR OF PROPOSAL 4 IF THERE ARE INSUFFICIENT VOTES AT THE SPECIAL MEETING TO APPROVE THE TRANSACTION
PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_82"></A>MARKET PRICE OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed for trading on the Nasdaq Capital Market under the symbol &#147;SONM.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The closing price of our common stock on Nasdaq on April&nbsp;12, 2022, the last trading day prior to the public announcement of the execution
of the Subscription Agreement, was $0.66 per share. On &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, the most recent practicable date before this proxy statement was mailed to our
stockholders, the closing price for our common stock on Nasdaq was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. In addition, the transaction consideration represents a discount of
approximately 29% and 25% to the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> and ninety <FONT STYLE="white-space:nowrap">(90)-day,</FONT> respectively, volume weighted average price per share of our common stock prior to the public
announcement of the execution of the Subscription Agreement. You are encouraged to obtain current market quotations for our common stock in connection with voting your shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have never declared or paid a cash dividend on our common stock and we intend to retain all available funds and any future earnings to fund
the development and growth of our business. We do not anticipate paying any cash dividends on our common stock in the foreseeable future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_83"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth certain information with respect to the beneficial ownership of our capital stock as of April&nbsp;29,
2022 for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our current directors and executive officers as a group; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person known by us to be the beneficial owner of more than 5% of the outstanding shares of our common
stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have determined beneficial ownership in accordance with the rules of the SEC, and thus it represents sole or
shared voting or investment power with respect to our securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares that they
beneficially owned, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of Sections 13(d) and 13(g) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have based our calculation of the percentage of beneficial ownership on 19,269,338 shares of our common stock outstanding as of
April&nbsp;29, 2022. In accordance with SEC rules, we have deemed shares of our common stock subject to stock options that are currently exercisable or exercisable within sixty (60)&nbsp;days of April&nbsp;29, 2022 and shares of our common stock
underlying RSUs that are currently releasable or releasable within sixty (60)&nbsp;days of April&nbsp;29 to be outstanding and to be beneficially owned by the person holding the common stock options or RSUs for the purpose of computing the
percentage ownership of that person. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Sonim Technologies, Inc., 6500 River Place
Blvd., Building 7, Suite 250, Austin, TX 78730. The information provided in the table is based on our records, information filed with the SEC and information provided to us, except where otherwise noted. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;Beneficially&nbsp;Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><B>Name of Beneficial Owner</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Directors and Named Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Tirva <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">318,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.65</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Liu <SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,603</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tom Wilkinson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Kneuer <SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan Howe <SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Susan G. Swenson <SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mike Mulica <SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All executive officers and directors as a group (7 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">457,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.37</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Represents beneficial ownership of less than one percent (1%) of the outstanding shares of our common stock.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 259,809 shares held directly by Robert Tirva, in addition to 47,445 shares subject to RSUs and
11,621 shares issuable upon the exercise of outstanding options held by Robert Tirva exercisable within 60 days of April&nbsp;26, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 99,336 shares held directly by Peter Liu, 2,038 shares subject to RSUs vesting and exercisable
within 60 days of April&nbsp;26, 2022 and 8,229 shares issuable upon the exercise of outstanding options held by Peter Liu exercisable within 60 days of April&nbsp;26, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 4,0,14 shares held directly by John Kneuer and 3,100 shares subject to RSUs vesting and
exercisable within 60 days of April&nbsp;26, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 4,933, shares held directly by Alan Howe and 3,100 shares subject to RSUs vesting and
exercisable within 60 days of April&nbsp;26, 2022 and 233 shares issuable upon the exercise of outstanding options that are fully vested. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 3,600 shares held directly by Susan Swenson and 3,100 shares subject to RSUs vesting and
exercisable within 60 days of April&nbsp;26, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Consists of 6,626 shares subject to RSUs held by Mike Mulica exercisable within 60 days of April&nbsp;26,
2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_84"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company files annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet
site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including us. The address of that site is<I> www.sec.gov</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You can also review the Company&#146;s SEC filings on its web site at <I>www.sonimtech.com</I>. Through links on the &#147;Investors&#148;
portion of our website, we make available free of charge our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> any amendments to those reports and other information filed with, or furnished to, the SEC pursuant to Sections 13(a) or 15(d) of the Exchange Act. Such material is made available through our website as soon as
reasonably practicable after we electronically file the information with, or furnish it to, the SEC. The information contained on or that can be accessed through our website does not constitute part of this proxy statement, other than documents that
we file with the SEC that are specifically incorporated by reference into this proxy statement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_85"></A>OTHER
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><A NAME="tx259893_86"></A>Submission of Stockholder Proposals for the 2022 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated bylaws provide that, for stockholder director nominations or other proposals to be considered at an annual meeting,
the stockholder must give timely notice thereof in writing to our Secretary at 6500 River Place Blvd., Building 7, Suite 250, Austin, TX 78730. To be timely for the 2022 Annual Meeting of Stockholders, a stockholder&#146;s notice must be received by
our Secretary at our principal executive offices between June&nbsp;28, 2022 and July&nbsp;28, 2022; provided that if the date of that annual meeting of stockholders is earlier than September&nbsp;26, 2022, or later than November&nbsp;25, 2022, you
must give the required notice not earlier than the 120th day prior to the meeting date and not later than the 90th day prior to the meeting date or, if later, the 10th day following the day on which public disclosure of that meeting date is first
made. A stockholder&#146;s notice to the Secretary must also set forth the information required by our amended and restated bylaws. Stockholder proposals submitted pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act
and intended to be presented at the 2022 Annual Meeting of Stockholders must be received by us not later than May&nbsp;26, 2022 in order to be considered for inclusion in our proxy materials for that meeting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx259893_87"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC allows us to &#147;incorporate by reference&#148; information into this proxy statement, which means that we can disclose important
information to you by referring you to another document filed separately with the SEC. The information incorporated by reference herein is deemed to be part of this proxy statement. This proxy statement incorporates by reference the documents and
reports listed below (other than, in each case, the portions that are deemed to have been furnished and not filed in accordance with SEC rules): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1178697/000156459022011226/sonm-10k_20211231.htm">
<U>Form <FONT STYLE="white-space:nowrap">10-K</FONT></U></A>, for the fiscal year ended December&nbsp;31, 2021, filed with the SEC on March&nbsp;21, 2022, as amended by Amendment No.&nbsp;
1 on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1178697/000119312522136529/d656384d10ka.htm">Form <FONT STYLE="white-space:nowrap">10-K/A</FONT></A> filed with the SEC on May&nbsp;2, 2022 and our Quarterly
Report on <U><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1178697/000156459022019279/sonm-10q_20220331.htm">Form <FONT STYLE="white-space:nowrap">10-Q</FONT></A></U> for the fiscal period ended March&nbsp;31,
2022, filed with the SEC on May&nbsp;10, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1178697/000119312522104993/d325458d8k.htm">
<U>Form <FONT STYLE="white-space:nowrap">8-K</FONT></U></A>, filed with the SEC on April&nbsp;14, 2022; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1178697/000119312519142714/d739083d8a12b.htm">
<U>Form <FONT STYLE="white-space:nowrap">8-A</FONT></U></A>, filed with the SEC on May&nbsp;9, 2019, and any amendment or report filed with the SEC for the purpose of updating the description. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also incorporate by reference the information contained in all other documents we file
with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than the portions that are deemed to have been furnished and not filed in accordance with SEC rules, unless otherwise indicated therein) on or after the date of
this statement and through the date on which the special meeting is held (including any adjournments or postponements thereof). Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be
modified or superseded for purposes of this proxy statement to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will provide, free of charge, to each person, including any beneficial owner, to whom a proxy statement is delivered a copy of any or all
of the documents incorporated by reference into this proxy statement (including any exhibits that are specifically incorporated by reference in those documents). Any such request can be made by writing or telephoning us at the following address and
telephone number: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SONIM TECHNOLOGIES, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6500 River Place Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Building 7,
Suite 250 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Austin, TX 78730 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx259893_88"></A>ANNEX&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Subscription Agreement dated as of April&nbsp;13, 2022 (this &#147;<U>Agreement</U>&#148;) is by and between Sonim
Technologies, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and AJP Holding Company, LLC, a Delaware limited liability company (the &#147;<U>Purchaser</U>&#148;). Capitalized terms used but not defined herein have the meanings
assigned to them in <U>Exhibit A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">WHEREAS, the Purchaser desires to purchase from the Company, and the Company
desires to issue and sell to the Purchaser, the aggregate of 20,833,333 of the Company&#146;s common stock, par value $0.001 per share (the &#147;<U>Common Stock</U>&#148;) comprising of the Initial Shares (as defined below) and the Remaining Shares
(as defined below) (collectively, the &#147;<U>Purchased Shares</U>&#148;), on the terms and subject to the conditions hereinafter set forth (the &#147;<U>Purchase and Sale</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In consideration of the premises and the mutual representations, warranties, covenants, and agreements contained herein, and
for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AND
SALE OF PURCHASED SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.1 <U>Purchase and Sale</U>. On the terms and subject to the satisfaction or
waiver of the conditions set forth in this Agreement, at the First Closing, the Purchaser shall purchase, and the Company shall issue and sell to the Purchaser 14,880,952 shares of Common Stock (the &#147;<U>Initial Shares</U>&#148;), free and clear
of any liens (other than liens incurred by Purchaser or its Affiliates, restrictions arising under applicable securities laws, or restrictions imposed by this Agreement) for an aggregate purchase price of twelve million five hundred thousand dollars
($12,500,000) (the &#147;<U>First Purchase Price</U>&#148;), provided that up to 952,381 shares of Common Stock shall be issued to a person or entity designated by the Purchaser subject to such person or entity executing, concurrent with the receipt
of such shares of Common Stock, a Purchaser Voting Agreement (subject to adjustments required to such Purchaser Voting Agreement to reflect such person or entity being the signatory thereto instead of Purchaser). On the terms and subject to the
occurrence of the First Closing, at the Second Closing, the Purchaser shall purchase, and the Company shall issue and sell to the Purchaser 5,952,381 shares of Common Stock (the &#147;<U>Remaining Shares</U>&#148;), free and clear of any liens
(other than liens incurred by Purchaser or its Affiliates, restrictions arising under applicable securities laws, or restrictions imposed by this Agreement) for an aggregate purchase price of five million dollars ($5,000,000) (the &#147;<U>Second
Purchase Price</U>&#148;). The number of shares Common Stock comprising the Purchaser Shares is subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the
Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.2 <U>First Closing</U>. On the terms and subject to the satisfaction or waiver of the
conditions set forth in <U>Article VII</U>, the closing of the issuance, sale, and purchase of the Initial Shares (the &#147;<U>First Closing</U>&#148;) shall take place remotely via the exchange of final documents and signature pages, no later than
the second Business Day following the satisfaction or waiver of all of the conditions set forth in <U>Article VII</U>, or such other time and place as the Company and the Purchaser may agree in writing. The date on which the First Closing is to
occur is herein referred to as the &#147;<U>First Closing Date</U>.&#148; At the First Closing, upon receipt by the Company of payment of the full First Purchase Price, which shall be paid at the First Closing by the Purchaser to the Company by wire
transfer of immediately available funds to an account designated in writing by the Company, the Company will deliver to the Purchaser evidence reasonably satisfactory to the Purchaser of the issuance of the Initial Shares in the name of the
Purchaser by book-entry on the books and records of the Company. At the First Closing, the Purchaser shall deliver to the Company a duly executed, valid, accurate, and properly completed Internal Revenue Service
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Form <FONT STYLE="white-space:nowrap">W-9</FONT> certifying that the Purchaser is a U.S. person and that the Purchaser is not subject to backup withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.3 <U>Second Closing</U>. On the terms and subject to the occurrence of the First Closing only, the closing of
the issuance, sale, and purchase of the Remaining Shares (the &#147;<U>Second Closing</U>&#148;) shall take place on August&nbsp;1, 2022, or such other time and place as the Continuing Directors and the Purchaser may agree in writing;
<U>provided</U>, that if the First Closing shall not have occurred by August&nbsp;1, 2022, the Second Closing shall take place no later than the fifth Business Day following the First Closing Date. The date on which the Second Closing is to occur is
herein referred to as the &#147;<U>Second Closing Date</U>.&#148; At the Second Closing, upon receipt by the Company of payment of the full Second Purchase Price, which shall be paid at the Second Closing by the Purchaser to the Company by wire
transfer of immediately available funds to an account designated in writing by the Continuing Directors, the Company will deliver to the Purchaser evidence reasonably satisfactory to the Purchaser of the issuance of the Remaining Shares in the name
of the Purchaser by book-entry on the books and records of the Company. At the Second Closing, the Purchaser shall deliver to the Company a duly executed, valid, accurate, and properly completed Internal Revenue Service Form <FONT
STYLE="white-space:nowrap">W-9</FONT> certifying that the Purchaser is a U.S. person and that the Purchaser is not subject to backup withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.4 <U>Purchaser Director Nominees</U><U>. Management</U>. Concurrent with the consummation of the First Closing,
(i)&nbsp;all the members of the Board of Directors other than the Continuing Directors shall resign and (ii)&nbsp;the Purchaser shall be entitled to designate such number of directors on the Board of Directors as will give the Purchaser, subject to
compliance with applicable Laws, representation on the Board of Directors equal to that number of directors, rounded down to the next whole number, which is the product of (i)&nbsp;the total number of directors on the Board of Directors (after
giving effect to the directors elected pursuant to this sentence, and after giving effect to any resignations from the Board of Directors prior to or concurrent with the First Closing) <U>multiplied</U> by (ii)&nbsp;the percentage that (A)&nbsp;such
number of Initial Shares bears to (B)&nbsp;the total number of shares of Common Stock outstanding as of the First Closing (after giving effect to the issuance of the Initial Shares) (such directors, the &#147;<U>Purchaser Designees</U>&#148;). The
Company shall, at such time, cause the Purchaser Designees to be so elected or appointed. Promptly following the election or appointment of the Purchaser Designees, the Company, subject to the terms and provisions of this Agreement and the Nasdaq
Listing Rules, shall also cause the Purchaser Designees selected by the Purchaser, to constitute the number of members, rounded down to the next whole number, on (i)&nbsp;each committee of the Board of Directors and (ii)&nbsp;each board of directors
(or similar body) of each Subsidiary of the Company identified by the Purchaser (and each committee thereof) that represents the same percentage as such individuals represent on the Board of Directors. In connection with the foregoing, the Company
shall promptly take all action necessary to accomplish the foregoing set forth in this <U>Section</U><U></U><U>&nbsp;1.4</U>, including by increasing the size of the Board of Directors; <U>provided</U> <U>however</U>, that nothing herein shall amend
or modify the rights with respect to the Continuing Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.5 <U>Continuing Directors</U>.
Notwithstanding anything herein to the contrary, until the Director End Time, the Board of Directors shall have at least two (2)&nbsp;directors (the &#147;<U>Continuing Directors</U>&#148;) who are either (i)&nbsp;Michael Mulica and Alan Howe or
(ii)&nbsp;if a Continuing Director ceases to be a director (including by reason of removal, resignation, death or disability), the subsequently appointed Continuing Director shall be an independent director and such appointment shall be approved by
the remaining Continuing Director, if and as applicable. No Continuing Director shall be removed from the Board of Directors without cause prior to the Director End Time. Following the First Closing and until the Director End Time, the affirmative
vote of the Continuing Directors shall be required to (x)&nbsp;amend, modify, enforce, or terminate this Agreement and/or the Voting Agreement on behalf of the Company, (y)&nbsp;exercise or waive any of the Company&#146;s rights or remedies
hereunder or under the Voting Agreement, or (z)&nbsp;extend the time for performance of the Purchaser&#146;s obligations hereunder or under the Voting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;1.6 <U>Appointment of Chief Executive Officer. Strategic Enhancement of Business</U>. As of the date hereof, the
Company shall appoint the Appointed Chief Executive Officer. Subject to compliance with applicable Law and the fiduciary duties of the Board of Directors, the Company shall in good faith commence the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
enhancement and optimization of the Company&#146;s business pursuant to the strategy developed by the Appointed Chief Executive Officer (the &#147;<U>Integration Plans</U>&#148;). The Company
shall issue a press release and file a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> in connection with the appointment of the Appointed Chief Executive Officer and disclose a summary of the anticipated enhancement and
optimization of the Company&#146;s business model in the manner mutually agreeable by the Company and the Purchaser. The terms of the employment agreement between the Company and the Appointed Chief Executive Officer shall be negotiated in good
faith by the Company and the Appointed Chief Executive Officer prior to the First Closing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company represents and warrants to the Purchaser that, except (a)&nbsp;as set forth in the SEC Documents (other than
disclosures in the &#147;Risk Factors&#148; or &#147;Forward-Looking Statements&#148; sections or similarly captioned sections of any such filings) and (b)&nbsp;as set forth on <U>Exhibit B</U> (the &#147;<U>Disclosure Letter</U>&#148;) (all such
exceptions disclosed in the Disclosure Letter being numbered to correspond to the applicable Section of this <U>Article II</U>, <U>provided</U>, <U>however</U>, that any such exception shall be deemed to be disclosed with respect to each other
representation or warranty to which the relevance of such exception is reasonably apparent on the face of such disclosure): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.1 <U>Organization and Power</U>. The Company and each of its Subsidiaries is a corporation, limited liability
company, partnership, or other entity validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation (as applicable) and has all requisite corporate, limited liability company, partnership or other entity
power and authority to own or lease its properties and to carry on its business as presently conducted and as proposed to be conducted. The Company and each of its Subsidiaries is duly licensed or qualified to do business as a foreign corporation,
limited liability company, partnership, or other entity in each jurisdiction wherein the character of its property or the nature of the activities presently conducted by it, makes such qualification necessary, except where the failure to so qualify
has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.2 <U>Authorization</U>. The execution, delivery, and performance by the Company of this Agreement and the
Registration Rights Agreement and the consummation by the Company of the transactions contemplated hereby and thereby (collectively, with the Purchase and Sale, but excluding the Reverse Stock Split Proposal and the Charter Amendment Approval, the
&#147;<U>Contemplated Transactions</U>&#148;) are within the Company&#146;s corporate powers and, except for the Company Stockholder Approval, have been duly and validly authorized by all necessary corporate action on the part of the Company. The
affirmative vote by the holders of a majority of the shares of Common Stock cast thereon in favor of the adoption of this Agreement is the only vote of the holders of any of the Company&#146;s capital stock necessary in connection with the
consummation of the Contemplated Transactions (the &#147;<U>Company Stockholder Approval</U>&#148;). Assuming due authorization, execution, and delivery by the Purchaser, this Agreement constitutes a valid and binding agreement of the Company
enforceable against the Company in accordance with its terms (subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws affecting creditors&#146; rights generally and general principles of equity).
At a meeting duly called and held, the Board of Directors has (i)&nbsp;determined that this Agreement and the Contemplated Transactions are fair to and in the best interests of the Company&#146;s stockholders, (ii)&nbsp;adopted and declared
advisable this Agreement and the Contemplated Transactions and (iii)&nbsp;resolved, subject to <U>Section</U><U></U><U>&nbsp;4.1</U>, to recommend adoption of this Agreement by the stockholders of the Company (such recommendation in the preceding
clause (iii), the &#147;<U>Company Board </U><U>Recommendation</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.3 <U>Government Approvals</U>.
No consent, approval, or authorization of, or filing with, any court or governmental authority is or will be required on the part of the Company in connection with the execution, delivery, and performance by the Company of this Agreement and the
Registration Rights Agreement, or in connection with the issuance of the Purchased Shares, except for (a)&nbsp;those which have already been made or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
granted; (b)&nbsp;the filing of a Form D (including any &#147;Blue Sky&#148; filing, if required) and Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> with the SEC; or
(c)&nbsp;filings with applicable state securities commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.4 <U>Authorized and Outstanding Stock.</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) The authorized capital stock of the Company consists of 100,000,000 shares of Common Stock and 5,000,000 shares of
preferred stock, par value $0.001 per share (&#147;<U>Preferred Stock</U>&#148;). As of April&nbsp;11, 2022, (i) 19,269,338 shares of Common Stock were issued and outstanding, (ii)&nbsp;no shares of Preferred Stock were issued and outstanding, (iii)
91,809 shares of Common Stock were subject to outstanding stock options to purchase shares of Common Stock (&#147;<U>Company Stock Options</U>&#148;) and (iv) 320,762 shares of Common Stock were subject to outstanding restricted stock unit awards
(&#147;<U>Company RSUs</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) All of the issued and outstanding shares of Common Stock of the Company are, and,
when issued in accordance with the terms hereof, the Purchased Shares will be, duly authorized and validly issued and fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and free of
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights. When issued in accordance with the terms hereof, the Purchased Shares will be free and clear of all liens (other than liens incurred by Purchaser or its Affiliates, restrictions arising
under applicable securities laws, or restrictions imposed by this Agreement or the Registration Rights Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c)
Except as otherwise expressly described in this Agreement, as of the date hereof there are no issued, reserved for issuance or outstanding: (i)&nbsp;shares of capital stock or other voting securities of or ownership interests in the Company,
(ii)&nbsp;securities of the Company convertible into or exchangeable for shares of capital stock or other voting securities of or ownership interests in the Company, (iii)&nbsp;warrants, calls, options or other rights to acquire from the Company, or
other obligation of the Company to issue, any capital stock, voting securities or securities convertible into or exchangeable for capital stock or voting securities of the Company, or (iv)&nbsp;restricted shares, stock appreciation rights,
performance units, contingent value rights, &#147;phantom&#148; stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock or voting
securities of the Company (the items in clauses (i)&nbsp;through (iv) being referred to collectively as the &#147;<U>Company Securities</U>&#148;). Except for the Voting Agreement, neither the Company nor any of its Subsidiaries is a party to any
voting agreement with respect to the voting of any Company Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.5 <U>Subsidiaries</U>. The
Company&#146;s Subsidiaries consist of all the entities listed on Exhibit 21.1 to the Company&#146;s Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021. Except as described in the SEC Documents, the Company,
directly or indirectly, owns of record and beneficially, free and clear of all liens, all of the issued and outstanding capital stock or equity interests of each of its Subsidiaries. All of the issued and outstanding capital stock or equity
interests of each of the Company&#146;s Subsidiaries (collectively, the &#147;<U>Company Subsidiary Securities</U>&#148;) has been duly authorized and validly issued, and in the case of corporations, is fully paid and
<FONT STYLE="white-space:nowrap">non-assessable.</FONT> Except as described in the SEC Documents, there are no outstanding rights, options, warrants, preemptive rights, conversion rights, rights of first refusal or similar rights for the purchase or
acquisition from any of the Company&#146;s Subsidiaries of any securities of such Subsidiaries nor are there any commitments to issue or execute any such rights, options, warrants, preemptive rights, conversion rights or rights of first refusal.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.6 <U>Private Placement</U>. Assuming the accuracy of the representations and warranties of the Purchaser
set forth in <U>Section</U><U></U><U>&nbsp;3.5</U> (<I>Investment Representations</I>), the offer and sale of the Purchased Shares pursuant to this Agreement will be exempt from the registration requirements of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.7 <U>SEC Documents; </U><U>Financial Information; Sarbanes-Oxley Act</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Since January&nbsp;1, 2019, the Company has filed with or furnished to the SEC all SEC Documents on a timely basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) No Subsidiary of the Company is required to file or furnish any report,
statement, schedule, form or other document with, or make any other filing with, or furnish any other material to, the SEC pursuant to the Securities Act or the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) As of its filing date (or, if amended or superseded by a filing prior to the date hereof, on the date of such filing),
each SEC Document filed pursuant to the Exchange Act complied in all material respects with the requirements of the Exchange Act and did not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) The
financial statements of the Company included in the SEC Documents (the &#147;<U>Financial Statements</U>&#148;) comply as of their respective dates in all material respects with applicable accounting requirements and the rules and regulations of the
SEC with respect thereto (except as may be indicated in the notes thereto or, in the case of the unaudited statements, as permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> promulgated by the SEC), and present fairly in all material
respects as of their respective dates the consolidated financial position of the Company and its Subsidiaries as at the dates thereof and the consolidated results of their operations and their consolidated cash flows for each of the respective
periods, all in conformity with GAAP, applied on a consistent basis during the periods involved (except as may be indicated in such Financial Statements or the notes thereto). The Company and its Subsidiaries do not have any liabilities or
obligations that would be required under GAAP, as in effect on the date of this Agreement, to be reflected on a consolidated balance sheet of the Company (accrued, absolute, contingent or otherwise), other than liabilities or obligations
(i)&nbsp;reflected on, reserved against, or disclosed in the Company&#146;s consolidated balance sheet included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021
(including the notes thereto), (ii) incurred in the ordinary course of business since December&nbsp;31, 2021, (iii) incurred in connection with the transactions contemplated hereby or (iv)&nbsp;that would not have, individually or in the aggregate,
a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) Each SEC Document that is a registration statement, as amended or supplemented, if
applicable, filed pursuant to the Securities Act, as of the date such registration statement or amendment became effective, complied in all material respects with the requirements of the Securities Act and did not contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) As of the date hereof, (i)&nbsp;there are no material outstanding or unresolved written comments from the SEC with respect
to the SEC Documents and (ii)&nbsp;to the knowledge of the Company, none of the SEC Documents is subject to ongoing SEC review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) The Company is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act. The
management of the Company has, in compliance with Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> under the Exchange Act, designed disclosure controls and procedures to ensure that material information relating to the Company, including its
consolidated Subsidiaries, is made known to the management of the Company by others within those entities, and disclosed, based on its most recent evaluation prior to the date hereof, to the Company&#146;s auditors and the audit committee of the
Company&#146;s Board of Directors (i)&nbsp;any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> under the
Exchange Act) which would adversely affect the Company&#146;s ability to record, process, summarize and report financial data and have identified for the Company&#146;s auditors any material weaknesses in the Company&#146;s internal control over
financial reporting and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) The Company has established and maintains disclosure controls and procedures (as such term is defined in Rule <FONT
STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15</FONT> under the Exchange Act) that are designed to provide reasonable assurance that material information relating to the Company, including its Subsidiaries, that
is required to be disclosed by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Company in the reports that it furnishes or files under the Exchange Act is reported within the time periods specified in the rules and forms of the SEC and that such material information is
communicated to the Company&#146;s management to allow timely decisions regarding required disclosure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.8
<U>Disclosure Documents</U>. The information supplied by the Company for inclusion in the proxy statement, or any amendment or supplement thereto, to be sent to the Company stockholders in connection with the Contemplated Transactions (the
&#147;<U>Proxy Statement</U>&#148;) shall not, on the date the Proxy Statement, and any amendments or supplements thereto, is first mailed to the stockholders of the Company or at the time of the Company Stockholder Approval contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Proxy Statement will comply in all material respects as
to form with the requirements of the Exchange Act. The representations and warranties contained in this <U>Section</U><U></U><U>&nbsp;2.8</U> shall not apply to statements or omissions included or incorporated by reference in the Proxy Statement
based upon information supplied by the Purchaser or any of its Representatives specifically for use or incorporation by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.9 <U>Litigation</U>. There is no litigation or governmental proceeding pending or, to the knowledge of the
Company, threatened in writing, against the Company or any of its Subsidiaries or affecting any of the business, operations, properties, or assets of the Company or any of its Subsidiaries which would reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is in default with respect to any order, writ, injunction, decree, ruling, or decision of any court, commission, board, or other government agency that is
expressly applicable to the Company or any of its Subsidiaries which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.10 <U>Compliance with Laws; Permits</U>. The Company and its Subsidiaries are in compliance with all applicable
Laws, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company and its Subsidiaries possess all permits and licenses of governmental authorities that are required
to conduct their business, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.11 <U>Taxes</U>. The Company and each of its Subsidiaries has filed all Tax Returns required to be filed within
the applicable periods for such filings (with due regard to any extension) and has timely paid all Taxes required to be paid, except for any such failures to file or pay that have not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect. The Company is not a United States real property holding corporation within the meaning of Section&nbsp;897 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.12 <U>Employee Matters</U>. Except where the failure to comply has not had, and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries are in compliance with all applicable Laws relating to labor, employment, fair employment practices, terms and conditions of employment,
and wages and hours, and with the terms of the ERISA Documents, and each such ERISA Document is in compliance with all applicable requirements of ERISA. No labor dispute with the employees of the Company or any of its Subsidiaries exists, or to the
knowledge of the Company, is imminent, in either case which dispute would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.13 <U>Environmental Matters</U>. The Company and its Subsidiaries are in compliance with all applicable
Requirements of Environmental Law and required Environmental Permits, except, in each case, where the failure to comply has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The
Company and its Subsidiaries have not received within the past three (3)&nbsp;years any written notice from any governmental authority of any violation or alleged violation of any Requirements of Environmental Law or Environmental Permit in
connection with their respective properties, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.14 <U>Registration Rights</U>. Except as provided in this
Agreement or the Registration Rights Agreement or disclosed in the SEC Documents, the Company has not granted any rights to register under the Securities Act any of its presently outstanding securities or any of its securities that may be issued
subsequently. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.15 <U>Investment Company Act</U>. The Company is not, and immediately after giving effect to
the sale of the Purchased Shares in accordance with this Agreement and the application of the proceeds thereof will not be required to be registered as, an &#147;investment company&#148; or a company &#147;controlled&#148; by an &#147;investment
company,&#148; within the meaning of the Investment Company Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.16 <U>Nasdaq</U>. As of the date hereof,
the Company&#146;s Common Stock is listed on The Nasdaq Stock Market, LLC (&#147;<U>Nasdaq</U>&#148;), and except for a deficiency letter (the &#147;<U>Notice</U>&#148;) described in the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on February&nbsp;18, 2022, no event has occurred, and the Company is not aware of any event that is reasonably likely to occur, that would result in the Common Stock being delisted from the
Nasdaq. The Company is in compliance with applicable continued listing requirements of Nasdaq except for the minimum bid requirement described in the Notice (&#147;<U>Minimum Bid Requirement</U>&#148;). The Company has not been informed that it is
ineligible for an additional one hundred eighty (180)&nbsp;calendar day compliance period as described in the Notice and is not aware of any facts or circumstances that would cause the Company to lose such eligibility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.17 <U>No Brokers or Finders</U>. No Person has or will have, as a result of the Contemplated Transactions, any
right, interest or claim against or upon the Company, any of its Subsidiaries or the Purchaser for any commission, fee, or other compensation as a finder or broker because of any act of the Company or any of its Subsidiaries, other than B. Riley
Securities, Inc. whose fees are the sole responsibility of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.18 <U>Illegal Payments; FCPA
Violations</U>. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since January&nbsp;1, 2022, none of the Company, any of its Subsidiaries or, to the knowledge of the
Company, any officer, director, employee, agent, representative or consultant acting on behalf of the Company or any of its Subsidiaries (and only in their capacities as such) has, in connection with the business of the Company: (a)&nbsp;unlawfully
offered, paid, promised to pay, or authorized the payment of, directly or indirectly, anything of value, including money, loans, gifts, travel, or entertainment, to any Government Official with the purpose of (i)&nbsp;influencing any act or decision
of such Government Official in his or her official capacity; (ii)&nbsp;inducing such Government Official to perform or omit to perform any activity in violation of his or her legal duties; (iii)&nbsp;securing any improper advantage; or
(iv)&nbsp;inducing such Government Official to influence or affect any act or decision of such Governmental Authority, except, with respect to the foregoing clauses (i)&nbsp;through (iv), as permitted under the U.S. Foreign Corrupt Practices Act or
other applicable Law; (b)&nbsp;made any illegal contribution to any political party or candidate; (c)&nbsp;made, offered or promised to pay any unlawful bribe, payoff, influence payment, kickback, unlawful rebate, or other similar unlawful payment
of any nature, directly or indirectly, in connection with the business of the Company, to any person, including any supplier or customer; (d)&nbsp;knowingly established or maintained any unrecorded fund or asset or made any false entry on any book
or record of the Company or any of its Subsidiaries for any purpose; or (e)&nbsp;otherwise violated the U.S. Foreign Corrupt Practices Act of 1977, as amended or any other applicable anti-corruption or anti-bribery law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.19 <U>Economic Sanctions</U>. Except as has not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect, the Company is not, and within the past five (5)&nbsp;years has not been, in contravention of any sanction, and has not engaged in any conduct sanctionable, under U.S. economic sanctions Laws,
including applicable Laws administered and enforced by the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control, 31 C.F.R. Part V, the Iran Sanctions Act, as amended, the Comprehensive Iran Sanctions, Accountability and Divestment
Act, as amended, the Iran Threat Reduction and Syria Human Rights Act, as amended, the Iran Freedom and Counter-Proliferation Act of 2012, as amended, and any executive order issued pursuant to any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.20 <U>Transactions with Affiliates</U>. Except as disclosed
in the SEC Documents, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than as
holders of Company Stock Options, Company RSUs, and/or warrants to purchase shares of Common Stock, and for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any
such employee has a substantial interest or is an officer, director, trustee or partner, in each case that would require disclosure in an SEC filing made by the Company (if such filing were being made on the date hereof) pursuant to Item 404 of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.21 <U>Insurance
Coverage</U>. The Company and its Subsidiaries maintain in full force and effect insurance coverage from a reputable insurer that is customary for similarly situated companies for the business being conducted and properties owned or leased by the
Company and its Subsidiaries, and the Company reasonably believes such insurance coverage to be adequate against all liabilities, claims and risks against which it is customary for similarly situated companies to insure. As of the date hereof,
approximately $[*******] of the $[*******] retention under the Company&#146;s directors&#146; and officers&#146; insurance policy has been exhausted with respect to the SEC Matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.22 <U>Intellectual Property</U>. The Company owns or possesses sufficient rights to use all Intellectual
Property which is necessary to conduct its businesses as currently conducted, except where the failure to own or possess such sufficient rights would not reasonably be expected to result, either individually or in the aggregate, in a Material
Adverse Effect. The Company has not received, since January&nbsp;1, 2022, any written notice of, and has no actual knowledge of, any infringement of or conflict with asserted rights of others with respect to any Intellectual Property which, either
individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect. For the purposes of this agreement, &#147;Intellectual Property&#148; means all of the
following: (a)&nbsp;patents, patent applications, patent disclosures and inventions (whether or not patentable and whether or not reduced to practice); (b) trademarks, service marks, trade dress, trade names, corporate names, logos, slogans and
Internet domain names, together with all goodwill associated with each of the foregoing; (c)&nbsp;copyrights and copyrightable works; (d)&nbsp;registrations, applications and renewals for any of the foregoing; and (e)&nbsp;proprietary computer
software (including but not limited to data, data bases and documentation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.23 <U>Customer Matters</U>.
Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company has not received, since January&nbsp;1, 2022, any written notice that any of its customers has ceased, or
intends to cease using its goods or services, or to otherwise terminate or reduce its relationship with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;2.24 <U>No Additional Representations</U>. Except for the representations and warranties made by the Company in
this <U>Article II</U>, neither the Company nor any other Person makes any express or implied representation or warranty with respect to the Company or any Subsidiaries or their respective businesses, operations, assets, liabilities, employees,
employee benefit plans, conditions or prospects, and the Company hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither the Company nor any other Person makes or has made any
representation or warranty to the Purchaser, or any of its Affiliates or representatives, with respect to (a)&nbsp;any financial projection, forecast, estimate, budget or prospect information relating to the Company or any of its Subsidiaries or
their respective business, or (b)&nbsp;any oral or written information presented to the Purchaser or any of its Affiliates or representatives in the course of their due diligence investigation of the Company, the negotiation of this Agreement or in
the course of the Contemplated Transactions. Notwithstanding anything to the contrary herein, nothing in this Agreement shall limit the right of the Purchaser and its Affiliates to rely on the representations, warranties, covenants, and agreements
expressly set forth in this Agreement, nor will anything in this Agreement operate to limit any claim by any Purchaser or any of its respective Affiliates for actual and intentional fraud. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Purchaser represents and warrants to the Company that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.1 <U>Organization and Power</U>. The Purchaser is a limited liability company duly formed, validly existing,
and in good standing under the laws of the jurisdiction of its formation and has all requisite limited partnership or other entity power and authority to own its properties and to carry on its business as presently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.2 <U>Authorization, Etc</U>. The execution, delivery, and performance by the Purchaser of this Agreement and
the Registration Rights Agreement and the consummation by the Purchaser of the Contemplated Transactions do not and will not: (a)&nbsp;violate or result in the breach of any provision of the certificate of formation (or similar organizational
document) of the Purchaser; or (b)&nbsp;with the exceptions that are not reasonably likely to have, individually or in the aggregate, a material adverse effect on its ability to perform its obligations under this Agreement and the Registration
Rights Agreement: (i)&nbsp;violate any provision of, constitute a breach of, or default under, any judgment, order, writ, or decree applicable to the Purchaser or any material contract to which the Purchaser is a party; or (ii)&nbsp;violate any
provision of, constitute a breach of, or default under, any applicable state, federal or local law, rule or regulation. Assuming due authorization, execution and delivery by the Company, this Agreement constitutes a valid and binding agreement of
the Purchaser enforceable against the Purchaser in accordance with its terms (subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws affecting creditors&#146; rights generally and general
principles of equity). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.3 <U>Government Approvals</U>. No consent, approval, license or authorization of,
or filing with, any court or governmental authority is or will be required on the part of the Purchaser in connection with the execution, delivery, and performance by the Purchaser of this Agreement and the Registration Rights Agreement, except for:
(a)&nbsp;those which have already been made or granted; (b)&nbsp;the filing with the SEC of a Schedule 13D or Schedule 13G and a Form 3 to report the Purchaser&#146;s ownership of the Purchased Shares; or (c)&nbsp;those where the failure to obtain
such consent, approval or license would not have a material adverse effect on the ability of the Purchaser to perform its obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.4 <U>Sufficient Funds</U>. The Purchaser has as of the date hereof, and will have as of the First Closing,
sufficient immediately available funds to pay the First Purchase Price pursuant to <U>Article I</U> at the First Closing. The Purchaser has as of the date hereof, and will have as of the Second Closing sufficient immediately available funds to pay
the Second Purchase Price pursuant to Article I at the Second Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.5 <U>Investment
Representations.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) The Purchaser is an &#147;accredited investor&#148; as that term is defined in Rule 501(a) of
Regulation D promulgated under the Securities Act. The Purchaser was not organized solely for the purpose of acquiring the Purchased Shares and is not required to be registered as a broker-dealer under Section&nbsp;15 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Purchaser has been advised by the Company that the Purchased Shares have not been registered under the Securities Act,
that the Purchased Shares will be issued on the basis of the statutory exemption provided by Section&nbsp;4(a)(2) under the Securities Act or Regulation D promulgated thereunder, or both, relating to transactions by an issuer not involving any
public offering and under similar exemptions under certain state securities laws, that the Contemplated Transactions have not been reviewed by, passed on or submitted to any federal or state agency or self-regulatory organization where an exemption
is being relied upon, and that the Company&#146;s reliance thereon is based in part upon the representations made by the Purchaser in this Agreement and the Registration Rights Agreement. The Purchaser acknowledges that it has been informed by the
Company of, or is otherwise familiar with, the nature of the limitations imposed by the Securities Act and the rules and regulations thereunder on the transfer of securities, including that such securities may be resold without registration under
the Securities Act only in certain limited circumstances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The Purchaser is purchasing the Purchased Shares for its own beneficial
account for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof in violation of federal or state securities laws. The Purchaser acknowledges and agrees that the Purchased Shares may not be sold,
transferred, offered for sale, pledged, hypothecated or otherwise disposed of without registration under the Securities Act and any applicable state securities laws, except pursuant to an exemption from such registration under the Securities Act and
such laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) By reason of its business or financial experience, the Purchaser has the capacity to protect its own
interest in connection with the Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) The Company has provided to the Purchaser all documents
and information that the Purchaser has requested relating to an investment in the Company. The Purchaser recognizes that investing in the Company involves substantial risks, and has taken full cognizance of and understands all of the risk factors
related to the acquisition of the Purchased Shares. The Purchaser is able to bear the economic risk of holding the Purchased Shares for an indefinite period (including total loss of its investment), and has sufficient knowledge and experience in
financial and business matters so as to be capable of evaluating the merits and risk of its investment. The Purchaser has carefully considered and has, to the extent it believes such discussion necessary, discussed with the Purchaser&#146;s
professional legal, tax and financial advisers the suitability of an investment in the Company, and the Purchaser has determined that the acquisition of the Purchased Shares is a suitable investment for the Purchaser. The Purchaser acknowledges and
affirms that, with the assistance of its advisors, it has conducted and completed its own investigation, analysis and evaluation related to the investment in the Purchased Shares and that it has not relied on the Company for any tax or legal advice
in connection with the purchase of the Purchased Shares. In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representations or other information (other than the representations and warranties of the
Company set forth in <U>Article II</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.6 <U>No Prior Ownership</U>. Prior to the First Closing, the
Purchaser does not have record or beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of any shares of the Company&#146;s Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.7 <U>No Brokers or Finders</U>. No Person has or will have, as a result of the Contemplated Transactions, any
right, interest or claim against or upon the Company, any of its Subsidiaries or any Purchaser for any commission, fee or other compensation as a finder or broker because of any act by the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.8 <U>ERISA</U>. The Purchaser does not hold, and no part of the funds used by the Purchaser to acquire any
Purchased Shares constitutes, &#147;plan assets&#148; (within the meaning of the ERISA Regulations). The Purchaser is not (a)&nbsp;an &#147;employee benefit plan&#148; that is subject to Part 4 of Title I of ERISA, (b)&nbsp;a &#147;plan&#148; to
which Section&nbsp;4975 of the Code applies or (c)&nbsp;an entity whose underlying assets could be deemed to include &#147;plan assets&#148; by reason of an employee benefit plan&#146;s or a plan&#146;s investment in such entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.9 <U>Foreign Control</U>. The Purchaser is wholly-owned and controlled by U.S. citizens and is not a
&#147;foreign person&#148; as that term is defined in the DPA. For the avoidance of doubt, the Purchaser is neither a &#147;foreign national,&#148; &#147;foreign government&#148; or &#147;foreign entity,&#148; nor an entity over which
&#147;control&#148; is exercised or exercisable, directly or indirectly, by any &#147;foreign national,&#148; &#147;foreign government&#148; or &#147;foreign entity,&#148; as those terms are defined in the DPA. The Purchaser has not entered into any
agreement or arrangement, formal or informal, directly or indirectly, with any &#147;foreign person&#148; pursuant to which the &#147;foreign person&#148; could acquire &#147;control&#148; of the Purchaser, as those terms are defined in the DPA.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;3.10 <U>No Additional Representations</U>. The Purchaser acknowledges and agrees, on behalf of itself and
its Affiliates, that, except for the representations and warranties contained in <U>Article II</U>, neither the Company nor any other Person, makes any express or implied representation or warranty with respect to the Company, its Subsidiaries or
their respective businesses, operations, assets, liabilities, employees, employee benefit plans, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
conditions or prospects, and the Purchaser, on behalf of itself and its Affiliates, hereby disclaims reliance upon any such other representations or warranties. In particular, without limiting
the foregoing disclaimer, the Purchaser acknowledges and agrees, on behalf of itself and its Affiliates, that neither the Company nor any other Person, makes or has made any representation or warranty with respect to, and the Purchaser, on behalf of
itself and its Affiliates, hereby disclaims reliance upon (a)&nbsp;any financial projection, forecast, estimate, budget or prospect information relating to the Company, its Subsidiaries or their respective business, or (b)&nbsp;without limiting the
representations and warranties made by the Company in <U>Article II</U>, any information presented to the Purchaser or any of its Affiliates or representatives in the course of their due diligence investigation of the Company, the negotiation of
this Agreement or in the course of the Contemplated Transactions. The Purchaser acknowledges and agrees with the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;2.24</U>. To the fullest extent permitted by applicable Law,
without limiting the representations and warranties contained in <U>Article II</U>, neither the Company nor any of its Subsidiaries shall have any liability to any Purchaser or its Affiliates or representatives on any basis (including in contract or
tort, under federal or state securities laws or otherwise) based upon any other representation or warranty, either express or implied, included in any information or statements (or any omissions therefrom) provided or made available by the Company
or its Subsidiaries to Purchaser or its Affiliates or representatives in the course of their due diligence investigation of the Company, the negotiation of this Agreement or in the course of the Contemplated Transactions. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS OF
THE COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.1 <U>Acquisition Proposals.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Subject to <U>Section</U><U></U><U>&nbsp;4.1(b)</U>, <U>Section</U><U></U><U>&nbsp;4.1(c)</U>,
<U>Section</U><U></U><U>&nbsp;4.1(d)</U>, <U>Section</U><U></U><U>&nbsp;4.1(e)</U> and <U>Section</U><U></U><U>&nbsp;4.1(f)</U>, from and after the date of this Agreement until the earlier of the First Closing or the termination of this Agreement in
accordance with its terms, (i)&nbsp;neither the Company nor any of its Subsidiaries shall, nor shall the Company or any of its Subsidiaries authorize or knowingly permit any of the directors of the Company, the officers or employees of the Company,
or any investment bankers, attorneys, accountants or other advisors or other Representatives retained by the Company or its Subsidiaries (collectively, &#147;<U>Company Representatives</U>&#148;) to, directly or indirectly, (A)&nbsp;solicit,
initiate or knowingly facilitate or encourage the submission of any inquiry, proposal or offer which constitutes, or would reasonably be expect to result in, an Acquisition Proposal, (B)&nbsp;enter into, continue or participate in any discussions or
negotiations with, or furnish any <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its Subsidiaries to, any Third Party in connection with an Acquisition Proposal, (C)&nbsp;approve, recommend, publicly
declare advisable or enter into any agreement in principle, letter of intent, merger agreement, acquisition agreement, joint venture agreement or other similar agreement relating to an Acquisition Proposal (other than any Acceptable Confidentiality
Agreement entered into in accordance with this <U>Section</U><U></U><U>&nbsp;4.1</U>), or (D)&nbsp;agree to or propose publicly to do any of the foregoing, and (ii)&nbsp;the Board of Directors shall not (x)&nbsp;fail to make, withdraw or modify in a
manner adverse to the Purchaser (or publicly propose to withdraw, modify or qualify in any manner adverse to the Purchaser) the Company Board Recommendation, (y)&nbsp;adopt, approve, or publicly recommend, endorse or otherwise declare advisable the
adoption of, an Acquisition Proposal, or (z)&nbsp;fail to include in the Proxy Statement the Company Board Recommendation (any of the foregoing in this clause (ii), an &#147;<U>Adverse Recommendation Change</U>;&#148; <U>provided</U>, <U>that</U>,
for the avoidance of doubt, but subject to compliance by the Company with the terms of this <U>Section</U><U></U><U>&nbsp;4.1</U>, none of (1)&nbsp;the determination by the Board of Directors in accordance with
<U>Section</U><U></U><U>&nbsp;4.1(f)</U> that an Acquisition Proposal constitutes a Superior Proposal, (2)&nbsp;the disclosure by the Company of such determination in accordance with <U>Section</U><U></U><U>&nbsp;4.1(f)</U>, or (3)&nbsp;the delivery
by the Company of the notice required by <U>Section</U><U></U><U>&nbsp;4.1(e)</U> shall constitute an Adverse Recommendation Change). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Notwithstanding anything contained in this Agreement to the contrary, if at any time after the date of this Agreement and
prior to obtaining the Company Stockholder Approval, the Company, any Subsidiary of the Company or any of the Company Representatives receives a written Acquisition Proposal from any Third Party that did not result from a breach of
<U>Section</U><U></U><U>&nbsp;4.1(a)</U> and that the Board of Directors determines in good faith </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(I)&nbsp;to be bona fide, (II)&nbsp;after consultation with its financial advisor and outside legal counsel, constitutes, or would reasonably be expected to result in, a Superior Proposal or
(III)&nbsp;after consultation with its outside legal counsel, that the failure to take such action would reasonably be expected to result in a breach of the fiduciary duties of the Company&#146;s directors under applicable Law, then the Company,
directly or indirectly through the Company Representatives, may (i)&nbsp;engage in negotiations or discussions with such Third Party and its Representatives and actual or potential sources of financing (including, as a part thereof, making any
counterproposal), and (ii)&nbsp;furnish to such Third Party or its Representatives and actual or potential sources of financing <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or any of its Subsidiaries
pursuant to an Acceptable Confidentiality Agreement; <U>provided</U>, <U>that</U>, prior to or substantially concurrently with the time it is made available to such Third Party, the Company shall make available to the Purchaser any <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or its Subsidiaries that is made available to such Third Party and that was not previously made available to the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Notwithstanding anything contained in this Agreement to the contrary at any time prior to obtaining the Company
Stockholder Approval, if (A)&nbsp;an Intervening Event has occurred, and (B)&nbsp;the Board of Directors determines in good faith and after taking into account any revisions to the terms of this Agreement that may be offered in writing by Purchaser
in accordance with this <U>Section</U><U></U><U>&nbsp;4.1(c)</U>, after consultation with outside legal counsel and its financial advisors, that the failure to make an Adverse Recommendation Change would reasonably be expected to result in a breach
of its fiduciary duties under applicable Law, then the Board of Directors may make an Adverse Recommendation Change; <U>provided</U>, <U>that</U>, if the Company is making an Adverse Recommendation Change in response to any Intervening Event (other
than an Acquisition Proposal, which shall be governed by <U>Section</U><U></U><U>&nbsp;4.1(f)</U>), then the Board of Directors of the Company shall not make such Adverse Recommendation Change unless the Company has (i)&nbsp;provided to the
Purchaser at least three (3)&nbsp;Business Days&#146; prior written notice (it being understood and agreed that any material change in facts or circumstances relating to an Intervening Event shall require a new notice and a new three
(3)&nbsp;Business Day period) that it intends to take such action and specifying in reasonable detail the facts underlying the decision by the Board of Directors to take such action and (ii)&nbsp;during such three (3)&nbsp;Business Day period, if
requested by the Purchaser, engaged in good faith negotiations with the Purchaser to amend this Agreement in such a manner that obviates the need for such Adverse Recommendation Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) In addition, nothing contained herein shall prevent the Board of Directors from (i)&nbsp;complying with Rule <FONT
STYLE="white-space:nowrap">14e-2(a),</FONT> Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> or Item 1012(a) of Regulation <FONT STYLE="white-space:nowrap">M-A</FONT> promulgated under the Exchange Act with regard to an Acquisition Proposal;
<U>provided</U>, that any such action taken or statement made that relates to an Acquisition Proposal shall not be deemed to be an Adverse Recommendation Change if the Board of Directors reaffirms the Company Board Recommendation in such statement
or in connection with such action or (ii)&nbsp;making any disclosure to the stockholders of the Company if the Board of Directors determines in good faith, after consultation with outside legal counsel, that the failure to take such action would
reasonably be expected to result in a breach of its fiduciary duties under applicable Law; <U>provided</U> further that in no event shall the Board of Directors be permitted to make any Adverse Recommendation Change except in accordance with
<U>Section</U><U></U><U>&nbsp;4.1(c)</U> or <U>Section</U><U></U><U>&nbsp;4.1(f)</U> hereunder, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) The
Company shall notify the Purchaser orally and in writing promptly (but in no event later than 24 hours) after receipt by the Company of any Acquisition Proposal, any proposals or inquiries that would reasonably be expected to lead to an Acquisition
Proposal, or any inquiry or request for nonpublic information relating to the Company or any of its Subsidiaries by any Person who has made, or has expressly indicated that such Person is contemplating making, any Acquisition Proposal. Any such
notice shall identify the Third Party making, and the material terms and conditions of (or the nature of), any such Acquisition Proposal, inquiry, or request and shall attach a copy of any written Acquisition Proposal (or summary of the terms of any
oral Acquisition Proposal) and a copy of all written materials provided by such Person with respect to such Acquisition Proposal. The Company shall keep the Purchaser reasonably informed promptly (but in no event later than 24 hours) after any
material changes in status or material terms of any Acquisition Proposal and shall provide to the Purchaser promptly (but in no event later than 24 hours) after receipt thereof of copies of proposed </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
transaction agreements or proposal letters sent or provided to the Company or any of its Subsidiaries that describe any material terms or conditions of any Acquisition Proposal, and keep the
Purchaser reasonably informed as to the nature of any information requested of the Company with respect thereto. Upon request of the Purchaser, the Company shall apprise the Purchaser of the status of any such Acquisition Proposal, inquiry, or
request. If an Acquisition Proposal shall have been publicly announced (other than by the Purchaser, its Subsidiaries, or any of their respective Affiliates or Representatives), the Company shall publicly reaffirm the Company Board Recommendation
within ten (10)&nbsp;Business Days after receipt of a written request by the Purchaser to provide such reaffirmation, unless an Adverse Recommendation Change is permitted by <U>Section</U><U></U><U>&nbsp;4.1(b)</U>; <U>provided</U>, <U>however</U>,
that in no event shall the Company be obligated to publicly reaffirm the Company Board Recommendation on more than one occasion with respect to each such publicly announced Acquisition Proposal by any Third Party or on more than one occasion with
respect to each publicly announced material modification thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) Notwithstanding anything in this Agreement to the
contrary, the Board of Directors may make an Adverse Recommendation Change in response to an Acquisition Proposal (or terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)(i)</U>), only so long as (i)&nbsp;such Acquisition
Proposal was not the result of a breach of this <U>Section</U><U></U><U>&nbsp;4.1(a)</U> and such Acquisition Proposal is not withdrawn, (ii)&nbsp;the Board of Directors has determined in good faith, after consultation with its financial advisor and
outside legal counsel and after taking into account any revisions to the terms of this Agreement that may be offered in writing by the Purchaser in accordance with this <U>Section</U><U></U><U>&nbsp;4.1(f)</U>, (A) that such Acquisition Proposal
constitutes a Superior Proposal, and (B)&nbsp;that the failure to take make an Adverse Recommendation Change would reasonably be expected to result in a breach of its fiduciary duties under applicable Law, (iii)&nbsp;the Company (A)&nbsp;notifies
the Purchaser in writing (a &#147;<U>Change Notice</U>&#148;) at least three (3)&nbsp;Business Days before the making of any Adverse Recommendation Change of the determination of the Board of Directors of the Company that such Acquisition Proposal
constitutes a Superior Proposal and of its intention to take such action, attaching the most current version of all proposed agreements under which such Superior Proposal is proposed to be consummated and all other material terms and conditions in
respect of such Acquisition Proposal and the identity of the Third Party making such Superior Proposal, (B)&nbsp;during the three (3)&nbsp;Business Day period beginning on the date of receipt (or deemed receipt in accordance with
<U>Section</U><U></U><U>&nbsp;9.6</U>) of the Change Notice by the Purchaser, is available to negotiate in good faith with the Purchaser (if requested by the Purchaser) any proposal by the Purchaser to amend the terms and conditions of this
Agreement such that such Acquisition Proposal would no longer constitute a Superior Proposal (provided that any amendment, supplement or modification to any Acquisition Proposal shall require the Company to deliver to the Purchaser a new Change
Notice and a new negotiation period, except that the new negotiation period under this <U>Section</U><U></U><U>&nbsp;4.1(f)</U> with respect to any revised Acquisition Proposal shall be two (2)&nbsp;Business Days, instead of three (3)&nbsp;Business
Days), and (iv)&nbsp;the Board of Directors (A)&nbsp;shall have considered in good faith any revisions to the terms of this Agreement offered in writing by the Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;4.1(f)</U>, and (B)&nbsp;shall
have determined in good faith, after consultation with its financial advisor and outside legal counsel, that such Acquisition Proposal remains a Superior Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.2 <U>Access to Information</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) From the date hereof until the earlier of the First Closing and the termination of this Agreement in accordance with its
terms and subject to applicable Law and the Confidentiality Agreement, the Company shall, and shall cause each of its Subsidiaries to, (i)&nbsp;give to the Purchaser, its counsel, financial advisors, auditors and other authorized representatives
reasonable access during normal business hours to the employees, offices, properties, books and records of such party, (ii)&nbsp;furnish reasonably promptly to the Purchaser, its counsel, financial advisors, auditors, and other authorized
representatives all information (financial or otherwise) as such Persons may reasonably request concerning the Company&#146;s and its Subsidiaries&#146; business, properties and personnel, and (iii)&nbsp;instruct its employees, counsel, financial
advisors, auditors, and other authorized representatives to reasonably cooperate with the Purchaser in its investigation. Any investigation pursuant to this <U>Section</U><U></U><U>&nbsp;4.2</U> shall be conducted under supervision of appropriate
personnel of the Company and in such manner as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
not to unreasonably interfere with the conduct of the business of the Company, and shall not include the collection or analysis of any environmental samples. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Purchaser will hold, and will cause its Representatives and affiliates to hold, any nonpublic information, including
any information exchanged pursuant to this <U>Section</U><U></U><U>&nbsp;4.2</U> and <U>Section</U><U></U><U>&nbsp;6.1</U>, in confidence to the extent required by and in accordance with, and will otherwise comply with, the terms of the
Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.3 <U>Restrictive Legends</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Each certificate representing the Purchased Shares (unless otherwise permitted by the provisions of
<U>Section</U><U></U><U>&nbsp;4.3(b)</U>) shall be stamped or otherwise imprinted with a legend in substantially the following form (in addition to any legend required under applicable state securities laws): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;<U>SECURITIES ACT</U>&#148;), AND SUCH SHARES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT (A)&nbsp;PURSUANT TO A REGISTRATION STATEMENT THAT IS EFFECTIVE UNDER THE SECURITIES ACT; OR (B)&nbsp;PURSUANT TO AN EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY
REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">AS LONG AS THE HOLDER OF THESE SECURITIES IS AN AFFILIATE OF THE ISSUER, THESE SECURITIES MAY NOT BE SOLD, OR OFFERED FOR SALE,
IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SALE OF THESE SECURITIES UNDER THE SECURITIES ACT, OR THE SALE OTHERWISE BEING EXEMPT FROM REGISTRATION UNDER SUCH ACT. THE ISSUER MAY REQUIRE AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION IS NOT REQUIRED.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Prior to any proposed Transfer of any
Purchased Shares, unless there is in effect a registration statement under the Securities Act covering the proposed Transfer, the Purchaser shall give written notice to the Company of the Purchaser&#146;s intention to effect such Transfer. Each such
notice shall describe the manner and circumstances of the proposed Transfer in sufficient detail, and shall be accompanied by either (i)&nbsp;an opinion of legal counsel reasonably satisfactory to the Company to the effect that the proposed Transfer
of the Purchased Shares may be effected without registration under the Securities Act, or (ii)&nbsp;any other evidence reasonably satisfactory to counsel to the Company. Upon delivery thereof that is reasonably satisfactory to the Company, the
Purchaser shall be entitled to Transfer such Purchased Shares in accordance with the terms of the notice delivered by the Purchaser to the Company. Notwithstanding the foregoing, in the event the Purchaser shall give the Company a representation
letter containing such representations as the Company shall reasonably request, the Company will not require such legal opinion or such other evidence in any transaction in which the Purchaser distributes the Purchased Shares solely to its majority
owned subsidiaries or Affiliates for no consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.4 <U>Conduct of Business Covenant</U>. Except for
matters set forth in <U>Section</U><U></U><U>&nbsp;4.4</U> of the Disclosure Letter, as expressly permitted or required by this Agreement including <U>Section</U><U></U><U>&nbsp;7.2</U> of this Agreement, as required by applicable Law or
Governmental Authority or with the prior written consent (which may include an electronic transmission) of the Purchaser (which consent shall not be unreasonably withheld, conditioned or delayed), from and after the date hereof and prior to the
earlier of the First Closing or the termination of this Agreement in accordance with its terms, the Company shall, and shall cause each of its Subsidiaries to, conduct its business in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the ordinary course consistent with past practice and use its commercially reasonable efforts to (i)&nbsp;preserve intact its present business organization, (ii)&nbsp;keep available the services
of its present directors, officers, and Key Employees, and (iii)&nbsp;preserve its relationships with its material customers, lenders, suppliers and others having material business relationships with it. Without limiting the generality of the
foregoing, except for matters set forth in <U>Section</U><U></U><U>&nbsp;4.4</U> of the Disclosure Letter, as expressly permitted or required by this Agreement, as required by applicable Law or with the prior written consent (which may include an
electronic transmission) of the Purchaser (which consent shall not be unreasonably withheld, conditioned or delayed), between the date hereof and the earlier of the Second Closing or the termination of this Agreement in accordance with its terms, as
applicable, the Company shall not, nor shall it permit any of its Subsidiaries to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a)&nbsp;(i) amend the certificate of
incorporation or bylaws of the Company or (ii)&nbsp;amend, other than immaterial changes in respect of wholly-owned Subsidiaries, the comparable organizational documents of any Subsidiary of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b)&nbsp;(i) split, combine or reclassify any shares of its capital stock, (ii)&nbsp;authorize, declare, set aside or pay any
dividends on, or make any other distributions (whether in cash, stock, property or otherwise) in respect of, or enter into any agreement with respect to the voting of, any capital stock of the Company or any of its Subsidiaries, other than dividends
and distributions by a direct or indirect wholly owned Subsidiary of the Company to its parent or (iii)&nbsp;redeem, repurchase or otherwise acquire or offer to redeem, repurchase or otherwise acquire any Company Securities or any Company Subsidiary
Securities, other than (A)&nbsp;the acquisition or withholding by the Company of shares of Common Stock in connection with the surrender of shares of Common Stock by holders of Company Stock Options in order to pay the exercise price thereof,
(B)&nbsp;the acquisition or withholding of shares of Common Stock to satisfy Tax obligations with respect to awards granted pursuant to the Stock Plans, (C)&nbsp;the acquisition by the Company of any restricted shares in connection with the
forfeiture of such awards and (D)&nbsp;as required by any Stock Plan as in effect on the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c)&nbsp;(i) issue, deliver, sell, grant, pledge, transfer, subject to any Lien or otherwise encumber or dispose of, any
Company Securities or Company Subsidiary Securities, other than the issuance of (A)&nbsp;any shares of Common Stock upon the exercise of Company Stock Options or any options or purchase rights under the Company ESPP or settlement of Company RSUs, in
each case, that are outstanding on the date of this Agreement and in each case in accordance with their terms on the date of this Agreement, (B)&nbsp;awards of Company RSUs to consultants under the Stock Plans and awards of Company RSUs under the
Stock Plans to any newly hired or promoted employees or to employees for retention purposes, in each case, in the ordinary course of business consistent with past practice or (C)&nbsp;any Company Subsidiary Securities to the Company or any other
wholly-owned Subsidiary of the Company; or (ii)&nbsp;amend any term of any Company Security or any Company Subsidiary Security; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial liquidation, dissolution,
restructuring, recapitalization or other reorganization, each with respect to the Company or any of its Subsidiaries (other than the dissolution of any inactive Subsidiary of the Company and reorganizations solely among Subsidiaries of the Company)
or consummate any of the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) acquire (by merger, consolidation, acquisition of stock or assets or otherwise),
directly or indirectly, any equity interest or securities in, or any material amount of other assets, properties, interests or businesses of, any Person, or enter into any new line of business that is material to the Company and its Subsidiaries,
taken as a whole; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) sell, lease, exclusively license, exchange, swap, abandon, allow to lapse or cancel any
Intellectual Property owned by the Company (other than the natural expiration thereof or, with respect to allowing Intellectual Property owned by the Company to become abandoned, lapsed, or cancelled, in connection with the Company&#146;s exercise
of its reasonable business judgment); or sell, lease, exchange, swap, or otherwise transfer or dispose of any of the Company&#146;s or its Subsidiaries&#146; material assets, securities, properties, interests or businesses,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
other than (i)&nbsp;pursuant to existing Contract in effect prior to the date of this Agreement, or (ii)&nbsp;sales of Company products and services, inventory or used equipment in the ordinary
course of business consistent with past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g)&nbsp;(i) repurchase, prepay, redeem, defease, assume, endorse,
guarantee, incur or otherwise become liable for or modify the terms of any indebtedness for borrowed money or sell or issue any debt securities or other rights to acquire any debt securities (directly, contingently or otherwise), or (ii)&nbsp;make
any loans, advances or capital contributions to, or investments in, any other Person (other than to the Company or any of its wholly-owned Subsidiaries in the ordinary course of business and advances of expenses to employees in the ordinary course
of business); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) except as required by the terms of any Company Employee Plan as in effect on the date of this
Agreement: (i)&nbsp;grant any severance, retention or termination pay to, or enter into or amend any employment, severance, retention, termination, change in control or severance agreement with, any current or former Key Employee, (ii)&nbsp;hire any
new employee who would constitute a Key Employee, other than in the ordinary course of business consistent with past practice in order to replace a Key Employee whose employment terminates (so long as the applicable replacement Key Employee receives
compensation and benefit terms that are no more favorable to the new Key Employee than compensation and benefits held by the Key Employee that is being replaced), (iii) grant to any current or former director or Key Employee of the Company or any of
its Subsidiaries any material increase in compensation, target bonus or benefits, in addition to those pursuant to arrangements in effect on the date hereof, other than in the ordinary course of business, (iv)&nbsp;establish, adopt, enter into or
materially amend or modify any Company Employee Plan (other than entering into offer letters that contemplate &#147;at will&#148; employment that is terminable without payment or notice or, where required by applicable Law, employment agreements
consistent with the Company&#146;s practices in the applicable jurisdiction, or cash bonus or cash incentive plans for performance periods not exceeding one (1)&nbsp;year in the ordinary course of business consistent with past practice to replace
such plans covering performance periods that end prior to the Second Closing), (v) take any action to accelerate any payment or benefit, or the funding of any payment or benefit, payable or to become payable to any of its directors employees or
other service providers, other than in the ordinary course of business consistent with past practice, (vi)&nbsp;establish, enter into, adopt or amend any works council, collective bargaining or similar labor-related agreement, except as required by
applicable Law, (vii)&nbsp;announce, implement or effect any material reduction in labor force, <FONT STYLE="white-space:nowrap">lay-off,</FONT> early retirement program or other effort concerning termination of employment of employees of the
Company or any of its Subsidiaries (other than routine employee terminations in the ordinary course of business), or (viii)&nbsp;terminate any Key Employee other than for cause; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) make any change in any financial accounting principles, methods or practices (including any Tax accounting policies or
procedures) or any of its methods of reporting income, deductions or other material items for financial or Tax accounting purposes, in each case except for any such change required by GAAP or applicable Law, including Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) make, change or revoke any material Tax election (other
than in the ordinary course of business consistent with past practice), change any annual Tax accounting period, adopt or change any method of material Tax accounting, amend, refile or otherwise revise any previously filed Tax Returns, enter into
any closing agreement, settle or compromise any Tax claim or assessment, consent to any extension or waiver of the statutory period of limitations applicable to any claim or assessment in respect of Taxes, enter into any Tax indemnity or similar
agreements or arrangements (other than customary commercial agreements not primarily related to Taxes), undertake any restructuring or engage in any transaction that may transfer the ownership of any Intellectual Property; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(k) discharge, pay, settle or offer or propose to settle, (i)&nbsp;any litigation, investigation, arbitration, proceeding or
other claim involving or against the Company or any of its Subsidiaries, (ii)&nbsp;any shareholder litigation or dispute against the Company or any of its officers or directors, or (iii)&nbsp;any litigation, arbitration, proceeding or dispute that
relates to the Contemplated Transactions; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(l) enter into, as a tenant or subtenant, any lease of real property, under
which the rent to be charged exceeds two hundred fifty thousand ($250,000) for any twelve (12)-month period, other than ordinary course of business extensions and renewals of leases existing as of the date hereof with a term of no more than one
(1)&nbsp;calendar year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(m) except in the ordinary course of business consistent with the past practice and except as
provided in an annual operating plan as approved by the Board of Directors of the Company, make any new capital expenditure or expenditures, or commit to do so; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(n) terminate, cancel, amend or modify any insurance coverage policy maintained by the Company or any of its Subsidiaries that
is not concurrently replaced by a comparable amount of insurance coverage, other than renewals in the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(o) except in the ordinary course of business consistent with past practice, (i)&nbsp;enter into any Contract that would, if
entered into prior to the date hereof, be a material Contract that was required to be filed or furnished by the Company as exhibits to the SEC Documents to which the Company is a party or the property or assets of the Company is subject
(collectively, the &#147;<U>Material Contracts</U>&#148;, (ii) materially modify, materially amend or terminate any Material Contract or (iii)&nbsp;waive, release, terminate, amend, renew or assign any material rights or claims of the Company or any
of its Subsidiaries under any Material Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(p) enter into or adopt any &#147;poison pill&#148; or similar
stockholder rights plan that would prevent or preclude the Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(q) agree, authorize or commit to
do any of the foregoing </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.5 <U>Proxy Statement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) As soon as reasonably practicable (and in no event later than forty (40)&nbsp;days after the date hereof), the Company
shall prepare and file the Proxy Statement in preliminary form with the SEC; <U>provided</U> that the Company shall provide the Purchaser and its counsel a reasonable opportunity to review the Company&#146;s proposed preliminary Proxy Statement in
advance of filing and consider in good faith any comments reasonably proposed by Purchaser and its counsel. Subject to <U>Section</U><U></U><U>&nbsp;4.1</U>, the Proxy Statement shall include (and shall not subsequently withdraw or modify) the
Company Board Recommendation. The Company shall use its reasonable best efforts to cause the Proxy Statement to be mailed to its stockholders as promptly as practicable following clearance of the Proxy Statement by the SEC. The Purchaser shall
furnish to the Company all information concerning the Purchaser as may be reasonably required by the Company in connection with the Proxy Statement. Each of the Company and the Purchaser shall promptly correct any information provided by it for use
in the Proxy Statement if and to the extent that such information shall have become false or misleading in any material respect, and the Company shall take all steps necessary to amend or supplement the Proxy Statement and to cause the Proxy
Statement, as so amended or supplemented, to be filed with SEC and mailed to its stockholders, in each case as and to the extent required by applicable Law. The Company shall (i)&nbsp;as promptly as practicable after receipt thereof, provide the
Purchaser and its counsel with copies of any written comments, and advise the Purchaser and its counsel of any oral comments, with respect to the Proxy Statement (or any amendment or supplement thereto) received from the SEC or its staff,
(ii)&nbsp;provide the Purchaser and its counsel a reasonable opportunity to review the Company&#146;s proposed response to such comments and (iii)&nbsp;consider in good faith any comments reasonably proposed by the Purchaser and its counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) In addition to the proposals required to effect the Contemplated Transactions, the Proxy Statement shall include
(i)&nbsp;a proposal to approve a reverse stock split of the issued and outstanding shares of Common Stock of the Company (the &#147;<U>Reverse Stock Split Proposal</U>&#148;), such split to combine a number of outstanding shares of Common Stock at a
ratio of between <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-2</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> such number consisting of only whole shares, into
one (1)&nbsp;share of Common Stock, provided that such reverse stock split, if approved by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
stockholders of the Company (such approval, the &#147;<U>Reverse Stock Split Approval</U>&#148;), shall be subject to the discretion of the Board of Directors and may be effected within one
(1)&nbsp;year of obtaining such Reverse Stock Split Approval and would require an amendment to the Certificate of Incorporation in the form attached hereto as <U>Exhibit C</U>; and (ii)&nbsp;a proposal to approve an amendment to the Certificate of
Incorporation in the form attached hereto as <U>Exhibit D</U> (such approval, the &#147;<U>Charter Amendment Approval</U>&#148;). Neither the Reverse Stock Split Approval nor the Charter Amendment Approval shall be deemed as a condition to any
obligation of the Purchaser under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.6 <U>Company Stockholder Meeting</U>. The Company shall
cause a meeting of its stockholders (the &#147;<U>Company Stockholder Meeting</U>&#148;) to be duly called and held as soon as reasonably practicable following clearance of the Proxy Statement by the SEC for the purpose of obtaining the Company
Stockholder Approval. As soon as reasonably practicable following the establishment of the record date for the Company Stockholder Meeting and clearance of the Proxy Statement by the SEC, the Company shall cause the definitive Proxy Statement to be
mailed to the stockholders of Company entitled to vote at the Company Stockholder Meeting. Notwithstanding the first sentence of this <U>Section</U><U></U><U>&nbsp;4.6</U>, the Company may adjourn or postpone the Company Stockholder Meeting
(i)&nbsp;after consultation with the Purchaser, to the extent necessary to ensure that any required supplement or amendment to the Proxy Statement is provided to the Company&#146;s stockholders within a reasonable amount of time in advance of the
Company Stockholder Meeting, (ii)&nbsp;as otherwise required by applicable Law or (iii)&nbsp;if as of the time for which the Company Stockholder Meeting is scheduled as set forth in the Proxy Statement, there are insufficient shares of Common Stock
represented (in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Stockholder Meeting or there are insufficient shares of Common Stock voting in favor to obtain Company Stockholder Approval. The Board of
Directors of the Company shall (A)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;4.1</U>, include the Company Board Recommendation in the Proxy Statement, (B)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;4.1</U>, use its reasonable best efforts to
obtain the Company Stockholder Approval, and (C)&nbsp;otherwise comply with all legal requirements applicable to such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.7 <U>Use of Proceeds</U>. The Company shall use the net proceeds from the Purchase and Sale for working
capital, capital expenditure and other general corporate purposes, including but not limited to, the implementation of the Integration Plans. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS OF
THE PURCHASER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;5.1 <U>Conduct of the Purchaser</U>. From and after the date hereof and prior to the
earlier of the Second Closing or the termination of this Agreement in accordance with its terms, the Purchaser shall use its commercially reasonable efforts not to, and shall use its commercially reasonable efforts to cause each of its Subsidiaries
not to, take or omit to take any action that impedes, interferes with, hinders or delays in any material respect, or would reasonably be expected to prevent or materially impede, interfere with, hinder or delay in any material respect, the
consummation by the Purchaser of the Contemplated Transactions on a timely basis. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS OF THE PARTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.1 <U>Reasonable Best Efforts</U>. Subject to the terms and conditions of this Agreement, the Company and the
Purchaser shall cooperate with each other and use their reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law to consummate the Contemplated
Transactions as promptly as practicable, including (i)&nbsp;preparing and filing as promptly as practicable after the date hereof with any Governmental Authority all documentation to effect all necessary filings, notices, petitions, statements,
registrations, submissions of information, financial statements, records, applications and other documents, in each case, to the extent applicable, (ii)&nbsp;obtaining and maintaining </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
all approvals, consents, registrations, Permits, authorizations, licenses, waivers and other confirmations required to be obtained from any Governmental Authority that are necessary to consummate
the Contemplated Transactions and (iii)&nbsp;executing and delivering any additional instruments necessary to consummate the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.2 <U>Public Announcements</U>. From and after the date of this Agreement, until such time as this Agreement has
been terminated in accordance with its terms, or an Adverse Recommendation Change has occurred in accordance with <U>Section</U><U></U><U>&nbsp;4.1</U>, the Purchaser and the Company shall consult with each other before issuing any press release,
having any communication with the press (whether or not for attribution), making any other public statement or scheduling any press conference or conference call with investors or analysts with respect to this Agreement or the Contemplated
Transactions and, except in respect of any such press release, communication, other public statement, press conference or conference call as may be required by applicable Law or any listing agreement with or rule of any national securities exchange
or association (in which case each party hereto shall endeavor, on a basis reasonable under the circumstances, to provide a reasonable opportunity to the other party to review and comment on such press release, communication, other public statement
or matters to be covered on such conference call in advance and shall consider in good faith all reasonable comments of such other party), shall not issue any such press release, have any such communication, make any such other public statement or
schedule any such press conference or conference call prior to such consultation. Notwithstanding the foregoing, this <U>Section</U><U></U><U>&nbsp;6.2</U> shall not apply to any press release or other public statement made by the Company or the
Purchaser (a)&nbsp;that is consistent with prior disclosure and does not contain any information relating to the Contemplated Transaction that has not been previously announced or made public in accordance with the terms of this Agreement or
(b)&nbsp;is made to its auditors, attorneys, accountants, financial advisors or limited partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.3
<U>Further Assurances</U>. At and after the First Closing, each of the Purchaser and the Company shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.4 <U>Notices of Certain Events</U>. Each of the Company and the Purchaser shall promptly notify the other of:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) any notice or other communication from any Person alleging that the consent of such Person is required in connection
with the Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) any notice or other communication from any Governmental Authority in connection
with Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) any actions, suits, claims, investigations or proceedings commenced or, to its
knowledge, threatened against the Company or any of its Subsidiaries or the Purchaser and any of its Subsidiaries, as the case may be, that relate to the consummation of the Contemplated Transactions; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) any representation or warranty made in this Agreement becoming untrue or inaccurate such that the conditions set forth in
<U>Article VII</U> would not be satisfied or of any failure to comply with any covenant to be complied with under this Agreement such that the conditions in <U>Article VII</U> would not be satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The failure to deliver any such notice shall not affect any of the conditions set forth in <U>Article VII</U> or give rise to any right to
terminate under <U>Article VII</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.5 <U>Cooperation Covenant</U>. Prior to the First Closing, the Company
shall use commercially reasonable efforts to provide to the Purchaser, and shall cause each of its Subsidiaries to use its commercially </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
reasonable efforts to provide, and shall use its reasonable best efforts to cause its Representatives to provide all cooperation reasonably requested by the Purchaser to assist and cooperate with
the Purchaser in connection with the Integration Plans. The Purchaser shall indemnify and hold harmless the Company and its Subsidiaries and their respective Representatives from and against any and all liabilities, losses, damages, claims, costs,
expenses (including attorneys&#146; fees), interest, awards, judgments and penalties suffered or incurred in connection with this <U>Section</U><U></U><U>&nbsp;6.5</U> to the extent arising or resulting from the Appointed Chief Executive
Officer&#146;s or Purchaser&#146;s gross negligence or willful misconduct. During the period from the date of this Agreement until the earlier of (x)&nbsp;the First Closing, (y)&nbsp;the termination of this Agreement in accordance with its terms or
(z)&nbsp;such time, if any, as the Company reasonably determines that any such meetings would have a detrimental effect on the Company&#146;s business, the Company shall use commercially reasonable efforts to assist the Purchaser, upon the
reasonable request of the Purchaser, in arranging meetings and facilitating access for Purchaser and its Representatives with customers and suppliers of the Company and its Subsidiaries; <U>provided</U> that the Company shall be present at all times
during any such meetings or conversations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.6 <U>Indemnification and Insurance</U>. From and following the
First Closing, the Purchaser shall cause the Company, and the Company hereby agrees, to do the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) All rights
to indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the First Closing and rights to advancement of expenses relating thereto now existing in favor of any Person who is or prior to the First Closing
becomes, or has been at any time prior to the date of this Agreement, a present or former director, officer, employee or agent (including as a fiduciary with respect to an employee benefit plan) of the Company, any of its Subsidiaries or any of
their respective predecessors (each, an &#147;<U>Indemnified Person</U>&#148;) as provided in the Certificate of Incorporation, the Bylaws, the organizational documents of any Subsidiary of the Company or any indemnification agreement, or other
agreements containing any indemnification provisions, including any employment agreements, between such Indemnified Person and the Company or any of its Subsidiaries shall survive the First Closing and the Company shall not take any actions to
amend, repeal or otherwise modify them in any manner that would adversely affect any right thereunder of any such Indemnified Person, unless otherwise required by Law. For six (6)&nbsp;years after the First Closing, the Company and each of its
Subsidiaries shall, and the Purchaser shall, if applicable, vote its shares of Common Stock to cause the Company and each of its Subsidiaries to, cause to be maintained in effect provisions in the Certificate of Incorporation and Bylaws and the
governing documents of each of its Subsidiaries (or in such documents of any successor to the business of the Company or any of its Subsidiaries) regarding elimination of liability of directors, indemnification of officers, directors and employees
and advancement of expenses that are no less advantageous to the intended beneficiaries than the corresponding provisions in the Certificate of Incorporation and Bylaws and the governing documents of each of its Subsidiaries in existence on the date
of this Agreement. From and after the First Closing, any agreement of any Indemnified Person with the Company or any of its Subsidiaries regarding elimination of liability, indemnification or advancement of expenses shall continue in full force and
effect in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) For six (6)&nbsp;years after the First Closing, the Company shall, and the
Purchaser shall, if applicable, vote its shares of Common Stock to cause the Company to, indemnify and hold harmless all Indemnified Persons to the fullest extent permitted by Delaware Law in the event of any threatened or actual claim, suit,
action, proceeding or investigation (a &#147;<U>Claim</U>&#148;), whether civil, criminal or administrative, based in whole or in part on, or arising in whole or in part out of, or pertaining to (i)&nbsp;the fact that the Indemnified Person is or
was a director (including in a capacity as a member of any board committee), officer, employee or agent of the Company, any of its Subsidiaries or any of their respective predecessors prior to the First Closing, or (ii)&nbsp;this Agreement or any of
the Contemplated Transactions, whether in any case such Claim is made before, on or after the First Closing, against any losses, claims, damages, liabilities, costs, expenses (including reasonable attorneys&#146; fees and expenses in advance of the
final disposition of any claim, suit, proceeding or investigation to each Indemnified Person to the fullest extent permitted by applicable Law upon receipt of any undertaking required by applicable Law and an undertaking from such Person prior to
the advancement of any such amounts that such Indemnified Person shall reimburse the Company any funds to which a court of competent jurisdiction has determined, by a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
final, nonappealable order or judgment, such Indemnified Person is not entitled), judgments, fines and amounts paid in settlement of or in connection with any such threatened or actual Claim.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>The Company shall not settle, compromise or consent to the entry of any judgment in any threatened or actual Claim for which indemnification could be sought by an Indemnified Person hereunder, unless
such settlement, compromise or consent includes an unconditional release of such Indemnified Person from all liability arising out of such Claim or such Indemnified Person otherwise consents in writing to such settlement, compromise or consent. The
Company shall reasonably cooperate with an Indemnified Person in the defense of any matter for which such Indemnified Person could seek indemnification hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Prior to the First Closing, the Company shall obtain and fully pay the premiums for the
<FONT STYLE="white-space:nowrap">non-cancellable</FONT> extension of the directors&#146; and officers&#146; liability coverage of the Company&#146;s existing directors&#146; and officers&#146; insurance policies and the Company&#146;s existing
fiduciary liability insurance policies (collectively, &#147;<U>D&amp;O Insurance</U>&#148;), in each case for a claims reporting or discovery period of at least six (6)&nbsp;years from and after the First Closing with respect to any claim related to
any period of time at or prior to the First Closing (including claims with respect to this Agreement and the Contemplated Transactions and other actions contemplated hereby) from an insurance carrier with the same or better credit rating as the
Company&#146;s current insurance carrier with respect to D&amp;O Insurance with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company&#146;s existing policies with respect to
any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed against a director or officer of the Company or any of its Subsidiaries by reason of him or her serving in such capacity
that existed or occurred at or prior to the First Closing; <U>provided</U> that in no event shall the Company be required to pay aggregate premiums for D&amp;O Insurance under this <U>Section</U><U></U><U>&nbsp;6.6(c)</U> in excess of $1,100,000, it
being understood that if the aggregate premiums of such insurance coverage exceed such amount, the Company shall be entitled to provide as much coverage as may be obtained for such $1,100,000 amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) If the Company or any of its successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall
not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&nbsp;transfers or conveys all or substantially all of its property and assets to any Person, then, and in each such case, proper provision shall be
made so that the applicable successor, assign or transferee shall assume the obligations set forth in this <U>Section</U><U></U><U>&nbsp;6.6</U> (including this <U>Section</U><U></U><U>&nbsp;6.6(d)</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) The rights of each Indemnified Person under this <U>Section</U><U></U><U>&nbsp;6.6</U> shall be in addition to any rights
such Person may have under the certificate of incorporation and bylaws of the Company or any of its Subsidiaries, under the DGCL or any other applicable Law, under any agreement of any Indemnified Person with the Company or any of its Subsidiaries
or otherwise. These rights shall survive consummation of the Contemplated Transactions and are intended to benefit, and shall be enforceable by, each Indemnified Person. The obligations of the Purchaser and the Company under this
<U>Section</U><U></U><U>&nbsp;6.6</U> shall not be terminated or modified in such a manner as to adversely affect the rights of any Indemnified Person without the consent of such Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) The Company shall pay all reasonable expenses, including reasonable attorneys&#146; fees, that may be incurred by any
Indemnified Person in enforcing the indemnity and other obligations provided in this <U>Section</U><U></U><U>&nbsp;6.6</U>; <U>provided</U> that each Indemnified Person shall, prior to the advancement of any such expenses, be required to provide a
written undertaking to the Company that such Indemnified Person shall reimburse the Company any funds to which a court of competent jurisdiction has determined by a final, nonappealable order or judgment such Indemnified Person is not entitled
hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) The Company shall pay on an <FONT STYLE="white-space:nowrap">as-incurred</FONT> basis the fees and
expenses of such Indemnified Person (including the reasonable fees and expenses of counsel) in advance of the final disposition of any action, suit, proceeding or investigation that is the subject of the right to indemnification, provided that such
Person shall, prior to the receipt of any such advancements, undertake to reimburse the Company for all amounts so advanced if a court of competent jurisdiction determines, by a final, nonappealable order or judgment, that such Person is not
entitled to indemnification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.7 <U>No Control of Other Party&#146;s Business</U>. Nothing
contained in this Agreement shall give the Purchaser, directly or indirectly, the right to control or direct the Company&#146;s or its Subsidiaries&#146; operations prior to the First Closing. Prior to the First Closing, the Company shall exercise,
consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries&#146; operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.8 <U>Registration Rights Agreement</U>. At or prior to the First Closing, each of the Purchaser and the Company
shall execute and deliver to the other party the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;6.9 <U>SEC Matter
Issuances</U>. From the First Closing until the Director End Time, in the event that during a fiscal quarter the Company incurs reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses related to the SEC Matter that are not reimbursable under the Company&#146;s insurance policy or otherwise excluded from such insurance policy covering the Company and its Subsidiaries in connection with the SEC Matter (the &#147;<U>SEC
Quarterly Expenses</U>&#148;), then the Purchaser shall be entitled to receive the number of shares of Common Stock (the &#147;<U>SEC Contingency Compensation</U>&#148;) equal to a quotient (A)&nbsp;the numerator of which is equal to the SEC
Quarterly Expenses, and (B)&nbsp;the denominator of which is equal to the volume-weighted average price of one (1)&nbsp;share of Common Stock for the trading period during the fiscal quarter for which the SEC Quarterly Expenses are payable. No
fractional shares shall be issued by the Company as the number of shares of the SEC Contingency Compensation shall be rounded down to the nearest whole number. The SEC Contingency Compensation shall be issued no later than the due date of the
Company&#146;s periodic report for the fiscal quarter for which such SEC Quarterly Expenses are payable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO THE PARTIES&#146; OBLIGATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;7.1 <U>Conditions to the Obligations of Each Party</U>. The respective obligations of each party to consummate
the Contemplated Transactions to be consummated at the First Closing are subject to the satisfaction, on or prior to the First Closing Date, of each of the following conditions precedent: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Company Stockholder Approval</U>. The Company Stockholder Approval shall have been obtained in accordance with Nasdaq
Listing Rule 5635(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>No Restraints</U>. No temporary restraining order, decree, ruling, injunction or judgment,
preliminary or permanent injunction or other judgment issued by any Governmental Authority of competent jurisdiction shall be in effect enjoining, restraining, or otherwise prohibiting the consummation of the Purchase and Sale and no Governmental
Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or declared applicable to the consummation of the Purchase and Sale any applicable Law that is in effect, which has the effect of enjoining, restraining or
otherwise prohibiting the consummation of the Contemplated Transactions (collectively, &#147;<U>Restraints</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;7.2 <U>Conditions to the Obligations of the Purchaser</U>. The obligations of the Purchaser to consummate the
Contemplated Transactions to be consummated at the First Closing are subject to the satisfaction, on or prior to the First Closing Date, of each of the following conditions precedent: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Performance</U>. The Company shall have performed and complied in all material respects with all of its obligations
under this Agreement required to be performed by it or complied with at or prior to the First Closing (or any such failure to perform or comply shall have been cured). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Representations and Warranties</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) The representations and warranties of the Company contained in <U>Section</U><U></U><U>&nbsp;2.1</U>,
<U>Section</U><U></U><U>&nbsp;2.2</U> and <U>Section</U><U></U><U>&nbsp;2.17</U> (disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
true in all material respects as of the date of this Agreement and at and as of the First Closing, as if made at and as of such time (other than such representations and warranties that by their
terms address matters only as of another specified time, which shall be true only as of such time); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the
representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U> (disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be true and correct in all but <I>de minimis</I>
respects as of the date of this Agreement and as of the First Closing, as if made at and as of such time (other than such representations and warranties that by their terms address matters only as of another specified time, which shall be true only
as of such time); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) the other representations and warranties of the Company contained in <U>Article II</U>
(disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be true and correct as of the date of this Agreement and at and as of the First Closing, as if made at and as of such time (other than representations
and warranties that by their terms address matters only as of another specified time, which shall be true only as of such time), with, in the case of this clause (iii)&nbsp;only, only such exceptions as would not have, individually or in the
aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) <U>Covenants</U>. The Company shall have performed and complied in all material
respects with all covenants and agreements required by this Agreement to be performed or complied with by it at or prior to the First Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) <U>Resignation of Directors</U>. At or prior to the First Closing, Company shall have obtained the resignation of all
current directors; <U>provided</U>, <U>however</U>, that in no event shall the Continuing Directors be required to resign; provided, further, that nothing in this Agreement shall prevent the resignation of all of the current directors, other than
the Continuing Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) <U>Voting Agreement</U>. Each officer and director of the Company shall have executed and
delivered to the Company an Insiders Voting Agreement, in the form attached hereto as <U>Exhibit E</U> (the &#147;<U>Insiders Voting Agreement</U>&#148;) and voted his or her shares for each of the proposals of the Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;7.3 <U>Conditions to the Obligations of the Company.</U> The obligations of the Company to consummate the
Contemplated Transactions are subject to the satisfaction, on or prior to the First Closing Date, of each of the following conditions precedent: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Representations and Warranties</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) The representations and warranties of the Purchaser contained in <U>Section</U><U></U><U>&nbsp;3.1,</U>
<U>Section</U><U></U><U>&nbsp;3.2</U> and <U>Section</U><U></U><U>&nbsp;3.4</U> shall be true in all material respects at and as of the date of this Agreement and at and as of the First Closing, as if made at and as of such time (other than such
representations and warranties that by their terms address matters only as of another specified time, which shall be true only as of such time); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) The representations and warranties of the Purchaser contained in <U>Section</U><U></U><U>&nbsp;3.9</U> shall be true in
all respects at and as of the date of this Agreement and at and as of the First Closing, as if made at and as of such time (other than such representations and warranties that by their terms address matters only as of another specified time, which
shall be true only as of such time); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) the other representations and warranties of the Purchaser contained in
<U>Article III</U> (disregarding all materiality and material adverse effect qualifications contained therein) shall be true at and as of the date of this Agreement and at and as of the First Closing, as if made at and as of such time (other than
representations and warranties that by their terms address matters only as of another specified time, which shall be true only as of such time), with, in the case of this clause (ii)&nbsp;only, only such exceptions as would not have, individually or
in the aggregate, a material adverse effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Covenants</U>. The Purchaser shall have performed and complied in all
material respects with all covenants and agreements required by this Agreement to be performed or complied with by the Purchaser at or prior to the First Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) <U>Consideration for the Initial Shares</U>. The Purchaser shall have paid the First Purchase Price for the Initial Shares
in full at the First Closing by wire transfer of immediately available funds to an account designated in writing by the Company, provided that the Purchaser may cause to have paid up to $800,000 at the First Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) <U>Voting Agreement</U>. The Purchaser shall have executed and delivered to the Company a Voting Agreement, in the form
attached hereto as <U>Exhibit F</U> (the &#147;<U>Purchaser Voting Agreement</U>&#148;), and the Purchaser Voting Agreement shall be in full force and effect as of the First Closing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;8.1 <U>Termination</U>. This Agreement may be terminated and the Purchase and Sale may be abandoned at any time
prior to the First Closing (notwithstanding any Company Stockholder Approval): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) by mutual written agreement of the
Company and the Purchaser; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) by either the Company or the Purchaser, if: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the First Closing has not been consummated on or before the date that is six (6)&nbsp;months after the date hereof (as
such date may be extended pursuant to <U>Section</U><U></U><U>&nbsp;9.12</U>, the &#147;<U>End Date</U>&#148;); <U>provided</U>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U> shall not be
available to any party whose breach of any provision of this Agreement in any material respect is the primary cause of the failure of the First Closing to be consummated by the End Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) if any Restraint shall be in effect permanently restraining, enjoining or otherwise permanently prohibiting the
consummation of the Purchase and Sale on substantially the terms contemplated by this Agreement, and such Restraint shall have become final and nonappealable; <U>provided</U> that the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(b)(ii)</U> shall not be available to any party whose breach of any provision of this Agreement in any material respect is the primary cause of such Restraint; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) at the Company Stockholder Meeting (including any adjournment or postponement thereof), the Company Stockholder
Approval shall not have been obtained; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) by the Purchaser: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) prior to obtaining the Company Stockholder Approval, if (A)&nbsp;the Board of Directors of the Company or any duly
authorized committee thereof shall have effected an Adverse Recommendation Change or (B)&nbsp;the Company or the Company Representatives willfully and materially violated <U>Section</U><U></U><U>&nbsp;4.1(a)</U> of this Agreement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) if there is any inaccuracy of any representation or warranty made by the Company in this Agreement or any breach,
violation or failure to perform any covenant or agreement on the part of the Company set forth in this Agreement, which inaccuracy, breach, violation or failure, either individually or in the aggregate, if continuing at the First Closing
(A)&nbsp;would cause the condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a) </U>or <U>Section</U><U></U><U>&nbsp;7.2(b)</U> not to be satisfied, and (B)&nbsp;is incapable of being cured by the End Date (a &#147;<U>Company Terminating
Breach</U>&#148;); <U>provided</U> that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)(ii)</U> shall not be available to the Purchaser if a Purchaser Terminating Breach shall have occurred and be
continuing at the time the Purchaser delivers notice of its election to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)(ii)</U>; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) by the Company, if: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the Board of Directors of the Company authorizes the Company, pursuant to, and in compliance with,
<U>Section</U><U></U><U>&nbsp;4.1(f)</U>, to enter into a definitive agreement concerning a Superior Proposal; <U>provided</U> that the Company pays the Company Termination Fee and the Reimbursement Obligations payable pursuant to
<U>Section</U><U></U><U>&nbsp;8.2(b)(ii)</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) there is any inaccuracy of any representation or warranty made by
the Purchaser in this Agreement or any breach, violation or failure to perform any covenant or agreement on the part of the Purchaser set forth in this Agreement which inaccuracy, breach, violation or failure, either individually or in the
aggregate, if continuing at the First Closing (A)&nbsp;would cause the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> not to be satisfied, and (B)&nbsp;is incapable of being cured by the
End Date (a &#147;<U>Purchaser Terminating Breach</U>&#148;); <U>provided</U> that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)(ii)</U> shall not be available to the Company if a Company Terminating
Breach shall have occurred and be continuing at the time the Company delivers notice of its election to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The party desiring to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1</U> (other than pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(a)</U>) shall give written notice of such termination to the other party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;8.2 <U>Effect of Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) If this Agreement is terminated pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U>, this Agreement shall become void and of
no effect without liability of any party (or any stockholder, director, officer, employee, agent, consultant or Representative of such party) to the other party hereto; <U>provided</U> that (i)&nbsp;the provisions of
<U>Section</U><U></U><U>&nbsp;6.5</U> as they relate to the Purchaser&#146;s indemnification, hold harmless and reimbursement obligations, this <U>Section</U><U></U><U>&nbsp;8.2</U>, <U>Article&nbsp;IX</U> and the Confidentiality Agreement shall
survive any termination hereof pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> and (ii)&nbsp;neither the Company nor the Purchaser shall be relieved or released from any liabilities or damages arising out of fraud or its willful and material
breach of any provision of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Company Termination Fee and Expense Reimbursement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) If this Agreement is terminated by the Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.1(c)(i)</U>, then the
Company shall pay amounts equal to (A)&nbsp;seven hundred fifty thousand dollars ($750,000) (the &#147;<U>Company Termination Fee</U>&#148;) and (B)&nbsp;up to three hundred fifty thousand dollars ($350,000) as reimbursement of reasonable,
documented and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the Purchaser in connection with this Agreement, including but not limited to reasonable, documented and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal and advisory fees paid in connection therewith (the &#147;<U>Reimbursement Obligations</U>&#148;) to the Purchaser in immediately available funds within
two (2)&nbsp;Business Days after such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) If this Agreement is terminated by the Company pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(d)(i)</U>, then the Company shall pay the Company Termination Fee and the Reimbursement Obligations to the Purchaser in immediately available funds substantially concurrently with (and as a condition to) such
termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) If this Agreement is terminated by either party pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(b)(iii)</U> of this Agreement, then the Company shall pay the Reimbursement Obligations to the Purchaser in immediately available funds within two (2)&nbsp;Business Days after such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iv) In no event shall the Company be required to pay the Company Termination Fee or the Reimbursement Obligations on more
than one occasion. The Purchaser agrees that, upon any termination of this Agreement under circumstances where the Company Termination Fee or the Reimbursement Obligations are payable by the Company pursuant to this
<U>Section</U><U></U><U>&nbsp;8.2(b)</U> and such fees or reimbursement obligations are paid in full, except in the case of fraud or a willful and material breach of the Company&#146;s representations, warranties,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
covenants or agreements set forth in this Agreement prior to termination of this Agreement, the Purchaser shall be precluded from any other remedy against the Company, at law or in equity or
otherwise, and the Purchaser shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages, against the Company or any of the Company&#146;s Subsidiaries or any of their respective
directors, officers, employees, partners, managers, members, stockholders or Affiliates or their respective Representatives in connection with this Agreement or the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(v) Each of the Company and the Purchaser acknowledges that the agreements contained in this
<U>Section</U><U></U><U>&nbsp;8.2(b)</U> are an integral part of the Contemplated Transactions and that, without these agreements, the other party would not enter into this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.1 <U>No Survival</U>. The representations, warranties, covenants and agreements of the Company contained in
<U>this Agreement</U> shall not survive, and shall terminate automatically as of, the First Closing, and there shall be no liability in respect thereof, whether such liability has accrued prior to or after the First Closing, on the part of the
Company or any of its Representatives; <U>provided</U> that this <U>Section</U><U></U><U>&nbsp;9.1</U> shall not limit any covenant or agreement by the Company that by its terms contemplates performance after the First Closing, including the
Company&#146;s obligations to consummate the Second Closing in accordance with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.2
<U>Counterparts</U>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, and will become effective when one or more counterparts have been signed by a party and delivered to the
other parties. Copies of executed counterparts of signature pages to this Agreement may be transmitted by PDF (portable document format), <FONT STYLE="white-space:nowrap">e-mail,</FONT> facsimile, or other means of electronic transmission and such
means of electronic transmission will be deemed as sufficient as if actual signature pages had been delivered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.3 <U>Governing Law.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) This Agreement shall be governed by, and construed in accordance with, the laws of the state of Delaware, without giving
effect to any choice of law or conflict of law rules or provisions (whether of the state of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the state of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Any dispute relating hereto shall be heard first in the Delaware Court of Chancery, and, if applicable, in any state or
federal court located in of Delaware in which appeal from the Court of Chancery may validly be taken under the laws of the State of Delaware (each a &#147;<U>Chosen Court</U>&#148; and collectively, the &#147;<U>Chosen Courts</U>&#148;), and the
parties agree to the exclusive jurisdiction and venue of the Chosen Courts. Such Persons further agree that any proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the
Contemplated Transactions or by any matters related to the foregoing (the &#147;<U>Applicable Matters</U>&#148;) shall be brought exclusively in a Chosen Court, and that any proceeding arising out of this Agreement or any other Applicable Matter
shall be deemed to have arisen from a transaction of business in the state of Delaware, and each of the foregoing Persons hereby irrevocably consents to the jurisdiction of such Chosen Courts in any such proceeding and irrevocably and
unconditionally waives, to the fullest extent permitted by law, any objection that such Person may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such Chosen Court or that any such proceeding brought
in any such Chosen Court has been brought in an inconvenient forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Such Persons further covenant not to bring a
proceeding with respect to the Applicable Matters (or that could affect any Applicable Matter) other than in such Chosen Court and not to challenge or enforce in another jurisdiction a judgment of such Chosen Court. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Process in any such proceeding may be served on any Person with respect
to such Applicable Matters anywhere in the world, whether within or without the jurisdiction of any such Chosen Court. Without limiting the foregoing, each such Person agrees that service of process on such party as provided in
<U>Section</U><U></U><U>&nbsp;9.6</U> shall be deemed effective service of process on such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) <U>Waiver of Jury
Trial</U>. EACH PARTY HERETO, FOR ITSELF AND ITS AFFILIATES, HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR OTHER PROCEEDING (WHETHER BASED ON
CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THE ACTIONS OF THE PARTIES HERETO OR THEIR RESPECTIVE AFFILIATES PURSUANT TO THIS AGREEMENT OR IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.4 <U>Entire Agreement; No Third Party Beneficiary</U>. This Agreement, the Purchaser Voting Agreement, the
Insiders Voting Agreement and the Registration Rights Agreement contain the entire agreement by and among the parties with respect to the subject matter hereof and all prior negotiations, writings and understandings relating to the subject matter of
this Agreement. Except for the rights of an Indemnified Person under <U>Section</U><U></U><U>&nbsp;6.6</U> and for the Continuing Directors under this Agreement, this Agreement is not intended to confer upon any Person not a party hereto (or their
successors and permitted assigns) any rights or remedies hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.5 <U>Expenses</U>. Except as otherwise
expressly provided by this Agreement, all fees, costs and expenses incurred in connection with this Agreement and the Contemplated Transactions, including accounting and legal fees shall be paid by the party incurring such expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.6 <U>Notices</U>. All notices, requests, demands and other communications under this Agreement shall be in
writing and shall be deemed to have been duly given or made as follows: (a)&nbsp;if sent by registered or certified mail in the United States return receipt requested, upon receipt; (b)&nbsp;if sent by nationally recognized overnight air courier,
one (1)&nbsp;Business Day after mailing; (c)&nbsp;if sent by <FONT STYLE="white-space:nowrap">e-mail</FONT> transmission, when properly transmitted; and (d)&nbsp;if otherwise actually personally delivered, when delivered, <U>provided</U>, that such
notices, requests, demands and other communications are delivered to the address set forth below, or to such other address as any party shall provide by like notice to the other parties to this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If to the Company prior to the First Closing, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sonim Technologies, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6500 River Place Boulevard, Bldg. 7, S#250 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Austin, TX, 78730 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: Mr.&nbsp;Robert Tirva </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>b.tirva@sonimtech.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">O&#146;Melveny&nbsp;&amp; Myers LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Two Embarcadero Center, 28th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: Brophy Christensen; Noah Kornblith </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>bchristensen@omm.com</U>; <U>nkornblith@omm.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If to the Purchaser or the Company following the First Closing, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">AJP Holding Company, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[********] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[********] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: [********] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">E-mail:</FONT> [********] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Venable LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Rockefeller Center, 1270 Avenue of the Americas, 25th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">New York, NY 10020 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: William N. Haddad, Kirill Y. Nikonov, Arif Soto </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>wnhaddad@venable.com</U>, <U>kynikonov@venable.com</U>,
<U>asoto@venable.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.7 <U>Successors and Assigns</U>. This Agreement will be binding upon and inure to
the benefit of the parties hereto and their respective successors and permitted assigns. No assignment of this Agreement or of any rights or obligations hereunder may be made by any party hereto without the prior written consent of the other parties
hereto. Any purported assignment or delegation in violation of this Agreement shall be null and void ab initio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.8 <U>Headings</U>. The Section, Article, and other headings contained in this Agreement are inserted for
convenience of reference only and will not affect the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.9
<U>Amendments and Waivers</U>. This Agreement may not be modified or amended except by an instrument or instruments in writing signed by each party hereto. Any party hereto may, only by an instrument in writing, waive compliance by any other party
or parties hereto with any term or provision hereof on the part of such other party or parties hereto to be performed or complied with. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof,
nor will any single or partial exercise of any right or power, or any abandonment or discontinuance of steps to enforce such right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The waiver by
any party hereto of a breach of any term or provision hereof shall not be construed as a waiver of any subsequent breach. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would
otherwise have hereunder. Notwithstanding anything in this Agreement to the contrary, from and after the First Closing, the approval of the Continuing Directors shall be required for the Company to (a)&nbsp;amend, modify or terminate this Agreement
or the Voting Agreement, (ii)&nbsp;exercise or waive any right of the Company under this Agreement or the Voting Agreement, or (iii)&nbsp;extend the time for performance of any obligation of the Purchaser under this Agreement or the Voting
Agreement. This Agreement may not be modified or amended from and after the Second Closing and the Company cannot waive any provision in this Agreement from and after the Second Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.10 <U>Interpretation; Absence of Presumption.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) For the purposes hereof: (i)&nbsp;words in the singular shall be held to include the plural and vice versa and words of
one gender shall be held to include the other gender as the context requires; (ii)&nbsp;the terms &#147;hereof,&#148; &#147;herein,&#148; and &#147;herewith&#148; and words of similar import shall, unless otherwise stated, be construed to refer to
this Agreement as a whole (including all of the Schedules and Exhibits) and not to any particular provision of this Agreement, and Article, Section, paragraph, Exhibit and Schedule references are to the Articles, Sections, paragraphs, Exhibits, and
Schedules to this Agreement unless otherwise specified; (iii)&nbsp;the word &#147;including&#148; and words of similar import when used in this Agreement shall mean &#147;including, without limitation,&#148; unless the context otherwise requires or
unless otherwise specified; and (iv)&nbsp;the word &#147;or&#148; shall not be exclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) With regard to each and
every term and condition of this Agreement and any and all agreements and instruments subject to the terms hereof, the parties hereto understand and agree that the same have or has been mutually negotiated, prepared and drafted, and if at any time
the parties hereto desire or are required to interpret or construe any such term or condition or any agreement or instrument subject hereto, no consideration will be given to the issue of which party hereto actually prepared, drafted or requested
any term or condition of this Agreement or any agreement or instrument subject hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.11
<U>Severability</U>. Any provision hereof that is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, shall be ineffective only to the extent of such invalidity, illegality or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
unenforceability, without affecting in any way the remaining provisions hereof, <U>provided</U>, <U>however</U>, that the parties will attempt in good faith to reform this Agreement in a manner
consistent with the intent of any such ineffective provision for the purpose of carrying out such intent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.12 <U>Specific Performance</U>. The parties hereto agree that irreparable damage could occur and that a party
will not have any adequate remedy at law in the event that any of the provisions of this Agreement are not performed in accordance with their terms or were otherwise breached. Accordingly, each party shall without the necessity of proving the
inadequacy of money damages or posting a bond be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms, provisions and covenants contained therein, this being in addition to any other
remedy to which they are entitled at law or in equity. If, prior to the End Date, any party brings any suit, action or proceeding, in each case in accordance with <U>Section</U><U></U><U>&nbsp;9.3(b)</U>, to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof, the End Date shall automatically be extended by (A)&nbsp;the amount of time during which such suit, action or proceeding is pending, plus twenty (20)&nbsp;Business Days or (B)&nbsp;such other
time period established by the court presiding over such suit, action or proceeding, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;9.13 <U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U>. Unless expressly agreed to otherwise by the
parties to this Agreement, in writing, this Agreement may only be enforced against, and any Proceeding in connection with, arising out of or otherwise resulting from this Agreement, or any instrument or other document delivered pursuant to this
Agreement or the Contemplated Transactions, may only be brought against the Persons expressly named as parties of this Agreement (or any of their respective successors, legal representatives and permitted assigns) and then only with respect to the
specific obligations set forth herein with respect to such party. No (i)&nbsp;past, present or future director, employee (including any officer), incorporator, manager, member, partner, stockholder, other equity holder or persons in a similar
capacity, controlling person, Affiliate or other Representative of any party or any of their respective successors and permitted assigns or (ii)&nbsp;past, present or future director, employee (including any officer), incorporator, manager, member,
partner, stockholder, other equity holder or persons in a similar capacity, controlling person, Affiliate or other Representative of any of the Persons set forth in the foregoing clause (i)&nbsp;or any of their respective successors and permitted
assigns (unless, for the avoidance of doubt, such Person is a party), shall have any liability or other obligation for any obligation of any party under this Agreement or for any Proceeding in connection with, arising out of or otherwise resulting
from this Agreement, or any instrument or other document delivered pursuant to this Agreement or the Contemplated Transactions; <U>provided</U>, <U>however</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;9.13</U> shall limit any liability or
other obligation of the parties for breaches of the terms and conditions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(The next page is the signature page)
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The parties have caused this Subscription Agreement to be executed as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">SONIM TECHNOLOGIES, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Robert Tirva</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Name: Robert Tirva</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Title: President, Chief Financial Officer and Chief Operating Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">AJP Holding Company, LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Jeffrey Wang</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Name: Jeffrey Wang</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Title: Managing Member</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINED TERMS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following capitalized terms have the meanings indicated: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Appointed Chief Executive Officer</U>&#148; means Peter Liu or, if he ceases to be the Chief Executive Officer
(including by reason of death or disability), the person subsequently designated by the Purchaser (and reasonably acceptable to the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Acceptable Confidentiality Agreement</U>&#148; means a confidentiality agreement that contains provisions that are no
less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement; <U>provided</U> that such confidentiality agreement may contain a less restrictive or no standstill restriction, in which case the Confidentiality
Agreement shall be deemed to be amended to contain only such less restrictive provision, or to omit such provision, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Acquisition Proposal</U>&#148; means, other than the Contemplated Transactions, any written or oral offer, or
proposal of any Third Party or &#147;group&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) relating to a transaction or series of related transactions involving: (i)&nbsp;any
acquisition or purchase (including through any lease, exchange, exclusive license, transfer or disposition, in each case, other than in the ordinary course of business), direct or indirect, of assets equal to 20% or more of the consolidated assets
or businesses of the Company and its Subsidiaries, taken as a whole, or to which 20% or more of the consolidated revenues or earnings of the Company and its Subsidiaries, taken as a whole, are attributable, or 20% or more of any class of equity or
voting securities of the Company, (ii)&nbsp;any tender offer or exchange offer that, if consummated, would result in such Third Party or group beneficially owning 20% or more of any class of equity or voting securities of the Company, or
(iii)&nbsp;a merger, consolidation, business combination, sale of all or substantially all of the assets, liquidation, dissolution or other similar extraordinary transaction (A)&nbsp;involving the Company or any of its Subsidiaries whose assets,
individually or in the aggregate, constitute 20% or more of the consolidated assets of the Company or to which 20% or more of the consolidated revenues or earnings of the Company and its Subsidiaries, taken as a whole, are attributable or
(B)&nbsp;pursuant to which the stockholders of the Company immediately prior to the consummation of such transaction would, as a result of such transaction, hold less than 80% of the equity interests in the surviving entity of such transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Affiliate</U>&#148; of any Person means any Person, directly or indirectly, Controlling, Controlled by or under
common Control with such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Law</U>&#148; means any federal, state, local or foreign statute, law
(including common law), ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Board of Directors</U>&#148; means the Company&#146;s board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Business Day</U>&#148; means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of
New York is authorized or required by law or executive order to close or be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Code</U>&#148; means the
Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Bylaws</U>&#148; means the Bylaws of the Company, amended and
restated, on May&nbsp;20, 2009, as the same may be further amended, supplemented or restated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Certificate of
Incorporation</U>&#148; means the Company&#146;s Amended and Restated Certificate of Incorporation, as the same may be further amended, supplemented or restated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Company 2019 Incentive Plan</U>&#148; means the Sonim Technologies,
Inc. 2019 Equity Incentive Plan, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Company ESPP</U>&#148; means the Sonim Technologies, Inc. 2019
Employee Stock Purchase Plan, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Company Employee Plan</U>&#148; means each &#147;employee benefit
plan,&#148; as defined in Section&nbsp;3(3) of ERISA (whether or not such plan is subject to ERISA) and each other employment, severance or similar Contract, plan, practice, arrangement or policy providing for compensation, bonuses, profit-sharing,
stock option or other stock-related rights or other forms of incentive or deferred compensation, vacation benefits, insurance (including any self-insured arrangements), health, medical or welfare benefits, perquisites, employee assistance program,
disability or sick leave benefits, or post-employment or retirement benefits (including compensation, pension, health, medical or life insurance benefits) which is maintained, administered or contributed to by the Company or any of its Subsidiaries
or with respect to which the Company or any of its Subsidiaries has any actual or contingent liability, other than any plan, policy, program or arrangement (i)&nbsp;mandated by applicable Law and maintained solely by a Governmental Authority or
(ii)&nbsp;sponsored or maintained by a professional employer organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Company Stock Plans</U>&#148; means
the Company 2019 Incentive Plan and the Company ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Confidentiality Agreement</U>&#148; means the <FONT
STYLE="white-space:nowrap">One-Way</FONT> <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement between Teleepoch LLC and the Company, dated November&nbsp;1, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Contract</U>&#148; means any legally binding contract, agreement, note, bond, indenture, lease, license, or other
legally binding agreement, commitment or undertaking, in each case, whether written or oral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Control</U>&#148;
(including its correlative meanings &#147;under common Control with&#148; and &#147;Controlled by&#148;) means, with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of such Person, whether through ownership of securities or partnership or other interests, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Director End Time</U>&#148; means final resolution or settlement of the SEC Matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>DGCL</U>&#148; means the General Corporation Law of the State of Delaware (as amended from time to time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>DPA</U>&#148; means Section&nbsp;721 of the Defense Production Act, as amended, 50 U.S.C. &#167; 4565, and all
interim or final rules and regulations issued and effective thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Environmental Permit</U>&#148; means any
permit, license, approval or other authorization under any applicable Law, rule or regulations of the United States or of any state, municipality or other subdivision thereof relating to pollution or protection of health or the environment,
including laws, regulations or other requirements relating to emissions, discharges, releases or threatened releases of pollutants, contaminants or Hazardous Substances or toxic materials or wastes into ambient air, surface water, ground water or
land, or otherwise relating to the manufacture, processing, distribution, recycling, presence, use, treatment, storage, disposal, transport, or handling of, wastes, pollutants, contaminants or Hazardous Substances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>ERISA Documents</U>&#148; means all material &#147;<U>employment benefit plans</U>&#148; as defined in
Section&nbsp;3(3) of ERISA that are maintained or sponsored by the Company or its Subsidiaries for the benefit of their respective current or former employees and with respect to which the Company or its Subsidiaries have any liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>ERISA Regulations</U>&#148; means the regulations promulgated by the Department of Labor in 29 C.F.R. &#167; <FONT
STYLE="white-space:nowrap">2510.3-101,</FONT> and any amendments or successor regulations thereto, as modified by Section&nbsp;3(42) of ERISA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934,
as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>GAAP</U>&#148; means generally accepted accounting principles as in effect in the United States.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Governmental Authority</U>&#148; means any supranational, national, state, municipal, local or foreign
government, any court, tribunal, arbitrator, administrative agency, commission or other governmental official, authority or instrumentality. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Government Official</U>&#148; means any officer or employee of a foreign governmental authority or any department,
agency, or instrumentality thereof, or of a public international organization, or any person acting in an official capacity for or on behalf of any such foreign governmental authority or department, agency, or instrumentality, or for or on behalf of
any such public international organization, or any political party, party official, or candidate thereof, excluding officials of the governments of the United States, the several states thereof, any local subdivision of any of them or any agency,
department or unit of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Hazardous Substance</U>&#148; means any waste, substance, product or
material defined or regulated as &#147;<U>hazardous</U>&#148; or &#147;<U>toxic</U>&#148; by any applicable Law, rule, regulation or order described in the definition of &#147;Requirements of Environmental Law,&#148; including petroleum and any
fraction thereof, and any radioactive materials and waste. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Intellectual Property</U>&#148; means any or all of
the following and all rights in: (i)&nbsp;all United States, international and foreign patents and applications therefor and all reissues, divisions, divisionals, renewals, extensions, provisionals, continuations and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part</FONT></FONT> thereof; (ii)&nbsp;all inventions (whether or not patentable), trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> databases, business
methods, processes, designs, schematics, drawings, formulae, technical data, specifications, research and development information, technology, business plans and customer lists and other proprietary information; (iii)&nbsp;all copyrights, whether
registered or unregistered, and registrations and applications for registration thereof, including in computer software, throughout the world, mask works, whether registered or unregistered, and any registrations and applications for registration
thereof; (iv)&nbsp;all industrial designs and any registrations and applications therefor throughout the world; (v)&nbsp;all trade names, trade dress, brand names, corporation names, logos, common law trademarks and service marks, domain names,
URLs, and trademark and service mark, whether registered or unregistered, and the goodwill associated therewith, together with any registrations and applications therefor throughout the world; and (vi)&nbsp;and any governmental grant for the
protection of inventions or industrial designs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Intervening Event</U>&#148; means a material fact, event,
circumstance, development or change that occurs, arises or comes to the attention of the Board of Directors after the date of this Agreement that (w)&nbsp;affects the business, assets or operations of Company and its Subsidiaries, (x)&nbsp;was not
known by, or if known, the effect of which was not reasonably foreseeable by, the Board of Directors (assuming consultations with appropriate officers and Representatives of the Company) on the date of this Agreement, (y)&nbsp;becomes known to the
Board of Directors prior to receipt of the Company Stockholder Approval, and (z)&nbsp;did not result from or arise out of the announcement or pendency of, or any actions required to be taken (or refrained from taken) pursuant to this Agreement;
<U>provided</U>, <U>however</U>, that in no event shall any of the following, alone or in combination, constitute an Intervening Event: (1)&nbsp;the receipt, existence of or terms of an Acquisition Proposal, (2)&nbsp;changes in the trading price or
trading volume of the Company Common Stock, in and of itself (it being understood that the facts or occurrences giving rise or contributing to such changes may be taken into account the extent otherwise permitted by the definition of
&#147;Intervening Event&#148;); or (3)&nbsp;meeting or exceeding any published analyst estimates or expectations of the Company&#146;s revenue, earnings or other financial performance or results of operations for any period, in and of itself, or
exceeding the Company&#146;s internal or external budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or
contributing to the Company meeting or exceeding such estimates, projections, budgets, plans or forecasts may be taken into account to the extent otherwise permitted by the definition of &#147;Intervening Event&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Investment Company Act</U>&#148; mean the Investment Company Act of
1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Key Employee</U>&#148; means an employee of the Company or any of its Subsidiaries whose
annual base compensation is $200,000 or more. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Material Adverse Effect</U>&#148; means a material adverse effect
upon the financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>, that any such effect resulting or arising from or relating to any of the following
matters shall not be considered when determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur: (a)&nbsp;any change, development, occurrence or event affecting the industry in which the Company and its
Subsidiaries operate; (b)&nbsp;any conditions affecting the United States general economy or the general economy in any geographic area in which the Company or its Subsidiaries operate or developments or changes therein or the financial and
securities markets and credit markets in the United States or elsewhere in the world; (c)&nbsp;political conditions, including the continuation, occurrence, escalation, outbreak or worsening of any hostilities, war, political action, acts of
terrorism, sabotage or military conflicts, whether or not pursuant to the declaration of an emergency or war; (d)&nbsp;any conditions resulting from the existence, occurrence or continuation of any force majeure events, including any earthquakes,
floods, hurricanes, tropical storms, fires or other natural or manmade disasters, any epidemic, pandemic (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or other similar outbreak (including any
<FONT STYLE="white-space:nowrap">non-human</FONT> epidemic, pandemic or other similar outbreak) or any other national, international or regional calamity; (e)&nbsp;changes in any law, rule, regulation or GAAP; (f)&nbsp;any action taken or omitted to
be taken by or at the written request or with the written consent of the Purchaser; (g)&nbsp;any announcement of this Agreement or the Contemplated Transactions; (h)&nbsp;changes in the market price or trading volume of Common Stock or any other
equity, equity-related or debt securities of the Company or its Affiliates (it being understood that the underlying circumstances, events or reasons giving rise to any such change can be taken into account in determining whether a Material Adverse
Effect has occurred or would reasonably be expected to occur); (i) any failure to meet any internal or public projections, forecasts, estimates or guidance for any period (it being understood that the underlying circumstances, events or reasons
giving rise to any such failure can be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur); or (j)&nbsp;any effect arising out of or resulting from any claims or proceedings made
by any of the Company&#146;s stockholders arising out of or related to this Agreement; <U>provided</U>, that any of the matters described in clauses (a), (b) or (c), will be taken into account for purposes of determining whether or not a Material
Adverse Effect has occurred to the extent that such matter disproportionately and adversely affects the Company and its Subsidiaries, taken as a whole, as compared with other companies operating in the industry in which the Company and its
Subsidiaries operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Person</U>&#148; means an individual, corporation, partnership, limited liability company,
joint venture, trust or unincorporated organization or a government or agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Proceeding</U>&#148; means any action, cause of action, claim, demand, litigation, suit, investigation, grievance,
citation, summons, subpoena, inquiry, audit, hearing, originating application to a tribunal, arbitration or other similar proceeding of any nature, civil, criminal, regulatory, administrative or otherwise, whether in equity or at law, in contract,
in tort or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Registration Rights Agreement</U>&#148; means the Registration Rights Agreement between
the Company and the Purchaser in the form attached hereto as <U>Exhibit G</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Representatives</U>&#148; means a
Persons&#146; Affiliates, employees, agents, consultants, accountants, attorneys or financial advisors and direct or indirect members or partners or Affiliates of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Requirements of Environmental Law</U>&#148; means all requirements imposed by any law (including the Resource
Conservation and Recovery Act, the Comprehensive Environmental Response, Compensation, and Liability Act, the Clean Water Act, the Clean Air Act, and any state analogues of any of the foregoing), rule, regulation, or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
order of any governmental authority which relate to (a)&nbsp;pollution, protection or <FONT STYLE="white-space:nowrap">clean-up</FONT> of the air, surface water, ground water or land;
(b)&nbsp;solid, gaseous or liquid waste or Hazardous Substance generation, recycling, reclamation, release, threatened release, treatment, storage, disposal or transportation; (c)&nbsp;exposure of Persons or property to Hazardous Substances; or
(d)&nbsp;the manufacture, presence, processing, distribution in commerce, use, discharge, releases, threatened releases, emissions or storage of Hazardous Substances into the environment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Sarbanes-Oxley Act</U>&#148; means the Sarbanes-Oxley Act of 2002. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>SEC</U>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>SEC Documents</U>&#148; means all reports, schedules, forms, statements, prospectuses, registration statements and
other documents required to be filed with or furnished to the SEC pursuant to the Securities Act or the Exchange Act by the Company since January&nbsp;1, 2019 (collectively, together with any exhibits and schedules thereto and other information
incorporated therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>SEC Matter</U>&#148; means the formal investigation relating to the Company by the SEC of
which the Company was notified of such formal investigation in August 2020, and all other matters, investigations, claims, actions, proceedings, circumstances, effects and actions relating or ancillary thereto, arising therefrom or in connection
therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Subsidiary</U>&#148; means, when used with reference to a party, any corporation or
other organization, whether incorporated or unincorporated, of which such party or any other Subsidiary of such party is a general partner or serves in a similar capacity, or, with respect to such corporation or other organization, at least a
majority of the securities or other interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions is directly or indirectly owned or controlled by such party or by any one
or more of its Subsidiaries, or by such party and one or more of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Superior Proposal</U>&#148;
means a bona fide, written Acquisition Proposal (with all percentages included in the definition of &#147;Acquisition Proposal&#148; changed to 50%) made after the date of this Agreement that the Board of Directors determines in good faith, after
consultation with its financial advisor and outside legal counsel, and taking into account all relevant terms and conditions of such Acquisition Proposal (including any termination or <FONT STYLE="white-space:nowrap">break-up</FONT> fees and
conditions to consummation), the Person making such Acquisition Proposal, the likelihood and timing of consummation of such Acquisition Proposal and all financial, legal, regulatory, and other aspects of such Acquisition Proposal, is more favorable
to the Company or to the Company&#146;s stockholders than the Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Tax</U>&#148; and
&#147;<U>Taxes</U>&#148; means all federal, state, local and foreign taxes (including, without limitation, income, franchise, property, sales, withholding, payroll and employment taxes), assessments, fees or other charges imposed by any Governmental
Authority, including any interest, additions to tax or penalties applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Tax Return</U>&#148; means
any return, report or similar filing (including the attached schedules) filed or required to be filed with respect to Taxes (and any amendments thereto), including any information return, claim for refund or declaration of estimated Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Third Party</U>&#148; means any Person, including as defined in Section&nbsp;13(d) of the Exchange Act, other than
the Purchaser or any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Transfer</U>&#148; means any direct or indirect (a)&nbsp;sale, transfer,
hypothecation, assignment, gift, bequest or disposition by any other means, whether for value or no value and whether voluntary or involuntary (including, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
without limitation, by realization upon any lien or by operation of law or by judgment, levy, attachment, garnishment, bankruptcy or other legal or equitable proceedings) or (b)&nbsp;grant of any
option, warrant or other right to purchase or the entry into any hedge, swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of Common Stock. The term
&#147;<U>Transferred</U>&#148; shall have a correlative meaning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Terms not otherwise defined in this <U>Exhibit A</U>, but defined
elsewhere in the Agreement, shall have the meaning set forth where defined in the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPANY DISCLOSURE LETTER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See attached). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF REVERSE STOCK SPLIT APPROVAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The undersigned, Robert Tirva, hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. He is the President, Chief Financial Officer and Chief Operating Officer of Sonim Technologies, Inc. (the
&#147;<B><I>Corporation</I></B>&#148;), a Delaware corporation, and is duly authorized by resolution of the Board of Directors of the Corporation to execute this instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. The present name of the Corporation is &#147;Sonim Technologies, Inc.&#148; The Corporation filed its Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of Delaware on May&nbsp;14, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. This
Certificate of Amendment to the Amended and Restated Certificate of Incorporation was duly approved by the Corporation&#146;s Board of Directors and duly adopted by the stockholders of the Corporation at a special meeting of the Corporation duly
called and held upon notice in accordance with the applicable provisions of Sections 222 and 242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <B>Article IV, Section A</B> of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended
to read in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A. This Company is authorized to issue two classes of stock to be
designated, respectively, &#147;<B><I>Common Stock</I></B>&#148; and &#147;<B><I>Preferred Stock</I></B>.&#148; The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 105,000,000.
100,000,000 shares shall be Common Stock of the par value of $0.001 per share and 5,000,000 shares shall be Preferred Stock of the par value of $0.001 per share </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of 5:00 p.m., Eastern time, on the date this Certificate of Amendment to the Amended and Restated Certificate of
Incorporation is filed with the Secretary of State of the State of Delaware (the &#147;Effective Time&#148;), each [___] shares of Common Stock, par value $0.001 per share, issued and outstanding prior to the Effective Time shall, automatically and
without any action on the part of the respective holders thereof, be combined and converted into one (1)&nbsp;share of Common Stock, par value $0.001 per share, of the Company. No fractional shares shall be issued and, in lieu thereof, any holder of
less than one (1)&nbsp;share of Common Stock shall, upon surrender after the Effective Time of a certificate, which formerly represented shares of Common Stock that were issued and outstanding immediately prior to the Effective Time, be entitled to
receive cash for such holder&#146;s fractional share based upon the closing sales price of the Company&#146;s Common Stock as reported on The Nasdaq Stock Market LLC on the date this Certificate of Amendment to the Amended and Restated Certificate
of Incorporation of the Company is filed with the Secretary of State of the State of Delaware.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">**** </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of
Amendment to the Amended and Restated Certificate of Incorporation to be executed this &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">SONIM TECHNOLOGIES, INC.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert Tirva</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President, Chief Financial Officer and Chief Operating Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF CHARTER AMENDMENT APPROVAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The undersigned, Robert Tirva, hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. He is the President, Chief Financial Officer and Chief Operating Officer of Sonim Technologies, Inc. (the
&#147;<B><I>Corporation</I></B>&#148;), a Delaware corporation, and is duly authorized by resolution of the Board of Directors of the Corporation to execute this instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. The present name of the Corporation is &#147;Sonim Technologies, Inc.&#148; The Corporation filed its Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of Delaware on May&nbsp;14, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. This
Certificate of Amendment to the Amended and Restated Certificate of Incorporation was duly approved by the Corporation&#146;s Board of Directors and duly adopted by the stockholders of the Corporation at a special meeting of the Corporation duly
called and held upon notice in accordance with the applicable provisions of Sections 222 and 242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4.<B> Article IV</B> of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended to include
an additional section identified as <B>Article IV, Section D</B> which shall read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">D. Any
transaction entered into with AJP Holding Company, LLC (&#147;<B><I>AJP</I></B>&#148;) or an affiliate of AJP that would result in the Common Stock of the Corporation no longer being listed on a nationally recognized securities exchange shall
require the approval by a majority of the holders of Common Stock of the Corporation that are unaffiliated with AJP prior to the closing of such transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">**** </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of
Amendment to the Amended and Restated Certificate of Incorporation to be executed this &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">SONIM TECHNOLOGIES, INC.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert Tirva</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President, Chief Financial Officer and Chief Operating Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF INSIDERS VOTING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See attached). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT F </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF PURCHASER VOTING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See attached). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT G </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See attached). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx259893_89"></A>ANNEX B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[LETTERHEAD OF B. RILEY SECURITIES, INC.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">April&nbsp;13, 2022 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sonim
Technologies, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6836 Bee Cave Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Building 1, Suite 279 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Austin, TX
78746 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: Board of Directors </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Members of the Board of Directors: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We understand that Sonim Technologies, Inc. (the &#147;Company&#148;) plans to enter into a Subscription Agreement (the &#147;Agreement&#148;)
by and between the Company and AJP Holding Company, LLC (the &#147;Purchaser&#148;), pursuant to which, among other things, the Company will issue and sell to the Purchaser in two closings (together, the &#147;Transaction&#148;) 20,833,333 shares in
the aggregate (the &#147;Purchased Shares&#148;) of the Company&#146;s common stock, par value $0.001 per share (the &#147;Common Stock&#148;), in exchange for aggregate consideration of $17,500,000 in cash (the &#147;Aggregate Consideration&#148;).
The terms and conditions of the Transaction are more fully set forth in the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You have requested our opinion (this
&#147;Opinion&#148;) with respect to the fairness, from a financial point of view, to the Company of the Aggregate Consideration to be received by the Company in exchange for the Purchased Shares in the Transaction pursuant to the Agreement. For
purposes of this Opinion, you have advised us and directed us to assume (i)&nbsp;the Company&#146;s consolidated financial statements as of and for the year ended December&nbsp;31, 2021, were prepared on the assumption that the Company would
continue as a going concern, (ii)&nbsp;the Company is experiencing significant liquidity issues, (iii)&nbsp;the Company has not obtained, and does not expect to obtain, alternative financing on terms more favorable to the Company from a financial
point of view, and (iv)&nbsp;in the absence of the Transaction or alternative financing for which the Company has not arranged and does not believe it could arrange to obtain on terms more favorable to the Company at this time, the Company&#146;s
ability to function as a going-concern will likely be severely impaired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In arriving at this Opinion, we have, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed the financial terms of a draft, dated April&nbsp;13, 2022, of the Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain publicly available business and financial information related to the Company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain other information relating to the Company concerning its business, financial condition and
operations made available to us by the Company, including (a)&nbsp;forecasts with respect to the future financial performance of the Company prepared by the management of the Company relating to the Company in the absence of the Transaction (the
&#147;Status Quo Projections&#148;) and (b)&nbsp;solely for informational purposes, forecasts with respect to the future financial performance of the Company prepared by the management of the Purchaser relating to the Company giving effect to the
Transaction and the business strategy contemplated thereby (the &#147;Financing Plan Projections&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Held discussions with members of senior management of the Company and the Purchaser concerning the Transaction
and the business, financial condition, and strategic objectives of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed certain publicly available financial data, stock market performance data and trading multiples of
companies which we deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed the publicly available financial terms of certain business combinations that we deemed relevant; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performed such other financial studies, analyses and investigations, and considered such other matters, as we
deemed necessary or appropriate for purposes of rendering this Opinion. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In preparing this Opinion, at your direction, we have relied, without assuming
responsibility or liability for independent verification, upon the accuracy and completeness of all financial and other information available from public sources and all other information provided to us or otherwise discussed with or reviewed by us.
Company management has advised us and, at your direction, we have assumed that the Status Quo Projections have been reasonably prepared in good faith and represent Company management&#146;s best currently available estimates and judgments with
respect to the future financial performance of the Company in the absence of the Transaction. In addition, at your direction, we have assumed that the Financing Plan Projections have been reasonably prepared in good faith and represent Purchaser
management&#146;s best currently available estimates and judgments with respect to the future financial performance of the Company giving effect to the Transaction and the business strategy contemplated thereby. We have assumed no responsibility for
and express no view or opinion as to the Status Quo Projections, the Financing Plan Projections or the respective assumptions on which they are based. At your direction, we have used and relied upon the Status Quo Projections for purposes of our
analyses and this Opinion and assumed that the Status Quo Projections provide a reasonable basis upon which to evaluate the Company and the proposed Transaction. We have also assumed that there have been no changes in the assets, financial
condition, results of operations, business or prospects of the Company since the respective dates of the last financial statements and other information, financial or otherwise, made available to us that would be material to our analyses or this
Opinion, and that there is no information or any facts or developments that would make any of the information reviewed by us inaccurate, incomplete or misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have not been asked to undertake, and have not undertaken, an independent verification of any information provided to or reviewed by us,
nor have we been furnished with any such verification, and we do not assume any responsibility or liability for the accuracy or completeness thereof. We did not make an independent evaluation or appraisal of the assets or the liabilities (contingent
or otherwise) of the Company, nor have we evaluated the solvency of the Company under any state or federal laws. We have undertaken no independent analysis of any pending or threatened litigation, possible unasserted claims or other contingent
liabilities to which the Company is a party or may be subject, including, without limitation, the ongoing investigation of the Company by the U.S. Securities and Exchange Commission, and our Opinion makes no assumption concerning, and therefore does
not consider, the possible assertion of claims, outcomes or damages arising out of any such matters, including, without limitation, the additional shares of Common Stock that may become issuable to Purchaser in connection therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also have assumed, with your consent, that (i)&nbsp;in the course of obtaining any regulatory or third party consents or approvals in
connection with the Transaction, no delay, limitation, restriction or condition will be imposed that would have an adverse effect on the Company or the contemplated benefits of the Transaction, (ii)&nbsp;the representations and warranties made by
the parties in the Agreement are accurate and complete in all respects; (iii)&nbsp;each party to the Agreement will perform all of its covenants and obligations thereunder; and (iv)&nbsp;the Transaction will be consummated in accordance with the
terms of the Agreement, without waiver, modification or amendment of any term, condition or provision thereof. We have also assumed that the Agreement, when executed by the parties thereto, will conform to the draft reviewed by us in all respects
material to our analyses and this Opinion. We are not legal, tax or regulatory advisors and have relied upon, without independent verification, the assessments of the Company and its legal, tax and regulatory advisors with respect to such matters.
Without limitation to the foregoing, with your consent, we have not evaluated the impact, if any, of the Transaction on the Company&#146;s ability to utilize its net operating loss carryforwards to reduce future tax liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Opinion is limited to the fairness, from a financial point of view, to the Company of the Aggregate Consideration to be received by the
Company for the Purchased Shares in the Transaction pursuant to the Agreement, and we express no view or opinion as to the fairness of the Transaction to the holders of any class of securities, creditors or other constituencies of the Company. This
Opinion does not address any other aspect or implication of the Transaction, the Agreement, or any other agreement or understanding entered into in connection with the Transaction or otherwise. We also express no view or opinion as to the fairness
of the amount or nature of the compensation to any of the Company&#146;s officers, directors or employees, or any class of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
such persons, relative to the Aggregate Consideration or otherwise. We express no view or opinion as to the prices or range of prices at which Company Common Stock may trade at any time.
Furthermore, we are not expressing any opinion as to the impact of the Transaction on the solvency or viability of the Company or the Purchaser, or the ability of the Company or the Purchaser to pay its obligations when they become due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Opinion is necessarily based upon economic, market, monetary, regulatory and other conditions as they exist and can be evaluated, and the
information made available to us, as of the date hereof. Although subsequent developments may affect this Opinion, we do not have any obligation to update, revise or reaffirm this Opinion. As you are aware, the credit, financial and stock markets
have experienced significant volatility, and we express no view or opinion as to any potential effects of such volatility on the Company or the proposed Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have acted as financial advisor to the Board of Directors (the &#147;Board&#148;) of the Company in connection with the Transaction and
will receive a fee for such services, a significant portion of which is payable upon the consummation of the Transaction. We will also receive a fee for rendering this Opinion, which is not contingent upon the conclusion set forth in this Opinion or
the successful completion of the Transaction. In addition, the Company has agreed to indemnify us and certain related parties for certain liabilities arising out of or related to our engagement and to reimburse us for certain expenses incurred in
connection with our engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are a full-service securities firm engaged in securities trading and brokerage activities as well as
providing investment banking and other financial services. In the ordinary course of business, we and our affiliates may acquire, hold or sell, for our and our affiliates&#146; own accounts and the accounts of customers, equity, debt and other
securities and financial instruments (including bank loans and other obligations) of the Company, the Purchaser and their respective affiliates. During the last two years we held significant positions in equity and debt securities of the Company,
until August 2021 and a senior executive of our affiliates B. Riley Financial and B. Riley Principal Investments served as a member of the Board until February 2022. In addition, we and our affiliates have in the past provided, and are currently
providing, investment banking and other financial services to the Company and certain of its affiliates, for which we and our affiliates have received, or would expect to receive, compensation, including, during the past two years having acted as
the Company&#146;s sales agent in connection with its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> offering&#148; programs. We and our affiliates may in the future provide investment banking and
other financial services to the Company, the Purchaser and their respective affiliates, for which we and our affiliates would expect to receive compensation. We have adopted policies and procedures designed to preserve the independence of our
research and credit analysts whose views may differ from those of the members of the team of investment banking professionals that are advising the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Opinion is for the information of the Board (in its capacity as such) in connection with its consideration of the proposed Transaction.
This Opinion does not constitute a recommendation to the Board, the Company, any security holder of the Company or any other person as to how to act or vote on any matter relating to the Transaction or otherwise including, without limitation,
whether or not to participate in any offering of securities by the Company. This Opinion does not address the relative merits of the Transaction as compared to alternative transactions or strategies that might be available to the Company or any
other party to the Transaction, nor does it address the underlying business decision of the Board, the Company or any other party to effect the Transaction. The issuance of this Opinion was approved by an authorized internal committee of B. Riley
Securities, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on and subject to the foregoing, we are of the opinion that, as of the date hereof, the Aggregate Consideration to
be received by the Company for the Purchased Shares in the Transaction pursuant to the Agreement is fair to the Company from a financial point of view. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ B. Riley
Securities, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. Riley Securities, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx259893_90"></A>ANNEX <FONT STYLE="white-space:nowrap">C-1</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The undersigned, Robert Tirva, hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. He is the President, Chief Financial Officer and Chief Operating Officer of Sonim Technologies, Inc. (the
&#147;<B><I>Corporation</I></B>&#148;), a Delaware corporation, and is duly authorized by resolution of the Board of Directors of the Corporation to execute this instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. The present name of the Corporation is &#147;Sonim Technologies, Inc.&#148; The Corporation filed its Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of Delaware on May&nbsp;14, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. This
Certificate of Amendment to the Amended and Restated Certificate of Incorporation was duly approved by the Corporation&#146;s Board of Directors and duly adopted by the stockholders of the Corporation at a special meeting of the Corporation duly
called and held upon notice in accordance with the applicable provisions of Sections 222 and 242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <B>Article IV, Section A</B> of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended
to read in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A. This Company is authorized to issue two classes of stock to be
designated, respectively, &#147;<B><I>Common Stock</I></B>&#148; and &#147;<B><I>Preferred Stock</I></B>.&#148; The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 105,000,000.
100,000,000 shares shall be Common Stock of the par value of $0.001 per share and 5,000,000 shares shall be Preferred Stock of the par value of $0.001 per share </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of 5:00 p.m., Eastern time, on the date this Certificate of Amendment to the Amended and Restated Certificate of
Incorporation is filed with the Secretary of State of the State of Delaware (the &#147;Effective Time&#148;), each [&nbsp;&nbsp;&nbsp;&nbsp;] shares of Common Stock, par value $0.001 per share, issued and outstanding prior to the Effective Time
shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1)&nbsp;share of Common Stock, par value $0.001 per share, of the Company. No fractional shares shall be issued and, in
lieu thereof, any holder of less than one (1)&nbsp;share of Common Stock shall, upon surrender after the Effective Time of a certificate, which formerly represented shares of Common Stock that were issued and outstanding immediately prior to the
Effective Time, be entitled to receive cash for such holder&#146;s fractional share based upon the closing sales price of the Company&#146;s Common Stock as reported on The Nasdaq Stock Market LLC on the date this Certificate of Amendment to the
Amended and Restated Certificate of Incorporation of the Company is filed with the Secretary of State of the State of Delaware.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">****
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of
Amendment to the Amended and Restated Certificate of Incorporation to be executed this &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SONIM TECHNOLOGIES, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert Tirva</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President, Chief Financial Officer and Chief Operating Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="anxc259893_1"></A>ANNEX <FONT STYLE="white-space:nowrap">C-2</FONT> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SONIM TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The undersigned, Robert Tirva, hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. He is the President, Chief Financial Officer and Chief Operating Officer of Sonim Technologies, Inc. (the
&#147;<B><I>Corporation</I></B>&#148;), a Delaware corporation, and is duly authorized by resolution of the Board of Directors of the Corporation to execute this instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. The present name of the Corporation is &#147;Sonim Technologies, Inc.&#148; The Corporation filed its Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of Delaware on May&nbsp;14, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. This
Certificate of Amendment to the Amended and Restated Certificate of Incorporation was duly approved by the Corporation&#146;s Board of Directors and duly adopted by the stockholders of the Corporation at a special meeting of the Corporation duly
called and held upon notice in accordance with the applicable provisions of Sections 222 and 242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4.<B> Article IV</B> of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended to include
an additional section identified as <B>Article IV, Section D</B> which shall read as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">D. Any
transaction entered into with AJP Holding Company, LLC (&#147;<B><I>AJP</I></B>&#148;) or an affiliate of AJP that would result in the Common Stock of the Corporation no longer being listed on a nationally recognized securities exchange shall
require the approval by a majority of the holders of Common Stock of the Corporation that are unaffiliated with AJP prior to the closing of such transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">**** </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of
Amendment to the Amended and Restated Certificate of Incorporation to be executed this &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SONIM TECHNOLOGIES, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert Tirva</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President, Chief Financial Officer and Chief Operating Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g259893dsp001.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">SONIM TECHNOLIGIES, INC 6500 RIVER PLACE BLVD BUILDING 7, SUITE 250 AUSTIN TX 78730 VOTE BY INTERNET&#151;www.proxyvote.com Use the
Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the meeting date. Have your proxy card in hand when you access the web site and follow the instructions to
obtain your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future
proxy statements, proxy cards&nbsp;and annual reports electronically via <FONT STYLE="white-space:nowrap">e-mail</FONT> or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when
prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE &#150;
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before
the meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o
Broadridge, 51&nbsp;Mercedes&nbsp;Way, Edgewood, NY 11717&nbsp;&nbsp;&nbsp;&nbsp;TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D60790-P62159 KEEP THIS PORTION FOR YOUR RECORDS&nbsp;&nbsp;&nbsp;&nbsp;DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. SONIM TECHNOLIGIES, INC The Board of Directors recommends you vote FOR the following proposal: 1. To approve the transactions contemplated by the Subscription Agreement. For Against Abstain
&#9744; &#9744; &#9744;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors recommends you vote FOR the following proposal: 2. To adopt the Amendment to the Company&#146;s Certificate of Incorporation, as amended, to effect a reverse stock split of the
Company&#146;s common stock. For Against Abstain &#9744; &#9744; &#9744; The Board of Directors recommends you vote FOR the following proposal: 3. To adopt the Amendment to the Company&#146;s Certificate of Incorporation, as amended, to include a
restriction on certain transactions with the Purchaser or its affiliates. For Against Abstain &#9744; &#9744; &#9744; The Board of Directors recommends you vote FOR the following proposal: 4. To vote on adjournment if there are insufficient votes at
the Special Meeting to approve the Transaction Proposal. NOTE: In his or her discretion, the proxy is authorized to vote on such other matters as many come before the meeting and any adjournment(s) or postponement(s) thereof. NOTE: This proxy should
be marked, dated and signed by the stockholder(s) exactly as his, her or its name appear(s) hereon, and returned in the enclosed envelope. For Against Abstain &#9744; &#9744; &#9744; Please sign exactly as your name(s) appear(s) hereon. When signing
as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by an
authorized officer.&nbsp;&nbsp;&nbsp;&nbsp;Signature (PLEASE SIGN WITHIN BOX) Date&nbsp;&nbsp;&nbsp;&nbsp;Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g259893dsp002.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Special Meeting: The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF SONIM TECHNOLOGIES, INC. FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON , 2022 The undersigned
stockholder of Sonim Technologies, Inc., a Delaware corporation, hereby acknowledges receipt of the Notice of Special Meeting of Stockholders and Proxy Statement, each dated , 2022, and hereby appoints Robert&nbsp;Tirva as proxy for the undersigned,
with full power of substitution and revocation, to represent the undersigned at the 2022 Special Meeting of Stockholders of Sonim Technologies, Inc. to be held at on , 2022, at 9:00 a.m. (local time), and at any adjournment(s) or postponement(s)
thereof, and to vote all shares of Common Stock that the undersigned would be entitled to vote if then and there personally present, on the matters set forth on the reverse side, and in accordance with the instructions set forth on the reverse side,
and in their discretion, upon such other matter or matters that may properly come before the meeting and any adjournment(s) or postponement(s) thereof. This proxy, when properly executed and returned, will be voted as directed or, if no direction is
indicated, will be voted &#147;FOR&#148; Proposal 1, &#147;FOR&#148; Proposal 2, &#147;FOR&#148; Proposal 3 and &#147;FOR&#148; Proposal 4. Continued and to be signed on reverse side </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g259893dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g259893dsp001.jpg
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M/'.<8QC^7/C]G_9_+_Y^.D^P_?''_;_]/Y>!^>./^W'_ *?^W^3_ -/'0?O
M_,YQCQSG.,8Q]N?'/\F/^W/_ &?R<KTD/''_ &XY08<W8@%:BQIUB-B04.:5
M$ H<HN0B#H\LW8"48.!$1GI;K+;Y,T6FLQHK",Y=D/NH;0E2E8QG.T.,Y+E<
MU]?C-?-L9\>')EM7'2U[5Q8:6RYLEHK$S&/%CK;)DO/XTI6;6F(B91M>E(ZW
MF(B9B/7T]9GI$?ZS/I#,\P4C@. X#@. X#@. X#@. X#@. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@5-[K=4Q/<C0Q/3\FYE]86F!<];;2U7MVM0(9&V:C
MVWJ*] =@T#8-7C3G&8KA0.: I:<;6M+<B'(?8<\6W5IR%=MX_'3F_P!\[!W7
M6FSX]!3VAZ1B^B^S!-CJ*KK' 4>NRMF?=?8="7@^#5%MH@3N ZQ('S?<"R3^
M8<AS#:H[Z)@<M-^/:5K'L57-N4#80YNAT+XWJ[\>]'HMF!E"]C:&TZTMV:M[
M!L5T8.PF2KN$1VHDN$V.9<>PE3^)*5*]/ =WH7T<O?2CJJ!ZMIV54KJ$J.FZ
MY0A-@17+K%FGKZ)IT>E%+T:8L6P+5@#7"0@ )]O7!"X\6 ZB6M#R_<-H8"D-
M!^$(K4NH'8/K 3WO5C$C=/27K;U&$G_X9GG1E5NO6<#9!]&[/+2<V0<MV+X)
M.G898/7A)8/7@,T'&>CH5*D2I2@OYVEZ7V_L=TMIW5F/L>NU6R@K9UCMQS8$
MVK&+ .,$.O.W]<;CGN(!XLXPG[N_F]=)COR)!!YV/@@](5F0ZC&%A^BNA(-C
MM;KCN;][%T_<=7E;; [.AZ]B3!E+["ZONC]^(:QK>V@Q(C+^JVW1AJ\.2*^?
M1GW3##LV&E"8DQ+<8*FF/B6N)_K77>OI7=-4?;%_);:_D"+F(5/N0))<-;=^
MW7?<[3T*0$V)#L=<((G7=\0W98D_$AEAA$MN(E_/D2&.['?$GM'L?N$5O QV
M)IE2ME2T%I_4U/ #M6V2QZZG&-']H9_8FI-;;I![9WTK<FK#@F2S7C-?*XPZ
M]*C-'(LN+.:8;9"R=E^.QBT;K =HF+Q"H._X5?WS0[]*H0PK#UYOG6NTP.R(
M^NZON:MS3+LRPE=&6O8"B5?,-OHFQF/>06_)&G92P$%U+XJ;_5OBZV9\:$?=
MU.0"NW5L+UY@;+^Y%W+3F;*Y18^NKEM$F!L&SR66(1( ('NC*N-F0AXR2U(\
M'W&GT(8#U;?H!\A5->!/XB6FF$:=FM/F9>OFZU'AVW(0<W$G ";%TK5R>:JQ
M5Y.5+1&7&()3A.$RTY\V5!Y$=A.K)$[W8G=B*_H7M^8:%7;5-E*":*_UAEZE
MV3,I=*V)KS8,A0R^]BJN><%;@UQ<0H0DS-$Q<QUU9J4VTI][UD_H']:_;VKQ
M_P!"X_K+DO(O"<%\VAR&#'DVXYZO(Z-=K:TMW3K\FGPNQAC)QN[K;6U@MBV,
MG?&_?#:\8Z=D\KN:%K\I.Y3#LSTM29BOQ=ENVMJV]+9(GI>LUK/6(_1U]YZJ
M^5_HPL([O<=)ZO=[#%(W?K'=FL44B=.ZA*&ZZ@[#V/=;WJHW1IF>V"YX@]U^
M@;-L(D)+;6B1(B3F/5<QB#$2UZ3R7^0==^GCNSB\N^O,'/\  <MQ>_.U2GD?
M?NWTM+5U.0Q;=?\ ST4R8>8OHZ>QM8[1-*9,63LK_P C--\.G%=ORUG!MSBR
MX[U[?V>E>ZUK4FO[OI./NM%9]^DQ_:&0F: [.:_ZI=IM%:@ZZ=I[=:.QM8V_
M%)'=MQNJ;<]@ILK09>M/BJK:JWV[CO:_BENS9B;?79:H1:.+C%I(Z%!;2S%?
M:QL'V1]3^2?<7B'V%YMY/XAI<1XOM\;:F+CK>032<>CR^//&38U\_CDQN6Q\
M%BQ<17'&77OL7U\6UGV+3?-CO6=/>P\?L:FMAV+9,U;]9O\ %[VQS'2)C-^/
M7+,Y.O2>D3-8CTB6M5'ISMR(;U^7LW6SMK'#5>-V4GMTFIJZU0Q^N[5OBNZ!
MA5,KI\E*[F+;#OZ;N&C7+-#<F17TR[#8I\MIJ)]F'-KS7WAX7FT.2TN*\I\,
MMO;=^#I.UL?]Y:^[K\1FYBVQCY*E?&8G+')ZW*UT<M<62LX]/2U\-[YO>L,?
M&[$6I:^#8[:_+^,?%^,Y(Q])I/S>G9-.Z.L>MK3/H[([JGV*"P-(2(&@^RA:
MV:6WQ6-QCR=LK/6@S7IE;%ZDUAI>[Z?CUA?=E;2:;N 50I=K-KDO/N,7XDT6
MCH\8JTR[6S]P_6._L<_BV?(_%</#<]X[GXR^/7S\YBS5SY.1W^4U>2G/'BW7
M^3QN3;Q\?JQ2M*WXC!?3RVZ9JSAK7C]VL8IC#GG)BS1?K,8ICI%*TM3I\_Z;
MQ6;VZ_[D]T>WKMU:ZM6V-4*X'=Z?=T*M.I/:RP[WUYF(0Z:V"72],W0M<W+S
MU2<)O=HFOKVL+)6]J6T<PJ3E]P6@O&<8\5C8GDTO*_;O#9>:VMZGFW@FYK[_
M (=AXG=[J>38:[7)ZN/5C4\AC'' S\._@S\?QV:\4[*[$ZV6N3I7:S=URFAD
MC'6O\;:K-=B<E?7#/;2TV[L77Y?6LQ>\>OMUCI^F&#LO4W=-BO4NY2]&]Q"<
M*)V&UWOFO52S ^IU@!27:-VH/=D(H2X1GNYC#9*=6ZQ85Z^K4V$F'@55HC#3
MC3R/%A&PXK[D\$XSQZG!X?(/",6>_C.[Q&;8P9?(<.6L;?C^'A+9=:T>,S-*
M9\^&.8WL66<G\CD,F2];TG]RT;\?M7R_+.+9F(S5R1$QBF/QRSDZ3^]Z](GX
MZS'3I2(]_9L==TAVWJG6JV=> 6L>W#<^Z*F$+5MTJ(T*?N]RLE=L=&+:V-V6
M"5^05ZN1(YNOU*0&V+!&1HC5PC$776EP'\NJ>UG)^?\ TQS'VII_9G(<MX7.
MOH=M-?CL>3E\.KK8,V#;Q[V+!?'X=&>UL6;9IL\+ESWR6XV^&E+UV,<4BDZ:
MO(X]&VG3'L=;>]YC'-K3$UFLSUV.GK$=N2(B.^)_I/OHVR^H>^;R.W - Z3[
M=T0=L_4]YUV)K84?UM75J.J\:>U!JB+7A4-[N^L@[J?6A+5C]LK0A,AJ;$LA
MZ4]F6E.,Y>Z#Q7[J^NO']KA-KD>>\*Y':XGF=3=R9\M^;C8V_P")R7)<A;-D
MM'BL4CD=ZG(4X[>V9I;%DT=3#3X9F8[+.?CMO+7)6F+9I7)CM6(CX^E>ZE*=
M(_?_ $5FG?6/>+6F>O\ >TWQX]9=NZ;[+WN^VC7NXJ#2[51-OCV1%O&:N'U"
M%)NW96Q;MJ >,JE=F-N$5O4&NWB17A;?T9B.F#%<<2_&PYB*KR'_ "8^U_"_
M./JKCO'>)Y/@^1YW3Y'C;SDULF_?9M75X/#Q6SDM_*X+CJ1&YFU*;N>?Y-[S
MER5K./+VSEC8<-H[.MO7S9*9:8K4O'28KT_++-XC\<MY_&+36/QZ=(]X]GMO
MSX'=0<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M'1.RAH 9@T63KZAWG;.K;7KV!=Q8JPNB(6U.B%+H.UWE&J=).YN,6/V8)K;
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M[D#-=*5J5C<>QT&:P>0YI&5&L( LU96RX\\)<Z^U%4>0E[*VT0%HSXMS9J)
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MA4B0\Z^^KQ6XM:U*5D-JX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MJ_&":K8*BP)^\ EC71HG7.0Z+M.KWK/2#MGZ_" -33:5!K)?2=BK$FTT@*J
M_#&F6!3;SC<M41V2V^Y+#$K^*4I$JFN*E3=[!=:,5'3FJ]>6$W1M0?2[(:NV
MLM,=CM,.[/"DV-AQF I2Z0.Q#Q,HU,8*RGYH=A"YCC3R_($CV7X[B-@L@FVQ
M;]J[7AB3%THW9G-6Z4ETQ< SJO:.Z=D%3>K9[NS#!&DR[@YNXBCTY+A9$2;'
M:DX]5O*HN C<A\5!.1+KYIC<U:<L8,0+8CS)VK2"A0BVU^?U4=&;%I@>+L:/
M]TK:88ZQJDEW6WWE2BMDD24+;RRI,L+\]<^ODG0]:V%4YEWF7<#<K^=N 484
M&IRFG"CPL5#FU-@N3FF;)9Q62,*1+8<,S9\J*S+Q"0\J+&82D*V]<OC[F:(L
M&H"T[;4>SQ=.Q:RT!;"43-)G/1*YUW:ZZ.43,ABV&V&=1FH<&+<9 %33OEO*
M72*'\(<2RT&7[(]"%=BKS>[,0W&>K8F[5". C0(X/ZB9IDR/JW<&JIT"LFOK
MHYI.O+F.VXJ>> O1E)GSQ3:O<)]?QCA%:_C!B0B%B)U6_42JMW@!/!6JL0]-
M19M6#PBFTJ1LDB&U=$EW++M!KD^16Y[KT?\ UY?UPJ\596P[E;2PT C\4-J)
M0X;4W>%))EA0 =#$64EJ ^\9@6L7JCI]K6)>X[^=N+?8L3$_JADRV\E[W")E
MC=\'O/&]:2%^.SFAV]YOZ:98'RHARC['9L>+Q&CUF3##4@J)F4S<5&,1#4Q!
M>8)W!J>RF 2408\C,:<[&FN9;5#97P*FG_C,GDI\LV-W@B,=B6>SSP$LWKU1
MP>1K=MM.Y2ST+8HF-=0B+A:*?4]VD*X *,.CDQ!,)AIZ/(9<<8P%F>G75)/5
MBN[ &SCU6N-BOUM"6 C; 5&53"$J!7]<TFACQ1?W-DM4TGZ4JJRB2,YE)::?
M*OI0WA67'70J0$^+!P2$'@F=P"A#.*CMD5(*5*A6"L'JKL"]VS;M@K6Y-93!
M>T(X\+?0@/;'T(LHW$L+!D6#'-MI@ICX1D-JLOQO$[?@C)*;0IP&49K0]N0)
MU_JJ=4:;6[M '[DA&9] KZMBEY-;HFV'=PNNW0$Y+E_6,P$I;DL8>QF.&JO?
M%M/<DU&$WMNHPJA5*K&#Q P75)BLV@;.F=?JYI&U0*AL"L;3#DZI2C!ZL)N<
M> F-*?8LI0D](D342U(P%VK#U^LA_K-5M!3MC0C!L()UB'/7^PZ^KLIFW1Z&
M=K10V]*I8M8BNA9UK@@G&6W8:4-BY$A,AAI664MY#S^HWQ37BA(BS!/82J?>
MJ*$'AI=MSILLN7;X-?J73T"%K>P(<K;,MZUT(T2ZFK?L(ER6W]4CW FTT_$>
M\9+X6U@]+/3Z.77IL2NM;E_>P/MH?'MT76Z(E8#O[)V!;-@#$MZXE6PDB0(J
MDVR-QDQ<%6E2&8N,H<CJ5C* V+0/4R5I;9MJV61V3-MQ ^,O0/$9@,Y7T%QM
MUV]8=O09-XQ@V6CV<WKERR/5VMRDMQ<P*XCVZL.97G* B6S] 7K?><V2T7+7
MMP%,=H0^_HF;=J)9B[S*<T2MATCIFU6U=Y2.M-= F+4M%7?<%,I"BV6XCL>9
MY,.Y".07QEV$2O6SKV[*[+)4/85+NYRT*U?8)%NV<]0;WJ@X**7DR:VX:5FV
MVBAZW? 6-X8D:),N$4S'!V$Q\0W0E3J[T,D]=;C1+$4V#6[_  -=:AI>L:@T
MU0[%4#%575-?5K61--87"V@3J,&EW4/489<B)D!9<E-E=ES6IR6Y"([ 87>G
MQ_G=T;L-[7D[1J# 4T5I#LNB&-4N$X9&OT[9?5G9:09\F-O0/%@ERIG7&; 3
M.EQ7EM#;4]'2WAN+E,L):$]3K**Z4".I\+:Z1%AKU9%@ FR0U9(Q14=NMW"/
M9Z^+E4W[XI)OTUT:/8"DA;!R*N2(4^PQ)B^="F@K[,^-:7*.C'V]BTJ#0XK6
MJQY/4;%#V*JBF E-K6P@]B@KD-[UB7"-*9,WO!.K2%%'_H*HBF'FYR'TKCAK
M^P/B[*7[6^:82VU09EIC0=[5=K9AO1N25QLU5W%K.X:Z%&]AD&ME0G[%MZE-
MV:/(S8XJQ[1+Z>G"X+"W$.,!L-Q^,J)9[$HLQL8%$!P]E@[T%IC^NTJKOW88
MVGU^V:4U!9(0RSB8=AUT SHEP74X^&(V  ^PR6U(E):4F4&(H'QGVJELUF)*
MW!K^Q!0<35H Q2C6F"I&@W.KT+6MYU=*9L%>D;6P^FQQ UH@2:Z09DIP#>$)
M:4U*:=3[<+T;]Z[@M\9UA+(%&P1O65Y38XACZ ,.N&*?80):C[7UO-CD,MH8
M [0UW89PR2XVKS17U1YB$+<BMIR%1'OC?]6ZA[R_M,:;)5;;"MA!H=LUV@^,
ML0AW;&P]E1A.Q87WLA,V.STX+LJ;5ZV;C8A+% VDM*COH=6TD*YGOB\V;0*&
M2+T.]56_;#%:EKNM(D<119%-M-K& NLFNNN;D-%C,;@'BFXDLI0(]N=&SIC,
M"?+;1 DO83_KW ]-^H6N;/JG0E1I5Q "ZU889"X%R(L5Z#3:)%JN)VU/ORA\
M"R7$*#F2'S2U*&C"L\2-3Y8T%Q,1IEIL+,<!P' <!P' <!P' <!P' <!P' <
M!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <
M!P' <"C'=Q_L]"#TPEU>KLX];H #L"_EZ'7=8G%!;7^'S8:=.SVG]C28>1LF
M=N'(4=GVCF&7X<V2W.\L3SN-A52YROD[+TS9U:KL>X352*YV4KM/LN6=*:ZV
M6Q/@YO!O0]W'3X."E/*N'HRPP#$%3-;E0'O3G/.R<9G9CAFYQSY)A<)1P,/V
M=9UFMC;W"QZL5!=7H$FHTT+OS5T[0QR4IM\)[P;8^NT.UL%'DSYTQ9>3'3[>
M*]Z+K0878;7R&6>A#[ BO[33=$:X[* ;7J]F#UE):_=VT[K2OQM7I'#2A)^/
ML#1YZ["2/TATTZDPPT42@FTA.//'#/7@O\G$TPU]!9+5<%,V!9 ]DQ4Z[I*P
MS@5;;M>VE4,_KA5O5*1/K!/5^*JZ9P9:?*0[-X-,MJC*G--ADM]UCMM?PW42
MY"-;%;'LRL:)NULV+22R=:HUR([!N5_49('BPBCA6>-^^ 0L/L:JM(AOOC81
MIF/B1+:B/+=6&.=D_),X<N:WS=\@UR(7TFC6R =,Z[S)Y:B6/MQ<!FTR5Z29
M@/.M;+I_4? :<_'AJAC,DLK5&9?EY=A-A-W36S=Q5S#(OM,%NI!HC4=5O@SI
MBMZB M!;KF'LV/LV%(1K<OA+@;+%8KDI*W&9"L%#KB(Z\1,>A!#T$X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X'E)\H3'9%\MT5_#>C92GT=MUYW+FG)W(Y1\:97H'=K<S^-36FG&
MS;VN\;/75E92KQ=P03'4UCRI?\ C_55RVE1^^&R;++K'=$]U@=Z+=4*WJ<'<
M:MONSQIF[)6V-S!=@2"8H\Q+%C=H+UY]SI-D)$?;S8T%"7I[K;Z)F,!1[6S?
MR4CNF_8QFNQ>S<GLZ[LS>S6M'+%C=V;JUU?;[WNO6AR!*W<_G5KFZ%]478Z-
M0XAYP33 PM/E]5"_ +J=]Z)L%KK&;N_4PGW9D[$>W=U&$@ZV$L_9-9H?0\]A
M=*2-[S@E1(36[K@3/TL*,MV!\DTXTEG,]+&42);_ *P52OP7O/1?DBMKE*9[
MH/=+JIV6Z(_^\-<.;HV ] UXYJ#9,;:<&J4RYR#-;VCI.R[:E A>TI4=4P[7
M8+C):"PZ]%=DQ V'7(;Y%G*AU5C[.>[&XVM]W.^;7R6RHI"\-U&? DUV^-:0
M_@$]75K&(L>=H.5=S72]>)Q/AU9N:F?Y'<O(6&O7C77R.:QU\[JJUV3LGN9C
M6O:?XY ^G.SFO;-M56S]X]-"_9$E8-[,;YH]"E1G0VU=7Z:S+KU_+N0HWWJ%
M,CY[J<2Y"VDAZ)=+ V]"SEE(=L96_178X)VM['$I#0\C<8NARFF4V_88O08R
MI,0EKU83U"O1Y&O/LL9Q@_BULN/3_">B3P//VM0._6>R>S702.US=0Q\HO8I
MZQ(N\C;?\+Y'QMN])PR&&J+'L#V8KCZ^SN6\T)%53]?;,9G*C^48J1E01CJY
MGO2STAZ"LWZ+W57V7:["_&_.[1/C6>VBBJ=(P;5ACL(UM5XXZYB=:),%T\N_
MH$^<?)%)%96G+OM<*"W6]:3V3[9]RMQ4W6]N[@]>=,[ ^-'8U0UELV ]NS4]
M*H7<$%V,,B*1L2)&CO!!T"WNT\/&),MO-LR2U5=2AQ/DDY1P(YW UWXM6G/C
M<VOBD;KUCV"V;OV@SNV^J MJWU9]::WU]6.J&VZH>#[+&ZA.SL#];F-U101A
M[,9#4Q^?-A^NIY<5Y> C+<$KO -[D+LFGZ_WI<ZC@X/Q@SIQ?*]]DMGUFMA=
M@[H@[]*5+5MM]:K;8,64-FCCML#)[,JPQZQ/=+1X<HL/>;;#T!ZGTS?M2[L=
MP]/[#L&_;;UOHM]I_9+K!L789':[\4@0WK32X#:779F]')605]UGU]L%>^H@
MQ3KSZ(:;7&:\JW Z7<!7ED;\A?WV$9*N;GSN'_YK5PEWN:W(L*^OJOBY]&U+
M'P@+ ]>=?9B.Z54*9@1XB,WI.S,*=7C[)#N0VSX[:/VVA?'&;N'9B=OG/8$M
MH.^U^*$MUFWK*W.HS 7=I LA;*O:RDLM#VWDNZT@:0 ,L+DB%04)RMQO&4A
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M(6]QQ<B,,LG:JE6<A]T-KA7H^)]E$(C--*<:P[F*%]7JUNOLE\;S):WF=_\
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M,%V#[#TG%?,3:5VUK%"(-M@PQ"4PS'+[2UN5)1D3EPXTFEN(A,>W:A,*"?\
M1_7#L75>S)/=VV[1KZU1<ZPVWK^ ;%V^_D;04:OFT:/L6E0R%0+5L?3ZL/UX
M$ /5U;@F7A19F'%GN,M/R'F& KE'Z8=[O=Q)Y'>(EYT66>LX:$*['=B!0D:>
MED>G)61!=ANUJ>[8*W$FZ9V+[=HP\3<=1=_"3ZN7IBDAB6^CG>^%22P87OH;
MBQDJ24K_ +\YV1[%&VFK19]0[LH1:Z1"<VKR2<!ZOV@[1"P^(RA+;CU?>?PJ
M))QAR6$Y4_JUVN9WK6=CW^^4(_21.^0.W<5)O8NSSB*JQ#U_VTUT>;ID*VU4
MCZ<\T'W-4%NL+G1XN<@Y3;66&6X360Y[?U.[)&MA7RRP]NEXE,O'8DE;R%8%
M;\W%6RL+2SFLJ:#JT:I%X]:L4>AVJA;.#&#B  F&V*,L&5-O$8[C366PK;IS
MJKW4O6H:Y9L[GV7K*;;Z:=KULUULW:&[%V\=>8T'<M;J>_(Y8ZF38Z3;ZO*/
MU:8BIQ?, *L &Y#LGW*FGN!*4OHGV/E'W[@[N%]5X?F=L!GW[3N?:$JQ#*UM
MW:&IKQJ*=6!%EJMGI )RLUO7\X*7KK8Y(=,,FMF,^XWGSH"SEYT=V(M\/JO%
MD[-@I9UX'A1-^Q*;>K]JO%JMT-&OB(W85-,1Q>P+ ;B C%2*15UDU)99-"K"
M^B43;6UG#X53I72SN94*PV+@[:IXJ;7*B*31!(':^SPU"BDD7EPU?M7VRKB=
M>C5'J=M("QG.+:V^R>K,TI)Q%&R\18[S@9V;T8[ *W"Y=:KLF/KZN&YU>.DY
M0S>N]K1:0A*M]:[=JNKB9\(U#@"]OAJ-MB2#LL51V5$04;@N)E16U?S;P8>5
MTQ[J*+UNP,;YRI8ID&5Q5&^P.]!M< W,59^HQ$X2ANL 9;MU!72+IW8,MV";
M87'A2+SF(EIZ.Y*>2&]5;K#W'%!R,"R;+K-MFXU[]%J! EO?L$P[4#CEOO2#
M@0KD.-#R=C@[513XI]LN3?;)AC Q+*6)D5J.Z@(H$=&>Q,"17S.XKA7+J*K9
M76TR[6:J; VM/V]8*=KO3W;G6929698;7@VRJV5B!O@*X)S"E-R5/#9&6WFW
ML1L/!;6N:!W:7Z@KHEBV=.@=D)<(!:1FQL%[B/%-[#UVH G6<JR"HAQTHQ63
MT"DB4W,+&?\ :E%32R,I7[M>5!"^XNIO<&P2KM#U)N8351!85JF=5B!;<6[8
MI('?:97;^[;C< 1$'' P05;[E8!N9$;Q(-/08F5X98D,L9X%D=FZ4WI<>P@&
M_P!=VI)K.N!% AP08P;;[ (?I>RX2=B0R9\GKJ)79E4W;5KD-N(O#X\P5#I%
MRZY&D-XEJ7A+ 5#V3TR[H6*Z;"M%>WV[F2=(66=5B/\ '_>E$'Q)7\/^L<&D
M3WM;UH(7I-=9$[5U1<#KXZ'B5"PQ9\,*]RT]*82'#<NG/=FU1MM0)&V:3*";
M*>VFJ/59.XMTYJPV%L'KMO[4> ,D42J9[)"ON7F[4^P.QY+DM$-P-(<B(0XB
M,TX%G]R=?NP%]:T_!HVVV]=C*IK;[L6.*$L5E$O5W8L>R:J-!=H5U\2.8:OZ
M 8"H'P>09EJ% G13V5N*0GUV7 T\=U/VXGJOJ/6!RT#['M^C[TU1N2W&;-MS
M;=J#6E= W*&N148U?CT&9=&FR%'$IBQ8ZQ_L&I>$MY9PWE3_  *]:FZ*=NM>
MUW7U$?V]!BZX *U@W9:E4^P.XA$QLE7]54RL6:X4BU2]?3R->B#;]3%SX52C
MM0@9>"8DX==&O(\'PGSL?U6W;M+L2WM*AV"OU^I2J)U]HAI</:FR-;7F<#US
MV-E;5V>#3/H59<D)"WC7)*4$9;P4;]63(SEY+3>$NX"$-=='.W=937L6C< H
MGDV:U&2W.0K.\MO5VY6^=2.N^H]3R[5#O;]")DY!6MWO5TLU'A.,16;/&LTI
M)&1"D1D.2 QX;HWW5#/U(B+[ R ]C'"J\@O8)'8WL'<8$2U)VIM>?:K0S2K.
M)>K=O:>T_;P@V*.()CQ7)8O+6?02TQ-R%A.OO5[>.KMK4W;5S,@;477IXYKV
M^CRN[MGWQ0FQF]E5.S3S%")677XF/*JDP7#)S61<F#!=&S5MPFY#S#SDM@+#
M]QM/VO?O6'>&FJ([6HERV9KNP4@"1MLX@,KXZ18640GI92>("V HU#88SEQ:
M&(CJGLHPC]'Q\R0TK&DMYR.RD7:;VSFAVMHMP%6F-5!9ZR(6U4G=)V&AVS2Q
M*G>T8I1H(6V\1A7QBS+RV8;FQE0LLX9\CF0KIN'07<,-(VW=Z;MRQ'*YBW[;
MV-4JM7;Y<(^T8(:S:![$4P?2:YB#7F:=9VA>R+S33%<%D1RW@;H!Q."!%3(U
MMH(FTIUS[BVDSK7:4JXVNG#*_:JB7G56X[Z['BVID:%O_-[OC(G65NIX^2Q4
M)FFBT^GAQ-FC>Z1Z:5.KRS[>=@-G[K:+[?1I^[-H:DN-C,TPD]]XZQ1M?;(W
M4,VDV5,ZVU_KARLURKTX9*%10\&XU!%B<DQ9B<I01FN^U0XTXJ<'HSUWUS:]
M5ZQC4^X6PK;I[-LV&;$O&;'8+E-K51M5]L=FI>O_ +XVW_WJM477E5+1 S$X
MC_K3S,)/FQA.$IP$X<!P' <!P' <!P' <!P' <!P' <!P' CO8VU:1JJ+6I-
MT*O07KI:8U(IPN ,)FSEJMTH,;L;5>KP0-$G$RI7[OUDC.RTRTI6(T)Y?\B.
M!'*NUVB</I:1<I#C"#5!JQ GBL6QL-7[EM0?72FN*/:B[X1H?5+M<8MO$8B"
M2+D6=AXM!9=:;>FQ&W@TECO=UEF:SG[@&78R7U^$";A.V@P)U_L"?+I;&@92
M(>X!UUKS%959*I8J2^O'KC)T1D@^CP<CLO-Y2O(9(OW;ZU5ZD;PO]BV ]7P7
M6^VAJ)NB*7J-SAV6E6VRC*@8JX=ZIJK^;(97:(%\$J'/#HLN-,5*RVVXIQF0
MEH-YO_8K7.L[/3J?:FKTV?O\E\?48H?6M]L;)LM#J5IOI )#F@:^1A+-#:;2
MR9&1%]3UFF(WAE/J.LH<#6QG;O1Q*JE+RLU9Q--$V$_3G+*>UY? PR?=*SM)
M.DRE)"*G5UJ0=N3FUU?0H(N(V]-*SL93!;D)QYN!U2_<;1@ I8@9TE=PQFHZ
M^V9M&RC">J=FPY8BDZ?ATLAL,L\A^IH3)R"A;%!NH9CY>=GI)M>S3(\'/('Q
M4>YO7Z\S;.'K-H.3K'2R>I!UJJ;U%NXZUA6-[1Q,G4UBDU\D B$W*;<D&F$,
MF6FW!C#Z7F9#[3T:2VR&-/\ >;K+6:?+OQ6_S$T]NC%=GASL.EW<C$NNN )J
MNU\_>==8@5Z0]L*LA"5M&9DR@R)J$12$:7CQB2&7UA(NP>R&H=4GA%>V/9)-
M.EF=:7[;S4TT /QP,#7^KW*K'OAHW8D#7 8-VO2[R'87$E2&IC[Y)EMAIU65
M82&'-=IM45R551QY&Q0Y6[W,'K^K"2>H=H#R)BTV6N6:V@H$:/,J;'E9( *:
M4>S(7E,>.Y#<8D+:D>#.0Q +N)HRQ5#7MY&%;@JO[=9K;^I5R=9[#AE-H-6N
MGV?8(9-" RJTT;LLQRBTPF6>B1XZI<:%%RMUI'G:PL)(V%N_7.KM0$][7$J3
M@ZR#5T;;"1N)6+,5(1:\5]DJ*1<K P1*M&,);GMK>:]GZ["?-EQ"?(KP".0'
M<CKU9$VCZ==I#,B@[(.ZGV1!+UFT 9^L[E6Z>2V"7;V)$-"(#M.KK%&$2"S9
MN;AH+)@MY=9E.8SC@2/KG=E VJ]EBG2K \IRL +M <-TNXU6,9IUI=(-5ZR
MYEF!"8A<<34,=SC#"UOLH]-;S;:7F<N!+/ <!P' <!P' <!P' <!P' <!P'
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M-1BQP'>*;FY!2S<" 32+5&]E8*E9:G8:^?D1"XLX%*CBXV>/:6P^G"EXR%8
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M#C3X3EH[K@.U#:]BW!B;*P5N@>AU)I"33QF,L?K.K1:.+OLN)("A!(O85ZK
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M@6F"S.:;8;)0(]FJ\M,65AMKW4;#;OIMY7Y$A,_ <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M>?D29#JW7WG5+>D/N+<<6MQ:E9#9N X#@. X#@. X#@. X#@. X#@. X#@.
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M)0J',-#XTI3$B;&:=#2Q/R6]23NM]J[5#W*USZEH=_=T/>:4:SV Q9-.$.O
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M:&L.U!BB6_8>X]J (^L;Q.VP+5,MT\U"HE[;M%!MPG9.I2%D*NNZ7NE&319
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M*P!]#$HW)>@"9,QAQK^:=B,K<\V,)SC 1%?N[56&VP-K_7XF85O*=F:"JMO
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MCQ^S@;>E.$I2G'FSA*<)QE2E+5X8QX8\RUY4M2O^W.<YSG_3P,-8:Z%M8>6
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MX^[ P$]5WTU/1<VQ[!'4-P).)21;5IV/L2KZO-'((+"8B(L6*EF;+C27F6W
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M#8<!;8#94-&,21F5#_J>1S[:GT,J<;:<5E&%K\OFR%C^ X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MM]SJCC(-6*M7/-6,9Q6L_1!GC7L9BM0<X!Y]KXB<9A1VV?\ 5_3_ )I"4?\
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M\*F0U%RI]+;4E;;BTN(0IM8>0=9[T[_AZCU9?3\O75DL^^^]^UNAM !MT<J
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M%CQ'_,Q&CH:#OG_CRU&8+GYHV^[CJ *Q]D];=N9M#J]AI[-'A[_UO8 UNS>
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MDR<H5(D9;0E&7WU--M-J>=RGS*RE*4Y5G/AC&/LX'-P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M(E;>4E,X6@H\C*(^<>.'U8SA'FSC@?*MT:=0VMU>V-:(:;8ERENJO=62VB-
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MW@?2Z93W,.8<JE:7AW!'#N%@A:L.X,92HOAS"HN?/@HI&,R?'Q]?.,>?S>'
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M!QHIE/;2VE%4K2$M('H:2@$+2EM EQ3PI#>,1<80@8ZO*H^,>&&59SE'AG/
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M<);8CQV$(999;3CP2E.,)QC^3' [/ <!P' <!P' <!P' <!P' <!P' <!P'
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MJPO(:.Y\B?25JNR;:[V-U^W6H6Z\];99M;Y1(^-V 2_[56EWW\C/!O9B9?\
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MJ7\C?3/=][9I B-+(B-8:9V Y9+G:"CSLF#[AH")SC+$=*W9;[BL(8:7GS>
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MAW&@I#DD-1"V&!TB4^PIW+"&WDM,A:7\&_4/\JW6_P#L.UC_ %7X#\&_4/\
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M4/\ *MUO_L.UC_5?@/P;]0_RK=;_ .P[6/\ 5?@/P;]0_P JW6_^P[6/]5^
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MFA(N?9B+H>MP2)*'!F6 NP,(&GA02-)>:>*D60PF5+4PPEQU,:,Z[E/D;6K
M9;@?*%H<0EQM25MK2E:%H5A2%H5C"DJ2I.<I4E2<^.,X^S..!]<#J.D(#,V*
M->G0VB,YB9*A0'9++<V9&'JBHGR8L52\/R&(*YS&'EH3E+67D85G'G3XAC:U
M:*S<PL.R4^Q K772.921Y^M%QYT+.5!F2!TU,,J+D2H,G,,A$=8=PAQ7IO-+
M0KP4G.,!F%/L(;=>4\TEIC#F7W5.(PVSAK&5.Y=7G.$MX;3CQ5XYQX8_EX'1
M"FPUE#B[#7"XP^ .0(A4*<"SXI4.7%SV$28)(63@NOPB$";&<2XT\TM;;B%8
M4G.<9QG@4%^.O_X=[>__ )PWN5_>E)X'H;P*O]/_ /<T1_X]=M?^J[=7 M!P
M' <!P*E=Y_\ E;V7_M.O_P"\ZF<"S%HK\2V5JP5:?(G1(-D"E ,V4,?1&(QX
MA>$_ DNP9*VGT1Y:&9"LMKRA7D7X9\,^' \Z+I\2O4:^::Z\:&.1MHHUYU=U
M/8-):EAC-E&1I,=KBQO:\<EA#1:.WB4?=B-:K!LQI,C*I#34/.//E3KJEA.5
M7Z-:$I6F]\Z#JHZT!=8]B7]M+NX.-:)SD@5"W>1M9K8H:EEI29!.M!2AV]FI
MD:.AUQ(UXDZF)EAI++;05^S\/71R2+*03%'N-A(G0(:E'+.9V+:7K(6UN%Z_
MR>KC>LI$R+-B1&*02T3.D IT>/'8D3$OJE.OJG8;DH#,#_B=ZBB]D&-KP8.U
M$70]N#5.[R4^9MNYF&';II':NRMPZN81&-SR2&JU4+7MDPQ%&I\(R!"HX_P]
MI$CM-A+VJ^A77;3.];=V%H@FX0[S<H>XX$T:2OEG-4<7$[ [-#[GW&S7Z63G
MR0@A-[VL&2=E>1O/IS7W\,^DR[EK :%K3XO^I.H+9J:YZ[K%LKAK2EPK]NH"
MV;N<F1AZ*7H^U=<:!4IK!%V7]2I- TU>"X82/=5G#*2#LAQ;LOROI#,R_CAZ
MS%=LW?<IT5<+#;+YO0'V8)PS-OG2:Q WO4M41=)479 FN-M,#VC-!UQ#:B!F
MG\2(4.4VB?AA4]MN2@- K'Q+]/*IJZ]Z?'!=B/4V_P"O^K&NB")VR;$^8"B^
MECD>3UM,U<TAUF>&M&NR4*-+3-2I:I\F,VJ8F1CS)4&\S_C<ZSSH6S1:(FQ!
M@?;6TM*[UMH0+LBRB C>\]"%M:&:-M^O"(,ED?6KM(EZ>K>"BX3;,(D@8CU8
MV<N/J=#"5_XM.GU2L='M-6IUG %]<;7UUMJEN#[O8,1P4_4TO>)'7U,C1I,F
M0TK7-;)]D;M):$KPI"G3KGG6I+$5+ ;G9?CUZU6K4_9S3! ':8M*[>V9ZW[P
M8#W P(F'K%*;!LSBXIR"XS$KI0NW7H^2$R(PW-)NX4],>??5ZO Z6R_CFZQ[
M8L^ZKC; MR38M^R-0G[^3!7NP@):-D:&>ICNI]P5.4+DQY5+V=4<:XKR&YXQ
MR,Q)0%B8D1WO3SY@U#8'Q6=0-F/;-F6NLW.44VV-LT.Y&(U_L,0F\3OS>BX^
MR[4-?:?\@JU[+A];:8P9ELI3ZS0CP92QF5+R^&OQ/B0ZE0C;MBCJVXDP[>:Q
ML94Q6T#*\IMM/[/;.[A@R*&E,Y92VQOS<!XLMGR^BZS)1#6G,5EII(?&M?B'
MZ:ZHDZ\GU$+L5LGJHSJTM1B178QPQ+$1]3:.5UO!UUWWWJQBE9.:;RD08B2V
MWTD%--2\Y3-:;D)#'C/AVZ9B"Y>Q086VF+(2L8^VP+&SMNU1C55L<#:>_-O?
M5*I.AO1UB'9UG[07QB2CP<:>%V%V(I/I,Q<,!/\ I;HMI#K1*CV/0HJ?6KL
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MR.X](#4J-\=-.UW8]48!XC>-9MK]POUJ#5^KUBLVRM(U%K34Y?3R]?8487&
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M]A<EUF6PA;WC%4N2%C^ X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M[U\NIBPR)^8N)+"JRRZAM*EOPY0=-K=/R4>?5YMVEFELE8@VP7ZD+Z^1QSX
MTC<O6NG6?5L^S1MBV1N6,'TNS[&*PK% ;2W)'!H;S6)66O4)A!3%^^2<%:MN
M;)J>K-JUZW[$J8ZUV"LV+40BYU9C9.LNORL1M=4QD;?DPHM6,[@#YKS11IY+
MQ<7+;F8D96EN9D+!F-R_) V&OPX52B[1.H5SLD0US9G]"QS6=R%J5;-WCM9
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M@. X#@?#K3;S;C+S:'674+:=:=0EQMQMQ.4K;<0K&4K0M.<XSC.,XSC/ Z\
M? %0XXX7"B#1\1O#46# C,PX<9K&<YPW'C1T-LLMXSG.?!*<8\<\#Z<A0WI4
M6:]$BNS829"(4MQAIR5$1+2VF4B+(4C+L=,E+2,.81G&%X3CQ\?#' [/ <!P
M' <!P' T_8-5=O%'M=08)X"R+&!)"(Q?,))) R5,C.-1I[@Y4F'@@U$?RE:F
M/69]5*<I\Z/'S8",AFMMKS+I2[-L#:=0L@NDSS1:"$K.J)U.E3"9:LEZNA<L
MS/V;<,8A189MYSTD14K<=PCQ<PG&<*"?> X#@04=UYM5NZ6:SZ^V?4:N.M38
M-P@&LVK)USD-$0H[Z5[F(7@[*IN$1)41IKQ97&<4AQ*E8<SA7E2&\ZQIC^O*
M%6*9*,)L$L$/S'FFD#DB&R<Y^0_,FS&129A# Z.]*DKRVQ[A_+2/!.7%YQE6
M0WS@. X&KW>MJN-+M]03/R+5:JN?K:2>(R9N1RC@F6,Q/Q#6]'3+S$S*]3TL
MN(PYY?+YL>/C@(I@ZWVZ0ME'.7[:U-L(:DGYUE8"5K4A"HS2!.54+14(Z7S4
M[:-N;8A1V+4Z^I"8F5N+:0GSIQYO$)^X#@. X%7^G_\ N:(_\>NVO_5=NK@6
M@X#@. X%2N\__*WLO_:=?_WG4S@6UX#@.!AR=> &I(N89!ARTP'*]\%EDQD*
M?)$3?T/]<%ORF'71\K^;3_.-90O]''V_9C@:W'U9K&)'D1(FN:'%BRZY(ITN
M-'J%?8CRJC+<E.RZM(9;'I;>KDIV<^IR"K&8JU/+SE&<K5XAC4:3TTVZQ(;U
M)K%#\:+%A1GD4*JI=CPH(&15841AS K"VHL.KRW1K3:<X0W =7'3C#2LHR$G
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' J_T_\ ]S1'_CUVU_ZKMU<"T' <!P' J5WG_P"5O9?^TZ__ +SJ
M9P)TVC9[13:0;L]2KH:SD@D9PG)&G;'*JP](8>VY--3,DX5>M$I<N*.CN*CQ
MTQ%>X?\ (A3C2,J<2'DO6?F0J0V@=$-O;VU,WJ74_>G2I_=X6XA;K9=FKU*
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M&$92E(8:%T,Z?#&]5QQ6@:((AZ4:BQM:#A,6>,%UV$/V<(W6+'."X,^./.#
MVWZ_!L\&,1;EL03D5N8PAM]/GX'=TSTBZO=>;(*MFEM6L:]-AJ/C6T1X';+W
M[&116;C;[\*K1@+-M$L)8!U8M=_-20N)\>2L$@I(8'JC1W%-<#O#.F?6092-
MZ:UQJ4&6H?9:[7/8^\:M:9]@N F_WC838I%RL<]BU%S.1DTTH%!<RF!F(RP_
M#8=80TZTA> P1WHCU6LY6!8;)J_)VT#]NZYWQBWE+KL&9<B6U]0 W*SJRU6*
MW.VO-CM6-?@'WH@J 3DRQD5J0]Y8WB\[E8=L'T<ZKUO4%&T&"U- &:?U?M('
MN?65%BV2Z(%ZXV+6+PO8]:,4)_[R9)U ?7;BZN5 %#WXXF&TXJ,S&1$5EC(1
MI3/B^Z+Z\G!RM*T:BNF*[9*3;JX<'[(VXD_7;#KQ&T6*I/KYYR_.& >(D'==
MLB268K[3!* >EQ)J)$9>&L!,VR>H'73;U_>VEL77+%EOSM)J>O&[$_8[?"?@
M5>A[/#[II+8>&,L$(8%.5+:U?@GAQ>(PR7B$(K:VY*<)PG@0NY\6_0=Z4P^Y
MUQJZXT<8&#8!+/WE52?%@=07[0@Z#-IBK3FISX_\(MIV,-(P]"<]ZT:EO2/5
ME.Y?X&^S^@73<O6TU,]U]H5F#>&U_<8M44A:"9%_><@!*V].+GS\\B>,E-@/
M54;]1E2I+TEU,".C"TH:0G :9LCXR.D&W;+<;?L722;+8;_9[=<K?.=V+M@<
M@S9+X U55K<2=A![V/@1OK==T?4H;C+#34=#(&-A"$>#F5AKFM/CT$ZO=[1R
M V[=FDL]I >V8-I&V @0/5H98MJ62WV)5V9KAHZ1@,G:PW;W8$5D3]$'O04Y
MP_'<>4EYL,OUO^-OK5UXKO7U4>JIN&V.O]7#!A>Y2)&U#K):3T#0=%ZT%+58
MA"+5/#37#&G]="A#8Z0F4-%Q8^$068_CG.0CF_?$KU8M!S22*G6(.NM;ZRL%
MZGWK60)D^] W#4[CUIMO52!K4U9DVR#8ZO0:=JBXR( P6/>P/CPT)B-L-Q5O
M-NA.TKX\>ELR!?1+O7VEMA]FARE<N@6(X<@ RE8/6,S<;%5(H6$7CBP=5LMP
ML$PN3&CV8L(@5>]W(:<D(;<0& KOQF]'ZE=$[$KFC(@JY8V94]PY-Q[WM'+K
MFQZ+:=J72H65^*[=W($ARO63=UJ?C1G&E0D),O,^CEA+3;87!H=(KFM:;6J#
M4(Y&)6*B(A@@48L?L%J)L#8#6&8S<ZQVLH;LAJ0EO'@J1-ER)#F?M6M6?MX&
MV\!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P/)'O[O
M;L5KSMK\?^FM$V4W&"]@%]GQNRZF#_AZ/FDVJ)J\18:.>CVJ\TJWXKTRMFI4
MF6S%;]%!Y4?V&<*4XGRA#U_^6#;&MKJ8U-"ZQ&+8?K>]:7U[9N5ZM,ZB#)LT
MMV2USUH9V+L1P'K@T/I(_9#-Z<O]9:@L36"%2%37L^WPC&4A[;UYX](  Y%I
M@"Q5G?#C'K&,!DY1L(-/.PF%EX <S-%@YI<7#(*<;CRGH4-V0RE*UL-*5EM(
M9=2DH2I:U)2A*<J4I6<)2E*<>*E*5GPQA.,8^W/ \(;U\K5VTQN[MO&MM8"7
M?3*.NM([+]*R.9@_78&X5&GWEW3G8H2=V47]V*+OABLL1>!JV6UR9M<)/18C
M+LF$]C 17>OFTNZ*L,KHO3E:C6W8?7CL1LL3?=6;8C;% Z_)4S5?;G86H"*C
M#NJS]!(D+U$ZR,--0''"3P\Q8&H1&$EZ(J'.#/57YH]E/7NX:O5UD1=I-/UD
M7LH"QCMI0X5GOIFGZ5Z4;>--3:^1U]4:8.GF(7:XG"@,Q2K:")JF3(;+;&7L
MXB!Z"=$>V]^[4V[MDFV@P5;JNK-H:G#:A'Q:_>*W92FM-D]8M*[K@VFT0;Z*
M &%ND;%L4E!95D? 6TL8]'=8;>8<QD/1'@4G[];?V[JWKK?HO6B0!>[56BF7
MEWKZ!/B46&"8MU+JQ"XS/? /<QG98K$$5[-V1^DQ#DSX[K^/2PK@>7M5^67;
MMK["4BXZTU[-VUUM[ =8^EU[J.KY4F-3KKJW8VWW>X*]P$L'/N#-23':MD:<
M!0+\P8)QF:FSX36TYS)PS(#($/F*VF+/$+.2TD-$4/\ "]J^^@Z!8H.PP=](
M;YNO;J_=9;K1,61BI'0)F%KEVG1'\J&L.B9_U5B4V84-DQ9R@A>P?.CM*GU"
MZ;B':!<N8JP"M.7.MZHM.P6JT[KP+;/C%.]X[%5Q9FN:0E6 V?;N]*DTYY!3
M$M2[ 382RY#3Y1R0_I/IUC8N-1JUNBL*BQK37 =CCQENH>7'8-C(I-EA;S>,
M-NJ9;E83E2<8PK./''V<#8^ X%7^G_\ N:(_\>NVO_5=NK@6@X#@. X%2N\_
M_*WLO_:=?_WG4S@63MMC:J-;,61X18CZ!$-<OZ)4@LNQ60HM.4H;A!PT%*GY
MLQ]Q>,)QXI;1CQ4XM"$J5@.I0;L!V51ZAL.K*(KK=WK8:U@5%Q!.OE<B3P]@
MG ^I S46"7$3O;24^K&DLM/,K\4K3A6,XX&V\"%MU[UJ>A@8NR70/<YP0H=K
M-:P0JM<>.QX!JZ7>H:YJ4$FXV^PB&[8+C>!\2/XYS^BIUY?D88><0&\UN\UV
MS*C0HTQ(ZR.A8AZ;2C+D8?=@8^;Y$M.':RJ0X2&8P\YAO*UIRTI><>5:L9QG
M(:'M'L/J34FLMF[9LEO#3JOJ,18BMS9KQ@&5,Q'ZN&FGR=>CCOJD?#UKR-'N
MJ8&J6B4^I/E0C*LXQP-I);;U8$C3Y9[8]$ ,B%Q63.3MNKX=023-'RBL:(92
M0(Q\BYCPV ^^EI_R+RRPXO&/*A6<!C9&\]-1:[LRW2-H45JKZ9E$(.U[ JRB
MOI&OIHH&.LI*):Y^).8X>3#!%HTEQ#JDJPV\G[/'/AP,!KKL?J+9@R^% MM%
MBVM9VVVU"ZQK(4"B)@)^HVHS4'CL]E11],2J'B0)]P40=4VS/C8PXW_I3@,W
MN+>6K-":\>VMM:VPJO0(Y:HA7K&MF61B(EWBRB*I7W/(+8FR%#W"9MAR3*PC
M,>%"2[+D+;C,NNH#-'-KZMK!&:(LNRJ!7BPUCW1$6<N-=$D8$;R07?<384\C
M'DQ6/3*1E>=:4I\LAK/CX.(\0^SNT]8U=<]NR[&H==6*?;C$T';?7Q"QTEZ'
M*(LQYZ2!&/F&^Z/A//I0YY5*996O&/*A6<!HM@[):?JNW(NEK';Q(2V2=>FM
ME.S"A4) KHT&#L=.K+\$P5E%&<BCTZ=>A[L.*^TC,R,MQQI2O37C ;["V?K4
ME#R1';#HT\?@L. 9G0K: E0\'2\*$1$A<RF""V,%B@\E'?CQO-ZS[,AM:$J2
MM.<AAH^\=,S"]: 0=KZ[(F[B=F5BK"AMRKY&<>L0^MO7&:%&QH,^0Y))1:K'
M406UC'G3%RES./*M&5!WHNW=5S2M@!1=C4ETS5+C U[8QGWF#HFAKV5"B;$-
MI\Z.Y+0XU9)X0[#DM0_#UW&I",X3GQ\.!H6WNS^E](%PM>OEP&P["8)4.,Z
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ML0%F2(T%32='J4\HB?)>0EEAGTWTLR,X8X$U#]GZU+,C)(K8=&)QS9I^N!I
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MOMRW?56G*(SB',_HJ3G(< S=&GS3L9@1M77!*1+E0H$:+"NU:DRGIY)E3X^
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MC>28%F+EM,84R\C#02?M;HY3]J;(N.R)EYM8N=;$1R[(M,<42A5V^#]);*T
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M*F!KT**ZMQ,A>/*QE/GS_P!W@5_KTNJ@-R:H%T7?MHV&W95WF'8JT6VU!O\
M#<'C:G)*1)V1/JR9,1V&4CL^62WE&$^?R*SG#F,<"Z7 <!P*?6QRH&]K;"@7
MC?5GUU]";J$4%6Q.VX5!B8'S@""$@A](R]&D2G99%]W"I*_/A?IX;3G'IYQP
M);Z]&IEATQK\O//2;1(EAEXQ8YDV.2EFXT8A-B0B4@E$0W&(O2X3#:U2$8\K
M^<^?[?-X\"9N X#@1WM\G+":FV@9@$G@\\1KN[$X1>.\U'?%2X%:)RHQ)E]]
M*V&'H+S274K6G*$Y3C.<9QC@5R%NTJO[)T\S1>PUJOLNPW@P#,U<GN*'>X9
M$C5NQSJUNA,ORG<9A%@D-Y+[>$K;4WC&5>52L*"Z/ <!P' J_P!/_P#<T1_X
M]=M?^J[=7 M!P' <!P*E=Y_^5O9?^TZ__O.IG MKP' <"B/<SJX:[0V?KV#7
MY8NM:^8W; W 4@E0<&U,4;:G7W8FGY ZJQ+!4[6/FS2DJ\(P^O*8SL6,TMUI
MS+N$(4%:GNK7=85<P=2KVPB\/0M9V:.CB_HW9C9HJU/:39W@/NL4"[%>K:B<
M:57M.SI=4PC!MV5*]FUG$I#665L!KMUZJ=X[/_#>W2+&RYN;6T/;[&;^)[!V
MB$/-V8P1U5BI6JO Y5"1]R*5>!E.E.'Z<A4H0P\E#'EE,K6XX$@P]'?(OB\'
M#T7;]> !)FS0]F"5LIL&W7NK#ZW-5.%V\9,BR15?LN6AD&)#+!&6B"@[A!QV
M%*#(BO9?CAO?7/1/;&N;5UA<MX[$NAH 'U=L%F_5W\01JY5B3NHH3UF-!&@M
M=@:]UM%+4)T)7[)/A0BK<EP1(-H1A*O393!#4A?73O%+V3K<Q>MV%2='&;7A
MD-J!JAMJW5)JY5H;)[$2X=L"1!XN')K0N9 NE#@SJ;&E,CG7:Z^[AY>6\.D@
MSVYNO/:Z];KL]NJM]*!*3#V%(+ZY]AN$^$)50'8^H5VU*9, JUFL&:J@F W(
M2'EXHLDS-'R%Y=F>9IS+C+@9[8.K>\!G3.@@5;NU3A[;J)6(6VC9PFPK_4Q)
MK(:\5<O#@(@$&[K)-C[32X!&"38*2RK,"5*PVPF8VI,R.%7QW2WM-5Y[]BH\
M*#6+9'";_BB#T?L%<7Y4:9L_OD)[#U^.I4T)/:5$5J%N7"(J6TK_ -I/+C)2
MZTZJ9@,_-ZQ][A5:OU8UE8PNOQUG$[E>KK ?==G#0JA<[YV3[-;6K-O$C@-2
MBI^KM5G9E703\76V'EPWVG436X;#4X-QJW6KNN*NTMR9L<@$I%BV#LK811VD
M;\,-GX-KLV*N=!39\6[Z@N0HY2/1;(5U==81!A#5QF2$5'A*4B$%X.LP#>=/
MUJ'J&^B8>VVX*@IZE^%EBTF59HTBTV+Z+]=%F99=\=8F*JV.=(9C3WQV9TAY
MN&AF.TVC 6*X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
M X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@=>7$B3XLB#.BQYL*6RY&E
MPY;+<F+*CO(RV\Q(CO)6T^RZVK*5(5C*58SX9QX<#7@]&I-=EY(5^GU8'/RR
MN/F:'KXD9+RPYE"G&<R841A[++BD)RI/F\,YQCQQ]G VG@. X&KF:/2K%+Q/
ML%/JQV<EE$=,TS7Q).6F.VI:VV,29L1][#+:G%92GS>7&59\,?;G@;!#AQ!\
M6/!@18T&%#9;C1(<-AJ-%BQV480RQ'CLI0RPRTA.,)2G&$IQCPQC@=C@. X'
M$^PS)9>C266I$>0TXP^P^VAUE]EU&6W67FG,*0XTXA64J2K&<9QGPSP-8$T*
MB@9K9(%2ZF%(M(<;:GB:X''36VWD9;=0W*APV7T(=1G*58PK&%8^S/ VS@.
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M7%1V&<*;::4M[SAZ/<!P' <!P' <!P' <!P' <!P' P]AL >J C%FL,YL8"
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MH\ [%'2;8(=5EO.//'*QW$>;Q<PV$1[_ .^(;1NT?N1*U]<BU?I9X"WMFQ0
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MN$@T"%6J(<)L6T)8(NT)@V^"B*&D#<4-;&E[/EP@^ZSZ6!6<J1A,F&J0%UN
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MTL)#V3UPTIMV6"G;$HT6Q2:S7Y55 KR6L(M(RO3;11KI+%1V0A<:S[9^TZS
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M#J0.?/KPH"1<:#+(I<(S\"%^T>E$(TB.A:4-MMH5&RM.,>JK& GC@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MN'8<-Z<PAUU*<H;6\A*LXRM.,A^#"XHU'<EAR4$I%9F3AST@?*8F,LD!<MZ
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MEP[GM"$71#GQGHBH\%3*?3\&D\"$M.]1^V%%M&LAUAVN\]IRCVY)B/3@V_\
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M <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <"K_3_ /W-$?\
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MV[R1 T$DND/86'7TX95'3*PIA#SB?*\H*R7;Y9J;0@4HB9UG!DF U<[ RK.
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M"98^S6<*W%%UK8]!L>">K5:]V5;B=8.UL*)+JK]=(7 #)(26GOILB3+:;?\
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MF\AZ2\!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M-YN0VDF(.Q:[7J7NGM9L4) JUI;MBHZ)0>H=EF0\-MZ']-8=KD9Q$1$92(;
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M5O@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M1M#-%C7VN5NXP\ZTHV1)^G%]J]K:^4N<NU0BXXT+4#U:$U>77EB! 4J80?\
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MRVI:O!.,YX$0?CIZ=_F1U'_3 ;^LX#\=/3O\R.H_Z8#?UG ?CIZ=_F1U'_3
M;^LX#\=/3O\ ,CJ/^F W]9P'XZ>G?YD=1_TP&_K. _'3T[_,CJ/^F W]9P'X
MZ>G?YD=1_P!,!OZS@/QT]._S(ZC_ *8#?UG ?CIZ=_F1U'_3 ;^LX#\=/3O\
MR.H_Z8#?UG ?CIZ=_F1U'_3 ;^LX#\=/3O\ ,CJ/^F W]9P'XZ>G?YD=1_TP
M&_K. _'3T[_,CJ/^F W]9P'XZ>G?YD=1_P!,!OZS@/QT]._S(ZC_ *8#?UG
M?CIZ=_F1U'_3 ;^LX#\=/3O\R.H_Z8#?UG ?CIZ=_F1U'_3 ;^LX#\=/3O\
M,CJ/^F W]9P'XZ>G?YD=1_TP&_K.!UY'?3IA#2VN9V<TS#0](C0V5R[R&BH>
MF3'D1X<-E;\AM+LN9(<2VRTGQ<=<5A*<95G&.!V/QT]._P R.H_Z8#?UG ?C
MIZ=_F1U'_3 ;^LX#\=/3O\R.H_Z8#?UG ?CIZ=_F1U'_ $P&_K. _'3T[_,C
MJ/\ I@-_6<#\SWJZ=8QG.>R6HL8QCQSG-P&8QC&/Y<YSEWPQC' LO7K""MH
M':ZN8&V&LV8.,L%=/AIL<B'. C,)DB(,"B$1QV+/&DX$EMYAYM2FW6EI4G.<
M9QG@9C@. X#@. X#@. X#@5?Z?\ ^YHC_P >NVO_ %7;JX%H. X#@.!4KO/_
M ,K>R_\ :=?_ -YU,X'[VNSG$GK!G&<XS^+35&/'&?#/@H5<TJQ]G^C*<YQG
M_P G MIP' <!P' <!P' <!P' <!P' <!P' <!P' <"I_>=2D=2MY*0I258I_
MAA2<Y3G'B7&8S]N/#/VXSX<"V' <!P' <!P*F]X,YQUKN'AG./\ WLTSC[/^
MS.[==8SC_P V<9\.!;+@. X#@. X#@. X#@. X#@.!4W=.<X[*],?#.<>-HW
M?C/_ )<?P6L.?#/_ &X\<8S_ /HX%LN X#@. X#@. X#@. X#@. X#@. X#@
M. X#@56[<J4FEZGPE2DX7VIZHI5Y<YQYD_Q]H6?*KP_E3XXQGPS_ -G M3P'
M <!P' Z9!2D0)RDJRE28<E25)SG"DJPRO.%)SCPSC.,X^S/ KQTT_P"4'JO_
M /BY:2_NUK7 LGP' <!P' <!P' <!P*O]/\ _<T1_P"/7;7_ *KMU<"T' <!
MP' J5WG_ .5O9?\ M.O_ .\ZF<!VO_\ M'6#_P#&UU/_ /LNY<"VO <!P' <
M!P' <!P' <!P' <!P' <!P' <!P*F]Z?^4C>?_W/Q_\ M@7P+9<!P' <!P'
MJ9WA_P"6NX?_ 'MTQ_?=KG@6SX#@. X#@. X#@. X#@. X#@5,W3_P RW3#_
M .].[_[E;%P+9\!P' <!P' <!P' <!P' <!P' <!P' <!P' JIVZ_P#@S4W_
M .-7U1_O\H? M7P' <!P' Z1+_\ UT__ &*5_P#X'.!7GII_R@]5O_Q<M)?W
M:UK@63X#@. X#@. X#@. X%7^G_^YHC_ ,>NVO\ U7;JX%H. X#@.!4KO/\
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ME!2,]J<]KOKU1=YRJ]=2T NMN883-MSX1Z2)PF-G,+W;27$N892&1W8-ZQZ
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M$2*#UDVW@I.%*]K*DQ7\0VI;+GI2DMMA8_\  MT__+OK#^CS/_CX#\"W3_\
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M7T+9NGPB[A9]L*";8,Z3FX!Z 1OA99^ZS&"$7M&T]ZUI/.KG3/-E279JU/\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g259893dsp002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g259893dsp002.jpg
M_]C_X1<?17AI9@  24DJ  @    -   ! P !    J (   $! P !    %P(
M  (! P #    J@    8! P !     @   !(! P !     0   !4! P !
M P   !H!!0 !    L    !L!!0 !    N    "@! P !     @   #$! @ >
M    P    #(! @ 4    W@   #L! @ )    \@   &F'!  !    _    #0!
M   (  @ " " _ H $"<  (#\"@ 0)P  061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD ,C R,CHP-3HQ,B P,#HP.3HT, !R<C R-S<V-0  !   D <
M!    # R,S$!H ,  0   /__   "H 0  0   *@"   #H 0  0   !<"
M       &  ,! P !    !@   !H!!0 !    @@$  !L!!0 !    B@$  "@!
M P !     @    $"!  !    D@$   ("!  !    A14       !(     0
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M2224I))))2DDDDE*22224I))))2DDDDE*22224__T?54DQ( DF .25'UJ?\
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M56&3X_0^A_PG\VF9U'&L87L]1P:\5_S5@.X]H<QO]I_\VQ)3:5?!_HP_K/\
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MG76WV.+MS]IV&YEK6_2TK;3_ #;?=_UQ6,'^C#^L_P#ZMZ2G_]7TS+^GC?\
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M6>CB-ECO2J=L_P"!_P (DIL_LK)AOZV-P(<7>A5J^ /4^C]+>QKU)O3+1SD
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M='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%
M6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F
M "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T
M   ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M     $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N
M=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M    4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L
M("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD
M(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%(            *
M=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M  !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M      !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG
M8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE
M9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E
M8W14;W!L;VYG       X0DE- ^T      !  2     $  @!(     0 ".$))
M300F       .             #^    X0DE- _(       H  /_______P
M.$))300-       $    'CA"24T$&0      !    !XX0DE- _,       D
M          $ .$))32<0       *  $          3A"24T#]0      2  O
M9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M!@       0 U     0 M    !@       3A"24T#^       <   ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H   X0DE-! @      !     !   "0    D      .$))
M300>       $     #A"24T$&@     #00    8              A<   *H
M    !@!D ', <  P #  ,@    $                          0
M       "J    A<                      0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   A<     4F=H=&QO;F<   *H    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   (7
M %)G:'1L;VYG   "J     -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M     #A"24T$*       #     (_\        #A"24T$$0       0$ .$))
M3004       $    !CA"24T$#      5H0    $   "@    ?@   >   .Q
M   5A0 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0
M# @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,
M# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@
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MO24A?]:.A,#C]K:XL +FM#G$2?3;[0W]_P!J3OK1T%M3;SEM-3GFKU '%H>
M+-KR&^SVN;]-';@98:]CLUY:]KA(96QP<?HV!U3&>Y0_9W407%O4G@NUD54]
MM/=^C]R2E9/U@Z1BFUM]X8ZAP:]I:Z=Q:VYK&>W](YS'_F?\7]-B#_SKZ#N#
M1E;I.T%K'D2(\&>>W^NCOP.HNKV-ZE8TRXEWIU3#@UK&?0_P<;OWT[^GY9+O
M3S[6-<2=I;6\:DF/TK'^S;[-B2F-O7^EU6.K-CGN86!^QCWAOJM==7OV-/\
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MAUP/<1ET%NYY:TT.T:?YACB+_I5_X1_^%_X-)38]/-_TU7_;1_\ 2R7IYO\
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MASG.H>'23IMWU;GNW_N)*0UY/6*8I& ZVMAVBZS(87. ?Z8L^C_A*?UCW?\
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MB.S*]KV%C]Y=EWOKV #;<S?39;O]GYG_ %OU/40[++'TBD&QQ;4-SV9;&/\
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MNEWE[G-R0T.$$>C49!#6O:YVS\_:YR1Z589'KMV<L9Z-4-=^CW.;[/SO3?\
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MX0/\E_\  ?\ 02_R7_P'_024G]:K]]OWA+UJOWV_>$#_ "7_ ,!_T$O\E_\
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M    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\
M8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300&
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MQ &B    !@(# 0             '" 8%! D#"@(!  L!   & P$! 0
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M\Q\@Z+KO";-^+M%L:N_G$=V?RGJ1\CM/M6KW2QVGUNF]]G]XUE;3]G08N/\
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MFTE'O#-5N<QE)M#:],)C-Y):9/?NO='7VS_-F^36]_D]\:^TZY]IX#XZU?\
M(-W?_-0[)Z$V]MW.93,[BWB^7VK+N':&)W=)NN@$N5QJ89J7;==54,]-0TU?
M6"HH:N>6*>#W7NESV'_-U^<O6G\NZ7YZUOQ[Z7RVT]Z[1_E];_Z3R53FV@V[
MO:H^66X\+M?NCJNHP^W>SMP[OP53TYE-PT#8;<^0BI:?,Q5+)+C4FII5/NO=
M/78'?'?W2O\ ,>VI)\C=@?#_ #OR-P'\M#Y\=O[+[@VKOWOGJSJW:?6_7O;F
M"SO7^P-^5F^M^9/8.(V]F<718FIWCN>MVY-68B>EJ)*&=:(F%O=>ZK0^=?\
M,\[A^9'\O7^9]LO<>$QFQLG\6]R?RBNQ>L>QM@46]MAYO,8?Y;;TZBWCG7I8
MLUEGSW\#H*HY.FP696/%39_:N2IY:B@@:1_-[KW5[?Q1_F2]@]O_ ,QCY-_
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M!1TE<.Q]J8ZJDRF*2.:&L2"6J> R(\H]U[I?=;?!#X)XFJZ)W]UETMUM5O\
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MCARN6BQZ4R9"N@CEG#M&FGW7NDGNWX2?%#?NZ.Y]Z[UZ+V-NK=7R'V=ANO\
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MW3D]D;DVY5[HZ\DK-S9"6;!U[5&*J7K)3+ Y8^_=>Z(I7?RF^O-W_.'O'O\
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MSMK^==WO\-:X[RZ^Z]S.\:CKS9O0/>V^-E9E,M@FJ=L;-[;VVN+3%5F6VY'
M*JC>IA&CSSZ_=>Z*ELSY=]A?%+^6I25/078&T<#N3J7I+^9E\C,;U70[(P>8
MJLA%U)\YMW8G;>X-U9K<533;7P'2>..4K<%78O%^+=.4R66HSC)8XJ&K(]U[
MH5MF=A]Z]$?)#Y>]F]*[^V;2; W1_.JZ!Z<[$^-U1UYA*ZK[5QOR3^.GPHVK
MO;=F&WS!D*7<F WQU]0;FEW;3?:PI0STF%R3Y*.I2?S4GNO=0>D_D#O;J[K_
M *^^+72O:W6/QRRG='?G\Z7>/7_9>]#M#&[3GW_T=\Z-\4NT>JL='NO;6Y]K
MR4-73;_J\]F\=#2P9BHP&$J!CJFE=99X_=>ZMP[6[O[#VUT5\3<ED.S^NML]
MI=Y]@=&;"SF0ZLV[7[_Q'9>XMV[1R>Z]Z;8^-TF\HZ+$41W%3;>KZ_#9S=D)
MQE!MVEGJJN,RB/W[KW5?/\N;Y=?(CY3_ "%^,NX^T>R)_P"#;O\ Y;N_^Q-U
M=>;=QFWL;L;,]H;9^7U3T[5;_%/2T=36)E<SM[;-,\B0UKT=+*TBT2PP3RQR
M^Z]TJ_G#\U/E)\7NY.Z]E8;<.-S=%0;7Z(^5'2>U\=UYA:W-;A^+W7>[,OA_
MYB&T9<E75L4>0WAU/L/&TNYL5D%0R*^>Q=!]O422,9?=>Z?>Z?EI\EMF8_I7
MM_:O:&W)NCOE[-\A>M^BJENML)75&W^UMZ;8K=U_R]LJM8]3!/NC:W<E/M"L
MHI:6H6GDKLAN/#P"IIOW)']U[I'XOYU?);=7Q!QWS/QFY,=MW:WQ[J/CY@?F
M1UYD]A8*NR5%N'KG>;;>_F1T>)R*RPSX"KZ7H:^=Z*51-2QR;9KETR>=##[K
MW0R?";Y<]U]Z]G[ZZN[ WAC(<IT1V5VSO?L#*MLW!X"@WO\ %+L/&8K<GP@W
MA2&":HI]N-V/L3<KY&KJUG,C9#:.9II8Z<:(X?=>Z+I\C?F/\R]B]S_.?-=:
M=R;(KMA?#;NSX#Q;3Z,GZJVYE<AW7L?Y2T>PL9N_K2MWO%DO[RX[-Y*LW;42
M[4R..B6H;,0PPSBII3) ?=>ZAXKYC?+RA%'E-W=_X0[>[?\ YK/:/\MK;F1Q
MO3VQ<70=(;5V5W'W108#LV?+UCY>+/=F[VP_7F/V5C(<K!+@H\SF*.JDHZF8
M-3U?NO=,^\OGO\U>N.H-W[\J=V;-WI5_&7YE?)_XR]LI3=8I-FNZ?CYUOMN"
MHA^8.V<%M>.MJL/6_%:IW31UW9&)QE+)BLXFWLM1T'\,K:B@I']U[HT7<GRA
M^0W3_;W5VR<7VOM3M'KSYG?'/#;3^&_9F!V%@GP]1\R:"3"U>0K]PY#"UF1P
M^:V#V'U;GY-^X>G26&EAQ&U<_']S,/LW7W7NE5@/D'\C,-\L>W/A[O'?,&;W
MMC]V]5]^=.YO&]=X"CJMS_"JJVE6_P"E"FJ<=!)+05F]<-W-LK);/GR(> 4S
M[FV]4K3J))@_NO=5N;G_ )A_R_W'\5NM^\<'VE1U-'\U/Y<?\P'Y"IA=H['V
MGC,W\+NW?C5UG#OO:\>T\U+C<C6Y[;FWLIECLC<T.ZH\C7Q[LIZ:HIZBB$SX
M^/W7NC0]>?+/Y$;Q[8Q_4&ROD1TOM#,_'&7X(TN^MB=ZY3#X_+_(3JCOKJ[8
MF[.Q=]P_9['R6^JS=^;R>[JS;^R*G UM'C1NG;\E/EHJU:IS![KW1D/E5\H-
MYP_)S!_%GK_Y']<_%:JRWQ7[,^0NSNWM][>V?O';N_=^=?\ 8V&V/7]?U5#O
M#(8O%5VT.O*.=\ANZ@Q=;0;CEI:^G:EK\<M+422^Z]T6W=7SS^1M3O7M'L?9
M6ZMO';O17\S+XY?!',_%Z?9V#?(]D]5]V1]$8*M[DHMPSRR=@8K?F:F[Q?>6
MU_!5C;_]U\)]K54E7*]1D(?=>Z0?3'RX^9G9NZ?B'MG+_(O#T<?R9WM_-7ZB
MW-DL!U!UQ!-M-_AIW%O[;W4G8&R(LI29>!-U2X39\=+EH,H,IAZNEGU+1152
M?=/[KW5K/\OKY [C^3OPJ^*G>>_JC;_^DKMOX]]6]E;XH]OJE'0G.;HVY3RY
M7*8_$>>HGQN(R69IZEJ>,LZ1Z6B5V\9/OW7NCE>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]7?X]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW0;4/3G4>+W/O'>N-ZLZYQV\>Q*#^%]@;MH=D;:I=S;ZQO
MC,(QV\<]3XV/*[FH1"Q00ULL\>DVM;CW[KW2;Q7QJ^.>!2EBPG072N&CH=EY
MCK:ACQ75FQL?'1]=;A>:3/[!I4I,%"M/LK.254C5F*0"@J6D8R1,6-_=>Z=^
MJ^BND^B^OX>I^E.H>LNH^KJ=LG)%USUIL7;.Q]CQR9IWDS$J[5VUC,=A!)EG
MD8U+>#5.3ZRWOW7NGO"=7]:;:VA3]>[;Z\V-M_85)(LM-L?![3P.)VA32ID$
MRJR4^VJ"@I\-"ZY6-:D%8014*)/UB_OW7NF.'HOI6F[3J^\:;J7KB#N6OH8<
M;7]J0[,V]%V!645-CCAH(:O=J8]<Y4>#"L:)&><NM$? #X?1[]U[INV]\<_C
M]M&MP.2VOT;U%M[([5W%N[=NULCA^N=H8^OVQNC?]1+5;YW!MNLI<1'4X+,;
MQJ)W?)U%(T,M<SGS%[GW[KW23POPV^(NW.N.Q>G=O?%SX\X/J7M[(UV9[6ZP
MP_3/7>-Z_P"R<MDYHYZ_)[[VA1[=@P&Z\A4SP([35U//)JC4WNJV]U[H0(>C
M^F*;J3_0#3=2=:TW1@VK+L8=-4^Q]M0=6C9<\#TDVTUV%%C$VNNW9:>1D:C%
M+]N58W3GW[KW21POQ.^+FW<C#F<#\<.B\3F(,U!N.#+T'5&Q:?*P;BIMM4>S
M(=P09),$M;%G%VCCX,8:Q7%0U!$L!<Q@+[]U[ILW#\,_B%NW$;,P&Z/BS\=]
MP8'KFGW52]?X+,=+]<Y##['I=]02TV]:7:6,J=N24.WJ;=T,S+DXZ1(DKKWF
M#GGW[KW0D;DZ7Z=WEM7;NQ-W]3=:;JV1M";#5&T]F[DV)M?.;4VO/MR..#;L
M^W=O9/%5.(PLV!AB5:)J:&)J55 B*@#W[KW3MN'K3KK=V7V?N#=>P-E;GSW7
MF0ER^P,WN':V#S67V/E9H%I9LGL_)Y*AJ:W;.0FI$$3S43P2-&-))7CW[KW2
M/3XZ= 1[WWAV4G275 [!["Q=;A-^;T'7^UCN7>>)RF-IL+E,?NG+MBS6YZER
MF%HH*.J6J>45-)!%#+JBC15]U[I+]A?';!Y#"3Y#HU=@_'SNF@V=MKKC9'>6
MW>F.M]U[JV-UQM[.XG(GKW$8_.8N&F?9-1BJ"6AAQ?ECHJ'SB>&-98D]^Z]T
M*'5_7.WNH]@;7ZYVHE5_!-K8T44%57R13Y3+5L\\U?F<_FJB&"FBJ\]N/,U=
M17U\RQQK-65,CA5U6'NO=)/:/QP^/NP-Z3]C;%Z1ZHV;OVII*W'R[PVOL#:^
M"W$:3*2Q3Y6!,KC,92U<$>7F@C>LT,IJVC0RERJV]U[I$U_PE^'&3I/L,G\5
M?CO7T/\ #-UX7[*LZ;Z_J*0X;?.X8MV[PQ)IY< \!QNY-U0KDZR#3XIJ]14,
MOE&OW[KW2BWG\5/C%V+CNQL/V!\>.DM\8CN"':T':^*W;U=LK<6-[)BV+1TF
M/V4N^*++X6KI=T-M*AH*>'&M6K,U%%3Q+"46) ONO=3JGXS?&^LI(*&L^/W2
M590TO7])U+34E3U5L6>EI^JJ#QFAZSAIY<$\,77U&84,6& &-C*@K"+#W[KW
M4+/_ !3^+^ZL'O+;&YOCET5N#;O8NV<%LOL#!YGJ;861Q6]]H;6,+;7VMNRA
MJ\!+3[AV]MEJ:,XZCJUEIZ$QJ8$0J+>Z]U)3XO\ QJCQ>%PB?'KH]<-MOK^;
MJ;;V)_T4;$..P75500U1UIB*(X$T^.V!4L+R8:%4QTAY:$GW[KW2KVSTYU)L
MK<TF\]G=8=?[3W;-LW;_ %W+N7;6S\!@LW)L':3SOM7939+&4%+5G:VVFJI/
ML*#5]K2!R(D0&WOW7N@[K?A]\3\EFLQN/)?&7H/)9[<.6WKGL]E\AU%L*OR&
M9S79-'2T'8F4RE558&66OK=^4E%$F9DE+-D_&IJ?(1?W[KW3IEOBS\9<]A-W
M[:S/QWZ.RNWNP-I8;8.^\)7]4;$JL5O/8VW!$-N[-W30S8%J;/[7V]X$^PH*
MI9:6B**840J+>Z]TI-B=%=)]7;=S^T.M.H.L>OMJ;LGEJMT[;V5L/:^V,%N:
MJGQ=-A)JG<.*PN+HJ'-5$N&HH:1GJ4E9J6)(B="JH]U[IZV=U;UGUWM ]?\
M7_76Q-C;#*UZ?W(V=M' ;9VAHRH891/[M87'T6&T9(2-]P/#:;4==[GW[KW0
M<X7XG_%W;>R_]'&"^.?1V+Z^_O'C-WKL>DZKV1'M)=UX-8TP6XTV]_!#B4S6
M!B@1*"I$0EHHXT2!HU50/=>Z?<[\=?C]NC(;CR^YNC.G-Q97>.4V]G-WY/.]
M9;+R^0W5FMH%3M/,;DK<AA9ZG.97:^@?PZHJFEFH;#PLEO?NO=*_:/6_7G7]
M1N6JV'L/9FR:K>>;EW-O"IVCM?![;J-V;CGC2";<&Y9L/0T<N=S<T$:H]75&
M6H95 +V ]^Z]U%VYU1U;LZ'=U/M'K;8.UJ?L'(UV8W[!M[9^WL)#O?+Y.!J;
M)97=\6-QU,FY<ED:9S'//6B:6:,E78CCW[KW2CV]MK;FT,5!@MJ;?PFV<)2M
M,]-A]NXJAPV+IWJ)7GJ)(,=C8*:DB>>9V=RJ NY)-R??NO=![)\?>A9O](AF
MZ1ZCF_TO(8NV!+UOLZ3_ $H1D!3'V)KPQ_OLA4 6R?W(MQ]/?NO=99^ANCY^
MJ:OHF3ISJX])5^+EP=9U"FP=JQ=8SX>>H^[EQ<FQ(L4FUS0O6 3>+[71Y@'M
MK /OW7NF+;OQ=^-.TL_1[JVM\?.D]N[HQVXZW>&.W+ANK=DX[<&/W;D<108#
M);HH,S2X.+)46X<CA,734E36Q2I4ST\"1R.RJ![]U[IUVC\>NA-@=F;^[IV+
MTGU/LSN'M6.EA[.[4VKUYM+ =B=APT3QO21[VWGBL32[BW1'!) C**VHF 9%
M/U4$>Z]TWU_QE^.>4W_+VMDNA^G\AV=-NO;^^Y.PJOKG:51O1][[2P=1M?;.
M\&W-+B7S']Z,#MJJ?'4M?YONH:$^!7$0"#W7NE3NCISJ7>VV=^[+WCUCL#=.
MT.U*O^(=F;8W!M# 9? ]@Y$8_"XA,AO3%5^/GHMRU\>+VWCJ=)ZQ)I4AH*9%
M8+!$%]U[I*8CXP_&W 2P3X3X_P#2V*GI=\-V;2S4'5^RZ:>D[(?$4N ?L"DF
MBPJO2[UDP=%%2/E8RM<U/&(S*5X]^Z]TQ9CX=_$O<&+Q6"S?QA^/V4P>#Q>^
M<'AL-6=/]?S8G%X7LYXI.Q\10XQMO_8TV,WY-3QRYB!$$61FC22=9'16'NO=
M*S$_'CH7;_8%+VM@NENK<-V;0X6@V[2]@8O8>V:#>%/@\5B/[NXO&0[BI<9%
ME4I<;M[_ ''TZB7]F@)IDM"2GOW7NDQNSX@?$W?NQZ?K'>WQB^/F[NMZ3>LG
M9-+L#<?3?7F9V73=AS5$M54;[@VQD-NU&%BWA55$\CRY)8!62M(^N1M37]U[
MH2=]]3]7=H8'$[5[(ZYV1OW;. SN W/@<!N_:^&W%B,)N3:TXJ=M9_#X_+45
M52XS,X"==5'4P*DU/<Z&4$W]U[I,;2^-_P ?=@Y/9^9V-T?U+LS+=>TF\L?L
M3);5Z]VIM^MV;C^Q,N,_OR@VO4XG%4DN"H=XYP"LR4-,8XZRI'DE#/S[]U[H
M1,OL[:.X,A!E<]M?;N:RE-@=P[6@R&6PN.R%=!MG=S8IMU;>AJZNFFGBP>YF
MP5$:^E5A!6&CA\JOXDT^Z]UBGV+LJHQ&V]O5&T-KSX'9U9M[(;1PDV!Q<N)V
MO7;2,+;5K=NXYZ4TF%J]M/3QF@DIDC>D*+XBEA;W7NN(V'L<;>W'M$;.VL-J
M[PFW34;LVT,!BA@=SS[YJ:^MWI+N#$?:F@S$N[JS*U4N3:HCD-=)42M-K+L3
M[KW4'(=8=:Y:@W?B\GU_LK(8W?\ M.GV%ON@K-K86IH]Y['H\=E\11[.W33R
MT3Q9_:U)BL_7TT5!5"6EC@K9XU0++(&]U[HG_5W\OOJ3K_Y0]U?)O*X3K;=V
M7[&J>EY>ML%4]1;=H*KH.GZ0ZX7K#;-#U[N>3)92JI:6? 1([)3TU"E-4 FG
M$:'0/=>Z,M4_'7X_UFR-X=:5'1_4<G7?8.7J=P;[V*.N=H1[2WCN&LKJ?*56
MX-T;>CQ"8K.9Z?*4D-4U;4Q251J8DEU^1%8>Z]U-QO0_2&'QV'Q.+Z>ZOH<;
MM_:.XNO\)14VPMKQT^)V+O">*JW?LW'H,7:EVONRK@27*4"6I<A*H>H21A?W
M[KW06[<^,-'M[M?:VZ*/=./QO2G5.&HH^A?C7M+K?8VR.ONG]WR;=S^T=Q[R
MQ>0VWCZ3)YB;)[9W'64E#0R+#1XI:VK,:R&9/![KW1C6VSMQMR0[R? 89MW4
M^$J=LT^Z&QE$VX8-MUM?292KP$.9,'\1CPU5DZ&"HDI1((7GA1RI9%(]U[H-
M,!\<_C]M3*=AYO;/2/5.!RW;<>8@[1R&'Z_VM05/84.XI9IMQ0;RDI<7&=Q4
M^XJFIDER"57E2MFD>2<.[,Q]U[I@I?B1\6:'=/5.^:3XW]%0[UZ)V^=I]*;P
M3JC8PW5U)MAA.IV]UQN(X,Y?9F% JY;4V/FIX@9I"%N[7]U[K'N?XA?%#>N%
MVAMO>7QFZ!W9M[8&_<YVIL3!;EZ@V!G<1LWLS<^?K]T[D[ VOC<IM^JI,!O/
M<.Y<M4Y"NR5*D5955M1)-+(TC%C[KW2TJNB>E*[M*F[OK.I.MZKN2CQU/B:;
MM.?9>WI>P(<=24U=145)'NU\><X(J*ARE5!!^]>&"JFC0JDLBM[KW3-0?&7X
MWXML.<9\?>DL:VW9MT5.WVH.JMB49P53O=98]ZSX4T^!C.+GW>DSC*/!XVR
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M&."G\FJD?UM+./1[]U[J0=J?(OSEQW3UD*?[_.3>'_0/F3(,;54@CV]0F?\
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MNO==?W2^2-O^9W=7WMMX7_T!9S]5&+;G:Q[T_3GGYI!_R[APQJOK[]U[KO\
MNE\C_P#G]O6'UW#_ ,T#S?TK(].V1_S/.]\%+ZJL_P#+Q'"?:_7W[KW70VG\
MD#]>[>L/^8=^G06;'_ -+;H_YKH;?QZ3U4G_ #KAPWW?U]^Z]UW_ '1^1_\
MS^SJ_P"FX/\ F@6;^M8EMLG_ )GI_P N-^:O_G8CA?M?K[]U[KK^Z7R0N/\
MC-O5]M6W20.@\WRM%%IW0MSWD;'/R^JD/_+M'I85?U]^Z]UW_=+Y(:;?Z;>K
MRVC< U?Z LW;76#_ '[+:?\ 3I],$>:H7_W(?V32^_=>Z\NT_D?J!/=G6!42
M;<) Z#S0+1T4.G=*:O\ 3D;-N">STC6_W&KZ6%7^KW[KW77]TODCI_YG;U>6
M\6X%U?Z LU;RUE_[M2Z?].GZ<'Q]TM_]R']DTOOW7NN0VG\C==SW7U@4\VW&
M*CH3-AC!10%-TQ!QWD;29^HL](]K8U1I=:O]7OW7NL?]T?DEH _TW=7>3P9]
M"XZ S>DU-62=MSZ/].O$>#7BJ2]\A_9:E]^Z]UD&U/D<) 3W5U@8_N-N.4'0
MN;#&FHJ<INF$/_IR-I<_4VDI)+$8U/0ZU9]7OW7NL8VC\DO&%/=_5QE^VSR&
M0= YL*:FK<G;E1X_].I/APL=A51ZKUY%U>F^GOW7NLHVG\C?(&/=?6/C^YV\
MYC_T"YH,:2CIV3<].)/].)"S9ZJ(DI)=)&.0:'2K/K]^Z]UB_NC\DO$%/=_5
MIF^USD9E_P!E_P YI-952EMO5(B_T[$B'#166IBU7KB-2O3?3W[KW64;3^1A
ME#'NOK$PBKV](T8Z%S8<T='3%=S4RR_Z<"!-G:HB2DETD8Y/0R51]?OW7NL(
MVC\D_$%/>'5IG%'FXC*/C_FQ&:ZKG9\!5B'_ $[%A3X>"R5,.N]<PU+)3_I]
M^Z]UF&U/D8)@Q[JZQ:$5F E:'_0+FQ(U!1TS1[EI%E'>)"SYRK(DI9M!&/0:
M&CJB=?OW7NL VC\E/#I/>'5K3_99J(RCX_9SQFOJ:C7@:P0GO>XI\3362H@U
MWK7]:R4X]/OW7NI VI\BS.K'NGK$TXKL#*T0Z&S8D..I*71N.B$_^G JM3FZ
MPB6EGT$4"#0T=2?7[]U[J.-H_)3PA3WAU::C[#,1&<?'_."(Y&IJ2^#K1#_I
MW+"EQ5):.H@UZJQQK66 >@>Z]U)&U/D5YPY[HZR-/]_@YC".A\T)3C:6E,>X
M:$3_ .G J*K,U=I*:HT%:%!H:*I/K]^Z]U&&T?DIX-![PZL^Y^PRT)G'Q^SB
MQ')SU1DPM<*?_3N6%+BZ*T4]/Y-56X\BRP#T>_=>ZDC:GR*^X#GNCK(TPR.$
MF, Z'S0E_A=)2&+/T J/]-Y45>8K;2TU1XRM"@\;15!]?OW7NHHVA\EOMPA[
MRZL-3_#<I"9_]E]S@B.5GK#)A\A]O_IX+BEQM"1%/3>3552#R++ /V_?NO=2
MAM3Y%?<!SW3UD:7^)8:;P#HC,B4XJFI&CSN/%3_IN*BLRU:1+3U/C*T48\;0
MU!_<]^Z]U%&T/DL*8(>\>K#5_P ,R<!J?]E^S@A_BT]<9<3D13?Z>-0H\=0$
M0S4OD+54@\@FA'[?OW7NI8VI\B?N0Y[HZS-+_$\1.:<=$9H3'$4](8\WC14'
MNXA:W*5Q$L%5XRM'&/&T,Y_<]^Z]U$&T?DM]N$/>759JQB\E3FH_V7W."(Y>
M:N,N+R0IO]/!845!CK0S4OD+5,O[HFA'[7OW7NI8VI\B?N0Y[GZS-)_%<74-
M3_Z",T)CAZ>D:/,8T5/^FW2*W)5Q$L%5X]-+&/&89C^Y[]U[J'_<_P"2_P!L
M(SWCU7]W_"JZG-2/C[G!"<S+D#-C<F*7_3P6%%18RT$M)Y-51*/*)XA^U[]U
M[J8-J_(D50D/<_69H_XKC:@TR]$9D3'#049CRN,%7_IM*BNR%;:6&K\16FC_
M &S!,?W/?NO=0AM#Y+_:B,]Y]5FL_A-;3FI_V7S."$YF7(&;'Y/[4=\E_L:/
M&?L24GEU3R_O">,?M>_=>ZG#:OR)^Z$A[GZS-'_%L?4&F_T$YL3G"PT9CR6+
M%5_INTBOKJZTL57XM%/'^V8)3^Y[]U[J$-H?)?[7QGO/JLUG\(JZ?[G_ &7S
M.B#^-29(S464^T_T\EOL*;%?Y/)1^75--^\)XQ^U[]U[J=_=7Y#_ '0D/<_6
M?V7\7HJDTHZ)S0G.$BH_'D,7]W_IM*BOK*\^:.L\6F"/]LP2']SW[KW4'^Z'
MR7%)X_\ 3EU7][_"*JF^Z_V7S.B#^-R9(ST>4^T_T\E_L*;%?Y.]'Y=4LW[P
MG0?L^_=>ZF_W5^1'W8D/<_6AHOXO2U)I?]!.9$QPD=%XJS$_=_Z;=(KZJN_>
M2L\6B*/]LP.?W/?NO=0O[H?)C[3Q?Z<^K/O?X/44WW?^R]YSP?QQ\EYZ;*_:
M?Z>M?\/@Q/\ D[4?EUR3?O?<*/V??NO=3?[J_(C[OR?Z9NM#1?QB"I^U_P!!
M.9\_\$2C\53BON_]-NG[^>N_>2L\6B./]LP,?W/?NO=0O[H?)?[3Q_Z<^J_O
M?X/+3?=?[+WG/!_'6ROW$&6^S_T]!OX?%B!]LU'Y=;S?OBH4?L^_=>ZG?W5^
M1'WGD_TS]:?8_P 9AJ?M?]!.9^X_@2T7BFQ/WG^FW1_$9*_]Y:WPZ$C_ &_M
MV/[GOW7NH/\ =#Y,_:>/_3IU5][_  :2F^Z_V7O.?;_QTY3SQY;[/_3UK_A\
M>(_R8T7FUM-^_P#< ?L^_=>ZG?W5^0_W?D_TS]:_9?QE:G[7_03F?/\ P(47
MB?$_=_Z;-'\0:O\ WA6^+0(_V_MR?W/?NO=0?[H?)C[/Q_Z<^JS7?P8TWW7^
MR]YS[?\ CIRGG7+?9_Z>M?\ #AA_\F-%YM9G_?\ N O[/OW7NIW]U?D/]YY/
M],_6GV7\9-3]K_H)S7G_ ($:'Q#$_>?Z;-/\0&0_>^]\6CQ_M?;W_<]^Z]U
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MNS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'OW7NO?\
M#>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\ <\>_=>Z]
M_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O_P!SQ[]U
M[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'
MOW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\
M<\>_=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O
M_P!SQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M
M]*__ '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_
M]&WTK_\ <\>_=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\
MQW_T;?2O_P!SQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V
M-?S'?_1M]*__ '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS
M_O8U_,=_]&WTK_\ <\>_=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>
M^[/^]C7\QW_T;?2O_P!SQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?
M\-[[L_[V-?S'?_1M]*__ '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>
MZ]_PWONS_O8U_,=_]&WTK_\ <\>_=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[
M]U[KW_#>^[/^]C7\QW_T;?2O_P!SQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W
M/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_
M /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\ <\>_=>Z]_P -[[L_[V-?S'?_ $;?
M2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O_P!SQ[]U[KW_  WONS_O8U_,=_\
M1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'OW7NO?\ #>^[/^]C7\QW
M_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\ <\>_=>Z]_P -[[L_[V-?
MS'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O_P!SQ[]U[KW_  WONS_O
M8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'OW7NO?\ #>^[
M/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\ <\>_=>Z]_P -
M[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O_P!SQ[]U[KW_
M  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__ '/'OW7N
MO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WTK_\ <\>_
M=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T;?2O_P!S
MQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'?_1M]*__
M '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U_,=_]&WT
MK_\ <\>_=>Z]_P -[[L_[V-?S'?_ $;?2O\ ]SQ[]U[KW_#>^[/^]C7\QW_T
M;?2O_P!SQ[]U[KW_  WONS_O8U_,=_\ 1M]*_P#W/'OW7NO?\-[[L_[V-?S'
M?_1M]*__ '/'OW7NO?\ #>^[/^]C7\QW_P!&WTK_ /<\>_=>Z]_PWONS_O8U
M_,=_]&WTK_\ <\>_=>Z]\ :GL3"[O^<_3N^>Y^TN\L7T5\JL)L?K[=O<>1VQ
MF=]T>T]P_%OXX]HU6#R&8VKM39N/R%)2;NW_ ).6G+48ECBF$9=@H/OW7NK'
M??NO=>]^Z]U[W[KW7__3W^/?NO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\
MOT=\^_=>ZLC]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW5>'PO_ .RC?YI7_BZNQ?\ X!;X?>_=>ZL/
M]^Z]U[W[KW7O?NO=?__4W^/?NO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\
MOT=\^_=>ZLC]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW5>'PO_ .RC?YI7_BZNQ?\ X!;X?>_=>ZL/
M]^Z]U[W[KW7O?NO=?__5W^/?NO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\
MOT=\^_=>ZLC]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW5>'PO_ .RC?YI7_BZNQ?\ X!;X?>_=>ZL/
M]^Z]U[W[KW7O?NO=?__6W^/?NO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\
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M6]]XG<U;#U]"<E49;LZII]PQRE;T=50QTT 2@>:ED]U[HNO7/RA_F.4WPL^
M/SYV+V1O'Y*P;>^'?7/>GSF^,4VV]DG=/R%V%V-5Y4=A=D],UN"VW@Z[:O<?
M3V/1\KA\)024N*SM)2&C,)J0@J?=>Z'OH;YO=H=O_++J+I?(=N=C8;XQ8O\
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M&5K-T;UQG96Y:S)=0["KJK<G9&$##"=B9^>JP,LV9W[A%<BBS-29,E2#B*9
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M/?>P:?K+)9+9N5Q&X*F"IH9LUA>Q):G&34KY&29<3*]1!2TU315,_NO=!?\
M*#Y[=L+T+\M\?UOUWNGK?L3HGKON;#;N[7VENC86\<1TYWKUSTCMOO3;^WJC
M'[ZVW14^Z=N;TP.Y:>BHZZ+&RU;5!D9J"FI-&33W7NA0RO\ ,9W'L_>>=V'V
M%\>I=JY; ]A=C='+DD[3I,WM_<'?V,Z>V!WOT5U?MW*T&QU%74?(/K[?9CHJ
MFHCI9L5G<368Z2EJ6-%-6>Z]U9[1O5RTE+)74\-)724\#UM+35+5M/2U;1*U
M33P5DE-1/5PPS$JDIAB,B@,46^D>Z]U61@/YF^T<_OW(=:1]=_8[FS&\>I=F
M=3Y.JW_B:C8/8.0[CW-\FMM[6>JWYBL+D<+BXUD^+&=9Y,3_ 'BI9ZFMHJ&F
MGGKFJ*>G]U[H)MN?/KLG;?R7^3W7NZ]NUF;RN#Z2ZR^1&UNE=S[MV;M^+KG:
M>$Z";=G<6P]B]C[3VKGMK]L;\@W]+112T7\4J4ABK),@:Z#&K3H_NO="GUE_
M,K'9N1V]LBAZ0K<-VSOW+[;I^N-GY;L3&C;VXL-N?XF8_P"7-#697?%+M>>+
M;V<I]HU4F(FQPH*P#*1>2.HDH1-5P>Z]TDX?YLFTON.L\OE.HLKMCKSM'&_&
MS>^)W3N?>"X_.87I_P"3NP=V5NT.R]R;3I-HY&+'T6W>\ML)UWEH$R,T%/E\
MMC:I:IZ>MA#>Z]TTX[YQ]K=>]_\ R,Z\W7M/<O:&]L[NOK*AZ'Z!H,KM7%';
M>9I/A=BOD!V=UM@]\Q[2PK9JHJ<Q15:T$^5ADFGJZIGEEH\=!*])[KW33V5_
M,(W74=Y]+;BV#A]YP],;1RGS9VMV_P!;8N?8^:WYV1OOX[_&NG[5J-EP;;3&
M9"KQ^<V]N5)Z'$S8_<J4F5J4>26*6BGQ]4WNO="W%_,@R]36MMK&?&O>&Y-]
M5T6^]R;*V]MS>>)&+[6ZRZRQ_1E?OG?G6&ZMVX39^-SD.(G[WH\>(JY,92+E
M,-E(*FMI4IXYI_=>Z,_T%\H]O][;W[HZ]@V[DMD[MZ7S\6*SFU-T_P 4QN\)
M<-D=Q;UPFU]Z'!97 8BFK-D;[H-FMDL%G,+69S Y.FG:&*O^]HZZEIO=>Z:_
MDC\H,IT+OGHW8N(ZOJNP*ONBK[-#Y4;MHML8[9^+ZHV2_8NY:ZMADQ&=RN:K
M*S:>/KVH*:DICYZVF2"22%9Q,GNO= !MG^8W/O6CZZ3;'06?ESG?NVVWS\8Z
M?-]C[*V_MWO39T/1]5WC5MA]SU(G&W-UT>,HSBVHJZD&-FKF,\&2FQU/75M'
M[KW2>[;_ )AZ_P"CKY&;AVAU%VE6;!Z<PO<&$W)VELK>W6^(SNW>PNGLWLK#
M;QVG3TFY*?/8ZES4E)NJMK\+5TT&>IJNFPLLD\-/%5XZ2K]U[H/^XOYJ>\=C
M[4[XK]O?'9*>NZ^HOFI@NO<_N7L>DK<%N+L+X7Y7'4^Z:3=^&V[MVIRVV=K[
MPV[D6R6&JXIJN2:HI)*"L2@>6FJ)O=>ZN/HC6/1TC9"*F@KVIH&K8:.HDK*2
M&L,2&IBIJN:EH):JFCF+!)&@A9U 8HA.D>Z]U4AW7_,KRD/0W<F]>G]AFCR\
MWQF^;W</0.]]P945F&K\U\+]ZQ=7=ATF_P#;D6 GJ]H9.'<68H\GAJ20U]/E
M*9)*:KEH*I6@]^Z]U9IU7MO<.UME8[&;HW?N+>N8GJ,AEZC)[GK\/EJ_'KFZ
MV?*IMJES&&VGLI,O@]LBJ^RH*FJH$KY:.&,U+RRZG;W7NJ;^SOY@_P @=M[V
MPF^J;:N*GVAUCW/_ #+-B;LZAVQNC&4>.[2V%\2.MJC<NVMQ9S>&YMC5F=VY
MO2.;;59+34F.*X^:IK4BJ6:("HI_=>Z/YT)\S<=\B.PJO!;%ZNW8W6=-/V/M
M]NVJW+[?AH<;V#UAE=L8S-;&W#M.:JASE!D,RFX*BIQDU&V15Z7&325BT23T
M)JO=>Z.U[]U[KWOW7NJ\/A?_ -E&_P TK_Q=78O_ , M\/O?NO=6'^_=>Z][
M]U[KWOW7NO_1W^/?NO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\ OT=\^_=>
MZLC]^Z]U[W[KW27WGO';O7NT]Q[ZW?728O:VT<-D-P;BRD>/R>5.,PN+IWK,
MED9*'$4=?DIJ>BI(FEE\4+E(T9B-*DCW7NBG;.VM\%]P8;J7:W7^U^JMP[5[
MGW36_+SI]MH8"3-[/WGO:@GQF\JWOW;NY,/1U>W?[U_?[EI,F<R:N.LFK*V.
M<.TT@8^Z]TM*?XO?$'K/,==[^H.@NF]O[JZ4VSNS%]3;CQ?6V J=[;&VQ7SY
M?=FZL#UW-08BKW3#2559D*ZN?'XT.SU%5,\<1DF?5[KW1A'BV_OK:KP9#&4^
M;VIO';[1UN'W%A9DILOM_<..*5.,SNW<_10SK!D,;6-%545;3HX5VBFC!U+[
M]U[HOM+\)_B'0T5+CL?\;.F,;24=/FJ6&+&; V]CM4&X^O8.I<_'4RT-%!-6
M?QCJZG3;M29FD,N$'V3$TY,9]U[J?0?#GXG8W/INJC^-G2,>Y(\*FW5SDG6>
MT:K*?P5=BKU<^/-958J:9H*CK-%V]/<EJC"(M#(7ID6(>Z]T&.7ZA^!?QGH^
MO, _3?3_ %U1TFU=_=<]=;4V?U7'4B@Z^[#S&UZ+M?#8W:6R]O9&2BZ\SF6R
M>%&YIY*5,2A:C>OD1$A9?=>Z4?<?PFZ.[6V1GMLX_:6V-B;DRFV,KM''[_Q>
MR]J;AS>.P&XMZ[4W]N[ 5E'NO%Y;&Y[;>_MP;*QW\?I*E/)D8J>,B:*HAIJB
M#W7N@3V7T#\&Z>LBZ*W]2]6]O]B9&7L'JROI,[LVDBPDT^Z<!MKLSLSIK;.*
M@IZW:>WL=D-N[.Q>X<OM.&LFGD6ECR%9'(Y$Q]U[HS&1^'7Q0R^3[0S>4^-_
M2V0S7=C[=G[>S55UOM6;,=E56T:S'9':^0WKE'QAK]PY3 9+#T=52553))4P
MU5'!,KB6&)E]U[H0<)MKJOX]=<UE!LO96#Z[ZYVJN;W#)MCK78TL=%2RY7(5
M><S]?C=F[%PU37Y+*9?+UT]74"DHYJJKJ9GD8/(S$^Z]T&O?>W_BMLO;&]NT
M_D'M'KJ+:NY*2AV#O_<6[=GQ;BHLY1=F/ANHZ;";AHX<5EGR$6ZJ?,T6 F>6
M%A)0RI3RN*8%1[KW2WI/CST10U&X:BEZ>ZXC?=V"J=L[I0[/P<M-N/ 5VW<;
ML_(XO-T<M%)29.ERNTL+18NL$R.:O'4<%-,7AAB1?=>Z+3F>@?Y<VR=U=._&
M#,],_'O:FXMX[![#P/1_4S]?X7#46<V)MK/;5[+[,P&Q,?!BJ?!S18G<6#PN
MX,E14S_<I48^CKW2]+#+'[KW3YM+J3X%=@]A]O=?;2ZXZ6WEV#U5E-RX?NG"
M4^U:+.3[5S_R*Q.V=][TQ.\*FJHJC&G<7:N)QN&S&8IY)9*RN$%%552EDIW'
MNO=#%N/XV?&_+45+4;PZ?ZPRN-V[LOL?9J2;GVUALACZ+8G:7@J^V<'7'+PS
M4LV![!?'Q3Y]*G7'DY($EJC(T:L/=>Z#[%?$CX492JI-M4/Q?Z4DFZ;[*H.Q
M,**[I#"4L&W.U,IM7;S0[^VOG<KM>"ES&Z*K;%-C::JR^/J:J3_)(Z6HF\M+
MXHO=>Z,+L#K38/56'K]O=<;1P6R\'E=R[DWED<5MZABQU#6;LWEF*K<.[=Q5
M$$("2Y?<N?KIZZNG(\E563R32%I)'8^Z]U&WAU/UEV#EMO9[?&PMI[LS>U%K
MHMN9;/8/'9+(8BFRD^-J\I04=74P23)C,G682BFJ:4DT\\]%3R.C/!$R>Z]U
M[9W6'6_6E=OS.;*VCM_:-?V/NFJW]V+DL321T$N[MX3T-+CZS=NY)E(&0SDN
M+QU/3R5<MY6IJ:&,MXXHU7W7N@OQ;?&SY8TG]YH,!MGM*DVG'4[=H=P9W9N3
M@'\"W_MS:V[*J';66W#B,:^XNO\ L+:M;B:MZC'256#S=,(;O.(M*>Z]UQ[+
MZO\ BSMK'[LW5V7U[UA0T?8U#1=:;JJ<AM7'35&_8MXX>AZNQ^R7Q=#0S5VZ
M\KNO;C4NW(:*""HK*_'+%CU62!$A'NO=(O9?0/PD[*Q-#N39?5W3^Y,?E<SE
M,U1UM'@*,54VX-D;2KOC;FJ]J:IB@R4&8VIL:GJ-D5321I-1XQ7Q3Z(;P^_=
M>Z6^)^'_ ,7L#78+)87H;K+&5^V<IUGFMNU=%M;'P383+=,;<K]G]29'',D8
M^TJNM-IY.IQF#=+'&4%1)3T_CB=E/NO=.-)\I>@J[J[9?=5)V/C)NKNP][[>
MZWV;N]<=GQ0YO>VZ^P!U7M[;\=*^)7)TE7D^P6&+1ZB"*%:@@NZH0_OW7NHV
M0^)/QARW6V]NG,ST'U5G.J>R=W9'L#?O7F=V7A,WL_=N_,QF8-QY3>F>P.5I
M*O'Y#=F0W%2QY"7(NAJWKXUJ#)Y@']^Z]T7;*8K^6IGNOH/E#D^N^@ZW8^Y-
MNQ?$&/M63J*E2KKMF5W8%5\=8NC*BHCVG'N2#9C;YJ)]KC'2Q)CHTFDA]-+*
MQ;W7NAPK/A/\2<C4Y6MK_CQU36U>=Q&;P&:J*O:>.J)LMA-R["PG5FXL3D9)
M8W:LQV>ZTVUCMOUD,FI*G#4%/1R!J>&.-?=>Z6Q^.'0I_O$3U#U^6W;MB39F
MZ'_NSC=>X-LS[5HMB5.*R[>'57Q5>R,;38>=Y-4L^+IH:5V:"*.-?=>Z8,C\
M5NC7V]N'"[5Z^VIU]DLYUM+U;1;NV=M;:]+N/;>W(=BU?6V EPC93#97$O7[
M2V95_P -QK5E)5Q0X^-:-D>CO ?=>Z"[H'X*]2],46VILQC-L;[W/LK,X_.[
M)S,>P\!LK$;*R^+VIFMBPY_:&T<"TN(V]NO*[.W#68W*9*G*S9"BF-,0E*J0
M+[KW4VCZ5^#'Q\SG4?5.#Z;Z1ZIRG:&_-X/U+L_:G66(V]C]Q[\QV)/;&[A0
MTVV\%#AX:V'&]>1YEUJVBB:3#021@RTL 3W7NC(=9=:;0ZAV7B^O]AXQ</M;
M#U6=K:#')H$--4;DW!E-T9;[>&*.&FI*>;,YFHDC@ACC@IT81Q(D:JH]U[HH
MNZZG^7OVIWIN[:._,9U'N/O;);AV3TANZ#>>VJJFSF:W1L:DIOD#UIU74YK/
MXRDQF;S. HU7>>W\1%432JH?*T49M)/[]U[H;(?B%\6H,]L?=0^/?4$NY^L]
MX[T[#Z\W'5[!V[79[8^^NQ\RVY-_[LVMF*V@GR&$SF\]R'^)9.HIY(Y*S(@5
M4I:<"0>Z]TL=F=&=7=>[L?>.R=IXO:^4'7>U.J((,'308O%TFP]E97<&:VU@
M8,=0QP4[4^*K]SUC0&42&G69UA\:R2!_=>ZR]J]%=+]YT.)QG<W5/7W:F.P4
MF9EPU%O_ &EA-UTN,;<FW\EM/<(HH,U1UD<$6=VSF*J@K$4!*FDG>.0,IM[]
MU[I^W!N78746T:&KSM?B=F[0Q#[=VKAX%B,-,E5DJV@VSM+:V Q5%#+55V2R
MF1JJ:@QV/HX9:BIGDCAAC9V53[KW0%]3]4_#_,5=+V1U1L+JJJR61[$[#WU2
M9R@P-$F47MNGS%7M;M/>4=#E*=*[']E4^:BGQV;R/@BRJ2ZZ>HD%RA]U[ITI
M/B1\2\7DMR1XWH#I3#9??O9&&[XW7%B=B[6P^0W=VILK,QYC!]IYJ/'4-+49
MG=FVMR9):V')RB2:FR-3YPXGE+M[KW3SM'XI_&78.)SV!V3\?^G=JX/=$6TX
M-R8? ]=;4QF,SU/L/,5>X-CT^6H:7%QTU?!LW-5LE3BDE5EQ\I!@$>E;>Z]U
M+WM\8?CCV3BH,%V!T3U)O/"TN>WUNB#$[EZ^VQF,?'N+M"FS5'V3FQ25N,F@
M;);_ *;<=>N9E*E\G]W*:@R%B??NO=);<WQ#^(^<V3N38F]/C]TKFNOMX]A8
M7LG<VU=U[%VQE-KYKM&ECQ. P.]:O%YFBJ,>^]8X:"BH:6N516&..*!'*A4]
M^Z]T92CHZ7'4M+04%+3T5!14\%'145'!%34E%24T2PTU-34T*QPT]-3PQJB(
MBA44   #W[KW0$GXI?&3^-=J[D7X_P#3L6XN\Y\75]QYV'KO:L&8[-K<)44=
M9B,AO;)0XQ*S<.2Q=?CJ:I@J:AWGBJJ:&97$L4;K[KW2![R^%G37</5W:VP<
M1MS;O6NY.TN@-_\ QJE[-VYM3#U>Z]N=6]ES5];NS!XP5B)35=+D,QDY\F\-
M3Y()LJ_W4RRR:M7NO=<I.M_B;@=U]4]!;HV9UC7]F5VV-]=A[%PE;L6 Y#.T
M&W*?9&T^U]TTE6V/K:2*"M3.8.DRE)45K&KIGI872:&!/'[KW2USOQ*^,6Z:
M3.4&Y^@^I]R4&Y>P=P]K9^AW!LC YJBR_96[=KU.R-U[XKZ7)4=5!/N7<VS:
MR7$Y"K*^6LQKFFF+P^CW[KW20[&ZO^''0>WLI\B-_=:=5[ PO31Q'9V2[&AV
M/3I5;-FZ^Z_DZPPF\%DV_BJG+?>[5ZOG? T]1%%)-3X-FI%M3:D]^Z]TIW^,
MGQ<H,)@';IOJS$X':&77=^V&7;>'P^.VKEI<!G=K09?"LD5)#@6IMK[MR>.I
MQ#X4IJ')55/$J1U$J/[KW2IZL^/_ %%TG7Y>LZKV5A=BP9C:W7FR'PVVZ.FQ
M.!H=I]58O)8386#QN(H8:>CI*/;N(RLM+3^EGCI1%3JP@@@CC]U[I$Q[<^+?
MS/VE@NR:C:^QN[=J4U-W'UM@<_N#;D]5'2T.3R67ZB[OVA3T^?H*.MIL?G:O
M:]9@\W3M$L-?#2M%()8;7]U[KK*?"WXCYNOWKE\K\;.E:_,=D['VYUGV%F:C
MKK;#YG?'7^T(\33[9VANS+_P\9+<& PM-M^@B@IZJ65%AH:>.VB&-5]U[I39
M/XN_&_-[YW5V?FNA^H\SV/OKKZ3JC>^^\MU]M?);NWEUK+0MBYMC;KW!6XV?
M*;BVS/BW-*])62S1/2GPL#'Z??NO=,^0^-6S*G<76YH?X;A>L>N<[_?RGZFQ
M^T]M?P?.=K8R>GDV=V1E-Q5%#-N?^-;0"N\"1U"B:I6GED8_;JC>Z]T)G:?:
MW7?2>Q<]V;VKNS%;(V+MB"&?-[BS$DHI:7[NJ@H*&GB@IHJBMKZ_(5]3'!34
MU/%+45$\BQQHSL%/NO=$?I=@?RJM\[-P5'CNOOB%N[87RGP.W,QB8\;LGK_.
M[6[7VWE.S&W)LW)UKT>)JL9/B9^YM\&3$359BC7=64\-*1D)_&WNO=);/;G_
M )2.:J>],EF9/B_7Y#X_56TJ?NP18?%/EMC24.V,_P!$[)BDQV.H/XE640VM
M7Y796.&+BJ*>6%ZO"Q:B)Z8>Z]T9'JSHWX4]D==[>W_U!USTEO+K/L3&];[O
MVKN[9N)P.7V_N'';#V8^Q^K\Y@LS0+*@&TNOYY,'CI()$>CQ+R4 TP%X??NO
M=#EF.G.I-P^ 9WK#K[,BDVWC=FTHR>S\!7+3;1PV;Q>Y</M:!:C'R+!M[$[A
MP=%7TU&MJ>"LI(9D19(T8>Z]T'N_OB)\7.UI=WS]G?'WJ'L.7?VZ]E;[WFV]
MMA;=W1_>/>O7&)?;^PMUY1<W05JU&X=H8"5Z#'UEA/34+M3HPA9D/NO= M\D
MOC_\,(C69/L'9W676/:7R2RLG0>TNY,;U=L_*]B5'8?9O7.9ZWQ=-A<OE=F[
MFQT.X\IUY0U&(\^0@^WJ,53BAG=J<)%[]U[J;UW_ "_?CY@-M;=Q'9_7G6'<
M^3VEOO']E;1J]R=5;0H=M[#WOB<7382BW+UQLLPY;&;&S<V,HXEK:NCE^YKW
M1?,YCCACB]U[H;^M*CH#'=F=N[ ZNH=I8KLW9<6R\CVYAL#@I,7D\72]@-NG
M=NRVR-6:"GHZBASE5/F<A#%2RR11U=15RNJ3SRE_=>Z7VXNM-@;MW9L/?FYM
MH8+-[SZOJ\[7]<[GR-!%4YK959NC$-@=QU.W*YQ]QBYL[@Y&HZLQ%3/2LT3W
M0D'W7NBE[S^-'\NWK_$;"Z-WC\<_C?@MM]W=ZS;FV%US+TMM23:^[OD%C=L;
MHWP^Y:3%4.UY\'0[WI]IX#+U*5\XIW-+'41+(1(T;^Z]T,&=^(7Q8W/G>TMT
M9_X[]-Y3<O>&VL7LWN+<-1UYMC^-]H;3PPQJXO;V^\K'CDKMSXBCBPU'&L%7
M)+&8J.!""D,2K[KW2#ZA^$O4W7.-[YQ^[,1MOMD_(/LGO#>N]9=X;*P3QS[8
M[ZS5-F-X]7U-++_$(<MLV044%-)'4:GKJ:EIUJO*T*,/=>Z-SBL7CL'C,;A<
M/14V,Q.(H*/%XO&T4*4]'C\;CZ=*6AH:2GC C@I:2FB6.-% "HH X'OW7N@>
MS7QH^/>X<7V-A,YTSUQD\/V]!FJ7L_%5.T\0^/WU2[GKH<INFFW+1_;"#)TV
MZ\G3I4Y:.12F3J%\M4)7NWOW7NA2FDPNR=KS3""HH]O;2P,DHIL=09/,5-+A
M<#CR_@H,9C:?(9C*3P4-+IBIZ>*>IF8!(T=R%/NO= 3D_B[\6=\+7;MS71?6
M.0;=S[XW3F<CE=C4&,K<O4]O;+H]F=E97/P5E!0UO\1W_L2EBQ>=^\C6>MH4
M-/5AEU+[]U[I1]=?'7X[=<;OS':_5G3G56S]][SVMMG;.>[$V;L[;F+W1NO:
M.V<7CL;M7&97=.,HH\GG,5C,/C*."F$T\J_;TM.H)2&(+[KW0Y^_=>Z][]U[
MJO#X7_\ 91O\TK_Q=78O_P  M\/O?NO=6'^_=>Z][]U[KWOW7NO_TM_CW[KW
M7O?NO=>]^Z]U6Y_*'_[=S?&3_P -[>G_ +]'?/OW7NK(_?NO=>]^Z]T'O;-!
MF\KU9V1B]M8RHS6XLIL/=N,P.(I:S'X^HR68R&!KZ3&T45?EJN@QM$]163(O
MEGFBBCOJ9@![]U[JF7%? #Y7=+T6\\1\4-W[>ZUZIWM\8-^938G3.=R:X^K^
M-?R]WEE.H*GL/ =7;IV]+F:';72W>>*VWFJFHIZ!:F/9^[YZC*8I1!7M30^Z
M]U/[+^&OR@S>]?\ 2+MG%;FDQ5/%\W*;I_9[]SKB^R?CKC>_/BWU'M'9.+P>
M]X=UI#"DO?O7N>R5.,7FICMN+<E.U)*L,,D=/[KW4N'HG^8O5X'M_%-0U=%V
M@O3.'JNB.[JOY+U^.P0J<ITQTUMS=?QV[%ZWQ6,W'3'=E#V)LC<#T6]O#EJ.
MB_CK9NG>2O>IHI/=>ZL@^(.S-\;)Z9I*/L/![YVCN//;KWCO&78?87:V#[FS
MG7U/NK/5>779='O3;."P6WQMO"RU$BXO'40JJ7%T#Q4T<[)&$C]U[IQ^5>U>
MWMX=0R8KI.LB3=M)V!U)N'-8%\W)M:7?W6NV.T-HY_MGK2@W9&5;;.3[ ZWQ
MV3Q5-5LT<7FJ5BEE@ADDGB]U[HD_5/Q=[RVO\H?C9V-OG$9?>.SNMZ'Y_4F,
MW#FMY8;+YKI[8O?7:W5&Z_C[U7D9Z[=%7N'>LFT-F[,R5#/40C(P8M9J2CBJ
M*JG@6HC]U[JVGW[KW5-G9WQG[4V9W?VQ\@NNI-T=&[,W-FNY=R?(_#4/:./R
MO1W:^QZ?X^;HVWM/OG9^UIZQ=^="?+S'9RFPE'59[:KX*DK<-CZJ3)SU\S4H
MB]U[HF_4G0GS;W_\>>@NU^M<UVWO;J7NWH?XT/VWU)5?*TX+MK.;[SGQKW!M
MS?\ \E>O.V=Z-V5BMF9*BWEN+ ULF$2>AJ*JMPTN96&#*014U9[KW1HM_?'W
MYUY7:?S#VL<3O?*]B5>TM]XSXW]^[(^665VH^^,%O+/=<9WKO:&>V##)L6EV
MQOOIP;5J<?59Z?[2EK*)JR:F,QSV1HH?=>Z#[NOXM_._LC,_*18]EY6?9G9^
M':BVOLZI[XQ6X,'E=P;5^;FVNTMC;IIL?NO< 7 5$OQ\DFIW5WIHL;44+8>E
MIUHH*&>I]U[J_@&X!(*FP)4V)%_P=)87'^!(]^Z]U6S\\_CMV]WKN3JG<?2^
M#QU'V=T+M[>_:_1W96X\MBJ+:.V^_P#"[PZDSFS=H;KI:?*1[U;9/:^R]K;D
MVGN*?'T50L.&S\OU<CQ^Z]T4'*_$WYC]>Y/Y-9#K/8U=NB@[ ^1?0G9&[Z3&
M]O[)ZVW1\E]CTWQNJNM.\I<!N.MAW52['W3#W770;IH*;.P4-/78_%1TBU-(
MSIXO=>Z2F_?A!\V>QNOOD[U#OL;YWQ#D?C_O;:O1N_-R?*7$9C;._L?N;K7K
M7%;6ZA[CVA_H[P&X,YVAL#?.R*J>/>$T]+BJB:MGRH99LE74">Z]T*7<7QF^
M76_^T=_2XS!]T8_J3</;6YMSX7;6$^4E?MS'X[8&;_EQR]24&U:#'8?MC$2X
MS'8?Y9TU)D::A@$-+1SK+EJ=4,TPD]U[I"]%9[MB7YC=6[([BWUVCDM]]9TG
M0]+OO:N&[<VMD<R^\C\.\%MGL# [PV%'VK@=R;DZ%'9>>?=U5F:+:V>H:C=5
M)]T,J85FI*/W7NK^??NO=55;@^/GRMS7<N^=R9O,Y/-;:C[>[IW'2UF,WZM)
MMWL_XO;\^,F1V/LOXUU6P:K+8^@PN[=J]WS4.33(5,,-#%'CY,A'D?N,G64B
M^Z]T;+X1]9[CZ8^'?Q>ZCWCML;1WEUAT+U5L+>.WDRN/SD-!NW:6RL-@=S"E
MS&)K\E09*AJLW03S4\T<I#P2(2D;7C3W7NHOS'Z6H^_NH*?KG)[!RF_<;5;_
M -B9RK;:78^2ZC[.V#+MG.19O%]K=.]B8G*X'(;:[5ZYS='2Y/$.E?0K.\+P
M23"*5U;W7NJP(/AQ\[<+N+";\?,T?86_Z'I.OZOJ^Q,WNS:&P^Q]V==;6^=^
M [KI^O.RJGKS&X7:$?<'=GQ?-?@,UNG 44.-_O++433/#'.*MO=>Z%[;WQ^^
M9^U>W>O8LY1[@[2^/&6["W[GL#MZ+Y#9#KO?OQ3I$^0=!VCUS)GLI12Y>3N;
M:=1UU3R;>K<1!7UYQ]"HP<0J<35U-3'[KW1:^N?AK\Q<?TMNCJ7LKJ&KW#/E
M?D-T+VELC<N%[9V?A)]D=0[=^>D/?/8O35;B*#L&GQ%/G-O;3Q4^X<;N7$HN
M1S4F?&,JY8IL5!++[KW0N]6_%WYWT4%%@=Q;EW?MVEP>]>MJWI/=>2[FFW3E
M^E=G==?-7MG?6^\!ONE_O9EINT\;W%\2]Q;?V_3"IGRTS-1-C<@*..FIZ]_=
M>Z"'.?#?YNY/KO\ T<S]5T>:VCDNQZCL3:>W)>\,'MJEZPW7B/YI>^OECN+-
M[HH\57Y'%;OH>W_C_N# T5))#_$*G%Y/ U%#44L,%8U5)[KW0@K\5_G%ND5L
M'9D/;DV?7Y.=-4>_-P[$^7";>Z^[GZ P/>&^=W;QW_@-A[8BZUW#L*NK.H-U
M1X++8>MR=15U!IZ6AI8ZB#&T617W7NC\_$SJGOWJWL+OB'LC+5.<ZJS^7H<G
MU+5;LW'-N#L?"^3=_8U5E-J93*X[<&1V_O#9F&V_D,-_ <U5XO!;H6C?^%Y5
M<D,92Y&;W7NC@;VAS]3LW=U/M2"GJ-T3[7S\&VZ>LR]=M^DGS\N*JTQ$-5G<
M93U>1PE/+D3$KUE/%+/3*3)&C,H!]U[K7^3XB_S L[M$[=W)CNV\?C*O.]P[
MB@P6!^6E=0MAZ;>O\O/9/6VWMMUN0Q?9.+K<D<-\Q]O5F:HZB:LR,U--5R99
MZDSU569?=>Z'O9GQY^:^6^27QE[ [@V>FZ:/J;NK;O9M;V17]S4,D>"ZUW'\
M!MP=$[MZXDZ_IIZZ#(;YVC\@L_D\K/5TT4M#EJ3*?>PUZS23TL/NO=77^_=>
MZJ23X49SL'Y%_-+MCMC9>\3A:[O3K;O;XMX_&=CX/#XO,;_V!\.]K?'[';\E
MI]JYZCW%A-V;?W#C\H^(_BE934M*9Z/(+''60*]/[KW01;&^(?S7PW774NVH
MMU[VV]NX_'_XBO4;YSG>F>WOGNG/E9UOV/3Y?Y5[RWC_ !G>&>C[2VMWKL7[
M:DA@I):ZBJ!C9J">BH:?(35/OW7ND=O?I+NGJ;;GR3KMX93<^P,)NG*[=[A^
M%.X-W]]9+-Y/K?O/ ]O[HW_MCX8YS"XK>^6R/8FUNW-WXR+(P-2QY 28#=M5
MM$*]-A,4C^Z]U<]T9M'/;+ZQVUC=W.[[WRJY+>&_5&6K,U24N^]\Y6MW?O#&
MXBOKI'F;;V&S^:GH\9&HCB@Q]/#'''&BJ@]U[H./F%TY1]]=+5/6>2Z_K.Q<
M9E=Z=?Y+(46W^P\GU/V!M--N;MQ>X*+LOJCL7"Y3 Y3:G:O6N5QM/FL%40U]
M"7K:-8FGC21C[]U[JL3-_$3YKXFEZ\W?-1MWKV3LCI#YM=.X'>>X.RMN]3=L
MOMKM#N_H[>O2.1[/W!U>-H;3S?<-?U;L/-X_.Y?;_P!A25V<J(#55$4=35Y!
M/=>Z20^'OSWPW@W[M[#4^1[7P'4?R.ZUP&8W%W=C(<U6;+JOY@FWOD/USUA-
MNO\ A&X:?;U-V+\7UK=DT-=#CJVGVS5HD51"M$D3>_=>Z==T?$?YDULF!K]L
M4/R-QE/C]A_'#*8#!YOYF#,9'8^],3\X]P=G=P;7J:[ ;MV+MG(/C/B_N>HV
M[%)3XZ:AJ,?'3XA*FL6E@JS[KW2NV%\;/G!B>P.I]O[HQ_:-5T/@.S^RY\"<
M)\IL5@]^]-;?V[\P>RNUNLLINO)9>B["SO;>P>P?C?N# ;0J<7#F%R]%#AY<
M74*M'6'(4ONO=!+LSX1_,N?9VS<1V-M;?.\Y<+_L@_8^ZL5V1\CO[^_Q[M3X
M]_-#L#>_:\^)RN<W]NB7'YW(?';-86%*L&FI,L<:E-.YJ*>%V]U[J^+K/>&;
MWUM.'<&X=CYGKS*-F]UXB3;><K<7DJO[7;NZ,O@,=G::OP]14T55B-U8_&Q9
M.B:ZR?:5<8D17# >Z]T7SYN[5^0&ZNH,.OQVH5W)N; ]F;'W'O7KB/>F+ZZR
M?:_5M!55<&]-@8+?6<P^<P&W<Y60UD-=3G(0I0US8\T,\]-%5-41^Z]U7!N/
MXO\ \Q1-U[5I>JMP;QV9%MGIW<O7F#[)["^35;V36356XOAUO39^S<CV;",?
MC)]Q[BZ[^2AQ%37U.+PE/#5B*/-(<A6R5*TWNO=,?<_Q0^6G;&S]K[KVWTAV
M%U'V/0="_."/";4Q?S%DW9D.K>_^T\)\<TZ8.V^QWW9M>LH]DS[ZZER.8%!2
M23XNE$B5%7 )ZR>C@]U[J_#&2U<V.H)JZFEI*Z:BI)*VDF:GDEI:J2!&J*>5
MZ.6>D:2"4LK&)WC)'I8K8^_=>ZJT_F;=!_)WY ;3W%L'J#;E-V#U[V%\7?DM
MU)7;2'9R]72;1[RW[C-HKU%VOFZF62"'=FTL5C\7F\15TRM-4T#Y5)HZ.JCE
MJ&I_=>Z*KW?\1/G+W'F_D-3Y391_N'O?:>;3%;!G^0)SFTMW[FV-\I?C]V_U
M//C(,S6Q3[:KZ[JC:NX\/$\E/C<?AJUVH8H(\>T=94^Z]T)55T3_ # 5SW<6
MYI,9NC(YW&=MXBJI:2C^2^%HNNODI\;JKY,TW:C["VUL:+:F%R'3_;&T>CY'
MV<<AELJ**=*9\?%5R8[(-64'NO='I^ ?4?8/1GQOH>N.R]N4NU-PT?;WR3W;
M18>FW@-\M!M3M'Y%=H]J;.%?N+Q@U.6BVQO2EBJT,E08ZB-QYI/U>_=>Z.C[
M]U[KWOW7ND'UYNW,[RPV3R>>V1F]@UV/WAO;;,>(SM7BZZ;)8W:NZ\MM_$;L
MH*K$5553/AMX8O'PY*D5RD\4-2(Y$#J2?=>Z0_R+SW:FV.J<YG>D>GZ7O#M:
M@JL9_<S95;N?:6SZ:'(U=;%05.Z)<_O2JH\13':^+JIZQ85=9ZUXQ3(\0F::
M/W7NJBLI_+\[BWCLNLP6WNO5Z7QO=7QY^._2FXL%F.P-J;OW3T1G>D/F-V%W
M]O#L?*9S:WVF!W9N/M; =FUV9M@?+'3;KI8:=C%1L*NG]U[H?)*OY=4O8/?O
M=&+_ )?$;]EXG:F'ZI^/CU_?O0J8FMZ[PW8];4XJIQV.I:\Q[>R<]-G*[=F7
M3(U$!:6GH,/2,VF>N'NO=&@^)46YNN=E=9]&Y#X[;FZ<Q>'ZMRN[ZZIK]];*
MW]2X;=E;V)EX<GMK=.;VE+#0UV_=YG(/N>IGQT+XDS5E5!%(#3@/[KW1S??N
MO=4 8KXN?/3-=LXBO[ P'9='U5G.V^J]Q]A[8V7\MLPU#+M[;F1^:^'[42"9
M]_;9W+N#![]VYV5UQ/#%5SI4R+B(T:FH#CJ:GA]U[KCMKXL_S <])\0J'N+;
M$N]Y>I-U?R_-_5VZ\[WM05$^P_\ 05M;+[2^1^W-T8N*NR@["WAN?<]2=T4.
M:C_B)ST=8D-94453C:82>Z]UL ^_=>ZIY[D^-'R;ROS=W)WKU?B=R8/#Y#L#
MX8TV,WGB.S<9B<-+L#8FV/D;@.\)MS]>#>.)BW?C<8G9^(T8[)44\E<\+/2!
M'A20^Z]T%75'Q0^8V9?XZOWGBNZ,958[NR@;Y-8["?,RIS>P-WX3:?QD[+ZY
MG[8VIA]F'J3+4^TNR>Y,EMG<,V#JON\RU102U-33TTR.:_W7NFK:WPW^7&\=
MO=957R*VKOW<^Z=A?(;K?-]O8_&?*6@R6![?PFS.E_D?U7N7NSHVFPF*ZLR?
M4>0["K^WL16Y3'5^7HLK44E :9KMCZ>7(^Z]T)OQ6Z*[8VKW]M#KS=7>-3W)
MC]A=3]1[M^4]4_96^]S9[:/REZFV]4[5ZXVW+65M<E.^*[1ZU[ HLWF8:A:2
M;*5^R:?*U-)(^=JG/NO=71^_=>ZH&_F([,^7FV<K\O.^\-D=V]>=*[4^.7RM
M2DW?L_Y$9S;T]=15_P /]HKU+F\5MRFS>/SNU=U[2^0^S*Y8J/%QT=/#+7QU
MT+5LV3R1B]U[H+NS.I^V(.T^D.NZ;=O>']T?E9E_E-N?JGI_&_*_>V.RFWJ%
M_ACU2*7/Y#?-#VC+%-1'Y"X;(;LQ<5-D,B< N2>IH(U>IJ,>GNO=&!R'Q2_F
M%OLG>&,S?;&Y-R]L8K9OR?P-;VML_M:MV51]\[;[&^.D>U.B=J87#4^7P4_5
M6^NM.ZVHLD,P(\>,<N'J*RDKI9,Y70)[KW21W#\/_FCO?+[WCR='V9%2]CU?
M<.R\R^\/D=/N#9=/U3V1_+1VCT_'A:W9B=C9W'0XP_,W"2YD0T6.>HHD+5]/
MH65XF]U[HV7Q#Z1^476/:>T,GO*C&#Z=7X][,V;FM@;EW=1;DKNN-_[.Z[Z:
MVI0T/5V:V?N-L;F]FYRLVWFI\GC,]B)Y<5E1)7XG,O!EZK'1>Z]U:+[]U[KW
MOW7NJ\/A?_V4;_-*_P#%U=B__ +?#[W[KW5A_OW7NO>_=>Z][]U[K__3W^/?
MNO=>]^Z]U[W[KW5;G\H?_MW-\9/_  WMZ?\ OT=\^_=>ZLC]^Z]U[W[KW05=
MY[BSVS^E>W=W;6KH<;N;:O6._-S;>KZFC@R-+29O ;6RF6Q<]705)2&MI$KJ
M1#+$S()([J&0D,/=>ZJN^''\Q/?V^-D;IWWW1-0;HV9CMH_ S:6$R5!LT]:=
M@Y#Y;?*[:^VJK<_3M-L7.Y6FJ)>NDR'9>RZ[;FZ*RGQV/JJ3/5215>4AH)*T
M>Z]TZ;G_ )FM3MGO#-9M]E=A9CH7KWH_N2J[NV)A]L;)E[ Z>[-Z&^2NU>H>
MS-Z9C*UN]J!=V[*P.W-R'(1TNWVRE378V-:NDAGFD^WC]U[H=-R?S)]@8BLQ
M VWT=\A^QMO[P['H>INO-][0V?MVCZ^WIOZK[8W-TG)MZCWKOC=VS=NXZNIM
M^[7D4QSU =L=/'6@>%*HTWNO=#%T'W9O_P"3W5'8VX*+;K]$;HVWWMW#TW0#
M)SX/L&JI:3ICMC*=>YG-304-4N$;+Y=-M5J)#Y:BEI*EU8/5Q(&E]U[HJ?2?
MRH[4K^J^F>S^WM_YG(Q=O_,?L+XPXO&; ZRV-%3XO);%^2_>O5VUJK<U=FL_
M35-%M+>>S^M*2FR]1105F2ILM*D]&L-/)(D7NO="%L+^9'M??V/ZWS\70?=6
MTMK]T;2[>SO4&<WI6=1T*;]W/T\E$,EUG24. [-W+78C?NZZEZU,)35RP05T
M>(KIO*L,4;R^Z]T._37RWV9W)W!V5TC0[5WAM?>O6FWJ'=>2&?&W*K%Y/!U?
M8_9G5328_(;<S^<ACKJ;=G5&29Z6?Q3)0U%)*X2666"#W7N@@[,_F0=,]4[[
M[)V#O?:N_P#%OUQM[-[GRFY7H,%7;3.V]K=B]1]9[OW)F<AB<YE*G9VUMKY7
MNK#Y"OK\O!20T>"CJ\A4B&G@5I?=>Z'#L_Y2;.ZMZ!VE\A9=K;MWKM'>F5Z4
MQ&%Q?7M3L3<.5DG[[WML[8.R:U,D=ZT6S,EA1N+?=!]S6T&5K(#32&>G:HC
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M\Q7;6[]X]8;2ZMZZS6[JC=?R*[!^/78..K-Q[4V_OCK+<'7O37;W;F0H]P;
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M=CU]51U6/ZYS/0?5V/W7M^>KVA,(YMVPYC/;@IEDA6>%$B@<,3Y 4]U[HO\
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M[NQ\,[YB&>BRV&,-?'21STDT_NO=&]Z<[5VEWKU/UKW1L*6NFV7VILC;._\
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M&J-O=>]>8"@VML[ U.;W!N.3"[?QD?AQV,&:W5E<WN"NIZ&"T41J:J9HXE5
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MH[$[R^<$G84^TLE@LG+@-S;JV_BM_; J\LN/E;*';%=7/0H<A$R1>Z]U9?\
MRU>MM[=7_!3HKK'L[9N>V5O#;. W?AL]M/>$> ;-TR2[^W=/129:';E;DL$6
MS&)JH:K3"X3QS@-'&;QK[KW5873NSOYA7QP^-75VW]K[=[[SW6FT>I_BGL3M
MOJRDPNQ<MW-USN?;N.[6V?W8OQIQ$69Z_P#[Q;.P<<&QJFJC3-S_ '5'#4SX
M.:IJ&K(9?=>ZN4BB^0.*^'L\&W,G6;S^4&.^/>0CVME^R,3M#:>2W1W32[!J
M1MFNW[A-L5N1V)M[(9?>$=.^4IZ&>7%4TLDJQ.8%!]^Z]U4'O7.?S%,]UE1[
MBV-F/G%M7(9_JCYF[OQ^Q]Q]3=0X?>FR^W=K]5=/U7Q[V%E:C#U7;U3F,-EN
MZ\7N3^&2U>8%/DZ:NJ:=Q_"%H)#[KW2UW'M7YJ-O+N+"[3I?DAC:'N7Y&_(3
M+R5!JI)=M#K'?_\ +4CH^HI\%N?*SY#/]34VT?E!0T>.I$QM7A7Q>59DJE:G
MC\D7NO=!_%B?E[UAD*7L#872GR%E3*_$O^6MUSW77X3:]'F>[JO%;$Q?RZI>
MW8=GG<6]-LQ;N[*Z]WGV#LVKS-/'F5R+8>:K^Q-5+$],?=>Z$RLVO\QMW_('
MXDXWMW8O>O8$?1_R9Z*WWB^S&V]U?@-A9+IK)?"/LKK_ '_O_L7&;;W%)BMN
M]T4'R(WCDEW%B\;+,E-15%'_  I:C'ZK^Z]T=7YS[8[[RF>^*NZ.@\?N[+YK
M8_;_ &17Y3&X3/5^,V<,AFOBYWSMWJW*=LXFBRN/&<ZWQ_=N1VTN2+QU7V<,
MS2^/2'8>Z]TY?#.?Y,5N2WIE.Z#OJFV+ENM/CY78#!]ITF$I]^;;[W;;6Z(/
MDOAJ>7"QI'5["CS4&!EQSHTV-_B,N2_A<K8S[94]U[I/=D;2^7U!WYW'#U?G
M=Q9OK[=O55!W!U'DMR;GH*+8^Q.]NO-L[OV0O0V4Q\$:YZ78':NXL[MG=,[G
MR1H,7F8'EC5Z*(>Z]T3[(;<^=^ZLIT7NNIH.\:S:>![B^+V\:O:VYLG28+=F
MW.R*KX[?(K:_?M!OZDVSDL5'NCX_XGN_+=?5DJ+_ !"@IZ@Y2IQ6O%PT_C]U
M[HYO\OG,_)+<VQMV[E^2=+W5MS=F2GV70Y'K[N/9_7FW(]F]@8':5)B>V).L
M\WL??.^:C>?6>Z-WTYR..K:B:FH@)F7'00TQ\$/NO=%B[MVS\A]]_(VBQ^?V
M[WAN?JW8/\S#XZ[XZ_KL;MN7'X'"](Q_$2MQV_<A%D=K8W#SY[KO"=W92J@J
MI,D:ZMCJ:EM+O2JC1^Z]T<WYL[.W]E>I.JZ;J7&;[D;9/R=^)^ZMQ;?ZGRM5
MM[-S]4;/[SV)5=@T$5#B<EAFRVW<=LN&IGJL8CLLM+3'3$[(J^_=>ZJ7Z:I/
MGQT!USE\'U]UG\@,ELY-N93?&>ZO79FW*;);>II_YA_:&2[ Q/1\.1KMB0/V
M1N3XP[NBRL&+FST!KZ6*-J2>'*"-3[KW0Q];5W\P;"]V=:R[@W=\KMZ=?T':
M_P 6,56)O[JKK+;&-RO56^NI.ZHNZ:S?F)V-B<G24E9M#<J[0;(3KF:JKQ^6
M4.)+25L*>Z]T=?\ F+9CY,X[I['4'Q:PW:E;V%FO])]-1YKJZ':5;)M[<5%T
M3VEE.KI=UXO<;4];6;=R?;M%@J96I:JCI(:YZ<Y1YL8:JCJO=>Z)!E-V?S+3
MO;>>Z-@T_?.4SV3W-WKB=@; W_LO8N&ZDHL/6?R^^O\ >G5;Y*KBVQCHL?34
MGS:H<AAJ/(5F2D9%EGIZJ1J)S/[]U[HU_P#+YVOOS&[_ /FCOO=G7G=>Q\%W
M#VSTQO[95=WO1[<H-\[BI:3XK=)["W6N2I,)DJN>&OV_OG9>1HZ@5$,2$JII
M7EIC$5]U[HDO?_2_R9K?D-V+F\!@_DM!5XKY6=^]H]6]G[48[MIMJ[#W-_*Y
M38&QH^MZW+C=%%MBCKOD)%48B7')0PH*V2,.@@8RCW7NG#>&^?YF^X]J]R5,
M6-^3&P.S,%\5\CO+JEM@]5=2YCKO?^YMR_%SK\X/;5=4[EW#E\IM;O79ORJ@
MS8J<2NUE+TDUC5/B&CDI/=>Z-+U?_LV^.^7F#V+N;)_)"?I+;U)B]X[/WYG-
MJ]<9_KSL[KK<W4-MU;,[FW5+N/;^Z-C]K[-[YR-344--2;72N;%4F-@CJ9*%
M\FL/NO=1/YB6\>]:/N#XZ]5]+=H=O[&J^UNGOF5/28;J'%;-R&7S/9_7>Q>O
ML_TYE:N;<VU<_+24F(W=D3!+Y9H<-+'6E,DOVS-)'[KW1<>S=R_S/YL7\EJ>
M1>_=I]M;!Z[K&Z^DZ8ZWZNW5T9VJ=PQ]-R;/R/7>X-S;@W/N&FW[M;-T6YZ;
M)8Q]MT<Q@K:R2IJ&I(\14I[KW0S;XE^??7V^>Q]O];)V;W#U12Q]<5&(W=G3
MC,!VO@=AXSL'H"F[>V_B,=D\>FR.TM[[FZLK-Z9+:><Q\^#S-#D8*W'9;%2S
M#!UK^Z]T"^X:K^91@NQ,M/#N7Y#9C8NVLUL/<75&/PVQMLY"EW'L&3Y\T.)F
MP_:DO]SAN+)[L/Q R-?)EZ2>JIZH8BFHZF18LZLVKW7NHF7C^:'96:W)0=H=
M4=_Y78U%\FOY?':.P\/O';.T<[7[-RW5W\PG?N8[UK\=EMEM3TM9A,-T3M7:
MF526CHJ7&G&(AI%GJY:NIK?=>Z<^@]E_)+8$OQ_ZUV_E>P.O\%W+V%\P-E=E
M]85&4Q>T,WTM@?\ 9P>VODCL/Y%;:VW5T,^2^V["ZD2OVG-*C20K5Y[!NL4;
M15X?W7NK /YAF_=\=<=)[!SVP][;TV+D,G\J?B+L3/5^P,=@LIN?,;&[.^1?
M777&^MM8ZCSF!W$6GS&U=TU2QM10QY!)UC:"0,"C^Z]U7^U!_,\PYW:N&W1W
MWO'*]??&K?\ NSI_$9[$]6XK'=E;FH_DUW#A^O-O=AYH[<P>+R7?.3^)>2V]
M428^LR>,Q9W)34DU4U+*M<3[KW0CX;-_S! O4NX.NHNW=W8O<T79$\FQ?D5L
MK"]1;LV(N[-P[PR'7-?NO/[2W)V;@\YA^L!3T.+R^!W-)3Y[*;=:EKL?EFRX
MJJ2I]U[H"LAF?YCFZNLMFYFARGS:V)G=TX[Y#R[XV1E.K^G\9N#8.^]J_$EU
MV?C<-G,#7]N569VCG_D_AX:K 5K5]-15L^2J*>&$X80+![KW1TOAINWM?KO,
M]IK\A-H]\+NCY#?);:-=L[(;BH<EG]L8>BW'\1^JMS5ZT=*<Q7?Z/]GXC?>S
M-R8FHI8J:"FQF4$5.T:0LDH]U[H8?F)4?(P9?K;&=0Q[\INO\UM+O>@WON+J
MJ'$5>_\ ;/;"[(QU3\=,B:++150GV/+N>#*Q9$^":B7)OBQD@,4U<P]U[HI7
M2V4^?M+\E>NJGN;*]QY' R]WTNS^S,)BMF;<CZ$I>O<E_+YV7N'=.>VS7T6U
M*7--MC%_./&5U!A\E-7S5J032PNTE%*93[KW1COFILOM#</:OQ6S^T,%V-N;
MK_;\OR8Q/:&$V57ULV"F_OG\<MZ878=3OO:5)DZ5-SXG^],8I*5I*>K%+65J
M+I43L3[KW56G6*?S%^H^F^M^I,/MOY7IUCC>H?BKM+*Y7:W7>P\[VWTQO',?
M$:7:>:CZWV_N;-=:8C<>P>K>]-NXYL[0S5>06BJIHW>.KP\F0"^Z]U=I\E).
MZ,;\-.ZI>LLGO%OD-0?'G>LFP,ILK [:R&]*SN2EV%7-M>3"[=JZ+<6TI,ID
M=ZQP+]NT510IY& 81@2#W7NJH=V[B_F'[+SF\<QLU_F1V/C:+M#M'";<VP=K
M=<453D.K-V? C![YQN9Q>1W'U]'AZ?.;5^:B5&-P-3D$J/LXU>@-/44+J&]U
M[H/>TNO?GYV5L/L Y+#?*BJW-%T/_,[ZRZVJ<#N*IV'55<N0[HZ;WS\4YLKC
M<;OE)$S6XNE,;E\1BLCD)ILI430&AKYQ4NVOW7NAG[NW7_,0K:KY91]>T/RB
MV+EMD];[TR?QS3977'6&[=@]D[6W%M'K!^H*>/<.[]R[HW+0]Y;-WI19JFSF
M-FVY%42?=UCU-5)0+CJB'W7NCK=,TGR8VE\I]P[2SV2[![+^-TVQJZ?;&^]_
MF/;NZMHY^BQ/64U%A=RTB8D;;[0Q^ZZ_)9JHQN7QIP&?PM33UV.S.,JJ9<77
MCW7NK"/?NO=>]^Z]U7A\+_\ LHW^:5_XNKL7_P" 6^'WOW7NK#_?NO=>]^Z]
MU[W[KW7_T=_CW[KW7O?NO=>]^Z]U6Y_*'_[=S?&3_P -[>G_ +]'?/OW7NK(
M_?NO=>]^Z]TC^P-^;4ZMV)O+LO?F8@V_LGK_ &OG=Y[OSM2LKTV&VWMK&5.8
MS>4J%A224P4&.HY)7TJ3I4\>_=>Z+WD_FW\><-E-@X/([LR$.;[(J]GT>W<3
M%@,G6UJR=B[LSFQ.N*NO2@@JHZ;!=@[PV[54.(RJM)B:H(M3]RM'(E2WNO=+
M7X_?('!_(;X\[!^1FW-J;NP&W>P]F'?.%VMN"CHDWC%BI5JIJ.EJ:&CKJBA.
M2KJ:G5HXTJ&0F11KMZO?NO=%,^.7\PC;G8/7?7O8G<M9A=E1=QX'X[[QVSM_
M [5WA+/U)C?D[3T^%ZBVKW1N U6>PE-E]^=AT]5CL%E8_P"'TN1BEI#-2T9G
MB,_NO=!WW7_->V-C^I]Y[P^/&R-[[VRU'\<OD7\@]D;M['ZUW[L'JS+XSXV5
MFPL?O+&UO]XJ3:^]:[SY/?4="DE%1M'!7020S.CC2?=>ZL7Z=[NV+WEA]U9;
M8TV=638N_=Q=8[SP^Z-K[AV;N#;>]MKK03Y/$9+!;GQV,R42RX[+4=;2S"-H
M:FBK(9HV97]^Z]T F:_F&?%3;U-45^5WWF5QS4&(S&WLAC=A;YW#2;YV_F.X
ML#T#'N383;<V_EI-U[?Q_;VZ<7AZVKIE:*C;)T53*5HJREJ9O=>Z&[8O?FPN
MRNH<KW5LU=RY+:V%/9%)D\16[:RFWMZ4.X.I=Q;EV?OS:5=M/<L.'R>-W/@]
MV;0K\>U/4B%7GA!5S$Z2'W7NB-]9_P S/:FZ.S-JT>_-N9+KSJ7M_H+X8=N]
M2YZOVKNFOS>#SWRVR_<V%Q&VNY,SADR^R]ET,^2ZXQ]-BZV6>"FFJ<CHDEY!
M3W7NCH]'_)OISY%2[N@ZGW--N&392;0J\R9,3E*"!\/V!MU-U;'W!BJRLI8J
M',87<V!<S024\LCQ/')#4)#/&\8]U[H%LQ_,8^+."C[#GR6Z-Y4E-UENCL'9
MFXJBMZN[%Q<==N;J2/<%5VKB=H#,;<QTF]ZOK[&[:GJ\@F)6L9J>:E-.)VK*
M5)O=>Z65'\VN@*K'[ZS,N?SV+P/6NY]P;:WQGLUM3-XG%[>CV[U1MWNM]U5D
MU;2PSML?-]=[OQ%7B\LD;TF2FR=-30,]1*(O?NO=(:3^9#\5(:V3&R;GWN:_
M'T';>7W+%2]2]F9*AV7@.B<KMG$]M;DW=G\5M>MVSB-N[)EWGB9ZJM^]>G:B
MR,%3&SP.)/?NO=+3(?./XX8B7KR#*;SJ:.H[-J-FQ[<@&#RE;(*'L7?#];[
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M#%"=*::03TN0AJ:<S0%I%]U[HTOOW7NO>_=>ZKP^%_\ V4;_ #2O_%U=B_\
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ML'9O5.R.PNM,G_=? XJ@R/5N]<5TGMB>JQ\L+U5-D<5%5T5723ZG/NO="_\
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M-D.DOG[V)N?>&\)=\]=[U^4.T.@=IR=)T-!287&]9KN;(=4[CV?@AM.CW7W
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M?)S;F^-P;+VE5[#V_L>?(;3JZ]MCST^'F-7D(<Y+Y%C,$L/A?W7N@O\ E/\
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M2*71_=>Z!?,_R)?C_N>'Y/-NWO\ ^3&[<U\K.L8^L.PMT[@S?659N.CI,/\
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M^_.O_P"YV]^Z]U[_ (=!^+W_ #S_ ,N__3?OSK_^YV]^Z]U[_AT'XO?\\_\
M+O\ ]-^_.O\ ^YV]^Z]U[_AT'XO?\\_\N_\ TW[\Z_\ [G;W[KW7O^'0?B]_
MSS_R[_\ 3?OSK_\ N=O?NO=>_P"'0?B]_P \_P#+O_TW[\Z__N=O?NO=>_X=
M!^+W_//_ "[_ /3?OSK_ /N=O?NO=>_X=!^+W_//_+O_ --^_.O_ .YV]^Z]
MU[_AT'XO?\\_\N__ $W[\Z__ +G;W[KW7O\ AT'XO?\ //\ R[_]-^_.O_[G
M;W[KW7O^'0?B]_SS_P N_P#TW[\Z_P#[G;W[KW7O^'0?B]_SS_R[_P#3?OSK
M_P#N=O?NO=>_X=!^+W_//_+O_P!-^_.O_P"YV]^Z]U[_ (=!^+W_ #S_ ,N_
M_3?OSK_^YV]^Z]U[_AT'XO?\\_\ +O\ ]-^_.O\ ^YV]^Z]U[_AT'XO?\\_\
MN_\ TW[\Z_\ [G;W[KW7O^'0?B]_SS_R[_\ 3?OSK_\ N=O?NO=>_P"'0?B]
M_P \_P#+O_TW[\Z__N=O?NO=>_X=!^+W_//_ "[_ /3?OSK_ /N=O?NO=>_X
M=!^+W_//_+O_ --^_.O_ .YV]^Z]U[_AT'XO?\\_\N__ $W[\Z__ +G;W[KW
M7O\ AT'XO?\ //\ R[_]-^_.O_[G;W[KW7O^'0?B]_SS_P N_P#TW[\Z_P#[
MG;W[KW7O^'0?B]_SS_R[_P#3?OSK_P#N=O?NO=>_X=!^+W_//_+O_P!-^_.O
M_P"YV]^Z]U[_ (=!^+W_ #S_ ,N__3?OSK_^YV]^Z]U[_AT'XO?\\_\ +O\
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%NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g259893g20s20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g259893g20s20.jpg
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MH]L\>5P R%4N, 82H)BVHQ[BO^:5[\%@N.)=7KQJ]KUJ;0FN,M<,04;#]+;
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= < < < < < < < < < < < < < < < < < __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
